<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t791lif2fhry st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file â€¢ PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="1_PDFsam_General Pharmacology.pdf">1_PDFsam_General Pharmacology.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">4.2MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> 1_PDFsam_General Pharmacology.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-administration">Drug administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="introduction">introduction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Factors to consider in drug administration</p>
<ul>
<li>In the administration of drug,the drug has to move from the external environment to the internal environment</li>
<li>The drug has to cross a cell membrane for it to be detected by cell,so physiologically a drug has to cross to a bloodstream/cellmembrane.</li>
<li>The factors inlude the following,</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Cont,,,,</p>
<ul>
<li>1.convinience to the patient</li>
<li>2.speed by which the drug is required by the site of action e.g emergency and elective</li>
<li>3.the length of time the drug should be available at the site of action</li>
<li>4.which organ of the body should the drug not reach</li>
<li>5.the cost of the drug</li>
<li>6.which other drugs are being administered</li>
</ul>
<p>Common used routes</p>
<ul>
<li>Oral administration</li>
<li>The dosage forms that are administerd orally include;tabs,capsules,caplets,mixtures,immersion s,powders</li>
<li>Absorption takes place from the git</li>
<li>Advantages</li>
<li>It is extremely convinient,self adm is possible,avoids fear of needles,the dosage formulation can be formulated in to slow release,</li>
</ul>
<p>Cont,,,,,,</p>
<ul>
<li>(eg capsules with different colour granuels,short and long acting),the git is a huge surface area for absorption,the dosage forms are easy to manufacture,it is safe,painless,portable,mask the taste,easy to reverse the effects incase of overdose,the drugs can be formulated in a way to protect them from gastric juices eg hcl</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li><strong>Disadvantages</strong></li>
<li>Absorption can be variable depending on the chemical nature of drug the ionization, solubility of the drug and ion structure</li>
<li>Absorption depends on stomach contents for instance antacids or milk prevent absorption of tetracycline(anti-biotic)</li>
</ul>
<p>Cont,,,,,,</p>
<ul>
<li>Absorption depends on the rate of peristalis and stomach emptying</li>
<li>There is slow onset on action,how soon the action eg conclusive child wont be right route</li>
<li>There is likelyhood of aspiration of drugs in to the lungs</li>
<li>The drug is exposed to food and drug interaction</li>
</ul>
<p>Cont,,,,,,,,,</p>
<ul>
<li>It depends on the compliance of the patient</li>
<li>It can't be used to patient who has undergone surgery</li>
<li>It cause staining of tooth</li>
<li>There tends to be drug drug interaction</li>
<li>NB.first pass metabolism-from git,absorption takes place and the drug is passed through the portal system to the liver then the rest of the body distribution</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>IV (intravenous)</li>
<li>The drug is directly administered to the vein</li>
<li>e g penincillin,paracetamol,insulin,diclofenac,hep arin,glucose.</li>
<li>Advantages</li>
<li>Rapid onset of action</li>
<li>Lower dose is required compared to oral</li>
</ul>
<p>Cont,,,,,,</p>
<ul>
<li>Drugs which are irritant when administered</li>
</ul>
<p>IM can be given IV</p>
<ul>
<li>Titration of the drug is possible but in oral is</li>
</ul>
<p>hard to titrate the tab</p>
<ul>
<li>A large volume of fluid can be administered</li>
<li>No absorption is required</li>
<li>There is high bioavailability(the</li>
</ul>
<p>fraction/concentration of drug that is available</p>
<p>Cont,,,,</p>
<ul>
<li>At the site of action/systemic circulation compared to that was administered.eg take 500mg paracetamol,300mg might be available in circulation.300/500 equals 0.6 or 60%</li>
<li>Disadvantages</li>
<li>Requires trained personnel</li>
<li>It can cause tissue damage</li>
<li>Accidental overdose has serious concequences</li>
</ul>
<p>Cont,,,,,</p>
<ul>
<li>It can cause fluid overload</li>
<li>It can cause electrolyte imbalance Na,K,Ca</li>
<li>It can cause infection at the site of injection</li>
<li>It is painfull less compared to IM</li>
<li>There is fear of needles</li>
<li>It can cause phlebitis</li>
<li>It can cause embolism</li>
<li>It can lead to hypothermia and clot</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Intramuscular IM</li>
<li>Drug is administred to the muscles</li>
<li>Advantages</li>
<li>Similar to IV,only easy to administer to IV</li>
<li>disadvantages</li>
<li>painfull</li>
<li>self administered not possible</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It can form an obsess at the site of injection</li>
<li>Absorption can be variable</li>
<li>Topical application</li>
<li>Directly to the surface</li>
<li>Eg ointments and inhalers(drops,gargle,lozenges{sweets},enema {intrarectal},pessaries{intravaginal},powders, suppositories{rectum}</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Advantages</li>
<li>It is good compliance</li>
<li>The drug is applied directly on the affected site</li>
<li>It acts fast at site of action</li>
<li>It is self convenient</li>
<li>Disadvantages</li>
<li>There is wastage</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Instruction may not be clear</li>
<li>Absorption may occur in the blood stream when not required</li>
<li>They could be irritant to the openings</li>
<li>Staining of clothes</li>
<li>Bad smell</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inhalation</li>
<li>The drug is applied in the respiratory system</li>
<li>Advantages</li>
<li>Local action at the target organ/lungs</li>
<li>Rapid absorption can take place therefore there is rapid onset of action</li>
<li>There is no first pass action</li>
<li>A lower dosage is required to oral</li>
</ul>
<p>cont</p>
<ul>
<li>You can regulate the drug</li>
<li>You can use it on unconciuoness patient</li>
<li>Use it on incorporate patient</li>
<li>Disadvantages</li>
<li>Skill is required in using the inhaler gadget</li>
<li>The cost of the gadget may be high</li>
<li>You require patient corporation at home</li>
<li>The airway must be clear</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The rate of onset is slower than IV and IM</li>
<li>Its expensive compared to oral route</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="example-of-plasma-conce-time-curve">Example of plasma conce time curve<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#example-of-plasma-conce-time-curve" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-66d1af88.jpeg" alt="img-0.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="topical-route">Topical Route<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#topical-route" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Skin (including transdermal patches)</li>
<li>Eyes</li>
<li>Ears</li>
<li>Nose</li>
<li>Lungs (inhalation)</li>
<li>Vagina</li>
</ol>
<p>Specialized infusion</p>
<ol>
<li>Intrathecal: inject onto CSF.</li>
<li>Intrapleural: injected onto pleural cavity.</li>
<li>Intraosseous: injected into rich vascular network of long bone.</li>
<li>Epidural: inject to epidural space.</li>
<li>Intraarticular: injected onto joint.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Testing of the new drugs before use</p>
<ul>
<li>Not teratogenic ( causes birth defect)</li>
<li>Carcinogenic ( causes cancer)</li>
<li>Toxicity studies not harmful to body system.</li>
<li>It should be specific in action and its mechanism of action understood as complitly as possible.</li>
<li>Optimal route of administration.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="essential-drugs">Essential drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#essential-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="introduction">introduction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="introduction">introduction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In response to the vast range of drugs that had become available, the world health organization formulated a model core list of drugs essential and relevant to health care needs</li>
<li>The essential drug concept was formalized with the publication of the first WHO model essential drug list in 1977.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont......<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Kenya was one of the first countries to recognize the importance of the concept and made its own list in 1981 based on the WHO model list.</li>
</ul>
<p>Cont,,,,,</p>
<ul>
<li>The Kenya essential drugs list was for the levels of health care</li>
<li>But was initially used for the rural health institutions</li>
<li>And also formed the basis of the drug kits</li>
<li>In the late 80s the MOH promoted the list at the secondary and tertiary health care facilities</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont.....<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In 1992 the ministry decided to revise the list and to vigorously implement the revised KEDL as the basis for managing drug supply in the public health sector</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="definition">definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Essential drugs are those that satisfy the health care needs of the majority of the population</li>
<li>They should therefore have the following characteristics</li>
<li>A)be available all the time</li>
<li>B)be in adequate amounts</li>
<li>C)appropriate dosage forms</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="choices-of-essential-drugs">Choices of essential drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#choices-of-essential-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The choice of such drugs depends on many factors such as</li>
<li>-the pattern of prevalent diseases</li>
<li>-the treatment facilities</li>
<li>-the training and experience of the available personnel</li>
<li>-the financial resources</li>
<li>-genetic, demographic and environmental factors</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="selection-of-essential-drugs">Selection of essential drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#selection-of-essential-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sound and adequate data on efficacy and safety are available from the clinical studies and for which evidence of performance in general use in a variety of medical settings has been obtained.</li>
<li>Each selected drug must be available in a dosage form in which adequate quality, including bioavailability, can be assured;its stability under the anticipated conditions of storage and use must be established.</li>
</ul>
<p>Cont.....</p>
<ul>
<li>Where two or more drugs appear to be similar in the above respects,the choice between them should be made on the basis of careful evaluation of the relative;efficancy,safety,quality,price, availability.</li>
<li>In costcomparisons between drugs,the cosst of the total treatment,and not only the unit cost of the drug,must be considered.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Cont,,,,</p>
<ul>
<li>The cost/benefit ratio is a major consideration in the choice of some drugs for the lists</li>
<li>In some cases the choice may be influenced by other factors such as comparative pharmacokinetic properties</li>
<li>Local considerations such as availability of facilities for manufacture or storage</li>
<li>Most essential drugs should be formulated as</li>
</ul>
<p>Cont,,,,</p>
<ul>
<li>Single compound.</li>
<li>Fixed ratio combination products are acceptable only when the dosage of each ingredient meets the requirements of a defined population group and when the combination has proven advantage over single compounds administered separately in therapeutic effect,safety or compliance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="metabolism-and-excretion-of-drugs">Metabolism and Excretion of Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metabolism-and-excretion-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="definition">Definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drug metabolism is the enzymemediated conversion of a lipophilic compound into a more water soluble one and hence more easily excreted.</li>
<li>Liver is the main organ of biotransformation of xenobiotics.</li>
<li>The metabolism occurs mostly within the endoplasmic reticulum of the hepatocytes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="first-pass-metabolism">First pass metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#first-pass-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>All drugs absorbed from the GIT get to the liver through the portal blood system where;</p>
<ul>
<li>drug passes unchanged</li>
<li>All or some drug is metabolised to inactive metabolite all Glycerly Trinitrate(GTN) is inactivated if swallowed?</li>
<li>Drug is converted to an active metabolite.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="why-does-drug-metabolism-occur">Why does drug metabolism occur?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#why-does-drug-metabolism-occur" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Most drugs are lipophilic chemicals, which favour their absorption from the GIT.</li>
<li>Lipophilic compounds will cross lipid cell membranes and so are readily reabsorbed in the kidney.</li>
<li>The body must make them hydrophilic (water soluble) to promote their excretion in urine.</li>
<li>This is where drug metabolism comes in.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phases-of-drug-metabolism">Phases of Drug Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phases-of-drug-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Phase I metabolism</li>
<li>Phase II metabolism</li>
</ul>
<table><thead><tr><th>Phase I</th><th>Phase II</th><th>Excretion</th></tr></thead><tbody><tr><td>Oxidation</td><td>Glucuronidation</td><td></td></tr><tr><td>Reduction</td><td>Methylation</td><td></td></tr><tr><td>Hydrolysis</td><td>Sulphation</td><td></td></tr><tr><td>Hydration</td><td>Acetylation</td><td></td></tr><tr><td></td><td>Glutathione Conjugation</td><td></td></tr><tr><td></td><td>Amino Acid Conjugation</td><td></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-i-metabolism">Phase I metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Oxidation</li>
<li>Reduction</li>
<li>Hydrolysis</li>
<li>Hydration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-i-metabolism">Phase I metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Oxidation and reduction reactions create new functional groups</li>
<li>Hydrolysis and hydration reactions expose masked functional groups.</li>
<li>Phase I reactions often produce a biologically inactive compound but may activate a prodrug.</li>
<li>A prodrug is any substance that is metabolized in the body to yield a pharmacologically active substance but is itself devoid of such activity e.g.</li>
</ul>
<p>Inactive (prodrug)</p>
<ul>
<li>Prontosil Red</li>
<li>Enalaprilat</li>
<li>Codeine</li>
</ul>
<p>Active
Sulphanilamide
Enalapril
Morphine</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="oxidative-reactions">Oxidative Reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oxidative-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Most oxidative and some reductive reactions are carried out by the enzymes cytochrome P450 (often abbreviated simply as P450 or CYP)</li>
<li>Other enzymes involved in drug oxidation include:</li>
<li>Monoamine oxidase (MAO)</li>
<li>Alcohol dehydrogenase</li>
<li>Aldehyde dehydrogenase</li>
<li>Amine oxidase</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="aromatic-hydroxylation">Aromatic Hydroxylation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aromatic-hydroxylation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Example is <strong>lignocaine hydroxylation</strong>: Lignocaine undergoes <strong>3-hydroxylation</strong>.</li>
<li><strong>Oxygen</strong> is inserted in the <strong>3-position</strong> to produce a <strong>hydroxylated product</strong> from local anaesthetic lignocaine.</li>
</ul>
<p><img src="assets/images/image-20251214-cb78eed0.jpeg" alt="img-1.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="reduction-reactions">Reduction Reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reduction-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Compounds are reduced by the addition of hydrogen or the removal of oxygen.</li>
<li>Examples of such include:</li>
</ul>
<ol>
<li>Azo-reduction</li>
<li>Nitro-reduction</li>
<li>Epoxide-reduction</li>
<li>Reductive defluorination</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hydrolysis">Hydrolysis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydrolysis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Involve the addition of water with the formation of two or more metabolites</li>
<li>Include:</li>
</ul>
<ol>
<li>Amide hydrolysis</li>
<li>Ester hydrolysis</li>
<li>Hydrazide hydrolysis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hydration">Hydration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Involves the addition of water without substrate breakage</li>
<li>Example is benzo-[a]-pyrene Epoxide hydration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Phase II metabolism involves conjugation - that is the addition of a second, usually relatively large and water soluble chemical grouping to the phase I metabolite (parent drug)</li>
<li>The additions include:</li>
</ul>
<ol>
<li>Glucuronic acid</li>
<li>Sulphate</li>
<li>Acetyl group</li>
<li>Amino acids</li>
<li>Glutathione</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Characteristically, conjugation reactions:</p>
<ul>
<li>Substantially increase water solubility</li>
<li>Abolish pharmacological activity</li>
<li>Increase the molecular weight sufficiently enough to sometimes allow biliary excretion
Although there are exceptions to these rules, they apply in the majority of the cases.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The following comprise phase II reactions:</p>
<ul>
<li>Glucuronidation</li>
<li>Methylation</li>
<li>Sulphation</li>
<li>Acetylation</li>
<li>Amino acid conjugation</li>
<li>Glutathione conjugation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="excretion-of-drugs">Excretion of Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#excretion-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Excretion is a process whereby drugs are transferred from the internal to the external environment, and the principal organs involved in this activity are the kidneys, lungs, biliary system, and intestines</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="renal-excretion">Renal Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#renal-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Kidney is the primary organ of removal for most drugs, especially for those that are water soluble and not volatile.</li>
<li>The three principal processes that determine the urinary excretion of a drug are:</li>
</ul>
<ol>
<li>Glomerular filtration</li>
<li>Tubular secretion</li>
<li>Tubular reabsorption (mostly passive backdiffusion).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="biliary-excretion">Biliary Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biliary-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Biliary excretion plays a major role (5-95% of the administered dose) in drug removal for some anions, cations, and certain un-ionized molecules, such as cardiac glycosides.</li>
<li>In addition, biliary elimination may be important for the excretion of some heavy metals.</li>
<li>On the other hand, most drugs that are secreted by the liver into the bile and then into the small intestine are not eliminated through the faeces. Why?</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pulmonary-excretion">Pulmonary Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pulmonary-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Any volatile material, irrespective of its route of administration, has the potential for pulmonary excretion.</li>
<li>Certainly, gases and other volatile substances that enter the body primarily through the respiratory tract can be expected to be excreted by this route.</li>
<li>No specialized transport systems are involved in the loss of substances in expired air; simple diffusion across cell membranes is predominant.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sweat-and-saliva">Sweat and Saliva<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sweat-and-saliva" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Excretion of drugs into sweat and saliva occurs but has only minor importance for most drugs.</li>
<li>The mechanisms involved in drug excretion are similar for sweat and saliva.</li>
<li>Excretion mainly depends on the diffusion of the un-ionized lipid-soluble form of the drug across the epithelial cells of the salivary glands membrane.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk">Milk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Many drugs in a nursing mother's blood are detectable in her milk.</li>
<li>The ultimate concentration of the individual compound in milk will depend on many factors, including:</li>
</ul>
<ol>
<li>The amount of drug in the maternal blood</li>
<li>Its lipid solubility</li>
<li>its degree of ionization</li>
<li>The extent of its active excretion</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk">Milk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A highly lipid-soluble drug should accumulate in milk fat.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk-very-important">Milk: Very Important<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk-very-important" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Breast-feeding should be discouraged when inherent drug toxicity is known or when adverse pharmacological actions of the drug on the infant are likely.</li>
<li>Infant drug exposure can be minimized, however:</li>
</ul>
<ol>
<li>Through short intermittent maternal drug use and</li>
<li>By drug dosing immediately after breastfeeding.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-distribution">Drug distribution<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drug distribution in the body is a process in pharmacokinetics and is taking place continuoslly</li>
<li>A drug will be highly distributed in the body if it has the following properties</li>
<li>1 high lipid solubility</li>
<li>2 if it has a lower plasma protein binding</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>3 a drug that has a high capillary/blood vessel penetration ability will be highly distributed</li>
<li>4 a drug will be highly distributed if high blood perfusion rate is high</li>
<li>5 if it has a specific transport mechanism which assist to move across the cell membrane</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">Cont,,,,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>6 if specific tissues in the body allow it to be permiable i.e tissue permiability increase in distribution eg bbb prevents the drug to enter the brain</li>
<li>NB organs which do not have preventive barrier will easily accumulate the drug.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cont">cont<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drugs will be less distributed in the body if opposite of the above occurs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-end">The End<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-end" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="metabolism-and-excretion-of-drugs">Metabolism and Excretion of Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metabolism-and-excretion-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="definition">Definition<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definition" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drug metabolism is the enzymemediated conversion of a lipophilic compound into a more water soluble one and hence more easily excreted.</li>
<li>Liver is the main organ of biotransformation of xenobiotics.</li>
<li>The metabolism occurs mostly within the endoplasmic reticulum of the hepatocytes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="first-pass-metabolism">First pass metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#first-pass-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>All drugs absorbed from the GIT get to the liver through the portal blood system where;</p>
<ul>
<li>drug passes unchanged</li>
<li>All or some drug is metabolised to inactive metabolite all Glycerly Trinitrate(GTN) is inactivated if swallowed?</li>
<li>Drug is converted to an active metabolite.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="why-does-drug-metabolism-occur">Why does drug metabolism occur?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#why-does-drug-metabolism-occur" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Most drugs are lipophilic chemicals, which favour their absorption from the GIT.</li>
<li>Lipophilic compounds will cross lipid cell membranes and so are readily reabsorbed in the kidney.</li>
<li>The body must make them hydrophilic (water soluble) to promote their excretion in urine.</li>
<li>This is where drug metabolism comes in.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phases-of-drug-metabolism">Phases of Drug Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phases-of-drug-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Phase I metabolism</li>
<li>Phase II metabolism</li>
</ul>
<table><thead><tr><th>Phase I</th><th>Phase II</th><th>Excretion</th></tr></thead><tbody><tr><td>Oxidation</td><td>Glucuronidation</td><td></td></tr><tr><td>Reduction</td><td>Methylation</td><td></td></tr><tr><td>Hydrolysis</td><td>Sulphation</td><td></td></tr><tr><td>Hydration</td><td>Acetylation</td><td></td></tr><tr><td></td><td>Glutathione Conjugation</td><td></td></tr><tr><td></td><td>Amino Acid Conjugation</td><td></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-i-metabolism">Phase I metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Oxidation</li>
<li>Reduction</li>
<li>Hydrolysis</li>
<li>Hydration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-i-metabolism">Phase I metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Oxidation and reduction reactions create new functional groups</li>
<li>Hydrolysis and hydration reactions expose masked functional groups.</li>
<li>Phase I reactions often produce a biologically inactive compound but may activate a prodrug.</li>
<li>A prodrug is any substance that is metabolized in the body to yield a pharmacologically active substance but is itself devoid of such activity e.g.</li>
</ul>
<p>Inactive (prodrug)</p>
<ul>
<li>Prontosil Red</li>
<li>Enalaprilat</li>
<li>Codeine</li>
</ul>
<p>Active
Sulphanilamide
Enalapril
Morphine</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="oxidative-reactions">Oxidative Reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oxidative-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Most oxidative and some reductive reactions are carried out by the enzymes cytochrome P450 (often abbreviated simply as P450 or CYP)</li>
<li>Other enzymes involved in drug oxidation include:</li>
<li>Monoamine oxidase (MAO)</li>
<li>Alcohol dehydrogenase</li>
<li>Aldehyde dehydrogenase</li>
<li>Amine oxidase</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="aromatic-hydroxylation">Aromatic Hydroxylation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#aromatic-hydroxylation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Example is <strong>lignocaine hydroxylation</strong>: Lignocaine undergoes <strong>3-hydroxylation</strong>.</li>
<li><strong>Oxygen</strong> is inserted in the <strong>3-position</strong> to produce a <strong>hydroxylated product</strong> from local anaesthetic lignocaine.</li>
</ul>
<p><img src="assets/images/image-20251214-f76d219c.jpeg" alt="img-2.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="reduction-reactions">Reduction Reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reduction-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Compounds are reduced by the addition of hydrogen or the removal of oxygen.</li>
<li>Examples of such include:</li>
</ul>
<ol>
<li>Azo-reduction</li>
<li>Nitro-reduction</li>
<li>Epoxide-reduction</li>
<li>Reductive defluorination</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hydrolysis">Hydrolysis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydrolysis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Involve the addition of water with the formation of two or more metabolites</li>
<li>Include:</li>
</ul>
<ol>
<li>Amide hydrolysis</li>
<li>Ester hydrolysis</li>
<li>Hydrazide hydrolysis</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hydration">Hydration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Involves the addition of water without substrate breakage</li>
<li>Example is benzo-[a]-pyrene Epoxide hydration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Phase II metabolism involves conjugation - that is the addition of a second, usually relatively large and water soluble chemical grouping to the phase I metabolite (parent drug)</li>
<li>The additions include:</li>
</ul>
<ol>
<li>Glucuronic acid</li>
<li>Sulphate</li>
<li>Acetyl group</li>
<li>Amino acids</li>
<li>Glutathione</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Characteristically, conjugation reactions:</p>
<ul>
<li>Substantially increase water solubility</li>
<li>Abolish pharmacological activity</li>
<li>Increase the molecular weight sufficiently enough to sometimes allow biliary excretion
Although there are exceptions to these rules, they apply in the majority of the cases.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-metabolism">Phase II Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The following comprise phase II reactions:</p>
<ul>
<li>Glucuronidation</li>
<li>Methylation</li>
<li>Sulphation</li>
<li>Acetylation</li>
<li>Amino acid conjugation</li>
<li>Glutathione conjugation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="excretion-of-drugs">Excretion of Drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#excretion-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Excretion is a process whereby drugs are transferred from the internal to the external environment, and the principal organs involved in this activity are the kidneys, lungs, biliary system, and intestines</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="renal-excretion">Renal Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#renal-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Kidney is the primary organ of removal for most drugs, especially for those that are water soluble and not volatile.</li>
<li>The three principal processes that determine the urinary excretion of a drug are:</li>
</ul>
<ol>
<li>Glomerular filtration</li>
<li>Tubular secretion</li>
<li>Tubular reabsorption (mostly passive backdiffusion).</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="biliary-excretion">Biliary Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biliary-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Biliary excretion plays a major role (5-95% of the administered dose) in drug removal for some anions, cations, and certain un-ionized molecules, such as cardiac glycosides.</li>
<li>In addition, biliary elimination may be important for the excretion of some heavy metals.</li>
<li>On the other hand, most drugs that are secreted by the liver into the bile and then into the small intestine are not eliminated through the faeces. Why?</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pulmonary-excretion">Pulmonary Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pulmonary-excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Any volatile material, irrespective of its route of administration, has the potential for pulmonary excretion.</li>
<li>Certainly, gases and other volatile substances that enter the body primarily through the respiratory tract can be expected to be excreted by this route.</li>
<li>No specialized transport systems are involved in the loss of substances in expired air; simple diffusion across cell membranes is predominant.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sweat-and-saliva">Sweat and Saliva<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sweat-and-saliva" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Excretion of drugs into sweat and saliva occurs but has only minor importance for most drugs.</li>
<li>The mechanisms involved in drug excretion are similar for sweat and saliva.</li>
<li>Excretion mainly depends on the diffusion of the un-ionized lipid-soluble form of the drug across the epithelial cells of the salivary glands membrane.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk">Milk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Many drugs in a nursing mother's blood are detectable in her milk.</li>
<li>The ultimate concentration of the individual compound in milk will depend on many factors, including:</li>
</ul>
<ol>
<li>The amount of drug in the maternal blood</li>
<li>Its lipid solubility</li>
<li>its degree of ionization</li>
<li>The extent of its active excretion</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk">Milk<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A highly lipid-soluble drug should accumulate in milk fat.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="milk-very-important">Milk: Very Important<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#milk-very-important" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Breast-feeding should be discouraged when inherent drug toxicity is known or when adverse pharmacological actions of the drug on the infant are likely.</li>
<li>Infant drug exposure can be minimized, however:</li>
</ul>
<ol>
<li>Through short intermittent maternal drug use and</li>
<li>By drug dosing immediately after breastfeeding.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-end">The End<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-end" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacodynamics">Pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-concepts">General Concepts<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-concepts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmaceutical">Pharmaceutical<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmaceutical" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetics">Pharmacokinetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacodynamics">Pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacotherapeutics">Pharmacotherapeutics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacotherapeutics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drug-dose-administration">Drug Dose Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-dose-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Disintegration of Drug</p>
<p>Absorption/distribution metabolism/excretion</p>
<p>Drug/Receptor Interaction</p>
<p>Drug Effect or Response</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="introduction">Introduction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Pharmacodynamics: Study of the biochemical and physiologic effects of drugs and their mechanisms of action.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-action">Drug action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The main ways by which drugs act are via interaction with cell proteins, namely receptors, ion channels, enzymes and transport/carrier proteins.</li>
<li>In addition, drugs can work by themselves mechanically or chemically.</li>
<li>Its useful to know what are the basic principles of drug action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principles-of-drug-action">Principles of Drug action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-drug-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Stimulation: Enhancement of the level of a specific biological activity (usually already ongoing physiological process). E.g. adrenaline stimulates heart rate.</li>
<li>Depression: Diminution of the level of a specific biological activity (usually already ongoing physiological process). E.g. barbiturate depress the CNS.</li>
<li>Replacement: Replacement of the natural hormones or enzymes (any substance) which are deficient in our body. E.g. insulin for treating diabetes.</li>
<li>Cytotoxic action: Toxic effects on invading micro organisms or cancer cells.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="how-does-all-this-happen">How does all this happen?<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-does-all-this-happen" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A drug can produce all the said effects by virtue of any of the following action</li>
</ul>
<ol>
<li>Through enzymes: a drug can act by either stimulating or inhibiting an enzyme</li>
</ol>
<ul>
<li>Through receptors: this is when a drug produces its response by attaching itself to a protein called a receptor which in turn regulates the cell function.</li>
<li>Receptor action is the most commonest way of producing action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="continuation">Continuation...<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#continuation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol start="2">
<li>Physical action: The physical property is responsible for drug action. E.g. radioisotope <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mi mathvariant="normal">I</mi><mn>131</mn></msup></mrow><annotation encoding="application/x-tex">\mathrm{I}^{131}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span class="mord mathrm">I</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">131</span></span></span></span></span></span></span></span></span></span></span></span></span> and other radioisotopes.</li>
<li>Chemical action: The drug reacts extracellularly according to simple chemical equations. E.g. antacids neutralising the gastric acid.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a-deeper-look-into-the-receptor">A deeper look into the receptor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-deeper-look-into-the-receptor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The best-characterized drug receptors are regulatory proteins, which mediate the actions of endogenous chemical signals such as neurotransmitters and hormones.</li>
<li>This class of receptors mediates the effects of many of the most useful therapeutic agents.</li>
<li>Word "Receptor" is used as a loose term</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-receptors">Other Receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Other classes of proteins that have been identified as drug receptors include</li>
</ul>
<ol>
<li>Enzymes, which may be inhibited (or, less commonly, activated) by binding a drug (eg, dihydrofolate reductase, the receptor for the antineoplastic drug methotrexate)</li>
<li>Transport proteins (eg, Na+/K+ ATPase, the membrane receptor for cardioactive digitalis glycosides)</li>
<li>Structural proteins (eg, tubulin)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="agonist-antagonist">Agonist &amp; Antagonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#agonist-antagonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>When a drug binds to a receptor the following can occur and based on this the drugs are classified.</li>
<li>Agonist: when a drug binds to the receptor and activates it to produce an effect</li>
<li>Antagonist: when a drug binds to a receptor and prevents the action of an agonist, but does not have an action on its own.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-terms">Other terms<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-terms" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Inverse agonist: when a drug activates a receptor to produce an effect in the opposite direction to that of the agonist
Partial agonist: when a drug binds to the receptor and activates it but produces a submaximal effect (by antagonising the full effect of the agonist)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="agonist-inverse-agonist">Agonist &amp; Inverse Agonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#agonist-inverse-agonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-edc1eb5d.jpeg" alt="img-3.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="affinity-intrinsic-activity">Affinity &amp; Intrinsic activity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#affinity-intrinsic-activity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Affinity: It is the ability of a drug to bind to the receptor (just bind)</li>
<li>Intrinsic activity: It is the ability of a drug to activate a receptor following receptor occupation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="terms-revisited">Terms revisited<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terms-revisited" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="agonist">Agonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#agonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Agonists are the chemicals that interact with a receptor, thereby initiate a chemical reaction in the cell and produces effect .</li>
<li>Example-ACh is agonist at muscarinic receptor in heart cell.</li>
<li>Will have both Affinity and maximal Intrinsic activity</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antagonist">Antagonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antagonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A drug that binds to the receptor and blocks the effect of an agonist for that receptor</li>
<li>Atropine is antagonist of ACh at Muscarinic receptors.</li>
<li>Will have only Affinity but no Intrinsic activity</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inverse-agonist">Inverse agonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inverse-agonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inverse Agonists are the chemicals that interact with a receptor, but produces opposite effect of the well recognized agonist for that receptor</li>
<li>Will have Affinity and negative Intrinsic activity</li>
<li>Example: Flumazenil is an inverse agonist of Benzodiazepine</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="partial-agonist">Partial agonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#partial-agonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Partial agonist activates receptor to produce an effect. Less response than a full agonist .</li>
<li>Partial agonist blocks the agonist action.</li>
<li>Will have Affinity but sub maximal Intrinsic activity</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="major-concepts">Major Concepts<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#major-concepts" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drugs often work by binding to a "receptor"</li>
<li>Receptors are found in the cell membrane, in the cytoplasm, and in the nucleus</li>
<li>Anything that binds to a receptor is a "ligand"</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-receptor-interaction">Drug-Receptor interaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-receptor-interaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In most cases, a drug (D) binds to a receptor (R) in a reversible bimolecular reaction
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">D</mi><mo>+</mo><mi mathvariant="normal">R</mi><mo>â‡Œ</mo><mrow><mi mathvariant="normal">D</mi><mi mathvariant="normal">R</mi></mrow><mo>â‡Œ</mo><msup><mrow><mi mathvariant="normal">D</mi><mi mathvariant="normal">R</mi></mrow><mo lspace="0em" rspace="0em">âˆ—</mo></msup><mo>â†’</mo><mo>â†’</mo><mo>â†’</mo><mo>â†’</mo><mo>â†’</mo></mrow><annotation encoding="application/x-tex">\mathrm{D}+\mathrm{R} \rightleftharpoons \mathrm{DR} \rightleftharpoons \mathrm{DR}^{*} \rightarrow \rightarrow \rightarrow \rightarrow \rightarrow</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord mathrm">D</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6943em; vertical-align: -0.011em;"></span><span class="mord mathrm">R</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">â‡Œ</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6943em; vertical-align: -0.011em;"></span><span class="mord"><span class="mord mathrm">DR</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">â‡Œ</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7619em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">DR</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7619em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ—</span></span></span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">â†’â†’â†’â†’â†’</span></span></span></span></span> Response</li>
<li>Antagonists can bind to the receptor and occupy its binding site and, therefore, participate only in the first equilibrium.</li>
<li>Agonists, on the other hand, have the appropriate structural features to force the bound receptor into an active conformation (DR*).</li>
<li>This conformational change leads to a series of events causing a cellular response.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="assessment-of-receptor-occupation">Assessment of Receptor Occupation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assessment-of-receptor-occupation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="measure-of-affinity">Measure of Affinity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#measure-of-affinity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">k</mi><mi mathvariant="normal">d</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{k}_{\mathrm{d}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">k</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3361em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">d</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is a relative measure of affinity of a drug for its receptor.</li>
<li>It varies inversely with the affinity of the drug for its receptor</li>
<li>High-affinity drugs have lower <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">k</mi><mi mathvariant="normal">d</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{k}_{\mathrm{d}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">k</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3361em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">d</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> values and occupy a greater number of drug receptors than drugs with lower affinities.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-receptor-interaction">Drug-receptor interaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-receptor-interaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Generally the intensity of response increases with dose</li>
<li>The drug receptor interaction obeys the law of mass action</li>
</ul>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mtable rowspacing="0.25em" columnalign="right left" columnspacing="0em"><mtr><mtd><mstyle scriptlevel="0" displaystyle="true"><mrow></mrow></mstyle></mtd><mtd><mstyle scriptlevel="0" displaystyle="true"><mrow><mrow></mrow><mi>E</mi><mo>=</mo><mfrac><mrow><msub><mi>E</mi><mi>max</mi><mo>â¡</mo></msub><mi>X</mi><mo stretchy="false">[</mo><mi>D</mi><mo stretchy="false">]</mo></mrow><mrow><msub><mi>K</mi><mi>D</mi></msub><mo>+</mo><mo stretchy="false">[</mo><mi>D</mi><mo stretchy="false">]</mo></mrow></mfrac></mrow></mstyle></mtd></mtr></mtable><annotation encoding="application/x-tex">\begin{aligned}
&amp; E=\frac{E_{\max } X[D]}{K_{D}+[D]}
\end{aligned}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 2.663em; vertical-align: -1.0815em;"></span><span class="mord"><span class="mtable"><span class="col-align-r"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.5815em;"><span style="top: -3.5815em;"><span class="pstrut" style="height: 3.427em;"></span><span class="mord"></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 1.0815em;"><span></span></span></span></span></span><span class="col-align-l"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.5815em;"><span style="top: -3.5815em;"><span class="pstrut" style="height: 3.427em;"></span><span class="mord"><span class="mord"></span><span class="mord mathnormal" style="margin-right: 0.05764em;">E</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.427em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord"><span class="mord mathnormal" style="margin-right: 0.07153em;">K</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3283em;"><span style="top: -2.55em; margin-left: -0.0715em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathnormal mtight" style="margin-right: 0.02778em;">D</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mopen">[</span><span class="mord mathnormal" style="margin-right: 0.02778em;">D</span><span class="mclose">]</span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord"><span class="mord mathnormal" style="margin-right: 0.05764em;">E</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: -0.0576em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mop mtight"><span class="mtight">m</span><span class="mtight">a</span><span class="mtight">x</span></span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mord mathnormal" style="margin-right: 0.07847em;">X</span><span class="mopen">[</span><span class="mord mathnormal" style="margin-right: 0.02778em;">D</span><span class="mclose">]</span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.936em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 1.0815em;"><span></span></span></span></span></span></span></span></span></span></span></span></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="law-of-mass-action">Law of mass action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#law-of-mass-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>E is observed effect at dose [D] of a drug</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">E</mi><mtext>max&nbsp;</mtext></msub></mrow><annotation encoding="application/x-tex">\mathrm{E}_{\text {max }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">E</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">max&nbsp;</span></span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is the maximal response</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">K</mi><mi mathvariant="normal">D</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{K}_{\mathrm{D}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3283em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">D</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is the dissociation constant of a drug receptor complex</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">K</mi><mi mathvariant="normal">D</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{K}_{\mathrm{D}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3283em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">D</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is usually equal to the dose of a drug at which half maximal response is produced</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-receptors">Classification of receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>G-protein coupled receptors</li>
<li>Ion channels</li>
<li>Enzymatic receptors</li>
<li>Intracellular receptors (regulates gene expression)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ion-channels">Ion channels<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ion-channels" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The cell surface enclose ion channels specific for <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">a</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup><mo separator="true">,</mo><msup><mi mathvariant="normal">K</mi><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Ca}^{2+}, \mathrm{K}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.0818em; vertical-align: -0.1944em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Ca</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8873em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span><span class="mpunct">,</span><span class="mspace" style="margin-right: 0.1667em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7713em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>, or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">N</mi><mi mathvariant="normal">a</mi></mrow><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Na}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8446em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Na</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8446em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span></li>
<li>These ion channels are controlled by the receptors</li>
<li>E.g. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">G</mi><mi mathvariant="normal">s</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{G}_{\mathrm{s}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">G</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">s</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> opens <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">a</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msup></mrow><annotation encoding="application/x-tex">\mathrm{Ca}^{2+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8873em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Ca</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8873em;"><span style="top: -3.1362em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span> channels in the myocardium and skeletal muscle and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi mathvariant="normal">G</mi><mi mathvariant="normal">i</mi></msub></mrow><annotation encoding="application/x-tex">\mathrm{G}_{\mathrm{i}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathrm">G</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3175em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">i</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> opens the <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mi mathvariant="normal">K</mi><mo lspace="0em" rspace="0em">+</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{K}^{+}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7713em;"></span><span class="mord"><span class="mord mathrm">K</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7713em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">+</span></span></span></span></span></span></span></span></span></span></span></span></span>channels in heart</li>
<li>Some receptors also modulate the ion channels without the intervention of coupling proteins or <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>2</mn><mtext>nd&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">2^{\text {nd }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord"><span class="mord">2</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">nd&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> messengers</li>
<li>E.g. benzodiazepines modulating <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow><mi mathvariant="normal">C</mi><mi mathvariant="normal">l</mi></mrow><mo lspace="0em" rspace="0em">âˆ’</mo></msup></mrow><annotation encoding="application/x-tex">\mathrm{Cl}^{-}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8557em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">Cl</span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8557em;"><span style="top: -3.1473em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">âˆ’</span></span></span></span></span></span></span></span></span></span></span></span></span>channels in the brain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ion-channels">Ion channels<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ion-channels" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-g-protein-coupled-receptors">(B) G-protein-coupled receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-g-protein-coupled-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-c7b396b9.jpeg" alt="img-4.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="schematic-illustration-of-a-gaba-sub-a-sub-receptor-with-its-binding-sites">Schematic Illustration of a GABA&lt;sub&gt;A&lt;/sub&gt; Receptor, with Its Binding Sites<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#schematic-illustration-of-a-gaba-sub-a-sub-receptor-with-its-binding-sites" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-3876a82d.jpeg" alt="img-5.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dose-response-relationship">Dose-response relationship<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dose-response-relationship" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dose-vs-response">Dose Vs Response<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dose-vs-response" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Increases in response until it reaches maximum, Later it remains constant despite increase in dose .. Plateau effect</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dose-response-curve">DOSE RESPONSE CURVE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dose-response-curve" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>After this point increase in dose doesn't increase the response</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="log-dose-response-curve">Log dose response curve<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#log-dose-response-curve" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The dose response curve is a rectangular hyperbola</li>
<li>If the doses are plotted on a logarithmic scale, the curve becomes sigmoid</li>
<li>A linear relationship between log of dose and the response can be seen</li>
</ul>
<p><img src="assets/images/image-20251214-1d71af0c.jpeg" alt="img-6.jpeg"></p>
<p>Fig. 3.9: Dose-response and log dose-response curves</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="efficacy-and-potency">Efficacy and Potency<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#efficacy-and-potency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Efficacy is the maximal response produced by a drug</li>
<li>It depends on the number of drug-receptor complexes formed</li>
<li>Potency is a measure of how much drug is required to elicit a given response</li>
<li>The lower the dose required to elicit given response, the more potent the drug is</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="a23113c8"><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">E</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{ED}_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">ED</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a23113c8" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is the dose of the drug at which it gives <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>50</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">50 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">50%</span></span></span></span></span> of the maximal response</li>
<li>A drug with low <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">E</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{ED}_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">ED</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is more potent than a drug with larger <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">E</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{ED}_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">ED</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="potency-of-drug-a-drug-b-drug-c">Potency of Drug A &gt; Drug B &gt; Drug C<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#potency-of-drug-a-drug-b-drug-c" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Potency</th><th>A</th></tr></thead><tbody><tr><td>100%</td><td>75%</td></tr><tr><td>50%</td><td>50%</td></tr><tr><td>25%</td><td>0%</td></tr><tr><td>10mg</td><td>10mg</td></tr><tr><td>20mg</td><td>20mg</td></tr><tr><td>30mg</td><td>30mg</td></tr><tr><td>40mg</td><td>40mg</td></tr><tr><td>50mg</td><td>50mg</td></tr><tr><td>200mg</td><td>200mg</td></tr></tbody></table>
<p><img src="assets/images/image-20251214-f6f0b15a.jpeg" alt="img-7.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="efficacy-and-potency">Efficacy and Potency<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#efficacy-and-potency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-3fc66c7f.jpeg" alt="img-8.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="potency">Potency<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#potency" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Dose of a drug that required to produce <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>50</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">50 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">50%</span></span></span></span></span> of maximal effect (ED <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">{ }_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4511em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> )</li>
<li>Relative</li>
</ul>
<p>Positions of the DRC on xaxis</p>
<ul>
<li>More left the DRC, more potent the drug</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="efficacy">Efficacy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#efficacy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Maximum effect of the drug</li>
<li>Height of the curve on x -axis indicates the efficacy of the drug</li>
<li>Taller the DRC ,more efficacious the drug</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-index">Therapeutic index<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-index" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-5d405150.jpeg" alt="img-9.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-index-ti">Therapeutic index (TI)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-index-ti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Lethal dose <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo fence="true">(</mo><msub><mrow><mi mathvariant="normal">L</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub><mo fence="true">)</mo></mrow><annotation encoding="application/x-tex">\left(\mathrm{LD}_{50}\right)</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="minner"><span class="mopen delimcenter" style="top: 0em;">(</span><span class="mord"><span class="mord"><span class="mord mathrm">LD</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mclose delimcenter" style="top: 0em;">)</span></span></span></span></span></span> is estimated only in preclinical animal studies</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">L</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{LD}_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">LD</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> is not calculated in humans-OFCOURSE</li>
<li>So we use the term "safety margin" of a drug or "therapeutic window"</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-window">Therapeutic window<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-window" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is a more clinically relevant index of safety
It describes the dosage range between the minimum effective therapeutic concentration or dose, and the minimum toxic concentration or dose
E.g. theophylline has an average minimum plasma conc of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>8</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">8 \mathrm{mg} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">8</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span> and the toxic effects are observed at <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>18</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">18 \mathrm{mg} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">18</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span>
The therapeutic window is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>8</mn><mo>âˆ’</mo><mn>18</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">8-18 \mathrm{mg} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">8</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">âˆ’</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">18</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span></p>
<p><img src="assets/images/image-20251214-861ba79e.jpeg" alt="img-10.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="8-mg-l">8 mg/L<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-mg-l" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="8-18-mg-l">8-18 mg/L<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-18-mg-l" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="18-mg-l">18 mg/L<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#18-mg-l" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="clinical-significance">Clinical significance<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-significance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drugs with a low TI should be used with caution and needs a periodic monitoring (less safe)</li>
<li>E.g. warfarin, digoxin, theophylline</li>
<li>Drugs with a large TI can be used relatively safely and does not need close monitoring (highly safe)</li>
<li>E.g. penicillin, paracetamol</li>
<li>Other terms used: wide safety margin, narrow safety margin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="combined-effect-of-drugs">Combined effect of drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#combined-effect-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="synergism-and-antagonism">Synergism and antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#synergism-and-antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>When two drugs are given together or in quick succession 3 things can happen:</li>
</ul>
<ol>
<li>Nothing (indifferent to each other)</li>
<li>Action of one drug is facilitated by the other (synergism)</li>
<li>Action of one drug may decrease or inhibit the action of other drug (antagonism)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="synergism">Synergism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#synergism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Two types:</li>
</ul>
<ol>
<li>Additive effect: the effect of two drugs are in the same direction and simply add up.</li>
</ol>
<ul>
<li>Effect of drug A + B = effect of drug A and B</li>
</ul>
<ol start="2">
<li>Supraadditive effect (potentiation): the effect of combination is greater than the individual effect of the components.</li>
</ol>
<ul>
<li>Effect of drug A + B &gt; effect of drug A + effect of drug B</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antagonism">Antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Different types of antagonism</li>
</ul>
<ol>
<li>Physical: based on physical property of a drug.</li>
</ol>
<ul>
<li>E.g. activated charcoal adsorbs alkaloids and prevents their absorption (in alkaloid poisoning)</li>
</ul>
<ol start="2">
<li>Chemical: based on chemical properties resulting in an inactive product.</li>
</ol>
<ul>
<li>E.g. chelating agents complex metals (used in heavy metal poisoning)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd..<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol start="3">
<li>Physiological antagonism: two drugs act on different receptors or by different mechanisms, but have opposite effects</li>
</ol>
<ul>
<li>E.g. histamine and adrenaline on bronchial smooth muscle and BP</li>
<li>E.g. several catabolic actions of the glucocorticoid hormones lead to increased blood sugar, an effect that is physiologically opposed by insulin.</li>
</ul>
<ol start="4">
<li>Receptor antagonism</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="receptor-antagonism">Receptor antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#receptor-antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>This when an antagonist interferes with the binding of the agonist with its receptor and inhibits the generation of a response</li>
<li>Receptor antagonism is specific</li>
<li>E.g. an anticholinergic will decrease the spasm of intestine induced by cholinergic agonists but not the one induced by histamine</li>
<li>Receptor antagonism can be competitive and noncompetitive</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="competitive-antagonism">Competitive antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#competitive-antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Competitive --- Surmountable</li>
<li>Competes with agonist in <strong>reversible</strong> fashion for same receptor site</li>
<li>Necessary to have higher concentration of agonist to achieve same response</li>
</ul>
<p><img src="assets/images/image-20251214-bb060971.jpeg" alt="img-11.jpeg"></p>
<p><img src="assets/images/image-20251214-02730fd2.jpeg" alt="img-12.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="noncompetitive-antagonism">Noncompetitive antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#noncompetitive-antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Noncompetitive --- Insurmountable</li>
<li>Antagonist binds to a site different to that of an agonist</li>
<li>No matter how much agonist â€” antagonism cannot be overcome</li>
</ul>
<p><img src="assets/images/image-20251214-612e4df4.jpeg" alt="img-13.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="competitive-vs-noncompetitive">Competitive Vs Noncompetitive<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#competitive-vs-noncompetitive" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antagonism">Antagonism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antagonism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>COMPETITIVE</li>
<li>Antagonist binds with same receptor</li>
<li>Chemical resemblance with agonist</li>
<li>Parallel rightward shift of DRC</li>
<li>Apparently reduces potency of agonist</li>
<li>Intensity of response depends both on antagonist and agonist concentration</li>
<li>Eg: Acetylcholine and Atropine</li>
<li>NONCOMPETITIVE</li>
<li>Another site of receptor binding</li>
<li>Does not resemble</li>
<li>Flattening of DRC</li>
<li>Apparently reduces efficacy of agonist</li>
<li>Intensity of response depends mainly on antagonist concentration</li>
<li>Eg: phenoxybenzamine (for pheochromocytoma)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="receptor-numbers-and-responses">Receptor Numbers and Responses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#receptor-numbers-and-responses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The NUMBER and AFFINITY of receptors may change</li>
<li>An increase in receptor number is called UPREGULATION</li>
<li>A decrease in receptor number is called DOWNREGULATION</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="upregulation-of-receptors">Upregulation of Receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#upregulation-of-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Upregulation: An increase in the number of receptors on the surface of target cells, making the cells more sensitive to a hormone or another agent.</li>
<li>For example, there is an increase in uterine oxytocin receptors in the third trimester of pregnancy, promoting the contraction of the smooth muscle of the uterus</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="downregulation-of-receptors">Downregulation of Receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#downregulation-of-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p><strong>Eg: Downregulation:</strong></p>
<ul>
<li>Prolonged use of propranolol can <strong>DECREASE</strong> the number of Î²â‚ receptors</li>
<li>Prolonged &amp; frequent use of short acting Î²â‚‚ receptor agonists decrease the number of Î²â‚‚ receptors</li>
</ul>
</li>
<li>
<p><strong>Clinical relevance:</strong></p>
<ul>
<li>A patient's response to drug therapy may change over time</li>
</ul>
</li>
</ul>
<p><img src="assets/images/image-20251214-08a9acda.jpeg" alt="img-14.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="biological-effects-of-biocomputers"><strong>BIOLOGICAL EFFECTS OF BIOCOMPUTERS</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biological-effects-of-biocomputers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="biological-effects-of-biocomputers"><strong>BIOLOGICAL EFFECTS OF BIOCOMPUTERS</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biological-effects-of-biocomputers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="biological-effects-of-biocomputers"><strong>BIOLOGICAL EFFECTS OF BIOCOMPUTERS</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biological-effects-of-biocomputers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li><strong>Bacteria and Bacteroidetes</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes</strong>: Increases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>: Decreases the ability of the bacteria to form new substances.</li>
<li><strong>Bacteroidetes and Bifidobacteria</strong>:</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tolerance">Tolerance<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tolerance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Gradual reduction in response to drugs is called a tolerance</li>
<li>Requirement of higher dose to produce a given response</li>
<li>It occurs over a period of time</li>
<li>E.g. tolerance to sedative-hypnotics</li>
<li>Many reasons for tolerance</li>
</ul>
<ol>
<li>Pharmacokinetic reasons-chronic use leads to enhanced clearance-less effective concentration</li>
<li>Pharmacodynamic reasons (reduced number and/or affinity of the receptors to the drugs)-downregulation</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tachyphylaxis">Tachyphylaxis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tachyphylaxis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Rapid desensitization to a drug produced by inoculation with a series of small frequent doses.</li>
<li>A rapidly decreasing response to a drug following its initial administration.</li>
<li>E.g. ephedrine, tyramine, nicotine.</li>
</ul>
<p><img src="assets/images/image-20251214-d92558d3.jpeg" alt="img-15.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="spare-receptors">Spare receptors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#spare-receptors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>In some cases, the response elicited by a drug is proportional to the fraction of receptors occupied</li>
<li>More commonly, a maximal response can be achieved when only a small fraction of receptors are occupied by an agonist</li>
<li>Receptors are said to be spare when maximal response can be elicited by an agonist at a conc. that does not result in occupancy of the full complement of available receptors</li>
<li>No qualitative difference form non spare receptors</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="graphical-representation-of-a-spare">Graphical representation of a spare<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#graphical-representation-of-a-spare" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-724d97c8.jpeg" alt="img-16.jpeg"></p>
<p><strong>receptoâ„¢</strong></p>
<ol start="5">
<li>Minneman &amp; Wecker: Brody's Human Pharmacology 4e <a href="http://www.stu" target="_blank" rel="noopener noreferrer">www.stu</a></li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="factors-affecting-drug-action">Factors affecting Drug Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-affecting-drug-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is a rule rather than an exception that there is a large variation in the drug response for the same dose in different individuals.</li>
<li>Pharmacokinetic handling of the drug</li>
<li>Number or state of receptors</li>
<li>Variations in neurogenic/hormonal tone</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd..<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Body Size/Wt.</p>
<ul>
<li>The average adult dose refers to individuals of medium built</li>
<li>For exceptionally obese and lean and for children the dosage should be calculated based on body wt.</li>
<li>Individual Dose <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo><mrow><mi mathvariant="normal">B</mi><mi mathvariant="normal">W</mi></mrow><mo stretchy="false">(</mo><mrow><mi mathvariant="normal">K</mi><mi mathvariant="normal">g</mi></mrow><mo stretchy="false">)</mo><mi mathvariant="normal">/</mi><mn>70</mn><mi mathvariant="normal">x</mi></mrow><annotation encoding="application/x-tex">=\mathrm{BW}(\mathrm{Kg}) / 70 \mathrm{x}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">BW</span></span><span class="mopen">(</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">Kg</span></span><span class="mclose">)</span><span class="mord">/70</span><span class="mord mathrm">x</span></span></span></span></span> average adult dose</li>
<li>Dosage calculation based on surface area more appropriate for children</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd..<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="age">Age<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#age" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Extreme care has to be taken while administering drugs to children and elderly</li>
<li>Drug metabolizing enzymes are very poor and in case of elderly they might have some other diseases</li>
<li>Reduced doses are ideal for these age groups.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd..<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="genetics">Genetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#genetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Deficiency of some enzymes may lead to drug toxicity because of poor or absence of metabolism
Route of drug administration
IV route has quicker and prominent action when compared to oral route
Psychological role is also a major determinant of drug effect</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd..<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathological-states">Pathological states<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathological-states" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Any underlying pathology may alter the drug response</li>
<li>Special care is taken if the patient has renal or hepatic impairment as the drugs are not eliminated and it may lead to severe drug toxicity.</li>
<li>Alzheimer's disease - memory loss- failure to take medications</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contd">Contd<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Co-administration of other drugs</p>
<ul>
<li>One drug may affect the drug action of others, it may be useful or it may be harmful.</li>
<li>Drug interactions play a very important part of therapeutics.
Diet &amp; environmental factors too play a important role in deciding the drug action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="things-to-know">Things to know<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#things-to-know" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>In pharmacodynamics you SHOULD know by now:</p>
<ol>
<li>Principles of drug action</li>
<li>Agonist &amp; its types</li>
<li>Antagonist and its types (on DRC)</li>
<li>Spare receptors</li>
<li>Affinity-intrinsic activity</li>
<li>Potency-efficacy (explain with DRC)</li>
<li>Therapeutic index and its calculation</li>
<li>Classification of receptors</li>
<li>G-protein coupled receptors</li>
<li>Second messenger concept (role of cAMP and <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">I</mi><mi mathvariant="normal">P</mi></mrow><mn>3</mn></msub><mi mathvariant="normal">&amp;</mi></mrow><annotation encoding="application/x-tex">\mathrm{IP}_{3} \&amp;</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">IP</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">3</span></span></span></span></span><span class="vlist-s">â€‹</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mord">&amp;</span></span></span></span></span> DAG)</li>
<li>Downregulation &amp; upregulation of receptors</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacokinetics">PHARMACOKINETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>"What the body does to the drug"</p>
<p><img src="assets/images/image-20251214-e56d8ae7.jpeg" alt="img-17.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacokinetics-pk">Pharmacokinetics (PK)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics-pk" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The study of the <strong>disposition</strong> of a drug</li>
<li>The disposition of a drug includes the processes of <strong>ADME</strong>
<ul>
<li>Absorption</li>
<li>Distribution</li>
<li>Metabolism</li>
<li>Excretion</li>
<li>Toxicity</li>
</ul>
</li>
</ul>
<p><img src="assets/images/image-20251214-2f7c5e2a.jpeg" alt="img-18.jpeg"></p>
<p><img src="assets/images/image-20251214-c94d6c72.jpeg" alt="img-19.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="admet">ADMET<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#admet" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="absorption">ABSORPTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#absorption" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-bc61893e.jpeg" alt="img-20.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="blood-stream">BLOOD STREAM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#blood-stream" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="protein-bound">Protein bound<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#protein-bound" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><img src="assets/images/image-20251214-219ca7e4.jpeg" alt="img-21.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="distribution">DISTRIBUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="tissue-bound">Tissue bound<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tissue-bound" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><img src="assets/images/image-20251214-34bc2a81.jpeg" alt="img-22.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-r-d"><strong>DRUG R&amp;D</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-r-d" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-4749d83f.jpeg" alt="img-23.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="discovery-phase"><strong>DISCOVERY PHASE</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#discovery-phase" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-4ef56e95.jpeg" alt="img-24.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="development-phase"><strong>DEVELOPMENT PHASE</strong><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#development-phase" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li><strong>10-15 years to develop a new medicine</strong></li>
<li><strong>Likelihood of success: 10%</strong></li>
<li><strong>Cost $800 million â€“ 1 billion dollars (US)</strong></li>
</ul>
<p><img src="assets/images/image-20251214-f4db0a15.jpeg" alt="img-25.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="why-drugs-fail">Why drugs fail<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#why-drugs-fail" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li><strong>Pharmacokinetics</strong>
<ul>
<li><strong>Animal Toxicity</strong></li>
<li><strong>Miscellaneous</strong></li>
<li><strong>Adverse Effects in Man</strong></li>
<li><strong>Commercial Reasons</strong></li>
<li><strong>Lack of Efficacy</strong></li>
</ul>
</li>
</ul>
<p><img src="assets/images/image-20251214-6061c19e.jpeg" alt="img-26.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="importance-of-pk-studies">Importance of PK studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#importance-of-pk-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-patients-may-suffer">(2) Patients may suffer:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-patients-may-suffer" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Toxic drugs may accumulate</li>
<li>Useful drugs may have no benefit because doses are too small to establish therapy</li>
<li>A drug can be rapidly metabolized.</li>
</ul>
<p><img src="assets/images/image-20251214-a402234d.jpeg" alt="img-27.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="routes-of-administration">Routes Of Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#routes-of-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-ac7d8ee5.jpeg" alt="img-28.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="absorption">Absorption<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#absorption" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The process by which drug proceeds from the site of administration to the site of measurement (blood stream) within the body.</li>
<li>Necessary for the production of a therapeutic effect.</li>
<li>Most drugs undergo gastrointestinal absorption. This is extent to which drug is absorbed from gut lumen into portal circulation</li>
<li>Exception: IV drug administration</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="iv-vs-oral">IV vs Oral<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-vs-oral" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>I.V Drug</th><th>Oral Drug</th></tr></thead><tbody><tr><td>Immediately</td><td>Delayed</td></tr><tr><td>completely</td><td>incomplete</td></tr></tbody></table>
<p><img src="assets/images/image-20251214-e29fde9c.jpeg" alt="img-29.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-process">The Process<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-process" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Absorption relies on
<ul>
<li>Passage through membranes to reach the blood</li>
<li>Passive diffusion of lipid soluble species.</li>
</ul>
</li>
</ul>
<p><img src="assets/images/image-20251214-2771506e.jpeg" alt="img-30.jpeg"></p>
<p><img src="assets/images/image-20251214-b1c6e37d.jpeg" alt="img-31.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="absorption-ionization">Absorption &amp; Ionization<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#absorption-ionization" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="non-ionised-drug">Non-ionised drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-ionised-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-8be3ccd7.jpeg" alt="img-32.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="more-lipid-soluble-drug">More lipid soluble drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#more-lipid-soluble-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Diffuse across cell membranes more easily</li>
</ul>
<p><img src="assets/images/image-20251214-aa51511f.jpeg" alt="img-33.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="first-pass-metabolism">First Pass Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#first-pass-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Destroyed in gut</li>
<li>Not absorbed</li>
<li>Destroyed by gut wall</li>
<li>Destroyed by liver</li>
</ul>
<p><img src="assets/images/image-20251214-b8cf2da1.jpeg" alt="img-34.jpeg"></p>
<ul>
<li>Bioavailability: the fraction of the administered dose reaching the systemic circulation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="determination-of-bioavailability">Determination of bioavailability<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#determination-of-bioavailability" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>A drug given by the intravenous route will have an absolute bioavailability of 1 (F=1 or 100% bioavavailable)</li>
<li>While drugs given by other routes usually have an absolute bioavailability of less than one.</li>
<li>The absolute bioavailability is the area under curve (AUC) non-intravenous divided by AUC intravenous</li>
</ul>
<p><img src="assets/images/image-20251214-925b2461.jpeg" alt="img-35.jpeg"></p>
<p><img src="assets/images/image-20251214-3db41521.jpeg" alt="img-36.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="toxicity">Toxicity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#toxicity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>The <em>therapeutic index</em> is the degree of separation between toxic and therapeutic doses.</p>
</li>
<li>
<p>Relationship Between Dose, Therapeutic Effect and Toxic Effect. The Therapeutic Index is Narrow for Most Cancer Drugs</p>
</li>
</ul>
<p><img src="assets/images/image-20251214-49f6d4c4.jpeg" alt="img-37.jpeg"></p>
<p><img src="assets/images/image-20251214-639bd4d1.jpeg" alt="img-38.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="distribution">Distribution<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The movement of drug from the blood to and from the tissues</li>
</ul>
<p><img src="assets/images/image-20251214-686211ec.jpeg" alt="img-39.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="distribution">DISTRIBUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Determined by:</li>
<li>
<div data-testid="stMarkdownPre" class="st-emotion-cache-acwcvw e1icttdg5"><div class="stCode st-emotion-cache-6ml83 e1xss9yb4" data-testid="stCode"><pre class="st-emotion-cache-1nqbjoj e1xss9yb2"><div style="background-color: transparent;"><code style="white-space: pre;"><span>- partitioning across various membranes</span></code></div></pre><div class="st-emotion-cache-chk1w8 e1xss9yb3"><button data-testid="stCodeCopyButton" title="Copy to clipboard" data-clipboard-text="- partitioning across various membranes" style="top: 0px; right: 0px;" class="st-emotion-cache-1lyayqq e1xss9yb5"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><rect x="9" y="9" width="13" height="13" rx="2" ry="2"></rect><path d="M5 15H4a2 2 0 0 1-2-2V4a2 2 0 0 1 2-2h9a2 2 0 0 1 2 2v1"></path></svg></button></div></div></div>
</li>
<li>binding to tissue components</li>
<li>binding to blood components (RBC, plasma protein)</li>
<li>physiological volumes</li>
</ul>
<p><img src="assets/images/image-20251214-a442de89.jpeg" alt="img-40.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="distribution">DISTRIBUTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>
<p>All of the fluid in the body (referred to as the total body water), in which a drug can be dissolved, can be roughly divided into three compartments:</p>
<ul>
<li>Intravascular (blood plasma found within blood vessels)</li>
<li>Interstitial/tissue (fluid surrounding cells)</li>
<li>Intracellular (fluid within cells, i.e. cytosol)</li>
</ul>
</li>
<li>
<p>The distribution of a drug into these compartments is dictated by its physical and chemical properties</p>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="total-body-water">TOTAL BODY WATER<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#total-body-water" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Vascular</th><th>Extravascular</th><th>Intracellular</th></tr></thead><tbody><tr><td>3 L</td><td>9 L</td><td>28 L</td></tr><tr><td>4% BW</td><td>13% BW</td><td>41% BW</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="distribution">Distribution<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distribution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Apparent volume of distribution (Vd) =</li>
</ul>
<p>Amt of drug in body/plasma drug conc</p>
<ul>
<li>VOLUME OF DISTRIBUTION FOR SOME DRUGS</li>
</ul>
<p>DRUG Vd (L)
cocaine 140
clonazepam 210
amitriptyline 1050
amiodarone <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>âˆ¼</mo><mn>5000</mn></mrow><annotation encoding="application/x-tex">\sim 5000</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">âˆ¼</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">5000</span></span></span></span></span></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="factors-affecting-drugs-vd">Factors affecting drugs Vd<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-affecting-drugs-vd" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Blood flow: rate varies widely as function of tissue
Muscle <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> slow
Organs <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>=</mo></mrow><annotation encoding="application/x-tex">=</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span></span></span></span></span> fast</p>
<ul>
<li>Capillary structure:
-Most capillaries are "leaky" and do not impede diffusion of drugs
-Blood-brain barrier formed by high level of tight junctions between cells
-BBB is impermeable to most water-soluble drugs</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="blood-brain-barrier">Blood Brain Barrier<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#blood-brain-barrier" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>-Disruption by osmotic means
-Use of endogenous transport systems
-Blocking of active efflux transporters</p>
<ul>
<li>Intracerebral implantation
-Etc
<img src="assets/images/image-20251214-744f9e82.jpeg" alt="img-41.jpeg"></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="plasma-protein-binding">Plasma Protein Binding<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#plasma-protein-binding" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Many drugs bind to plasma proteins in the blood stream</p>
<p>Plasma protein binding limits distribution.</p>
<p>A drug that binds plasma protein diffuses less efficiently, than a drug that doesn't.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="physiochemical-propertiespo-w">Physiochemical propertiesPo/w<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiochemical-propertiespo-w" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The Partition coefficient (Po/w) and can be used to determine where a drug likes to go in the body</li>
<li>Any drug with a Po/w greater than 1 (diffuse through cell membranes easily) is likely be found throughout all three fluid compartments</li>
<li>Drugs with low Po/w values (meaning that they are fairly water-soluble) are often unable to cross and require more time to distribute throughout the rest of the body</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="physiochemical-properties">Physiochemical Properties-<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#physiochemical-properties" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="size-of-drug">Size of drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#size-of-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>-The size of a drug also dictates where it can go in the body.
-Most drugs : 250 and 450 Da MW
-Tiny drugs (150-200 Da) with low Po/w values like caffeine can passively diffuse through cell membranes
-Antibodies and other drugs range into the thousands of daltons
-Drugs &gt;200 Da with low Po/w values cannot passively cross membranes- require specialized protein-based transmembrane transport systems- slower distribution
-Drugs &lt; thousand daltons with high Po/w values-simply diffuse between the lipid molecules that make up membranes, while anything larger requires specialized transport.</p>
<p><img src="assets/images/image-20251214-bd0eff41.jpeg" alt="img-42.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="elimination">Elimination<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#elimination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The irreversible removal of the parent drugs from the body</li>
</ul>
<p><img src="assets/images/image-20251214-c1bd04b7.jpeg" alt="img-43.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="excretion">Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="drug-metabolism-biotransformation">Drug Metabolism (Biotransformation)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-metabolism-biotransformation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-4fbfe14c.jpeg" alt="img-44.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-metabolism">Drug Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The chemical modification of drugs with the overall goal of getting rid of the drug</li>
<li>Enzymes are typically involved in metabolism</li>
</ul>
<p><img src="assets/images/image-20251214-488821bb.jpeg" alt="img-45.jpeg"></p>
<p><img src="assets/images/image-20251214-a9ecd8a0.jpeg" alt="img-46.jpeg"></p>
<p><img src="assets/images/image-20251214-af961266.jpeg" alt="img-47.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="metabolism">Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li><strong>Drug</strong>: More polar (water soluble)</li>
<li><strong>Drug</strong>: Excretion</li>
</ul>
<p><img src="assets/images/image-20251214-630a0284.jpeg" alt="img-48.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="metabolism">METABOLISM<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>From 1898 through to 1910 heroin was marketed as a non-addictive morphine substitute and cough medicine for children. Bayer marketed heroin as a cure for morphine addiction.</p>
<p>Heroin is converted to morphine when metabolized in the liver.</p>
<p><img src="assets/images/image-20251214-4c3a19f8.jpeg" alt="img-49.jpeg"></p>
<p>Am. J. Ph.</p>
<p>[December, 1901]</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="bayer-pharmaceutical-products">BAYER Pharmaceutical Products<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#bayer-pharmaceutical-products" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2cd6ff0a">HEROINâ€”HYDROCHLORIDE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2cd6ff0a" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>is pre-eminently adapted for the manufacture of cough elixirs, cough balsams, cough drops, cough lozenges, and cough medicines of any kind. Price in 1 oz. packages, $4.85 per ounce; less in larger quantities. The efficient dose being very small (1-48 to 1-24 gr.), it is</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="the-cheapest-specific-for-the-relief-of-coughs">The Cheapest Specific for the Relief of Coughs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-cheapest-specific-for-the-relief-of-coughs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>(In bronchitis, phthisis, whooping cough, etc., etc.)</p>
<p><strong>WRITE FOR LITERATURE TO</strong></p>
<p><strong>FARBENFABRIKEN OF ELBERFELD COMPANY</strong></p>
<p><strong>BELLING AGENTS</strong></p>
<p>P. O. Box 2100 40 Stone Street, NEW YORK</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phases-of-drug-metabolism">Phases of Drug Metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phases-of-drug-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Phase I Reactions</p>
<ul>
<li>Convert parent compound into a more polar (=hydrophilic) metabolite by adding or unmasking functional groups (-OH, -SH, -NH2, -COOH, etc.) eg. oxidation</li>
<li>Often these metabolites are inactive</li>
<li>May be sufficiently polar to be excreted readily</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phases-of-metabolism">Phases of metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phases-of-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phase-ii-reactions">Phase II Reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Conjugation with endogenous substrate to further increase aqueous solubility</li>
<li>Conjugation with glucoronide, sulfate, acetate, amino acid</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="intravenous-administration">Intravenous administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#intravenous-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="systemic-circulation">Systemic circulation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#systemic-circulation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Mostly occurs in the liver because all of the blood in the body passes through the liver.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="biotransformation">Biotransformation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#biotransformation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hepatic-portal-vein">Hepatic portal vein<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hepatic-portal-vein" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="oral-administration">Oral administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#oral-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="intestines">Intestines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#intestines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251214-017dcb77.jpeg" alt="img-50.jpeg"></p>
<p><img src="assets/images/image-20251214-3f4960ff.jpeg" alt="img-51.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-most-important-enzymes">The Most Important Enzymes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-most-important-enzymes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Microsomal cytochrome P450 monooxygenase family of enzymes, which oxidize drugs</li>
<li>Act on <strong>structurally unrelated</strong> drugs</li>
<li>Metabolize the <strong>widest</strong> range of drugs.</li>
</ul>
<p><img src="assets/images/image-20251214-3fbc9c8b.jpeg" alt="img-52.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cyp-family-of-enzymes">CYP family of enzymes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cyp-family-of-enzymes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Found in liver, small intestine, lungs, kidneys, placenta</li>
<li>Consists of <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>&gt;</mo><mn>50</mn></mrow><annotation encoding="application/x-tex">&gt;50</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.5782em; vertical-align: -0.0391em;"></span><span class="mrel">&gt;</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">50</span></span></span></span></span> isoforms</li>
<li>Major source of catalytic activity for drug oxidation</li>
<li>It's been estimated that <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>90</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">90 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">90%</span></span></span></span></span> or more of human drug oxidation can be attributed to 6 main enzymes:</li>
<li>CYP1A2 ãƒ»CYP2D6</li>
<li>CYP2C9 ãƒ»CYP2E1</li>
<li>CYP2C19 ãƒ»CYP3A4
-In different people and different populations, activity of CYP oxidases differs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inhibitors-and-inducers-of-microsomal-enzymes">Inhibitors and inducers of microsomal enzymes<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inhibitors-and-inducers-of-microsomal-enzymes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inhibitors: cimetidine prolongs action of drugs or inhibits action of those biotransformed to active agents (pro-drugs)</li>
<li>Inducers: barbiturates, carbamazepine shorten action of drugs or increase effects of those biotransformed to active agents</li>
<li>Blockers: acting on non-microsomal enzymes (MAOI, anticholinesterase drugs)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii">Phase II<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Main function of phase I reactions is to prepare chemicals for phase II metabolism and subsequent excretion</p>
<p>Phase II is the true "detoxification" step in the metabolism process.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-ii-reactions">Phase II reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="conjugation-reactions">Conjugation reactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conjugation-reactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Glucuronidation (on -OH, -COOH, -NH2, -SH groups)</li>
<li>Sulfation (on -NH2, -SO2NH2, -OH groups)</li>
<li>Acetylation (on -NH2, -SO2NH2, -OH groups)</li>
<li>Amino acid conjugation (on -COOH groups)</li>
<li>Glutathione conjugation (to epoxides or organic halides)</li>
<li>Fatty acid conjugation (on -OH groups)</li>
<li>Condensation reactions</li>
</ul>
<p>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="glucuronidation">Glucuronidation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glucuronidation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Conjugation to a-d-glucuronic acid</li>
<li>Quantitatively the most important phase II pathway for drugs and endogenous compounds</li>
<li>Products are often excreted in the bile
<img src="assets/images/image-20251214-a4aff301.jpeg" alt="img-53.jpeg"></li>
</ul>
<p>Figure 1.30 Synthesis of UDP-glucuronic acid.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="phase-i-and-ii-summary">Phase I and II - Summary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-and-ii-summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Products are generally more water soluble</li>
<li>These reactions products are ready for (renal) excretion</li>
<li>There are many complementary, sequential and competing pathways</li>
<li>Phase I and Phase II metabolism are a coupled interactive system interfacing with endogenous metabolic pathways</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="excretion">Excretion<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#excretion" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The main process that body eliminates "unwanted" substances.</li>
<li>Most common route - biliary or renal</li>
<li>Other routes - lung (through exhalation), skin (through perspiration) etc.</li>
<li>Lipophilic drugs may require several metabolism steps before they are excreted</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adme-summary">ADME - Summary<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adme-summary" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>I.V.
<img src="assets/images/image-20251214-06bad4d6.jpeg" alt="img-54.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacology">PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b-mugambi-latest">B mugambi(latest)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-mugambi-latest" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="objective">Objective<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#objective" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>By the end of this unit the learner should be able to administer drugs safely in the management of patients and to promote health and prevent illness.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="introduction-to-pharmacology">INTRODUCTION TO PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction-to-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Definition of terms:
*Pharmacology is the study of effects of chemical substances on the function of living systems.</li>
</ul>
<ul>
<li>pharmacology is the science of drugs which includes their preparation, use and effects.
*It is also the science that deals with the origin, chemistry, effects and uses of drugs.
*Pharmacy: Branch of health science that deals with preparation and dispensing of drugs.
*pharmacotherapy: The study of therapeutic uses and effects of drugs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="terminology">Terminology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pharmacognosy: the study of drugs that come from natural sources e.g. plants, animals and minerals as well as search for new drugs from natural sources.
*Pharmacokinetics :this is the study of the body acts on the drugs; it is characterized by absorption, distribution, metabolism(biotransformation)and excretion/elimination. It can further be described as how the body handles a drug from site of administration to the site of action and elimination.</li>
<li>Pharmacodynamics/mechanism of action: the study of how drugs act on the body.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>*Pharmacogenetics: the study of the effects that genetics have on an individuals response to drugs.
Contra-indication: A health condition/ state that will prelude the administration of a drug e.g. aspirin is contraindicated in peptic ulcer disease.
Half life or half time (t1/2): Time taken for plasma concentration to fall by half following its elimination in the body.
Drug interactions :effects produced when some drugs are given together
Desired therapeutic effect: This should indicate the mechanism of action of a drug e.g.an analgesic is for pain relief, accompanied by central nervous system depression inhibition of inflammation, neutralization of acid in the stomach, vasodilation in angina or muscle relaxation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Toxicology: This branch of pharmacology which deals with the an desirable effects of chemicals on living systems from individual cells to complex body systems.</li>
<li>Drug: Any substance used in diagnosis, cure, treatment and prevention of disease/condition or any substance that brings a change in biological functions through its chemical actions. The term drug, medication, and medicine are used synonymously.</li>
<li>Placebo: Any component of therapy that is without specific biological activity e.g. inactive substance such as normal saline or distilled water usually used in clinical trials research and for psychological treatment.</li>
</ul>
<p>drug reactions and interactions</p>
<p>Any physiologically active drug has the potential to cause an undesirable reaction that may induce illness in the recipient. These include toxic reaction, side effects, allergic reactions, cumulative reaction, tolerance and dependence and detrimental drug reaction.</p>
<ul>
<li>Side effects: these are physiological effects exerted by the chemical that are not related to the desired therapeutic effects. you must therefore be familiar with serious side effect and commonly occurring effects.</li>
<li>Adverse drug reaction: this an injury occurring by taking medication .It may occur following a single dose or prolonged administration of a drug or result from a combination of two or more drugs. The study of ADR is known as pharmacovigilance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drug interaction: this is when an interactant chemical modifies the therapeutic results that are anticipated with a drug the interact may be another drug, some combination of a drug, natural or artificial components in the diet, pollutants chemical from the environment, endogenous body chemicals and Chemicals used for diagnostic laboratory test. Drug interaction may be detriment or beneficial drug and may vary from one person to another. This may affect the absorption, distribution ,metabolism or excretion of the drugs.</li>
<li>Allergic reactions: This the body's immunological response to a drug following previous exposure to the same drug.</li>
</ul>
<p>Cont.</p>
<ul>
<li>Idiosyncratic reactions: this is genetically determined, un expected response to a drug. The response may take the form of extreme sensitivity to low doses or extreme insensitivity to high doses to the drug.</li>
<li>Chain reaction: Medication are often added to a regime to control side effects of other drugs. This can initiate a chain reaction e.g. cortisone is prescribed to treat a serious inflammatory condition it can cause hypertension, ulcers, diabetes and a reactivation of arrested tuberculosis.</li>
<li>Cumulative reaction: Drugs accumulate in the body whenever the dosage exceeds the amount the body can eliminate through metabolism or excretion</li>
<li>Tolerance and dependence: Tolerance occurs when a person no longer responds to the drug in the way that person initially responded as a result of continued use of the drug causing a need to increase dose of a drug to achieve the same effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>cont.</p>
<ul>
<li>There three basic types of tolerance.</li>
</ul>
<p>metabolic /pharmacokinetics tolerance this occurs due to increased metabolism of a drug leading to reduction in drug concentration at the receptor site.</p>
<p>cellular/pharmacodynamic tolerance this caused by adaptive changes that take place at the receptor site or drug action site.</p>
<p>cross tolerance when tolerance to one drug confers tolerance to another drug. Drugs that have the same chemical structure tend to portray cross tolerance e.g. people tolerance to one barbiturates are usually tolerant to all barbiturates e.g., phenobarbital, thiopental. However drugs of similar class can also portray cross-tolerance.</p>
<ul>
<li>Intolerance: low threshold to normal pharmacological response. A drug causes an exaggeration of a normal pharmacological response e.g. morphine may cause coma instead of respiratory distress which occurs with administration of a normal dose.</li>
</ul>
<p>Cont.</p>
<ul>
<li>Dependence: A state arising from repeated periodic or continuous administration of a drug that results in harm to the individual or sometimes society. People feel desire or compulsion to continue using the drug and feel ill if abruptly withdrawn or an antidote is used. Substance that cause dependence are taken to induce a good feelings or avoid discomfort of their absence.</li>
</ul>
<p>Types dependence:</p>
<p>a. psychological dependence: usually first to appear, where the individual have a craving for the effect the drug produces motional distress like fear, anxiety and irritability occur when the drug is withdrawn.</p>
<p>b. Physical dependence: this dependence is usually defined in terms of withdrawal/abstinence syndrome that are physical in nature e.g. tremors, ataxia, shivering.</p>
<p>Cont.</p>
<ul>
<li>Iatrogenic responses: these are responses produced an intentionally during the cause of treatment e.g. penicillin may cause hepatic toxicity, steroid may cause Cushing's syndrome.</li>
<li>Anaphylaxis: A sudden serious life threating allergic reaction and should be treated as a medical emergency, it causes more than one of the following ; an itchy rash throat and tongue swelling, shortness of breath ,vomiting, lightheadedness and low blood sugar.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-development">drug development<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-development" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>After a chemical that has shown therapeutic value has been identified, it must under go a series of scientific test to evaluate its actual therapeutic and toxic effects. The process is controlled by legally established bodies e.g. pharmacy and poisons board and food &amp; drug administration (FDA)development IN Kenya and USA respectively. Before receiving legal approval to be marketed to the public ,drugs must pass through several sequential stages of development.
Pre-clinical trials: this phase involves testing the drug on laboratory animals to test their pharmacodynamics, pharmacokinetics and toxicology. The toxicity studies include mutagenic, carcinogenic and reproductive studies.</li>
</ul>
<p>Conti.</p>
<p>Phase I: clinical pharmacology</p>
<p>This is first phase human volunteers, usually 20-50 (healthy volunteers or volunteer patients depending on the class of drug and its safety)are used to test the drug. Pharmacodynamics and pharmacokinetics era tested. Toxicity and therapeutic effects are further tested.</p>
<p>Phase II: therapeutic exploration</p>
<p>Tests are done on patients who have the disease usually 100-200 patients are involved in the study. Pharmacodynamics and pharmacokinetics era determined as well as dosing requirements and efficacy of the drug at the given dose</p>
<p>Phase III: Therapeutic confirmation</p>
<p>The drug is used on Avast clinical market 300-3000 patients are involved. Prescriber observes patients closely for drug adverse effects and therapeutic effects.</p>
<p>Conti.</p>
<p>Phase IV: continuous evaluation</p>
<p>the prescribers are expected to report to the regulatory bodies any unexpected effects which then evaluates this information. A drug may be withdrawn from the market if it produces toxic effects e.g. thalidomide.</p>
<p>â€¢ Orphan drug : drugs that have been discovered but are not financially viable and therefore have not been adopted by any drug company. may be useful in treating a rare disease or may have potentially dangerous adverse effects. They are often abandoned after preclinical trials or phase I studies.</p>
<p>sources of drugs</p>
<p>a)Plants sources: plants have been used as a source of drugs since pre-historic times. Plants are an important source of chemicals that are developed into drugs. Any part of a plant; including leaves, roots and back can be used. Drug can be processed using the synthetic version of the active chemical found in plants e.g. dronabinol which contains the active ingredients delta-9-tetrahydrocannabinol found in marijuana.it prevents nausea and vomiting in cancer patients but does not cause adverse effects as when one smokes marijuana.</p>
<p>Examples of active ingredients in plants.</p>
<p>i)alkaloids: Taste bitter and are poorly absorbed in water but become soluble if dissolved in acids examples of drugs derived from alkaloids includes; atropine, caffeine, cocaine, quinine, codeine and morphine.</p>
<p>Conti.</p>
<p>ii)Glycosides: these are digitalis products e.g. digoxin, digitoxin which are gotten from digitalis purpureal or foxglove plants.</p>
<p>iii)Gums: these are polysaccharides exudates that can be used for bulk laxatives and dental adhesives.</p>
<p>iii)Resins: the most common resins is benzoin which is used as an antiseptic.</p>
<p>iv)Oils: These can be volatile oils like peppermint, spearmint, menthol, cinnamon, lemon camphor. They have pleasant fragrance and evaporate easily. The other types of oils is fixed oils which include castor oil used as a laxative, olive oil for cooking, emollients used in cosmetics and solvents for injections.</p>
<p>Conti.</p>
<p>b) Animal sources: these are used to replace human chemicals that are not produced adequately due to disease or genetic problems e.g. insulin from pancreases of pigs and cows. Thyroid drugs and growth hormone preparations from animals hypothalamus. Despite these animal sources most of these products are being currently produced synthetically which provides purer and safer products than animal sources.</p>
<p>c)Inorganic sources: salts of various elements have therapeutic effect in the human body e.g., aluminum ( used as antacids),fluoride( used to prevent dental cavities and osteoporosis), gold( used for rheumatoid arthritis), iron( used for anemia) and potassium (used in potassium K+ supplements.)</p>
<p>Conti.</p>
<p>d)Synthetic sources: Many drugs are developed synthetically after chemicals in plants ,animals or other environment have been screened for signs of therapeutic activity. This eliminates side effects and increases drug potency. Drugs have genetic engineering are used to produce chemicals that have therapeutic effects.</p>
<p>e)Microbiological sources: example penicillins,tetracycline</p>
<p>f)recombinant DNA technology</p>
<p>uses of drugs</p>
<ol>
<li>curative: this is the primary therapy e.g. in treating infections or auxiliary therapy e.g. application of anaesthetic medication.</li>
<li>suppress signs and symptoms, hence improve quality of life without attaining cure e.g. anti diabetics.</li>
<li>prevent/prophylaxis- this could be primary e.g. use of vaccines to prevent one from getting a disease or secondary to stop progression of an existing disease.</li>
<li>diagnosis- for instance the use of tuberculin test to diagnose PTB</li>
</ol>
<p>drug nomenclature</p>
<p>Nomenclature is the systematic naming of drugs especially pharmaceutical drug Drugs in majority of circumstances have three types of names.</p>
<ol>
<li>i)Chemical/molecular/ scientific name: this is the chemical/molecular structure of a drug. It states the structure in terms of atoms and molecules accompanied by a diagram of the chemical structure. Most useful to a few technically trained personnel e.g. chemist or research pharmacist the names are unsuitable for general use since they are long. e.g. acetyl-p-amino-phenol is for paracetamol or acetaminophen</li>
<li>ii)generic/non-proprietary/approved name; this is the abbreviated and approved name. it is the official medical name assigned by the producer in collaboration with the food and drugs board and nomenclature committee. The generic name can be used by any interested party and it removes confusion of giving several names to the same drug regardless of who manufactures them once they have the same chemical structure. A generic name is not capitalized e.g. acetylsalicylic acid commonly known as aspirin,</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>iii)Trade name/proprietary/brand name: name given to the drug by the manufacturing and marketing company. One drug may have so many trade name e.g. acetaminophen has about 30 names some are paramol, Tylenol, Panadol etc. they are usually capitalized.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="example-of-drugs-chemical-name-generic-name-and-trade-name">example of drugs chemical name, generic name and trade name.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#example-of-drugs-chemical-name-generic-name-and-trade-name" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Chemical name</th><th>Generic name</th><th>Trade names</th></tr></thead><tbody><tr><td>2-(4-isobutylphenyl)propanoic acid</td><td>ibrufen</td><td>Brufen, advil, nurofen</td></tr><tr><td>N-acetyl-para-aminophenol</td><td>Paracetamol, acetaminophen</td><td>Calpol, Panadol, tylenol</td></tr><tr><td>2-(2-methl-5-nitro-1h-imidazol1-</td><td></td><td></td></tr><tr><td>y)ethyl benzoate.</td><td>metronidazole</td><td>Flagyl ,metrogyl</td></tr></tbody></table>
<p>two major methods of dispensing drugs</p>
<ul>
<li>Over the counter drugs (OTC):they do not need a prescription and can be purchased at the chemical shops; examples pain relief, blood tonics, vitamin preparation, ORS, antacids, antimalarial.</li>
<li>Prescription drugs: They need a prescription and must be controlled from abuse and dependence; e.g. antibiotics, anti-hypertensives, sedatives, diabetics drugs etc.</li>
</ul>
<p>Patients education -about OTC drugs</p>
<ul>
<li>You need to give your attention to all the drugs the patient is taking whether prescription or OTC.</li>
<li>Caution patient not to treat themselves with OTC drugs.</li>
<li>Inform them that most of the OTC medication contain more than one active ingredient.</li>
<li>Tell he patient that interactions can occur when takes more than one OTC medication at a time or takes one with a prescription drugs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="patients-education-about-drugs-prescription-drugs">patients education about drugs - prescription drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#patients-education-about-drugs-prescription-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inform patient about special consideration and drug safety precaution.</li>
<li>Encourage: complete medication list complete adverse reaction list.</li>
<li>Patients compliance.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Pharmacokinetics is the process by which the body, sick or well, handles and affects the drug.</li>
<li>It is characterized by four processes</li>
</ul>
<p>i) absorption ;This is the process by which a drug is transferred from the site of administration into the circulating fluids of the body e.g. Blood and lymph.</p>
<ul>
<li>The rate of absorption is vital because it determines when the drug is available to exert its action.</li>
<li>Bioavailability: This is the fraction extent to which a dose of drug reaches its site of action .for example;1. hepatic metabolism and biliary excretion may occur before a drug taken orally reaches systemic circulation.(first pass effect)</li>
</ul>
<ol start="2">
<li>Drug given intravenously its bioavailability is 100%thus bioavailability must be considered when calculating none intravenous routes of administration.</li>
</ol>
<p>factors affecting absorption</p>
<ul>
<li>Route of drug administration.</li>
<li>Dose.</li>
<li>Dosage formulation.</li>
<li>Food and fluids administered with the drugs.</li>
<li>Status of the absorptive surface.</li>
<li>Rate of blood flow to the small intestines.</li>
<li>acidity of the stomach</li>
<li>Status of GI motility.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Factors influencing drug administration</p>
<p>â€¢ The nature of the absorbing surface.</p>
<p>â€¢ Blood flow to the site of administration; increase in blood flow facilitates abortion ; and e.g. sublingual route and pulmonary epithelium.</p>
<p>â€¢ The health status of the person taking the drug. This affects the rate of absorption and transportation.</p>
<p>â€¢ The lipid solubility of drugs the higher the solubility the more a drug is absorbed especially in the GIT.</p>
<p>â€¢ The PH of the drug.</p>
<p>â€¢ Drug concentration and critical concentration.</p>
<p>routes of drug administration</p>
<p>A drugs route of administration affects the rate and extend of absorption.</p>
<p>â€¢ Enteral route : drugs given along any portion of the GIT.it is most common, safe, convenient. and economical. but it is the slowest, it can be orally, sublingually, and rectally.</p>
<p>â€¢ Parenteral route: intradermally, subcutaneous, intramuscular, intrathecal intravenous.</p>
<p>â€¢ Pulmonary route: administered by in halation.</p>
<p>â€¢ topical: applied on the skin, mucus membrane of eyes, ears, nasal mucosa, bladder, vagina and the penis.</p>
<p>Factors to consider when choosing the route of drug administration</p>
<ol>
<li>
<p>The time at which the effect of the drug is required.</p>
</li>
<li>
<p>The method most suitable for the drug required.</p>
</li>
<li>
<p>The site of drug action.</p>
</li>
<li>
<p>Patients status whether conscious or unconscious.</p>
</li>
<li>
<p>Desire off the patient.</p>
</li>
</ol>
<p>Conti.</p>
<ul>
<li>When prescribing drugs the dose may vary with certain factors ; age, route, assimilation.</li>
</ul>
<p>ii)distribution: this is the transport of a drug in body fluids to various tissues of the body and ultimately site of action.</p>
<p>The rate of distribution depends on;</p>
<ul>
<li>The permeability of the capillary to the drug.</li>
<li>Lipid solubility and ionization of the drug. lipid soluble drugs are more rapidly absorbed and distributed than their lipid insoluble drugs</li>
<li>Cardiac function e.g. cardiac out put and regional blood, drug are fast distributed to areas with rich blood flow(Heart, kidneys, brain) later to areas of low blood flow (muscle, fat tissue).</li>
</ul>
<p>Conti.</p>
<ul>
<li>Drugs are widely distributed in body water (free fraction of drug)and partly as bound to plasma proteins and or tissues.</li>
<li>Plasma protein and tissue binding of drug reservoirs that sustain pharmacological action of a drug. The bound fraction and the free fraction are usually in a state of equilibrium</li>
<li>other proteins involved in drug binding include; lipoproteins, glycoprotein and globulins.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Biological membranes which limit the distribution of drugs</p>
<ul>
<li>Blood brain barrier: allows distribution of only lipid soluble drugs e.g. general anesthetics, barbiturates into the brain and spinal cord.</li>
<li>Placenta barrier: lipid soluble and some lipid insoluble can diffuse through hence some drug meant for the mother may pass through and harm the baby e.g. steroids ,narcotis and anaesthetics.</li>
<li>Blood-testes barrier: this may limit some chemotherapeutic agents used for treating testicular neoplasms.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>metabolism</p>
<p>iii)metabolism/biotransformation:</p>
<p>the biological transformation of a drug into an inactive metabolite, a more soluble compound ,or a more potent metabolite.</p>
<p>The Liver is the main organ of metabolism.</p>
<p>The Kidneys, gut mucosa, lungs and the skin are also involved in drug metabolism.</p>
<p>NB: Delayed drug metabolism results in accumulation of drug in the body and prolonged effect of the drug</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="factors-influencing-metabolism">Factors influencing metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-influencing-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Physiological factors like starvation, liver diseases, cardiovascular problems, these depress microsomal enzyme systems.</li>
<li>Age people with extreme ages have decreased metabolism</li>
<li>Genetic predisposition genetic differences in the rate of metabolism of some drugs exist.</li>
<li>Prior administration of the particular drugs or other drugs e.g. repeated administration of a particular drug may cause induction or inhibition</li>
</ul>
<p>Enzyme induction or inhibition</p>
<ul>
<li>enzyme induction this is a situation whereby the re is an increase in amount and activity of the liver microsomal enzymes usually due to exposure to certain substances such as drugs and endogenous substances.</li>
<li>A drug may induce its own metabolism</li>
</ul>
<p>pharmacological Importance of enzyme induction</p>
<ol>
<li>Drug interaction may occur.</li>
<li>Disease may result .</li>
<li>Tolerance (metabolic) to the drug.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>conti.</p>
<ul>
<li>Enzyme inhibition this refers to decrease synthesis and activity of liver microsomal enzymes.it results in reduced metabolism of other drugs/inhibiting drug and endogenous substance.</li>
<li>General enzyme inhibition(beyond liver enzymes )has a greater pharmacological importance utility than enzyme induction.</li>
<li>Examples of drugs that inhibit enzymes include chloramphenicol and cimetidine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>excretion</p>
<p>iv) Excretion: this the process by which drugs and pharmacologically active or inactive metabolites are eliminated from he body primarily through the Kidneys.</p>
<p>Net renal excretion of a drug is as a result of 3 processes</p>
<ol>
<li>
<p>filtration (passive glomerular filtration)</p>
</li>
<li>
<p>re-absorption,</p>
</li>
<li>
<p>active tubular secretion.</p>
</li>
</ol>
<p>other routes through which drugs are eliminated include</p>
<p>intestines or biliary excretion e.g. neomycin</p>
<p>Pulmonary elimination e.g. volatile liquids (general anaesthetics)</p>
<p>Sweat and saliva elimination e.g. thiazides.</p>
<p>Breast milk elimination e.g. narcotics.</p>
<p>Pharmacodynamics/mechanism of action</p>
<p>The study of how drugs act on the body. It is the chemical changes or effects that a drug has on body cell and tissues.</p>
<p>â€¢ Drug action: the cellular process involved in the drug and cell interaction.</p>
<p>â€¢ Drug effects: the physiology reaction of the body to the drug.</p>
<p>The common drug molecules (targets) on which drugs bind to produce therapeutic effects include enzymes, carrier molecules, ion channels, and receptors.</p>
<p>â€¢ The receptor : these are proteins that are found within or on the surface of cells</p>
<p>Two terms related to receptors are affinity and efficacy.</p>
<p>â€¢ Efficacy the tendency of a drug to activate the receptor once bound.</p>
<p>â€¢ Affinity the tendency of a drug to bind to the receptor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-interactions">Drug interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="harmful-interactions">Harmful interactions-<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#harmful-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>-Oral contraceptives and anti TB drugs - contraceptive failure.
-Tetracycline and antacids - cimetidine renders tetracycline ineffective.
-Anticoagulants warfarin and aspirin - may result to bleeding.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="beneficial-drug-interactions">Beneficial drug interactions-<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#beneficial-drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>-Amino glycoside &amp; penicillin's achieve synergic antimicrobial effects
-probenecid plus penicillin prolong action of penicillin..
-Morphine poisoning-naloxone is used as an antidote.</p>
<p>Conti.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="synergism">Synergism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#synergism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This can either be</p>
<p>summation- this occurs when the effect of two drugs having the same action are additive e.g. beta blockers plus thiazide diuretics have an additive anti hypertensive effects.</p>
<p>Potentiating- this means to make more powerful, occurs when the action of one drug increases the action of another. e.g trimethoprim plus sulfamethoxazole.</p>
<p>antagonism</p>
<ul>
<li>Agonist- drug binds to a receptor there is a response.</li>
<li>Antagonist-drug binds to a receptor-no response, prevents binding of agonist(alpha and beta blockers)</li>
<li>Partial agonist-a drug that is able to both stimulate and block at receptor.</li>
<li>Antagonism- occurs when two or more drugs oppose the action of one another producing opposite pharmacodynamic effects e.g.</li>
</ul>
<p>Antacids and tetracycline form a complex which is excreted in feaces chemical antagonism.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="administration-of-medication">Administration of medication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#administration-of-medication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administration of medication involves all the activities related to safe drug use which are the nursing responsibilities.</li>
</ul>
<ol>
<li>Assessing the risk to a client of a new drug order.</li>
<li>Delivering the drug dose to the proper body tissues.</li>
<li>Assessing the client's response to drug therapy.</li>
<li>Treatment of adverse reactions to drugs.</li>
<li>Consulting with the doctor about adjusting the prescribed regime.</li>
<li>Educating the client about proper use of drugs substances.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principles-of-drug-administration">Principles of drug administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-drug-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>For a Nurse administration of medication is an important responsibility.to avoid errors a nurse must adhere to the principles of drug administration.</li>
<li>To provide safe administration of drugs a nurse should practice the rights of drug administration. they are</li>
</ul>
<ol>
<li>Right patient.</li>
<li>Right drug.</li>
<li>Right dose.</li>
<li>Right time.</li>
<li>Right route.</li>
</ol>
<p>conti.</p>
<p>Five additional right are essential in professional nursing practice. they are</p>
<ol>
<li>
<p>The right assessment e.g. patients ability to swallow, allergies, contraindication, new signs and symptoms that may indicate adverse effects of administration, heart, liver or kidney disorders.</p>
</li>
<li>
<p>The right documentation.</p>
</li>
<li>
<p>The clients right to information of name, purpose, action and potential side effects.</p>
</li>
<li>
<p>The right evaluation.</p>
</li>
<li>
<p>The clients right to refuse medication regardless of the consequences.</p>
</li>
</ol>
<p>Conti.</p>
<ul>
<li>Right client/patient:</li>
</ul>
<p>-You should make sure that the right client receives the right drug.</p>
<p>-You should only give drugs to the person for whom they are prescribed or recommended for.</p>
<p>-If the patient is wearing an identification bracelet, check the clients name on the identification bracelet with the name, hospital number on the medication card in your hand.</p>
<p>-Alternatively if the patient is conscious and sane simply call out the patients name.</p>
<p>Conti.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="right-drug">Right drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#right-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>â€¢ You must check and double check the package label , the cardex and the medication card or sheet.</p>
<p>â€¢ The right drug label should be read at list three times;</p>
<p>-before removing the drug from the cupboard.</p>
<p>-Before preparing or measuring the actual prescribed does.</p>
<p>-Before replacing the drug on the shelf just before administering the drug to the client.</p>
<p>â€¢ You must prepare the medication you give yourself and DO NOT giver drugs prepared by someone else.</p>
<p>â€¢ You should recheck the order, label and the medication card if a client questions the medication.</p>
<p>A Mentally alert person will notice a change in medication or mention problems that have arisen from the medication.</p>
<p>ensure that you take the following precaution when administering medicine.</p>
<ol>
<li>
<p>All doses are best prepared from the original container.</p>
</li>
<li>
<p>Medicines should not be prepared in the dark</p>
</li>
<li>
<p>You should caution clients about the use of non-labelled pillboxes</p>
</li>
<li>
<p>Do not mix supplies of several tablets or capsules in a single container</p>
</li>
<li>
<p>make sure you check medication label before removing from the shelf before pouring or measuring and when returning to the shelf.</p>
</li>
</ol>
<p>right dose:</p>
<p>-to obtain the right dose you must carefully measure the medicine.</p>
<p>-when pouring solid drugs such as capsules and tablets use proper technique to avoid contaminating the drugs. you should pour the medication in the container cap, and transfer the number of units required from the cap to the medication cup</p>
<p>-if a half a tablet is required a scored tablet may be cut into two pieces with a knife-edge or folded in a clean paper and broken with the fingers. this procedure is easiest with large tablets.</p>
<p>-for small tablets which provide little leverage for fingers ,should be cut with a knife.</p>
<p>-DO NOT ATTEMPT to split NON-SCORED tablets or to divide a dose of a single capsule.</p>
<p>-when you split tablets, give the two halves in successive doses so that any deviation from the prescribed dose due to uneven breakage is levelled out as quickly as possible.</p>
<p>-DO NOT break all the tablets available and mix the halves.</p>
<p>Liquids should be measured with a scale that provides a mark for the required dose e.g. plastic glasses or spoons.</p>
<p>Dosage calculation use the (WIG) calculation; what you want multiply by what's in and divide by what you got equal to amount to give.</p>
<p>Right route:</p>
<p>â€¢ The right route must be used for drug delivery.</p>
<p>â€¢ Most drugs are given orally or by topical application .</p>
<p>â€¢ Ensure the patient understands how the drug is to be taken.</p>
<p>â€¢ sub lingual or chewable tablets should NOT BE swallowed whole.</p>
<p>â€¢ Crush oral drugs if swallowing is difficult or if they are to be taken in liquid form.</p>
<p>â€¢ Demonstrate to the patient the procedures for application of topical drugs.</p>
<p>â€¢ Always check the doctors orders ,the cardex and the treatment sheet to verify the medication route.</p>
<p>Alert the doctor if the route is not in accord with which is recommended for the drug preparation.</p>
<p>Right time:</p>
<ul>
<li>Under normal circumstances the right time for drug administration Is not indicated by the doctor. The doctor only indicates the number of times a drug is to be given.</li>
<li>For example;</li>
</ul>
<p>The hourly interval between doses</p>
<p>The relationship of dose to the clients activity ,such as before or after meals, on rising or retiring, every 4hours, hour, 12 hours.</p>
<p>Patients with poor time orientation, short term memory defects or distracting activity schedule need some systems for guiding them in self medication.</p>
<ul>
<li>Most hospitals have set up routines for intervals and times for medication</li>
<li>Nonetheless you must be familiar with times for medications and the appropriate times for administering them.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>medication in children</p>
<p>Take great care when administering drugs in children;</p>
<p>â€¢ There is high risk of errors due to changes in weight and age.</p>
<p>â€¢ Most drugs have not been tested in children.</p>
<p>â€¢ Many drugs are marked in dosage forms and concentration suitable for adults. Therefore this requires dilution, calculation preparation and administration of very small doses.</p>
<p>â€¢ Children have limited sites for IV (intravenous)administration ,several drugs may be given through the same site.</p>
<p>â€¢ This increases the need for small volumes of fluid and flushing between sites.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-errors">medication errors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-errors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Wrong client</li>
<li>Wrong route</li>
<li>Wrong medication or IV fluids</li>
<li>Wrong dose or IV rate</li>
<li>Omission of dose</li>
<li>Incorrect discontinuation of treatment.</li>
</ul>
<p>drug records</p>
<p>â€¢ Every health institution has its own records for drug accountability,</p>
<p>these are;</p>
<ol>
<li>
<p>patients drug order card/treatment sheet</p>
</li>
<li>
<p>Antibiotic register oral and injectables this has, stock at hand, drugs received from pharmacy, drug issued to patients, date and time issued, signature of the dispensing nurse. this book is balanced at he end of each page.</p>
</li>
<li>
<p>Handing over register for the purpose of handing over drug during each shift.</p>
</li>
<li>
<p>Requisition register for ordering drugs from pharmacy should always be accompanied by the drug register.</p>
</li>
</ol>
<p>drug storage</p>
<ul>
<li>Many factors can change your medication including heat, .air , light, and moisture. This will infective or even harmful.</li>
<li>Drugs require careful storage and handling to maintain their safety and potency.</li>
<li>Every medication has its owner recommended storage condition from room temperature, refrigeration and freezing thus check the specific storage condition.</li>
<li>They must be kept in special spaces secured from access by unauthorized persons.</li>
<li>Storage areas should be kept clean, cool, and dry with no direct sun light.</li>
<li>Drugs should not be placed on the floor.</li>
<li>Sterile substances should be protected from contamination.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Drugs are best kept in their original containers. original containers protect their content.</p>
<ul>
<li>Do not transfer sterile substances from container to container as it increases the probability of contamination. Protect the label from soiling to ensure it remains legible.</li>
<li>Drugs should only be labeled in pharmacy.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Stock control;</p>
<p>This is done by use of a medication stock sheet for each drug .</p>
<p>Content of the sheet is the</p>
<p>-name of the drug</p>
<p>-date and time</p>
<p>-quantity stock</p>
<p>-quantity received</p>
<p>-quantity used</p>
<p>-quantity discarded</p>
<p>-Expiary date.</p>
<p>Use FEFO (first expiry first out) when arranging and issuing drugs , for drugs with the same expiry date use FIFO (first in first out)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-drugs">Classification of drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Classification systems enable us to readily identify the similarities and differences among a large number of medications within or outside a classification.
Drugs can be classified according to;</p>
<ol>
<li>
<p>Body systems as follows;
-Respiratory medications
-Cardiovascular system medications
-Nervous system medications
-GIT medications</p>
</li>
<li>
<p>Their functions or use e.g.
-antidepressant
-diuretics
-analgesics
-antibiotics
3.Their chemical make up
-estrogens
-opioids</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antibiotics-anti-infective-agents">antibiotics/anti- infective agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antibiotics-anti-infective-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antibiotics are among the most commonly used and misused of all drugs.</li>
<li>The inevitable consequence of their widespread use has been the emergence of antibiotic-resistance pathogens.</li>
<li>There different groups of antibacterial agents based on molecular structure and members of each group have a comparable pharmacokinetic and pharmacodynamics.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-antibiotics">Classification of antibiotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-antibiotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Beta- lactam antibiotics</li>
<li>tetracycline</li>
<li>Aminoglycoside</li>
<li>Macrolides</li>
<li>Quinolones</li>
<li>Azoles</li>
<li>Antimycobacterial</li>
<li>Sulphonemides</li>
<li>lincosamides</li>
<li>Unclassified antibiotics like chloramphenicol, spectinomycin and vancomycin</li>
</ul>
<p>Beta â€“lactam antibiotics</p>
<p>All beta â€“lactam compounds ,so named because of their unique four membered lactam ring as a basic chemical structure.</p>
<p>They are sub divided in to</p>
<p>â€¢ Penicillin</p>
<p>â€¢ Cephalosporins</p>
<p>â€¢ Others e.g. carbapenems and monobactams</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="penicillins">penicillins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#penicillins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification-of-penicillins">Classification of penicillins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-penicillins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Narrow spectrum e.g. benzyl penicillin, phenoxy methyl penicillin, penethicillin.</li>
<li>Antistaphylococcal penicillin also called beta-lactamase resistant penicillin, or penicillinase resistant penicillin's e.g. nafcillin, cloxacillin, flucloxacillin, methicillin.</li>
<li>Broad spectrum penicillin e.g. ampicillin, amoxicillin, bacampicillin</li>
<li>Antipseudomonal (extended spectrum penicillin) e.g. carbecillin, carfecillin, ticarcillin, temocillin.</li>
</ul>
<p>Mechanism of action</p>
<ul>
<li>All beta lactam anti biotics inhibit bacteria cell wall synthesis.</li>
<li>By inactivating enzymes located in the bacteria cell membrane .</li>
<li>They are bactericidal agents acting against multiplying bacteria (diving cells) as resting bacteria do not make new cell walls.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Mechanism of bacterial resistance</p>
<p>general mechanism of bacteria resistance to antibiotics including beta â€“lactams are;</p>
<ol>
<li>
<p>Decreased penetration to the target cells</p>
</li>
<li>
<p>Alteration of the target site</p>
</li>
<li>
<p>Inactivation of the antibiotics by a bacterial enzyme e.g. beta â€“lactamase.</p>
</li>
</ol>
<p>pharmacokinetics</p>
<ul>
<li>Benzylpenicillin is destroyed by gastric acid hence it is parenterally administered.</li>
<li>Phenoxymethylpenicillin can be orally given.</li>
<li>Metabolism is in the liver.</li>
<li>Half life less than 2hours.</li>
<li>poor lipid solubility hence they donâ€™t cross the BBB.</li>
<li>distribution in body fluids and tissues with a few exception. they are polar hence extracellular concentrations exceed he intracellular.</li>
<li>Elimination in the kidneys by glomerular filtration and tubular secretion.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="benzyl-penicillin-g">Benzyl penicillin G<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#benzyl-penicillin-g" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Penicillin G is gastric acid unstable is used where high plasma concentration era required.</li>
<li>Maximum plasma concentration is reached after 15 minute of administration</li>
<li>Half life 0.5 hours hence reasonably spaced doses have to be large to maintain a therapeutic concentration high doses can be maintained by use of probenecid.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indication-for-penicillin-g">Indication for penicillin G<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication-for-penicillin-g" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is generally active against gram positive and gram negative cocci, hence indicated for treatment of conditions such as;</p>
<ul>
<li>Otitis media</li>
<li>Gonococcus infection</li>
<li>Throat infections</li>
<li>Streptococcal endocarditis</li>
<li>Meningococcal meningitis</li>
<li>Pneumonia meningitis</li>
<li>actinomycosis</li>
</ul>
<p>cloxacillin</p>
<ul>
<li>half live is 30 minutes</li>
</ul>
<p>indication for infections due to penicillinase (enzyme against penicillin) producing staphylococci especially skin infections and soft tissue infections e.g. cellulitis, otitis externa, impetigo</p>
<p>Dosage; Adults by oral 500mg every 6 hours at least 30 minutes before meals because food decreases absorption.</p>
<p>IM 250mg every 4-6 hours.</p>
<p>IV injection or infusion 500mg every 4-6 hours .</p>
<p>The dose may be increased in severe infections.</p>
<ul>
<li>A child less than 2 years should get <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi mathvariant="normal">/</mi><mn>4</mn></mrow><annotation encoding="application/x-tex">1 / 4</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/4</span></span></span></span></span> of adult dose.</li>
<li>Children 2-10 years should receive <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi mathvariant="normal">/</mi><mn>2</mn></mrow><annotation encoding="application/x-tex">1 / 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/2</span></span></span></span></span> of adult dose.</li>
</ul>
<p>Ampicillin</p>
<ul>
<li>Is gastric stable, it is moderately 50 % absorbed orally as food interferes with absorption..</li>
<li>The drug is concentrated in the bile and it under goes enteral hepatic recycling.</li>
<li>Excretion is through the kidneys 1/3 of the administered drug appears unchanged in urine.</li>
<li>Almost all staphylococcus aureus ,50% of E.coli, and 50% of haemophilus influenza are now resistant .</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications">Indications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Urinary tract infections.</li>
<li>Sinusitis .</li>
<li>Chronic bronchitis.</li>
<li>Invasive salmonellosis gonorrhea</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="side-effects">Side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Diarrhea is quiet common, nausea
Macular rashes resembling measles/rubella - discontinue treatment</p>
<p>Dosage</p>
<p>â€¢ Adults oral 0.25 to 1g 6 hourly at least 30 minutes before food.</p>
<p>â€¢ Different dose are used in treating different condition.</p>
<p>â€¢ Gonorrhea 2-3g is administered as a single dose with probenecid.</p>
<p>â€¢ UTI :500mg every 8 hours IM/IV/infusion.</p>
<p>â€¢ Children under age 10 years give half the adult dose.</p>
<p>amoxicillin</p>
<ul>
<li>This is a broad spectrum penicillin.</li>
<li>A derivative of ampicillin and differs by only one hydroxyl (OH) group.</li>
<li>Have similar anti bacteria spectrum as ampicillin.</li>
<li>when given orally absorption is better than ampicillin.</li>
<li>Absorption is not affected by food in the stomach.</li>
<li>Half life is 1 hourâ€™</li>
</ul>
<p>Indication</p>
<ul>
<li>UTI, otitis media, sinusitis, chronic bronchitis, inversive salmonellosis and gonorrhea.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>dosage</p>
<ul>
<li>Adult dose orally 250mgs 8 hourly which can be doubled in severe infections.</li>
<li>Children up to 10 years of age get 125mg 8 hourly this is doubled in severe infections.</li>
<li>IM/IV adults 500 mg 8 hourly.</li>
<li>IM/IV children get 50-100mg /kg daily in divided doses.</li>
</ul>
<p>Side effects</p>
<p>Diarrhea is less frequent with the use of amoxicillin than ampicillin</p>
<p>co- amoxiclav</p>
<ul>
<li>Amoxicillin ( 250mg or 500mg )can be combined with clavulanic acid (125mg) to make co- amoxiclav.</li>
<li>clavulanic acid itself has no significant anti bacteria activity but binds to beta-lactamase and there by competitively inhibits its activity hence protecting the penicillin. This potentiate the action of penicillin.</li>
</ul>
<p>Indication</p>
<p>Active against beta-lactamase producing bacteria that are resistant to amoxicillin which include; staphylococcus aureus, 50% of E-coli, 15% of H. influenzae strains and klebsiella spp,</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-effect-of-penicillin-s">adverse effect of penicillin's<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-effect-of-penicillin-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>1gE -mediated allergic reactions.</li>
<li>serum sickness.</li>
<li>Dermatological reactions e.g. eryema multiforme ,steven johsons syndrome and exfoliative dermatitis.</li>
<li>Neurologic reactions.</li>
<li>Gastrointestinal reactions.</li>
<li>Hepatobiliary reaction.</li>
<li>Renal reactions.</li>
</ul>
<ul>
<li>
<p>Nursing Administration</p>
<ul>
<li>
<p>Instruct clients that penicillin V, amoxicillin, and amoxicillin-clavulanate may be taken with meals. All others should be taken with a full glass of water 1 hours before meals or 2 hours after.</p>
</li>
<li>
<p>Instruct clients to report any signs of an allergic response such as skin rash, itching, and/or hives.</p>
</li>
<li>
<p>IM injection should be done cautiously to avoid injection into a nerve or an artery.</p>
</li>
<li>
<p>Advise clients to complete the entire course of therapy regardless of presence of absence of symptoms.</p>
</li>
</ul>
</li>
</ul>
<p>cephalosporins are the most frequently prescribed class of antibiotics.</p>
<ul>
<li>They are structurally and pharmacologically related to the penicillins. they have a wider spectrum of activity than penicillins hence they are more expensive.</li>
</ul>
<p>mechanisms of action</p>
<ul>
<li>They are bactericidal, interfere with the bacterial cell wall synthesis.</li>
</ul>
<p>Classification of cephalosporins</p>
<ul>
<li>They are grouped in â€œgenerationsâ€ based on their spectrum of antimicrobial activity.</li>
<li>The first cephalosporins were designated first generation while later, more extended generation cephalosporins.</li>
<li>Each newer generation of cephalosporins has a significantly greater gram negative antimicrobial properties than the preceding generation, in most cases with decreased activity against gram positive organism.</li>
<li>The newer agents have a much longer half life resulting in the decreased of dosing frequency.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>first generation cephalosporins</p>
<ul>
<li>These are generally active against gram positive bacteria. They have moderate activity against gram negative bacterial.</li>
<li>They include;</li>
<li>cephalexin.</li>
<li>Cephaloridine</li>
<li>Cephalothin</li>
<li>Cephapirin</li>
<li>Cefazolin</li>
<li>Cephradine</li>
<li>Cefadroxil.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>second generation cephalosporin</p>
<ul>
<li>They have a greater gram-negative spectrum eg H.influenza n. gonorrhea, E.coli, shigella.</li>
<li>Also some gram-positive organism e.g. clostridium, staphylococcus, streptococcus and pneumococcus.</li>
<li>they are more resistant to beta lactamase.</li>
</ul>
<p>Indication</p>
<ul>
<li>Upper and lower respiratory tract infection</li>
<li>Sinusitis</li>
<li>Otitis media</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Third generation cephalosporins</p>
<ul>
<li>They are especially better than SECOND AND FIRST generation cephalosporin against gram negative bacteria.</li>
<li>These are;</li>
<li>Cefriaxone</li>
<li>Cefperazone</li>
<li>Cefotaxime</li>
<li>Ceftazidine</li>
<li>Cefodizime</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Fourth generation cephalosporin</p>
<ul>
<li>These drugs are very good against both gram positive and gram negative bacteria</li>
<li>Examples ;</li>
<li>Cefepime</li>
<li>Cefditoren and loracarbef.</li>
</ul>
<p>Pharmacokinetic of cephalosporins</p>
<p>Usually given parenterally, though few may be given orally e.g.</p>
<p>cephalexin</p>
<p>cephradine</p>
<p>cefadroxil</p>
<p>Distribution- Wide distribution because of lipid solubility.</p>
<p>Metabolism- in the liver with half life of 1-4 hours.</p>
<p>Excretion- excreted unchanged in urine especially tubular secretion.</p>
<p>â€¢ Dosage should be reduced for patients with renal impairment.</p>
<p>â€¢ Active excretion in the kidneys can be blocked by probenecid.</p>
<p>Indication; Septicemia, Pneumonia, Meningitis, Biliary tract infection, Peritonitis, Urinary tract infection, sinusitis</p>
<p>Unwanted effects of cephalosporins</p>
<ul>
<li>Hypersensitivity is the most common</li>
</ul>
<p>10% of the patients sensitive to penicillin are sensitive to cephalosporin.</p>
<ul>
<li>
<p>Hemorrhage due to interference with blood clotting factors.</p>
</li>
<li>
<p>Use of cephalosporin for more than two weeks causes thrombocytopenia, neutropenia, interstitial nephritis and abnormal liver function tests.</p>
</li>
</ul>
<p>Drug interactions</p>
<ul>
<li>Cephalosporin with alcohol- disulfiram like effects.</li>
</ul>
<p>Patient should avoid alcohol when taking the drug.</p>
<ul>
<li>
<p>Cephalosporin with high frusemide and torsemide are likely to cause nephrotoxicity.</p>
</li>
<li>
<p>Cephalosporin with aminoglycoside â€“ nephrotoxicity.</p>
</li>
<li>
<p>Cephalosporin with oral anticoagulant like warfarin may cause bleed because both interfere with clotting factors.</p>
</li>
</ul>
<p>Ceftriaxone (Rocephin)</p>
<ul>
<li>Half life 4hours hence requires to be administered once a daily.</li>
</ul>
<p>Indication; Septicemia, Pneumonia, UTI, RTI, soft tissue infections.</p>
<p>Contraindication;</p>
<ul>
<li>penicillin sensitivity</li>
<li>Administer with caution in renal impairment.</li>
<li>Do not administer to infants below 6 weeks.</li>
<li>Cephalosporin hypersensitivity.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<ul>
<li>
<p>Nursing administration</p>
<ul>
<li>
<p>Instruct clients to complete the prescribed course of therapy, even though symptoms may resolve before the full course of antimicrobial treatment is completed.</p>
</li>
<li>
<p>Advise clients to take oral cephalosporins with food.</p>
</li>
<li>
<p>Instruct clients to store oral cephalosporin suspensions in a refrigerator.</p>
</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tetracyclines">tetracyclines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tetracyclines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>First isolated in 1948, isolated from Streptomyces fungi.</li>
<li>Naturally occurring;
-tetracycline
-chlortetracycline
-oxytetracycline
-demeclocycline
Semi-synthetic
Doxycycline, lymecycline, meclocycline, methacyline, minocycline, rolitetracycline.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Tetracyclines are partially absorbed in the alimentary tract EXCEPT minocycline and doxycycline which have a good absorption.</li>
<li>Absorption is increased in absence of food</li>
<li>antacids and milk decrease absorption as they contain metals like magnesium, calcium, aluminum ,iron which chelate with them.</li>
<li>Distribution is narrow but they cross the placenta barrier.</li>
<li>Metabolism is in the liver</li>
<li>Excretion in urine via glomerular filtration unchanged.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacodynamics">pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Tetracyclines are broad spectrum bacteriostatic.</li>
<li>They inhibit protein synthesis by binding to the 30s sub unit of the bacterial ribosomes.</li>
<li>Indication; psittacosis, pneumonia, brucellosis, shigellosis, rickettsia diseases e.g. Q fever, typhus, cholera, borrelia ( lame disease, relapsing fever)acne ,amoebic dysentery, spirochetes, protozoa, bacillary dysentery and chlamydia infections</li>
</ul>
<p>aminoglycosides</p>
<p>Examples;</p>
<p>Gentamycin, kanamycin, amikacin, tobramycin, streptomycin, neomycin,</p>
<p>They are always used in combination of beta lactam antibiotic because of their synergism effect.</p>
<p>pharmacokinetics; they are water soluble hence hey not absorbed through the gut .</p>
<p>They are given IM/IV route</p>
<p>distribution; narrowly distributed hence do not cross the blood brain barrier.</p>
<p>Pharmacodynamics/mechanism of action</p>
<ul>
<li>they are bactericidal act by binding to the 30s ribosomal sub unit and they inhibit bacterial protein synthesis.</li>
<li>Drug interaction;</li>
<li>-muscle weakness or paralysis when given with neural muscular blocking agent.</li>
<li>Ototoxicity when given with ototoxic agent.</li>
<li>Synergic effect when give with beta lactam antibiotic .</li>
<li>Bone marrow depression when give with bone marrow depressing agents.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Unwanted effects</p>
<ul>
<li>Have serious un wanted effects and that are dose dependent</li>
</ul>
<p>these are; nausea, vomiting, diarrhea , lethargy, hypersensitivity and headache.</p>
<p>Others are ,nephrotoxicity, ,ototoxicity, bone marrow depression, neuromuscular blockade, palpitation, numbness, tingling sensation, depression and disorientation.</p>
<p>Contraindication</p>
<ul>
<li>Patients with hearing deficit because thy damage the 8^{th} cranial nerve(vestibular cochlear/auditory nerve)</li>
<li>Myasthenia gravis since they cause neural muscular blockade.</li>
<li>Patients with severe renal disease as they are nephrotoxic</li>
<li>Hypersensitivity</li>
<li>Neonates, geriantrics, infant, botulism and patients with packinsonism</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Gentamycin</p>
<ul>
<li>This is the most active aminoglycoside.</li>
<li>Half life 2-3 hours and reaches peak plasma concentration within 30 minute.</li>
<li>route of administration IM/IV.</li>
<li>indication gram negative and gram positive; septicemia, meningitis, endocarditis, UTI, neonatal sepsis and acute pyelonephritis among other infections.</li>
</ul>
<p>Contraindications; is like for the other aminoglycoside.</p>
<p>dosage adults GIVE 2-5 MG/kg body weight daily 8hrly for 7 days. Reduce the dose in renal impairment and the elderly.</p>
<p>Children below 2wks 3mgs/kg body weight every 12 hours.</p>
<p>Those aged 2wks-12years 2mg/kg every 8 hourly.</p>
<p>Aminoglycoside can replace penicillin in penicillin sensitive patients</p>
<ul>
<li>
<p>Gentamycin combine with penicillin have a synergic antibiotic effect expands the spectrum of antibiotics activity and prevent emergence of resistance..</p>
</li>
<li>
<p>Neomycin and kanamycin can be used for hepatic coma to reduce normal flora and therefore ammonia gas formation.</p>
</li>
<li>
<p>Amikacin has broadest antibacterial spectrum because it is stable to 8 of the 9 classified aminoglycoside inactivating enzymes whereas gentamycin is inactivated by five of them.</p>
</li>
<li>
<p>Amikacin is indicated for serious gram negative infections resistant to gentamycin.</p>
</li>
<li>
<p>Neomycin and framycetin are too toxic for systemic use hence used topically for treatment of aer, nose and skin infections,</p>
</li>
<li></li>
</ul>
<p>quinolones</p>
<ul>
<li>these are broad spectrum antibiotic though some like nalidixic acid and cinoxacin have a narrow antibacterial spectrum.</li>
</ul>
<p>other newer quinolones include</p>
<p>norfloxacin</p>
<p>Ciprofloxacin</p>
<p>Ofloxacin</p>
<p>Levofloxacin</p>
<p>Acrofloxacin</p>
<p>pefloxacin</p>
<p>Pharmacodynamics</p>
<ul>
<li>They are act by inhibiting bacterial DNA gyrase the enzyme that maintains the Helical twist/structure of the DNA.</li>
<li>They are bactericidal but some are bacteriostatic</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Pharmacokinetics</p>
<ul>
<li>
<p>Quinolones are absorbed in the gut though aluminum and magnesium antacid interfere with the absorption.</p>
</li>
<li>
<p>Distribution wide distribution such that they cross the placenta and are distributed in breast milk.</p>
</li>
<li>
<p>They are concentrated in the lungs, kidneys, prostate, and phagocytes.</p>
</li>
<li>
<p>They donâ€™t cross the BBB except ofloxacin and pefloxacin.</p>
</li>
<li>
<p>Metabolism they under go hepatic metabolism with a variable half life</p>
</li>
<li>
<p>Norfloxacin and ciprofloxacin half life of 2-3 hours, 5 hour ofloxacin, perfloxacin10 hour.</p>
</li>
<li>
<p>Excretion/elimination via renal and biliary.</p>
</li>
<li></li>
</ul>
<p>Adverse effects</p>
<p>â€¢ GIT effects like nausea, vomiting, and diarrhea</p>
<p>â€¢ CNS effects like dizziness, headache, confusion and convulsions.</p>
<p>â€¢ Allergic reactions in form of skin rashes,</p>
<p>They are reported to cause arthropathy in immature animals hence not recommended for children and adolescence unless the benefit out ways the risk.</p>
<p>â€¢ Photosensitivity</p>
<p>â€¢ Bone marrow suppression.</p>
<p>contraindication</p>
<ul>
<li>History of epilepsy or seizures.</li>
<li>Glucose-7-phosphatedehydrogenase deficiency.</li>
<li>Myasthenia gravis.</li>
<li>Pregnancy and breast feeding.</li>
</ul>
<p>Indication; quinolones are basically indicated for UTI ciprofloxacin has a broader spectrum of antibacterial activity.</p>
<p>These are often caused by gram negative organisms like E.coli, proteus spp. Therefore infections like complicated UTI, inversive otitis externa, salmonella typhi infection, gonorrhea, bacteria prostatitis and cervicitis.</p>
<p>They are also indicated for anthrax which has been used as a biological warfare.</p>
<p>So the soldiers can take quinolones just before they go to war just in case they are at risk of exposure to anthrax.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-interactions">drug interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>These antibiotics are enzyme (cytochrome p-450) inhibitor hence interact with other drugs at metabolism e.g. theophylline, warfarin, and caffeine.</li>
<li>NSAIDS and quinolones causes an increase in the risk of convulsion.</li>
<li>NSAIDS tends to potentiate the effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ciprofloxacin">ciprofloxacin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ciprofloxacin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>half life is 3hours</li>
<li>It is mostly effective against gram negative bacteria e.g. salmonella, shigella, Campylobacter, pseudomonas, enterobacteria.</li>
<li>It is indicated for chlamydia and some mycobacteria</li>
</ul>
<p>Indication UTI and genital urinary tract infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dosage">Dosage<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Oral 250-750mg bd.</li>
<li>IV infusion (30-60) 200-400mg twice daily.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>Cationic compounds (aluminum-magnesium antacids, iron salts, sucralfate, milk and dairy products) decrease absorption of ciprofloxacin;</li>
</ul>
<p>Administer cationic compounds 6 hrs. before or 2 hrs after ciprofloxacin</p>
<ul>
<li>Plasma levels of theophylline can be the increased with concurrent use of ciprofloxacin;</li>
</ul>
<p>Monitor levels and adjust dosage accordingly.</p>
<ul>
<li>Plasma levels of warfarin can be increased with concurrent use of ciprofloxacin;</li>
</ul>
<p>Monitor prothrombin time and INR, and adjust the dosage of warfarin accordingly.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="administration">Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Ciprofloxacin is available in oral and intravenous forms.</li>
<li>Decrease doses of ciprofloxacin in clients with renal dysfunction.</li>
<li>Intravenous ciprofloxacin should be administered slowly over 60 min.</li>
<li>For inhalation anthrax infection, ciprofloxacin is administered every 12 hrs for 60 days.</li>
<li>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</li>
</ul>
<p>MACROLIDES</p>
<ul>
<li>These broad spectrum antimicrobials including;</li>
<li>Erythromycin</li>
<li>Azithromycin</li>
<li>Spiramycin</li>
<li>Clarithromycin</li>
</ul>
<p>Pharmacodynamics; they inhibit protein synthesis by irreversibly binding to ribosomal 50s sub unit of the sensitive micro-organism hence they are bacteriostatic.</p>
<p>But sometimes can be bactericidal if the dose is high.</p>
<p>Example azithromycin is bactericidal against streptococcus pyogenes, streptococcus pneumonia and hemophilus influenza</p>
<p>pharmacokinetics</p>
<ul>
<li>They can be administered orally though erythromycin is unstable in acidic environment.</li>
<li>Distribution is good except that the drugs do not cross the BBB</li>
<li>Metabolism is in the liver and have variable half life.</li>
</ul>
<p>E.g. clarithromycin has4.5 hours , azithromycin less than 3.5 hours and erythromycin has1.4 to 2 hours.</p>
<ul>
<li>
<ul>
<li><strong>Therapeutic Uses/indication</strong></li>
</ul>
</li>
</ul>
<ul>
<li>Used to treat infections in <strong>clients with a penicillin allergy</strong>, such as for <strong>prophylaxis against rheumatic fever</strong> and <strong>bacterial endocarditis</strong>.</li>
<li>Used for clients <strong>with Legionnairesâ€™ disease, whooping cough</strong> (pertussis), <strong>and acute diphtheria</strong> (eliminates the carrier state of diphtheria) .</li>
<li>Used for chlamydia infections (<strong>urethritis and cervicitis; pneumonia</strong> caused by Mycoplasma pneumoniae**; respiratory tract infections** caused by <strong>Streptococcus pneumoniae and Neisseria gonorrhea.</strong></li>
</ul>
<p>Complications /Side/Adverse Effects; Nursing Interventions/Client Education</p>
<p>Gastrointestinal discomfort</p>
<p>â€¢ (nausea, vomiting, epigastric pain) Administer erythromycin with meals.</p>
<p>â€¢ Observe for GI symptoms and notify the provider.</p>
<p>Hepatotoxicity (abdominal pain, lethargy, jaundice) . Instruct clients to notify the provider because the medication should be discontinued. Prolonged QT interval causing dysrhythmias and possible sudden cardiac death</p>
<p>â€¢ Use in clients with prolonged QT intervals is not recommended.</p>
<p>â€¢ Avoid concurrent use with medications that affect hepatic drug metabolizing enzymes.</p>
<p>Contraindications/Precautions.</p>
<p>â€¢ pre-existing liver disease</p>
<p>erythromycin</p>
<p>â€¢ Erythromycin is the commonest macrolide in use.</p>
<p>Pharmacokinetic;</p>
<p>Erythromycin is inactivated by gastric enzymes hence it is administered as protected enteric coated tablets.</p>
<p>It is hydrolyzed in the 1^{st} phase metabolism to release the active erythromycin.</p>
<p>It is dissolved and absorbed in the small intestines where it undergoes enetro hepatic recirculation.</p>
<p>â€¢ Distribution is very good as it is well distributed in the spleen, liver, placenta, breast milk and inflamed meninges.</p>
<p>â€¢ Excretion 90% in feaces and small amounts in urine.</p>
<p>Dosage and route of administration</p>
<ul>
<li>Orally adults and children above 8years 250-500mg 6 hourly.</li>
<li>Maximum dose is 4g in severe infections.</li>
<li>Children up to 2years 125mg 6hourly.</li>
<li>IV infusion 25-50/kg body wt. daily as continuous infusion.</li>
</ul>
<p>Drug interaction</p>
<p>Macrolides are enzyme inhibitor and they interfere with the metabolism of drugs like warfarin, carbamazepine, theophylline , corticosteroids, oral contraceptives, digoxin, and cyloserine and sodium valproate</p>
<ul>
<li>food tends to decrease the absorption of macrolide, hence should be given one hour before food or 2-3 hours after meals.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Azithromycin</p>
<ul>
<li>azithromycin is derived from erythromycin by adding a methylated nitrogen into the lactogen ring,</li>
<li>Its specrum of activity and clinical uses are virtually identical to those of clarithromycin.</li>
<li>Azithromycin is active against mycobacteria avium complex and toxoplasma gondii</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sulphonamide">sulphonamide<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sulphonamide" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>These are among the first antibacterial drugs to be discovered in 1935.</li>
<li>Examples</li>
<li>Sulphfamethoxazole,</li>
<li>sulphadiazine,</li>
<li>sulfisoxazole,</li>
<li>sulphadimidine,</li>
<li>sulfasazine,</li>
<li>sulfametopyrazine,</li>
<li>sulphaloxate</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>they have good absorption except a few of them sulpadiazine and which are poorly absorbed in the gut.</li>
<li>Distribution widely distributed in body tissues and fluid including crossing the BBB.</li>
<li>They are metabolized in the liver withhalf life of 10 hours.</li>
<li>Majority are excreted in urine hence dose should be reduced in renal impairment.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side and adverse effects</p>
<p>â€¢ Hypersensitivity including Stevens-Johnson syndrome</p>
<ul>
<li>
<p>Do not administer TMP-SMZ to clients with allergies to: Sulfonamides (sulfa), Thiazide diuretics [hydrochlorothiazide (HCTZ)] , Sulfonylurea-type oral hypoglycemics [tolbutamide (Orinase)], Loop diuretics [furosemide (Lasix)]</p>
</li>
<li>
<p>Stop TMP-SMZ at the first indication of hypersensitivity, such as rash.</p>
</li>
</ul>
<p>â€¢ Blood dyscrasias (hemolytic anemia, agranulocytosis, aplastic anemia) â€¢</p>
<p>-Draw the clientâ€™s baseline and periodic CBC levels to detect any hematologic disorders.</p>
<ul>
<li>Observe for any bleeding episodes, sore throat, or pallor. â€¢ If the above symptoms occur, instruct clients to notify the provider.</li>
</ul>
<p>â€¢ Crystalluria</p>
<ul>
<li>
<p>Maintain adequate oral fluid intake.</p>
</li>
<li>
<p>Instruct client to drink 2 to 3 L/day.</p>
</li>
</ul>
<p>â€¢ Kernicterus (jaundice, increased bilirubin levels)</p>
<ul>
<li>
<p>Avoid administering TMP-SMZ to women who are pregnant near term, breastfeeding mothers, and infants younger than 2 months.</p>
</li>
<li>
<p>Monitor the clientâ€™s liver function. Photosensitivity</p>
</li>
<li>
<p>Avoid prolonged exposure to sunlight, use sunscreen, and wear appropriate</p>
</li>
</ul>
<p>cotrimoxazole(sulphonamides 400mg/trimethoprim 80mg) serpin.</p>
<ul>
<li>. This has replaced use of sulphonamide due to resistance.</li>
</ul>
<p>Dosage for children</p>
<ul>
<li>6weeks to 5months 120mg every 12 hours</li>
<li>6months to 5years 240mg 10 hourly</li>
<li>6years to 12 years 480mg 12hourly</li>
</ul>
<p>Indications</p>
<ul>
<li>Pneumocystic carinii pneumonia</li>
<li>Toxoplasmosis</li>
<li>UTI</li>
<li>sometimes chronic bronchitis</li>
<li>Others sulphonamides are used for topical application for prophylaxis of burns, leg ulcers, pressure sores because of their wide anti bacteria spectrum</li>
</ul>
<p>drug Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>
<p>Sulfonamides can increase the effects of warfarin (Coumadin), phenytoin (Dilantin), sulfonylurea oral hypoglycemic, and tolbutamide (Orinase) by inhibiting hepatic metabolism.</p>
</li>
<li>
<p>dosages of these medications may be required during therapy.</p>
</li>
</ul>
<p>Nursing Administration Instruct clients to take the drugs on an empty stomach with a full glass of water. (Plenty of oral fluids)</p>
<ul>
<li>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</li>
</ul>
<p>Nursing Evaluation of Medication Effectiveness</p>
<ul>
<li>Depending on therapeutic intent, effectiveness may be evidenced by: Improvement of infection symptoms, such as improvement of urinary tract symptoms (decreased frequency, burning, and pain during urination) and negative urine cultures</li>
</ul>
<p>AZOLES</p>
<ul>
<li>This includes several classes of drugs e.g. metronidazole and tinidazole which have both anti bacteria and anti protozoal activity.</li>
<li>others are fluconazole, itraconazole econazole, ketoconazole, and miconazole which are anti fungal drugs .( to be covered under anti fungal drugs)</li>
<li>others are mebendazole, thiabendazole, which are anti helminths (to be covered under ant-helminths)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>metronidazole</p>
<ul>
<li>It is very effective against anaerobic bacterial and protozoa.</li>
</ul>
<p>Pharmacodynamics/MOA</p>
<ul>
<li>metronidazole is converted into an active form and bind to the bacterial DNA and prevents nucleic acid formation which consequently interferes with bacterial replication hence its bacteriostatic.</li>
</ul>
<p>Pharmacokinetics;</p>
<p>well absorbed after oral and rectal administration</p>
<p>Distribution is wide.</p>
<p>Metabolism is in the liver.</p>
<p>It is excreted in urine partly unchanged and partly as metabolite.</p>
<p>Half life is 8 hours.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications">indications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>used for treatment of sepsis caused by orgasms like Bacteroides
and anaerobic cocci.</li>
<li>Intra-abdominal infections</li>
<li>Septicemia, wounds, pelvic infection</li>
<li>Osteomyelitis.</li>
<li>pelvic infections</li>
<li>Infections of the brain and lungs.</li>
<li>Used in prevention of post operative infection especially after bowel, antibiotic related colitis, eg pseudomembranous colitis, amoebiasis EH</li>
<li>other indications include giardiasis, acute ulcers, gingivitis, and dental infections. and anaerobic vaginosis</li>
<li>Treatment of protozoal infections (intestinal amoebiasis, giardiasis, trichomoniasis) and obligate anaerobic bacteria (Bacteroides fragilis, antibiotic-induced Clostridium difficile, Gardnerella vaginalis)</li>
<li>Treatment of H. pylori in clients who have peptic ulcer disease in combination with tetracycline and bismuth salicylate.</li>
</ul>
<p>Dosage and route of administration</p>
<p>Established anaerobe are usually treated for 7 days.</p>
<p>â€¢ The dose per oral is then 8oomgs initially for 3 days then 400mg or 500mg 8 hourly, or just 400mg 8 hourly for 7 days.</p>
<p>â€¢ By rectum 1gm every 8 hours for 3 days then1gm 12 hourly.</p>
<p>â€¢ By infusion 500mg 8 hourly.</p>
<p>â€¢ In children 7.5/kg every 8 hours by any route.</p>
<p>for surgical prophylaxis</p>
<p>â€¢ Per oral 400mg 8 hourly started 24 hours before surgery then continued postoperatively by IV infusion until oral administration can be resumed for 2days</p>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Gastrointestinal discomfort (nausea, vomiting, dry mouth, and metallic taste) Advise clients to observe for symptoms and to notify the provider.</p>
<p>Darkening of urine Advise clients that this is a harmless effect of metronidazole.</p>
<p>CNS symptoms (numbness of extremities, ataxia, and seizures)</p>
<p>Advise clients to notify the provider if symptoms occur.</p>
<p>Stop metronidazole.</p>
<p>Contraindications/Precautions</p>
<ul>
<li>Use cautiously in clients with renal dysfunction to prevent accumulation of toxic levels with prolonged use.</li>
<li>Avoid use during the first trimester of pregnancy and use with caution during the rest of pregnancy because metronidazole can pass through the placenta.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Interactions</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>â€¢ Alcohol causes a disulfiram-like reaction/ Advise clients to avoid alcohol consumption.</p>
<p>Metronidazole inhibits inactivation of warfarin.</p>
<p>â€¢ Monitor prothrombin time and INR, and adjust warfarin dosage accordingly</p>
<p>Nursing Administration</p>
<p>â€¢ Administer by oral or IV route.</p>
<p>â€¢ Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<p>Nursing Evaluation of Medication Effectiveness</p>
<p>â€¢ Depending on therapeutic intent, effectiveness may be evidenced by: Improvement of symptoms (resolution of bloody mucoid diarrhea, formed stools, negative stool results for ameba and Giardia, , decrease or absence of watery vaginal/ urethral discharge, negative blood cultures for anaerobic organisms in the CNS, blood, bones and joints, and soft tissues)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="chloramphenicol">Chloramphenicol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chloramphenicol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is soluble in water and poorly soluble in alcohol</li>
<li>Chloramphenicol succinate which is used for parenteral administration is highly water soluble</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>The usual dosage of chloramphenicol is 50-100mg/kg/d.</li>
<li>After oral administration crystalline chloramphenicol is rapidly and completely absorbed.</li>
<li>A 1g oral dose produces blood levels between 10and 15mcg/ml</li>
<li>Chloramphenicol palmitate is a pro drug that is hydrolyzed in the intestine to yield free chloramphenicol.</li>
</ul>
<p>Pharmacodynamic chloramphenicol potent inhibitor of microbial protein synthesis.</p>
<p>It binds to the 50s sub unit of the bacteria ribosome</p>
<p>It is bacteriostatic, broad spectrum against both aerobic and anaerobic gram positive and gram negative bacterial.</p>
<p>clinical uses</p>
<ul>
<li>it is rarely used due to it potential toxicity and bacterial resistance.</li>
<li>Used to treat; serious rickettsia infections such as typhus and rocky mountain spotted fever.</li>
<li>Alternative for beta lactam antibiotics for treatment of meningococcal meningitis and pneumococcal meningitis</li>
<li>Topical eye infections</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Adverse reactions</p>
<p>GIT disturbance nausea, vomiting and diarrhea.</p>
<p>-This rare in children.</p>
<p>-Oral and vaginal candidiasis may occur due to alteration of the normal flora.</p>
<p>Born marrow disturbance</p>
<p>-suppression of the born marrow</p>
<p>-Aplastic anemia it is irreversible and fatal</p>
<p>Toxicity for new born infants:</p>
<ul>
<li>new born infants lack glucuronic acid for the conjugation and detoxification of chloramphenicol.</li>
</ul>
<p>-Therefore drugs may accumulate resulting in gray baby syndrome with vomiting flaccidity, hypothermia, gray colour, shock and collapse</p>
<p>ANTI-FUNGAL DRUGS</p>
<ul>
<li>Fungi are saprophytic organism as they lack chlorophyll which is present in plants.</li>
<li>Many fungi are commensals in the bodies of healthy people but pose a problem when immune system is compromised.</li>
<li>Since 1970s incidence of fungal infections has increased due to the following reasons</li>
</ul>
<ol>
<li>Increase use of broad spectrum antibiotics which decrease non pathogenic bacterial that compete with the fungi.</li>
<li>Increases number of people with immunosuppression, use of cancer chemotherapy, and immunosuppressants, diabetes mellitus or have burns.</li>
<li>Inversive procedures may introduce fungi into systemic circulation.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and non opportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis)</li>
<li>Resistant is usually due to a</li>
</ul>
<p>1.decrease in membrane ergosterol content
2.Or a change in membrane structure</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-anti-fungal-drugs">Classification of anti fungal drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-anti-fungal-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Topical anti-fungal</li>
</ol>
<ul>
<li>Polyenes anti-fungal agents e.g. nystatin</li>
<li>Benzoic acid</li>
</ul>
<ol start="2">
<li>Systemic anti fungal</li>
</ol>
<ul>
<li>Polyenes anti-fungal agents e.g. amphotericin B</li>
<li>Fluorinated pyramids e.g. only flu cytosine</li>
<li>Azoles ;imidazole and triazoles
-Imidazole's include clotrimazole and econazole, sulconazole, fenticonazole, ketoconazole, and miconazole
-triazole include fluconazole, itraconazole and voriconazoles among others</li>
</ul>
<ol start="3">
<li>Miscellaneous; terbinafine and Griseofulvin</li>
</ol>
<ul>
<li>
<p>Polyenes anti-fungal agents; nystatin and amphotericin B are the only ones in clinical use.</p>
<ul>
<li>MOA; they act by binding to the ergostel in fungal cell walls forming pores or channels which increase permeability and allow leakage of fungal cellular molecules e.g. potassium and magnesium</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and nonopportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis).</li>
<li>Some antifungals treat superficial fungal infections:</li>
<li>dermatophytic infections (tinea Pedis [ringworm of the foot], tinea cruris [ringworm of the groin]); candida infections of the skin and mucous membranes; and fungal infections of the nails (Onychomycosis).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="amphotericin-b">Amphotericin B<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#amphotericin-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Amphotericin B has been available for use since 1950s</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="moa-pharmacodynamics">MOA/PHARMACODYNAMICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#moa-pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Amphotericin B deoxycholate is an antifungal agent that acts on fungal cell membranes to cause cell death.</li>
<li>Depending on concentration, these agents can be fungi static (slows growth on the fungus) or fungicidal (destroys the fungus).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetics">PHARMACOKINETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>administered intravenously</li>
<li>wide distribution though poor penetration to the CNS</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>90</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">90 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">90%</span></span></span></span></span> bound to plasma, half life of 24 and 15 days</li>
<li>excretion predominantly via the biliary route(slow excretion over a period of days)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and nonopportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis).</li>
</ul>
<p>side/ adverse reactions</p>
<p>Infusion reactions (fever, chills, rigors, and headache) 1 to 3 hr. after initiation</p>
<p>â€¢ Pretreat with diphenhydramine (Benadryl) and acetaminophen.</p>
<p>â€¢ Meperidine (Demerol), Dantrolene, or hydrocortisone may be given for rigors.</p>
<p>Thrombophlebitis Observe infusion sites for signs of erythema, swelling, and pain.</p>
<p>â€¢ Rotate injection sites.</p>
<p>â€¢ Administer in a large vein and administer heparin before infusing amphotericin B</p>
<p>Nephrotoxicity</p>
<p>â€¢ Obtain baseline kidney function (BUN and creatinine) and do weekly kidney function test, Monitor I&amp;O.</p>
<p>â€¢ Infuse 1 L of saline on the day of amphotericin B infusion.</p>
<p>Hypokalemia</p>
<p>â€¢ Monitor electrolyte levels, especially potassium.</p>
<p>â€¢ Administer potassium supplements accordingly.</p>
<p>Bone marrow suppression â€¢ Obtain baseline CBC and hematocrit, and monitor weekly.</p>
<p>ketoconazole</p>
<p>Hepatotoxicity (anorexia, nausea, vomiting, jaundice, dark urine, and clay-colored stools)</p>
<p>â€¢ Obtain baseline liver function studies and monitor liver function monthly.</p>
<p>â€¢ If symptoms occur, notify provider and discontinue medication.</p>
<p>Effects on sex hormones:</p>
<p>â€¢ In males, gynecomastia (enlargement of breast), decreased libido, erectile dysfunction</p>
<p>â€¢ In females, irregular menstrual flow</p>
<p>Advise clients to observe for these symptoms and to notify the provider.</p>
<p>Contraindications/Precautions</p>
<ul>
<li>Antifungals are contraindicated in clients with renal dysfunction because of the risk for nephrotoxicity.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>Aminoglycosides (gentamicin, streptomycin, cyclosporine) have additive nephrotoxic risk when used concurrently with antifungal medications.</li>
</ul>
<p>Avoid use of these antimicrobials when clients are taking amphotericin B due to additive nephrotoxicity risk.</p>
<ul>
<li>Antifungal effects of Flucytosine (Ancobon) are potentiated with concurrent use of amphotericin B.</li>
</ul>
<p>Potentiating the effects of flucytosine allows for a reduction in amphotericin B dosages.</p>
<p>Nursing Administration</p>
<ul>
<li>Amphotericin B is highly toxic and should be reserved for severe life-threatening fungal infections</li>
</ul>
<p>Systemic infection for mucocutaneous infections</p>
<p>Griseofulvin</p>
<p>â€¢ Griseofulvin is a very insoluble fungistatic drug derived from a species of penicillium.</p>
<p>â€¢ It is only used in the systemic treatment of dermatophytosis.</p>
<p>â€¢ It is administered in a microcrystalline at a dose of 1g per day.</p>
<p>â€¢ Absorption is improved when it is given with fatty foods.</p>
<p>â€¢ Nail infections may require therapy for months to allow regrowth of the new protected nail and is often followed by relapse.</p>
<p>Topical anti fungal</p>
<p>Nystatin</p>
<p>â€¢ Nystatin is a polyene macrolide much like amphotericin B.</p>
<p>â€¢ it is too toxic for parenteral administration and is only used topically</p>
<p>â€¢ nystatin is currently available in creams, ointments, suppositories and other forms for application to skin and mucous membrane.</p>
<p>â€¢ nystatin is active against most candida species and is most commonly used for suppression of local candida infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-mycobacterial-agents-anti-tuberculosis">Anti mycobacterial agents (anti-tuberculosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-mycobacterial-agents-anti-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The main mycobacterial infection are the tuberculosis and leprosy. The treatment of tuberculosis assumes the principle of combination therapy for two main reasons,
I. To prevent emergency of resistance (tubercle bacilli develops resistant very fast when monotherapy is used).
II. To reduce the rate of spread by reducing bacterial population rapidly.
For this reason the available tablets contain multiple drugs in a fixed dose combination (FDC).</li>
</ul>
<p>anti-TB contiâ€™</p>
<ul>
<li>Anti TB are divided into two first line and second line</li>
</ul>
<p>I. First line; this is not a universal principle but depend on local scientific evidence.</p>
<p>The drugs include isoniazid, ethambutol, pyrazinamide and streptomycin.</p>
<p>ii Second line drugs include capreomycin, cycloserine, clarithromycin and ciprofloxacin</p>
<p>Anti TB cont.â€™</p>
<ul>
<li>First initial phase: takes two months and three drugs are used concomitantly.</li>
<li>These includes Isoniazid (H), Rifampicin (R) Pyrazinamide (Z) plus (Ethambutol or streptomycin) if resistant organism are suspected. This combination reduces bacterial population rapidly.</li>
<li>Continuation phase takes four months and two drugs are used these are isoniazid and rifampicin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="isoniazid">ISONIAZID<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#isoniazid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Expected Pharmacological Action</li>
<li>This medication is highly specific for mycobacteria. Isoniazid inhibits growth of mycobacteria by preventing synthesis of mycolic acid in the cell wall.</li>
<li>Therapeutic Uses; Indicated for active and latent tuberculosis</li>
<li>Latent: INH only - 6 to 9 months</li>
<li>Active: Multiple medication therapy including INH, for a minimum of 6 months</li>
<li>The initial phase (induction phase) focuses on eradicating the active tubercle bacilli, which will result in non infectious sputum.</li>
<li>The second phase (continuation phase) works toward eliminating any other pathogens in the body.</li>
</ul>
<p>isoniazid cont.â€™</p>
<ul>
<li>Length of treatment varies and may be as short as 6 months for medication-sensitive tuberculosis (2 months for the initial phase and 4 months for the continuation phase) or as long as 24 months for medication-resistant infections.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<ul>
<li>Allergic skin eruptions are the commonest side effects</li>
<li>Others are fever , GIT disturbance</li>
<li>Peripheral neuropathy (tingling, numbness, burning, and pain resulting from deficiency of pyridoxine, vitamin B6 ).</li>
</ul>
<p>Instruct clients to observe for symptoms and to notify the provider if symptoms occur.</p>
<p>Administer 50 to 200 mg of vitamin B6 daily.</p>
<ul>
<li>Hepatotoxicity (anorexia, malaise, fatigue, nausea, and yellowish discoloration of skin and eyes).</li>
</ul>
<p>Instruct clients to observe for symptoms and notify the provider if symptoms occur.</p>
<p>Monitor liver function tests.</p>
<p>Instruct clients to avoid consumption of alcohol.</p>
<p>Medication may need to be discontinued if liver function test results are elevated.</p>
<p>Contraindications/Precautions</p>
<p>INH is contraindicated for clients with liver disease.</p>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>INH inhibits metabolism of phenytoin, leading to buildup of medication and toxicity.</p>
<p>Ataxia and incoordination may indicate toxicity.</p>
<p>Monitor the clientâ€™s levels of phenytoin.</p>
<p>Dosage of phenytoin may need to be adjusted based on phenytoin levels.</p>
<p>Concurrent use of alcohol, rifampin, and pyrazinamide increases the risk for hepatotoxicity.</p>
<p>Instruct clients to avoid alcohol consumption.</p>
<p>Monitor liver function.</p>
<p>Interactions cont.'</p>
<ul>
<li>Induce liver enzymes ,hence affect the metabolism of warfarin, glucocorticoids, narcotics, oral anti diabetes, dapsone and estrogens and oral contraceptives.</li>
<li>Advice clients on oral contraceptives to change method of family planning or use a back up method.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing Administration</p>
<p>â€¢ Administer by oral route</p>
<p>â€¢ For active tuberculosis, direct observation therapy (DOT) is done to ensure adherence.</p>
<p>â€¢ Advise clients to take INH 1 hours before meals or 2 hours after.</p>
<p>â€¢ If gastric discomfort occurs, the client may take INH with meals.</p>
<p>â€¢ Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<p>rifampicin</p>
<ul>
<li>This is one of the most active anti TB .it is also active against gram positive and gram negative bacteria.</li>
<li>Mechanism of action: Rifampin is bactericidal as a result of inhibition of protein synthesis.</li>
<li>Indications:</li>
</ul>
<p>Rifampin is a broad-spectrum antibiotic effective for gram-positive and gram-negative bacteria,</p>
<p>M. tuberculosis, and M. Leprae.</p>
<p>pharmacokinetics</p>
<ul>
<li>Given orally</li>
<li>Has a wide distribution</li>
<li>It causes orange tinge coloration to saliva ,sputum, tears, sweat and urine.</li>
<li>It is excreted in urine and under goes enterohepatic recycling.</li>
<li>Metabolism is in the liver and the metabolites has anti bacterial activity but poorly absorbed from the gut.</li>
<li>Half life is one to five hours but reduces during treatment since it induces microsomal enzymes, hence its own metabolism.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/adverse effects</p>
<p>i) Discoloration of body fluids.</p>
<p>â€¢ Inform clients of expected orange color of urine, saliva, sweat, and tears.</p>
<p>ii)Hepatotoxicity (jaundice, anorexia, and fatigue)</p>
<p>â€¢ Monitor the clientâ€™s liver function.</p>
<p>â€¢ Inform clients regarding symptoms of anorexia, fatigue, and malaise, and instruct them to notify the provider if symptoms occur.</p>
<p>â€¢ Avoid alcohol.</p>
<p>iii) Mild gastrointestinal discomfort associated (anorexia, nausea, and abdominal discomfort.</p>
<p>â€¢ Abdominal discomfort is mild and usually does not require intervention</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Use cautiously in clients with liver dysfunction.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Rifampin accelerates metabolism of warfarin (Coumadin), oral contraceptives, protease inhibitors, and NNRTIs (medications for HIV), resulting in diminished effectiveness.</p>
<p>â€¢ Increased dosages of HIV medications may be necessary.</p>
<p>â€¢ Monitor PT (prothrombin time) and INR (international normalized ratio)</p>
<p>â€¢ Clients may need to use alternative form of birth control.</p>
<p>Concurrent use with INH and pyrazinamide increases risk of hepatotoxicity.</p>
<p>â€¢ Instruct clients to avoid alcohol consumption. Monitor liver function.</p>
<p>Nursing Evaluation of Medication Effectiveness</p>
<p>Depending on therapeutic intent, effectiveness may be evidenced by:</p>
<p>â€¢ Improvement of tuberculosis symptoms such as clear breath sounds, no night sweats, increased appetite, no afternoon rises of temperature</p>
<p>â€¢ 3 negative sputum cultures for tuberculosis, usually taking 3 to 6 months to achieve.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ethambutol">ethambutol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ethambutol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pharmacodynamics;</li>
<li>Mechanism of action through inhibiting inhibition of bacterial growth through suppression of RNA synthesis. Resistance emergence occurs rapidly if used on its own.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetic">Pharmacokinetic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>good absorption from GIT.</li>
<li>Metabolism is in the liver.</li>
<li>Excretion in urine.</li>
<li>It can reach therapeutic concentrated with CSF for tuberculosis.</li>
</ul>
<p>Unwanted effects</p>
<p>These are common.</p>
<p>â€¢ Optic neuritis dose related especially if renal function decreases.</p>
<p>this leads to visual disturbances, red/ green color blindness followed by decreased visual acuity.</p>
<p>Monitor color vision in long treatments</p>
<p>Contraindication</p>
<p>â€¢ Patients with known optic neuritis</p>
<p>Patients who are unable to appreciate and report visual side effects or changes in vision e.g.</p>
<p>â€¢ young children and unconscious patients</p>
<p>pyrazinamide</p>
<ul>
<li>It is often inactive in neutral PH.</li>
</ul>
<p>Pharmacodynamics.</p>
<ul>
<li>
<p>its mechanism of action is unknown but it is tuberculostatic at acidic PH.</p>
</li>
<li>
<p>it is very effective against intracellular organism in macrophages since after phagocytosis, in which PH is low.</p>
</li>
</ul>
<p>Pharmacokinetic</p>
<ul>
<li>
<p>it has good gut absorption .</p>
</li>
<li>
<p>it is widely distributed in that it crosses the BBB</p>
</li>
<li>
<p>excreted in the kidneys</p>
</li>
</ul>
<p>DAPSONE</p>
<ul>
<li>pharmacodynamics</li>
<li>DAPSONE is chemically related to sulphonemides and it acts by inhibiting the enzyme dihydrofolate reluctance hence inhibits folate synthesis.</li>
<li>Its action is antagonized by PABA. resistance to this drug</li>
<li>Has increased, hence it â€˜s combined with other drugs during treatment.</li>
<li>Pharmacokinetic</li>
<li>Good oral absorption.</li>
<li>It under goes enteral hepatic recycling.</li>
<li>It has a half life of 24 to 48 hours</li>
<li>it is excreted in feces</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Unwanted effects</p>
<ul>
<li>Hemolysis of white blood cells .</li>
<li>Anorexia , nausea and vomiting.</li>
<li>Fever and allergic dermatitis,</li>
<li>neuropathy</li>
<li>Leprareation where there is exacerbation of lepromatous lesions can occur and a syndrome resembling infectious mononucleosis which can be fatal.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Antiviral agents</p>
<ul>
<li>Viruses present a more difficulty problem of chemotherapy than do higher organisms, e.g. bacteria, for they are intracellular parasites that use the metabolism of the host cells.</li>
<li>Antiviral agents are most active when virus are replicating.</li>
<li>The earlier the treatment is given the better.</li>
<li>Apart from primary infections ,viral illness is often the consequences of reactivation of latent virus in the body.</li>
<li>Patients whose immune system is compromised may suffer particular severe illness.</li>
<li>Viruses are capable of developing resistance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antiviral-and-antiretroviral-cont">Antiviral and antiretroviral cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiviral-and-antiretroviral-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Drug</th><th>viruses</th><th>Chemical type</th><th>target</th></tr></thead><tbody><tr><td>Non nucleotide reverse</td><td></td><td></td><td></td></tr><tr><td>transcriptase inhibitor.</td><td></td><td></td><td></td></tr><tr><td>(NNRTIs);Nevirapine,</td><td></td><td></td><td></td></tr><tr><td>Delavirdine.</td><td>HIV Virus</td><td>Non nucleotide analogue</td><td>Reverse transcriptase</td></tr><tr><td>protease inhibitors;</td><td></td><td></td><td></td></tr><tr><td>Saquinavir, Ritonavir,</td><td></td><td></td><td></td></tr><tr><td>Indinavir, Nelfinavir.</td><td>HIV virus</td><td>Peptide analogue</td><td>HIV protease</td></tr><tr><td>Ribavirin</td><td>Broad spectrum: HCV, HSV,</td><td></td><td></td></tr><tr><td>Measles, Lasa fever, SARS</td><td>Triazole carboxamide</td><td>RNA mutagen</td><td></td></tr><tr><td>Amantadine/Rimantadine</td><td>Influenza A strains</td><td>Tricyclic amine</td><td>Matrix</td></tr><tr><td>protein/hemagglutinin</td><td></td><td></td><td></td></tr><tr><td>Zanamivir, oseltamivir</td><td></td><td></td><td></td></tr><tr><td>phosphate</td><td>Influenza strains A and B</td><td>Neuraminic acid mimetic</td><td>Neuraminidase inhibitor</td></tr><tr><td>Pleconaril</td><td>picornaviruses</td><td>Small cyclic</td><td>Blocks attachment and</td></tr><tr><td>coating</td><td></td><td></td><td></td></tr><tr><td>Interferons</td><td>Hepatitis B and C virus</td><td>protein</td><td>Cell defense</td></tr></tbody></table>
<table><thead><tr><th>Drug(</th><th>Viruses</th><th>chemical</th><th>Target</th></tr></thead><tbody><tr><td>vidarabine</td><td>herpesvirus</td><td>Nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>acyclovir</td><td>Herpes simplex (HSV)</td><td>Nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>Ganciclovir and valganciclovir</td><td>Cytomegalovirus (CMV)</td><td>nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>Nucleoside reverse transcriptase inhibitor (NRTI) zidovudine( AZT) didanosine (ddI), zalcitabine (ddC), stavudine (D4T), lamivudine (3TC)</td><td>Retroviruses (HIV)</td><td>Nucleoside analogue</td><td>Reverse transcriptase</td></tr><tr><td>Non nucleotide reverse transcriptase inhibitor (NNRTI) nevirapine and delavirdine</td><td>HIV virus</td><td>Non nucleotide analogue</td><td>Reverse transcriptase</td></tr><tr><td>Protease inhibitors saquinavir, Ritonavir, indinavir, nelfinavir</td><td>HIV virus</td><td>Peptide analogue</td><td>HIV protease</td></tr></tbody></table>
<p>ACYCLOVIR</p>
<ul>
<li>Expected Pharmacological Action</li>
<li>Acyclovir prevents the reproduction of viral DNA and thus interrupts cell replication.</li>
</ul>
<p>Therapeutic Uses</p>
<ul>
<li>Acyclovir is used to treat herpes simplex and varicella-zoster viruses</li>
</ul>
<p>Ganciclovir is used for treatment and prevention of cytomegalovirus (CMV).</p>
<ul>
<li>Prevention therapy using ganciclovir is given for clients who have HIV/AIDS, organ transplants, and other immunocompromised states.</li>
<li>Interferon alfa-2b and lamivudine are used to treat hepatitis.</li>
<li>Oseltamivir is used to treat influenza A and B.</li>
<li>Ribavirin is used to treat respiratory syncytial virus (RSV) and influenza.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Complications Side/Adverse Effects Nursing Interventions/Client education</p>
<p>Acyclovir Phlebitis and inflammation at the site of infusion</p>
<p>â€¢ Rotate IV injection sites.</p>
<p>â€¢ Monitor IV sites for swelling and redness.</p>
<p>Nephrotoxicity</p>
<p>â€¢ Administer acyclovir infusion slowly over 1 hr.</p>
<p>â€¢ Ensure adequate hydration during infusion and 2 hr. after to minimize nephrotoxicity by administering IV fluids and increasing oral fluid intake as prescribed.</p>
<p>Mild discomfort associated with oral therapy (nausea, headache, diarrhea)</p>
<p>â€¢ Observe for symptoms and notify the provider.</p>
<p>Complications Side/Adverse Effects Nursing Interventions/Client education cont.'</p>
<p>Ganciclovir</p>
<p>Granulocytopenia and thrombocytopenia</p>
<p>â€¢ Obtain baseline CBC and platelet count.</p>
<p>â€¢ Administer granulocyte colony-stimulating factors.</p>
<p>â€¢ Monitor WBC, absolute neutrophil, and platelet counts.</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Acyclovir should be used cautiously in clients with renal impairment or dehydration, and clients taking nephrotoxic medications.</p>
<p>â€¢ Ganciclovir is Pregnancy Risk Category C;</p>
<p>â€¢ contraindicated in clients with a neutrophil count below 500/mm3 or platelet counts less than 25,000/mm3, and should be used cautiously in clients with pre-existing low white and platelet counts.</p>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Acyclovir</p>
<p>â€¢ Probenecid may decrease elimination of acyclovir.</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>â€¢ Concurrent use of zidovudine may cause drowsiness.</p>
<p>â€¢ Use with caution</p>
<p>Ganciclovir</p>
<p>â€¢ Cytotoxic medications may cause increased toxicity.</p>
<p>â€¢ Use together with caution.</p>
<p>Nursing Administration</p>
<p>Acyclovir:</p>
<p>For topical administration, advise clients to put on rubber gloves to avoid transfer of virus to other areas of the body.</p>
<p>Administer IV infusion slowly over 1 hr or longer.</p>
<p>Inform clients to expect symptom relief but not cure.</p>
<p>Instruct clients to wash affected area with soap and water 3 to 4 times/day and to keep the lesions dry after washing.</p>
<p>Advise clients to refrain from sexual contact while lesions are present.</p>
<p>Clients with healed herpetic lesions should continue to use condoms to prevent transmission of the virus.</p>
<p>Nursing administration</p>
<p>Ganciclovir</p>
<p>Administer IV infusion slowly, with an infusion pump, over at least 1 hr.</p>
<p>Administer oral medication with food.</p>
<p>Administer intraocular for CMV retinitis.</p>
<p>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antiretroviral-drugs">Antiretroviral drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiretroviral-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>antiretroviral therapy goal is to delay disease progression and to prolong survival by suppressing the replication of the virus.</li>
<li>Two types of antiretroviral combination are recommended for initial HIV therapy;</li>
</ul>
<ol>
<li>first line ; 1 NNRTI plus 2NRTI.</li>
<li>second line; 1PI plus 2 NRTI.</li>
<li>protease inhibitors are preserved for second line</li>
</ol>
<p>five goals of ART</p>
<ol>
<li>to reduce amount of HIV virus in the body.</li>
<li>Support and restore the immune system.</li>
<li>Improve the quality of life.</li>
<li>Reduce HIV related illness and deaths.</li>
<li>reduce general risk of transmission.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action-of-arvs">Mechanism of action of ARVs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-arvs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Block reverse transcriptase to disrupt copying of HIV genetic cord(NRTIs, NNRTIs).</li>
<li>Block protease enzyme, preventing maturation of new virions.(PIs).</li>
<li>Prevent fusion of HIV with cell membranes (fusion inhibitors).</li>
<li>Block CCR5 co receptor (CCR5 antagonist)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hiv-life-cycle-targets-for-antivirals">HIV life cycle: Targets for antivirals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hiv-life-cycle-targets-for-antivirals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-a5ff7bde.jpeg" alt="img-55.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="zidovudine-retrovir">ZIDOVUDINE (RETROVIR)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#zidovudine-retrovir" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Other Medications:</li>
<li>Didanosine (Videx)</li>
<li>Stavudine (Zerit)</li>
<li>Lamivudine (Epivir)</li>
<li>Abacavir (Ziagen)</li>
</ul>
<p>Combination Medications:
Abacavir, lamivudine zidovudine (Trizivir)
Abacavir, lamivudine (Epzicom)
Lamivudine, zidovudine (Combivir)</p>
<p>Expected Pharmacological Action</p>
<ul>
<li>Reduces HIV symptoms by inhibiting DNA synthesis and thus viral replication.</li>
</ul>
<p>Therapeutic Uses</p>
<ul>
<li>Used to treat HIV infection</li>
<li>Route of Administration: Oral, IV</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Suppressed bone marrow resulting in anemia, agranulocytosis (neutropenia) and thrombocytopenia</p>
<p>â€¢ Monitor CBC and platelets.</p>
<p>â€¢ Advise clients that transfusions may be needed.</p>
<p>Lactic acidosis</p>
<p>â€¢ Monitor for symptoms of lactic acidosis, such as hyperventilation, nausea, and abdominal pain.</p>
<p>â€¢ Pregnancy increases the risk of lactic acidosis.</p>
<p>Nausea, vomiting, diarrhea</p>
<p>â€¢ Clients may take the medication with food to reduce gastric irritation. Monitor fluids and electrolytes.</p>
<p>Hepatomegaly/fatty liver</p>
<p>â€¢ Monitor liver enzymes</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Probenecid, valproic acid, and methadone may increase zidovudine.</p>
<p>â€¢ Reduce dosage</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>Ganciclovir or medications that decrease bone marrow production may further suppress bone marrow.</p>
<p>â€¢ Use together with caution.</p>
<p>Rifampin and ritonavir may reduce zidovudine levels.</p>
<p>â€¢ Adjust dosage if needed.</p>
<p>Phenytoin may alter both medication levels.</p>
<p>â€¢ Monitor medication levels.</p>
<p>Nursing Administration</p>
<ul>
<li>Monitor for bone marrow suppression.</li>
<li>Obtain baseline CBC and platelets at the start of therapy and every 4 weeks.</li>
<li>Anemia may be treated with epoetin alfa or transfusions.</li>
<li>Neutropenia may be treated with colony-stimulating factors.</li>
<li>Advise clients to monitor for fever, sore throat, increased bleeding, bruising or fatigue.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="non-nucleoside-reverse-transcriptase-inhibitors-nnrti-s">Non-nucleoside reverse transcriptase inhibitors (NNRTI s)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-nucleoside-reverse-transcriptase-inhibitors-nnrti-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Select medication: delavirdine (Rescriptor), efavirenz (Sustiva)</li>
<li>Other Medications: nevirapine (Viramune), etravirine (Intelence)</li>
<li>Expected Pharmacological Action</li>
<li>NNRTIs act directly on reverse transcriptase to stop HIV reprication</li>
<li>Therapeutic Uses</li>
<li>Primary HIV-1 infection</li>
<li>Often used in combination with other antiretroviral agents to prevent medication resistance</li>
<li>Route of administration:</li>
<li>Oral</li>
<li>Monitor for rash.</li>
</ul>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Rash, which may become serious and lead to Stevenâ€™s-Johnson syndrome</p>
<p>â€¢ Monitor for rash.</p>
<p>â€¢ Treat with diphenhydramine (Benadryl), if prescribed.</p>
<p>â€¢ Notify the provider for fever or blistering.</p>
<p>Flu-like symptoms, headache, fatigue</p>
<p>â€¢ Monitor for adverse reactions.</p>
<p>â€¢ Encourage rest and adequate oral fluid intake</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>NNRTIs are Pregnancy Risk Category C.</li>
<li>These medications are contraindicated in clients with medication hypersensitivity.</li>
<li>Use with caution in clients who have liver disease.</li>
</ul>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Antacids may decrease absorption of delavirdine.</p>
<p>â€¢ Allow 1 hr. between medications.</p>
<p>NNRTIs may increase effects of amphetamines, antihistamines, calcium channel blockers, ergot alkaloids, quinidine, warfarin, and others.</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>Rifampin and phenytoin may cause decrease in levels of delavirdine.</p>
<p>â€¢ Do not use together.</p>
<p>Didanosine may reduce both medicationsâ€™ absorption.</p>
<p>Allow 1 hour between medications.</p>
<p>NNRTIs hypotension and changes in vision.</p>
<p>â€¢ may cause increase in sildenafil level.</p>
<p>â€¢ Monitor for Use together with caution.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="protease-inhibitors">Protease inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#protease-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Members of this group are;
ritonavir (Norvir)
Saquinavir (Invirase)
Indinavir (Crixivan)
Amprenavir (Agenerase)
Nelfinavir (Viracept)
Mechanism Of Action
Protease inhibitors act against HIV-1 and HIV-2 to alter and inactivate the virus by inhibiting enzymes needed for HIV replication.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication">Indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Used to treat HIV infections
Should be used with another antiretroviral medication to reduce medication resistance
Route of administration: Oral</p>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>â€¢ Diabetes mellitus/hyperglycemia ; Monitor serum glucose,</p>
<p>Adjust diet and administer anti-diabetic medications as prescribed. Advise clients to monitor for increased thirst and urine output.</p>
<p>â€¢ hypersensitivity reaction;</p>
<p>Monitor for rash.</p>
<p>Notify the provider if rash develops.</p>
<p>â€¢ Nausea and vomiting; Take medication with food to reduce GI effects and increase absorption.</p>
<p>â€¢ Elevated serum lipids</p>
<p>Monitor for hyperlipidemia.</p>
<p>Adjust diet.</p>
<p>â€¢ Thrombocytopenia, leukopenia</p>
<p>Monitor CBC. Monitor for signs of infection (fever, sore throat). Monitor for bleeding, blood in stool and bruising</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-food-interactions-nursing-interventions-client-education">Medication/Food Interactions Nursing Interventions/Client Education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-food-interactions-nursing-interventions-client-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Ritonavir may cause these medications to accumulate to toxic levels: Bupropion, carbamazepine, diazepam, lidocaine, prednisone clozapine, lovastatin, simvastatin, alprazolam, and ergotamine.
Avoid concurrent use.</li>
<li>Ritonavir may increase medication levels of sildenafil, tadalafil, and vardenafil.
Use with caution. Dosages of these medications may need to be reduced.</li>
<li>Ritonavir decreases levels of ethynyl estradiol in oral contraceptives. Instruct clients to use an alternative form of birth control.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="entry-fusion-inhibitors">Entry/fusion inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#entry-fusion-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Enfuvirtide this is the first antiretroviral to target the host cell attachment.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action-pharmacodynamics">Mechanism of action/pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It inhibits fusion of the cellular and viral membranes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetic">Pharmacokinetic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is give by S.C. injection half life is 4 hours.
adverse effects</li>
<li>Limited to mild injection site reactions</li>
<li>Hypersensitivity and peripheral neuropathy may occur.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="standard-1st-line-regime-for-adults-in-kenya">Standard 1st line regime for adults in Kenya<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#standard-1st-line-regime-for-adults-in-kenya" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Stavudine (D4T)/Zidovudine (AZT)+ Lamivudine (3TC)+ Nevirapine (NVP)</li>
</ul>
<p>OR</p>
<ul>
<li>Stavudine (D4T)/Zidovudine (AZT) + Lamivudine (3TC) + Efavirenz</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assignment">Assignment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assignment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Find out the standard 1st line and the 2nd line ART regime in children.</p>
<p>ANALGESICS, NON STEROIDAL ANTI INFLAMMATORY DRUGS(NSAIDS)</p>
<ul>
<li>Analgesics may be defined as any member or group of drugs used to achieve analgesia, relief from pain. They relieve pain without causing any loss of consciousness.</li>
<li>Analgesics drug works in various ways on the periphery and the CNS.</li>
<li>NSAIDs are referred to as non narcotic analgesics or non-opioid analgesics.</li>
<li>They differ from opioids in the aspects;
-they are less potent
-fail to produce drowsiness or CNS depression
-non additive in nature
-posses anti inflammatory/antipyretic activities</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nsaids-cont">NSAIDs cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nsaids-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>1st generation NSAIDs (COX-1 and COX-2 inhibitors):</li>
<li>Aspirin</li>
<li>Ibuprofen (Motrin, Advil)</li>
<li>Naproxen (Naprosyn)</li>
<li>Indomethacin (Indocin)</li>
<li>Diclofenac (Voltaren)</li>
<li>Ketorolac (Toradol)</li>
<li>Meloxicam (Mobic)</li>
<li>2nd generation NSAIDs (selective COX-2 Inhibitor):</li>
<li>Celecoxib (Celebrex)</li>
</ul>
<p>Mechanism of action</p>
<p>â€¢ Inhibition of prostaglandin synthase, also known as cox â€” Inhibition of COX-1 can result in decreased platelet aggregation and kidney damage.</p>
<p>â€¢ Inhibition of COX-2 results in decreased inflammation, fever, and pain.</p>
<p>Therapeutic Uses /indication ( analgesic , antipyretic, and anti inflammatory)</p>
<p>â€¢ Inflammation suppression.</p>
<p>â€¢ Analgesia for mild to moderate pain, such as with osteoarthritis and rheumatoid arthritis.</p>
<p>â€¢ Fever reduction.</p>
<p>â€¢ Dysmenorrhea.</p>
<p>â€¢ Inhibition of platelet aggregation, which protects against stroke and myocardial infarction. (aspirin)</p>
<p>â€¢ The exception of acetaminophen which is an analgesic and antipyretic.</p>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<ul>
<li>Gastrointestinal discomfort (dyspepsia, abdominal pain, heartburn, nausea)</li>
<li>Damage to gastric mucosa may lead to GI bleeding and perforation, especially with long-term use. â€¢</li>
<li>Advise clients to take medication with food or with a full glass of water or milk.</li>
<li>Advise clients to avoid alcohol.</li>
<li>Observe for signs of bleeding (passage of black or dark-colored stools, severe abdominal pain, nausea, vomiting).</li>
<li>Administer a proton pump inhibitor, such as omeprazole (Prilosec), or an H2 receptor antagonist, such as ranitidine (Zantac) to decrease the risk of ulcer formation. Use prophylaxis agents such as misoprostol (Cytotec).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>side/adverse effects cont.â€™</p>
<p>Renal dysfunction (decreased urine output, weight gain from fluid retention, increased BUN and creatinine levels)</p>
<p>â€¢ Use cautiously with older adults and clients who have heart failure.</p>
<p>â€¢ Monitor I&amp;O and kidney function (BUN, creatinine).</p>
<p>Increased risk of heart attack and stroke (non aspirin NSAIDs)</p>
<p>â€¢ Use the smallest effective dose for clients with known cardiovascular disease.</p>
<p>â€¢ Salicylism may occur with aspirin. Signs and symptoms include tinnitus, sweating, headache and dizziness, and respiratory alkalosis.</p>
<p>â€¢ Advise clients to notify the provider and to stop taking aspirin if symptoms occur.</p>
<p>â€¢ Reyer syndrome is rare, but serious in childhood.</p>
<p>â€¢ This occurs when aspirin is used for fever reduction in children who have a viral illness, such as chickenpox or influenza</p>
<p>â€¢ Advise clients to avoid giving aspirin when a child has a viral illness, such as chickenpox or influenza.</p>
<p>Complication and adverse effects cont.'</p>
<p>Aspirin toxicity</p>
<p>â€¢ Aspirin toxicity should be managed as a medical emergency in the hospital.</p>
<p>Therapy includes:</p>
<p>â€¢ Cooling with tepid water.</p>
<p>â€¢ Correction of dehydration and electrolyte imbalance with IV fluids.</p>
<p>â€¢ Reversal of acidosis and promotion of salicylate excretion with bicarbonate.</p>
<p>â€¢ Gastric lavage Activated charcoal may also be given to decrease absorption.</p>
<p>â€¢ Hemodialysis may be indicated.</p>
<p>Contraindications for aspirin and other 1st generation NSAIDs include</p>
<ul>
<li>Pregnancy (Pregnancy Risk Category D)</li>
<li>Peptic ulcer disease</li>
<li>Bleeding disorders such as hemophilia, vitamin K deficiency</li>
<li>Hypersensitivity to aspirin and other NSAIDs</li>
<li>Children with chickenpox or influenza (aspirin)</li>
<li>Use NSAIDs cautiously in older adults, clients who smoke cigarettes, and in clients with H. pylori infection, hypovolemia, asthma, chronic urticaria, and/or a history of alcoholism.</li>
<li>Celecoxib is contraindicated in clients with allergy to sulfonamides.</li>
<li>Ketorolac is contraindicated in clients with advanced renal dysfunction</li>
<li>Use should be no longer than five days because of the risk for kidney damage.</li>
<li>2nd generation NSAIDs should be used cautiously in clients who have known cardiovascular disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acetaminophen">acetaminophen<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acetaminophen" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action">Mechanism Of Action;<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Acetaminophen slows the production of prostaglandins in the central nervous system.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Analgesic (relief of pain) effect</li>
<li>Antipyretic (reduction of fever) effects</li>
</ul>
<p>complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Acute toxicity that results in liver damage with early symptoms of nausea, vomiting, diarrhea, sweating, and abdominal discomfort progressing to, hepatic failure, coma and death</p>
<p>â€¢ Advise clients to take acetaminophen as prescribed and not to exceed 4 g/day.</p>
<p>â€¢ Administer the antidote, acetylcysteine (Mucomyst).</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Use cautiously in clients who consume three or more alcoholic drinks/day and those taking warfarin (interferes with metabolism).</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Alcohol increases the risk of liver damage.</p>
<p>â€¢ Advise clients about the potential risk of liver damage with consumption of alcohol.</p>
<p>Acetaminophen slows metabolism of warfarin (Coumadin) leading to increased levels of warfarin.</p>
<p>â€¢ This places clients at risk for bleeding.</p>
<p>â€¢ Instruct clients to observe for signs of bleeding (bruising, petechiae, hematuria).</p>
<p>â€¢ Monitor prothrombin time and INR levels and adjust dosages of warfarin accordingly</p>
<p>Opioid analgesics/narcotic analgesics</p>
<p>â€¢ Opioids are classified as agonists, agonist-antagonists, and antagonist.</p>
<p>Opioid Agonists</p>
<p>â€¢ morphine sulfate</p>
<p>â€¢ Fentanyl (Sublimaze, Duragesic)</p>
<p>â€¢ Meperidine (Demerol)</p>
<p>â€¢ Methadone (Dolophine)</p>
<p>â€¢ Codeine, oxycodone (OxyContin)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Opioid agonist produce analgesia by binding to specific proteinscoupled receptors that are located in the brain and the spinal cord regions involved in the transmission and modulation of pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication-therapeutic-uses">Indication/Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication-therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Relief of moderate to severe pain (postoperative, myocardial infarction, cancer)</li>
<li>Sedation</li>
<li>Reduction of bowel motility</li>
<li>Codeine: cough suppression</li>
</ul>
<p>route of administration</p>
<ul>
<li>Morphine sulfate â€“ Oral, subcutaneous, IM, rectal, IV, epidural, and intrathecal</li>
<li>Fentanyl (Sublimaze, Duragesic) â€“ IV, IM, transmucosal and transdermal</li>
<li>Meperidine (Demerol) â€“ Oral, subcutaneous IM, and IV</li>
<li>Codeine â€“ Oral, subcutaneous IM, and IV</li>
<li>Methadone (Dolophine) â€“ Oral, subcutaneous, and IM</li>
<li>Oxycodone (OxyContin) â€“ Oral, rectal</li>
<li>Hydromorphone (Dilaudid) â€“ Oral, subcutaneous, IM, IV</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/Adverse Effects Nursing Interventions/Client Education (morphine sulphate)</p>
<p>Respiratory depression.</p>
<p>â€¢ Monitor the clientâ€™s vital signs.</p>
<p>â€¢ Stop opioids if the clientâ€™s respiratory rate is less than 12/ min, and then notify the provider.</p>
<p>â€¢ Have naloxone (Narcan) and resuscitation equipment available.</p>
<p>â€¢ Avoid the use of opioids with CNS depressant medications (barbiturates, benzodiazepines, and consumption of alcohol).</p>
<p>Constipation</p>
<p>â€¢ Increased fluid intake and physical activity.</p>
<p>â€¢ Administer a stimulant laxative, such as Bisacodyl (Dulcolax), to counteract decreased bowel motility, or a stool softener, such as docusate sodium (Colace), to prevent constipation.</p>
<p>Side/ adverse effects cont.'</p>
<p>Orthostatic hypotension</p>
<ul>
<li>Advise clients to sit or lie down if symptoms of lightheadedness or dizziness occur.</li>
<li>Avoid sudden changes in position by slowly moving clients from a lying to a sitting or standing position.</li>
<li>Provide assistance with ambulation as needed.</li>
</ul>
<p>Urinary retention</p>
<ul>
<li>Advise clients to void every 4 hr.</li>
<li>Monitor I&amp;O.</li>
<li>Assess the clientâ€™s bladder for distention by palpating the lower abdomen area every 4 to 6 hr. side and adverse effects</li>
</ul>
<p>Adverse effects cont.'</p>
<p>Cough suppression</p>
<p>Advise clients to cough at regular intervals to prevent accumulation of secretions in the airway.</p>
<p>Auscultate the clientâ€™s lungs for crackles, and instruct clients to increase intake of fluid to liquefy secretions.</p>
<p>Sedation</p>
<p>Advise clients to avoid hazardous activities such as driving or operating heavy machinery.</p>
<p>Biliary colic</p>
<p>Avoid giving morphine to clients who have a history of biliary colic. Use meperidine as an alternative.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emesis">Emesis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administer an antiemetic such as promethazine (Phenergan).</li>
</ul>
<p>Opioid overdose triad of coma, respiratory depression, and pinpoint pupils</p>
<ul>
<li>Monitor the client's vital signs.</li>
<li>Provide mechanical ventilation.</li>
<li>Administer opioid antagonists, such as naloxone (Narcan) or nalmefene (Revex)</li>
</ul>
<p>Contraindications/Precautions</p>
<ul>
<li>Morphine is contraindicated after biliary tract surgery.</li>
<li>Morphine is contraindicated for premature infants during and after delivery because of respiratory depressant effects.</li>
<li>Meperidine is contraindicated for clients with renal failure because of the accumulation of normeperidine, which can result in seizures and neurotoxicity.</li>
</ul>
<p>Use cautiously with: Clients who have asthma, emphysema, and/or head injuries; infants, and older adults.</p>
<p>Use cautiously with:</p>
<ul>
<li>
<p>Clients who have asthma, emphysema, and/or head injuries; infants, and older adult clients (risk of respiratory depression).</p>
</li>
<li>
<p>Clients who are pregnant (risk of physical dependence of the fetus).</p>
</li>
<li>
<p>Clients in labor (risk of respiratory depression in the newborn and inhibition of labor by decreasing uterine contractions)</p>
</li>
<li>
<p>Clients who are extremely obese (greater risk for prolonged side effects because of the accumulation of medication that is metabolized at a slower rate)</p>
</li>
<li>
<p>Clients with inflammatory bowel disease (risk of megacolon or paralytic ileus)</p>
</li>
<li>
<p>Clients with an enlarged prostate (risk of acute urinary retention)</p>
</li>
<li>
<p>Clients with hepatic or renal disease</p>
</li>
<li></li>
</ul>
<p>Opioid agonist-antagonist</p>
<ul>
<li>butorphanol (Stadol)</li>
<li>Nalbuphine hydrochloride (Nubain)</li>
<li>Buprenorphine hydrochloride (Buprenex)</li>
</ul>
<p>Expected Pharmacological Action</p>
<ul>
<li>These medications act as antagonists on mu receptors and agonists on kappa receptors.</li>
</ul>
<p>Compared to pure opioid agonists, agonist-antagonists have:</p>
<ul>
<li>A low potential for abuse causing little euphoria.</li>
<li>In fact, high doses can cause adverse effects (anxiety, restlessness, mental confusion).</li>
<li>Less respiratory depression.</li>
<li>Less analgesic effect.</li>
</ul>
<p>opioid agonist- antagonist</p>
<p>cont.â€™ |</p>
<p>Indication</p>
<p>â€¢ Relief of moderate to severe pain</p>
<p>â€¢ Treatment of opioid dependence (buprenorphine)</p>
<p>â€¢ Adjunct to balanced anesthesia</p>
<p>â€¢ Relief of labor pain (butorphanol)</p>
<p>Route of administration:</p>
<p>â€¢ Butorphanol â€“ IV, IM, intranasal</p>
<p>â€¢ Nalbuphine â€“ IV, IM, subcutaneous</p>
<p>â€¢ Buprenorphine â€“ IV, sublingual, epidural</p>
<p>Side effects</p>
<p>Abstinence syndrome (cramping, hypertension, vomiting )</p>
<p>Sedation respiratory depression</p>
<p>Dizziness</p>
<p>Increased intracranial pressure, headache</p>
<p>Contraindications/Precautions</p>
<p>Use cautiously in clients who have a history of myocardial infarction, renal or liver disease, respiratory depression, or head injury, and clients who are physically dependent on opioids.</p>
<p>Interactions medication/Food Interactions Nursing Interventions/Client Education</p>
<p>â€¢ CNS depressants and alcohol may cause additive effects.</p>
<p>â€¢ Use together cautiously.</p>
<p>â€¢ Monitor respirations.</p>
<p>â€¢ Opioid agonists may antagonize and reduce analgesic effects of the opioid. Do not use concurrently.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="opioid-antagonist">Opioid antagonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#opioid-antagonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Naloxone (Narcan)</li>
<li>Naltrexone (Re Via, Depade ),</li>
<li>nalmefene (Revex )</li>
</ul>
<p>Mechanism of Action Opioid antagonists interfere with the action of opioids by competing for opioid receptors. Opioid antagonists have no effect in the absence of opioids.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Treatment of opioid overdose Reversal of effects of opioids, such as respiratory depression
Reversal of respiratory depression in an infant</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="route-of-administration">Route of administration:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#route-of-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Naloxone- IM, IV, subcutaneous
nalmefene - IV, IM, subcutaneous
Naltrexone - Oral</p>
<p>Opioid antagonist cont.â€™</p>
<p>Therapeutic Uses</p>
<p>Treatment of opioid overdose Reversal of effects of opioids, such as respiratory depression</p>
<p>Reversal of respiratory depression in an infant</p>
<p>Route of administration:</p>
<p>Naloxone,</p>
<p>nalmefene â€“ IV, IM, subcutaneous</p>
<p>Naltrexone â€“ Oral</p>
<p>Opioid anti-agonist cont.â€™</p>
<p>Side Effects</p>
<p>â€¢ Tachycardia and tachypnea</p>
<p>â€¢ Abstinence syndrome (cramping, hypertension, vomiting)</p>
<p>â€¢ Pulmonary edema</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Opioid antagonists are Pregnancy Risk Category B.</p>
<p>â€¢ These medications are contraindicated in clients with opioid dependency.</p>
<p>Adjuvants medication for pain</p>
<p>â€¢ Tricyclic antidepressants: amitriptyline (Elavil) â€“ oral/IM</p>
<p>â€¢ Anticonvulsants: carbamazepine (Tegretol) â€“ gabapentin (Neurontin) oral</p>
<p>â€¢ CNS stimulants: methylphenidate (Ritalin) â€“ oral</p>
<p>â€¢ Antihistamines: hydroxyzine (Vistaril) â€“ oral/IM</p>
<p>â€¢ Glucocorticoids: dexamethasone (Decadron) â€“ oral, IV, IM</p>
<p>â€¢ Bisphosphonates: etidronate (Didronel) â€“ oral</p>
<p>â€¢ NSAIDs: ibuprofen (Motrin) â€“ oral</p>
<p>â€¢ Other Medication: Tricyclic antidepressants: imipramine (Tofranil) â€“ oral</p>
<p>â€¢ Anticonvulsants: phenytoin (Dilantin) â€“ oral, IV, IM</p>
<p>â€¢ CNS stimulants: dextroamphetamine (Dexedrine) â€“ oral</p>
<p>â€¢ Glucocorticoids: prednisone (Deltasone) â€“ oral</p>
<p>â€¢ Bisphosphonates: pamidronate (Aredia) â€“ IV</p>
<p>â€¢ NSAIDs: ketorolac (Toradol)</p>
<p>Expected Pharmacological Action</p>
<p>â€¢ Adjuvant medications for pain enhance the effects of opioids</p>
<p>Therapeutic Uses</p>
<p>â€¢ These medications are used in combination with opioids and cannot be used as a substitute for opioids.</p>
<p>â€¢ NSAIDs are used to treat inflammation.</p>
<p>â€¢ Tricyclic antidepressants are used to treat depression and neuropathic pain such as cramping, aching, burning, darting, and lancinating pain.</p>
<p>â€¢ Anticonvulsants are used to relieve neuropathic pain.</p>
<p>â€¢ CNS stimulants augment analgesia and decrease sedation.</p>
<p>â€¢ Antihistamines decrease anxiety, prevent insomnia and relieve nausea.</p>
<p>â€¢ Glucocorticoids decrease pain from intracranial pressure and spinal cord compression.</p>
<p>â€¢ Bisphosphonates manage hypercalcemia and bone pain</p>
<p>ANTI HELMINTHIC</p>
<p>â€¢ Benzimidazole (BZAs)</p>
<p>These are broad spectrum anthelmintic agents.</p>
<p>Thiabendazole., Mebendazole and Albendazole have been used extensively for human helminth infections.</p>
<p>â€¢ Other drugs are ;pyrantel pamoate, ivermectin, praziquental, piperazine citrate , benzdiazepines and diethylcarbamazine.</p>
<p>Indication/uses;</p>
<p>Thiabendazole is active against a wide range of nematodes that infect the GI tract but it clinical use has declined due to its toxicity.</p>
<p>Mebendazole is used for the treatment of intestinal roundworm infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthic-cont">Anthelminthic cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthic-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Albendazole is used primarily against a variety of intestinal and tissue nematodes but also against Larva forms of certain cestodes (cysticercosis, hydatidosis)</li>
<li>Used with ivermectin or diethylcarbamazine for control of helminthes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthics-action">Anthelminthics action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthics-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The BZAs inhibit microtubule polymerization by binding to b-tubulin.</li>
<li>Mebendazole and Albendazole are highly effective in treating the major infections (ascariasis, enterobiasis, trichuriasis, and hookworm)'
-These drugs are active against both larva and adult stages of the nematodes, and they are ovicidal for ascaris and trichuris .
-Immobilization and death of susceptible GI parasites occur slowly and their clearance from the GI tract may not be complete until several days after treatment.
Albendazole is more effective than mebendazole for strongyloidiasis, cystic hydatid disease caused By Echinococcus Granulosus And Neurocysticercosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthic-cont">Anthelminthic cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthic-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The choice of drug depends on specific helminths involved</li>
<li>Example cestodes infestations e.g. echinococcus granulosus the drugs used are thiabendazole, Albendazole, piperazine citrate, pyrantel pamoate, ivermectin and diethylcarbamazine (hetrazan).</li>
</ul>
<p>Absorption, fate, and excretion</p>
<ul>
<li>thiabendazole is absorbed rapidly after oal ingestion and reaches peak plasma concentration after 1 hour. Most of the drug is excreted in urine.</li>
<li>Mebendazole is rapidly metabolized resulting to low systemic bioavailability.</li>
<li>Albendazole is variably absorbed after oral administration, a fatty meal enhances absorption. It is well distributed into various tissues including hydatid cysts. It excreted in urine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>ANTI PROTOZOA AND ANTIMALARIA</p>
<ul>
<li>The common protozoa infection include;</li>
<li>Amoebiasis ,</li>
<li>trypanosomiasis,</li>
<li>giardiasis,</li>
<li>malaria,</li>
<li>cutaneous and visceral leishmaniasis</li>
<li>Chagas disease,</li>
<li>toxoplasmosis and</li>
<li>trichomoniasis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antimalarial">antimalarial<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antimalarial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Examples include; quinine, chloroquine, mefloquine, proguanil, pyrimethamine/sulfadoxine, tetracycline, doxycycline &amp; minocycline, primaquine, and also artemether-Lumefantrine (coartem)</p>
<ul>
<li>The first line treatment of uncomplicated malaria in Kenya is Artemether-Lumefantrine.</li>
<li>The second line treatment for uncomplicated malaria in Kenya is dihydroartemisinic-piperaquine (DHA-PPQ)</li>
<li>This is available in a fixed dose combination with adult tablets containing <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>30</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mn>320</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">30 \mathrm{mg} / 320 \mathrm{mg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">30</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/320</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span></span></span></span></span> of DHA-PPQ</li>
<li>Pediatric tablets containing <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>20</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mn>160</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">20 \mathrm{mg} / 160 \mathrm{mg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">20</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/160</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span></span></span></span></span> of DHA-PPQ</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dosage-artemether-lumefantrine">Dosage; Artemether Lumefantrine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage-artemether-lumefantrine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>WEGHT IN KG</th><th>AGE IN YEARS</th><th>NUMBER OF TABLETS PER DOSE</th><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr><td></td><td></td><td>day 1</td><td></td><td>day 2</td><td></td><td>day 3</td><td></td></tr><tr><td></td><td></td><td><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> dose</td><td>8 hours</td><td>24 hours</td><td>36 hours</td><td>48 hours</td><td>60 hours</td></tr><tr><td>5-14</td><td>5/12- 3 years</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>15-24</td><td>3-7 years</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td></tr><tr><td>25-34</td><td>8-11 years</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td></tr><tr><td>Above 34</td><td>Above 12 years</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-malaria-cont">anti-malaria cont.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-malaria-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Other anti-malarial drugs for uncomplicated malaria are;</li>
<li>Amodiaquine plus artesunate</li>
<li>Mefloquine plus artesunate</li>
<li>Halofantrine (halfan) .this drug can cause arrhythmias, and is contraindicated in patients with heart disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="quinine">Quinine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#quinine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Quinine is an alkaloid derived from cinchona tree.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication">Indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Reserved for severe and complicated malaria.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacodynamics-mechanism-of-action">Pharmacodynamics/mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics-mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It binds to plasmodium DNA to prevent protein synthesis but its exact mode of action remains uncertain.</li>
<li>It is used to treat plasmodium falciparum in areas of multiple drug resistant.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Quinine is well absorbed in the gut but absorption is delayed by antacids. It can be given via slow IV Infusion.</li>
<li>Metabolism occurs in the liver, the excretion is in the kidneys.</li>
<li>It is used for the treat of chloroquine resistant P . falciparum often With Combination Of Pyrimethamine/ Sulfadoxine</li>
</ul>
<p>unwanted effects</p>
<ul>
<li>has a low therapeutic widow and it produces effects in the skeletal muscles and can cause; GI irritation, renal damage, hemolytic anemia (rarely)associated with â€œblack water feverâ€ in previously sensitized patients.</li>
<li>black water fever has a fatality rate of 25% due to intravascular coagulation and renal failure.</li>
</ul>
<p>unwanted effects cont.â€™</p>
<p>â€¢ Hypotension</p>
<p>â€¢ Hypoglycemia</p>
<p>â€¢ Cinchonism</p>
<p>Dosage;</p>
<p>Loading dose IV Quinine 20mg/kg body wt. in 500mls of 5% or 10% dextrose (MAX 1200MG) for 4 hours then 10mg/kg body wt. as intravenous infusion in 500mls of 5% or 10% dextrose to run for 4hrs every 8 hourly ( maximum 600mgs)</p>
<p>After 3 IV doses of quinine, one should try to change into oral treatment and treatment should continue for 7 days.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="quinine-cont">quinine cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#quinine-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>for children loading dose is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>20</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">20 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">20</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wt. in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>15</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">s</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">15 \mathrm{mls} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">15</span><span class="mord"><span class="mord mathrm">mls</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> of isotonic fluid to run over 4 hours and maintenance dose <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>10</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">10 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">10</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wtin 10mls /kg of isotonic fluids to run over 4 hours every 12 hourly un til the patient can take orally.</li>
<li>Oral quinine is given <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>10</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">10 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">10</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wt 8 hourly to complete a total of (parenteral + oral ) 7 days.</li>
</ul>
<p>Prevention of malaria</p>
<ul>
<li>Chemoprophylaxis; mefloquine or atovaquone-proguanil or doxycycline.</li>
<li>Intermittent presumptive treatment (IPT) in recommended for pregnant women in areas of high malaria transmission.</li>
<li>Current recommended IPT medication is sulphadoxine 500mg ,pyrimethamine 25mg given as a dose of 3 tablets.</li>
</ul>
<p>Amoebicidal drugs</p>
<p>metronidazole was covered under azoles antibiotics.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sedatives-hypnotics">SEDATIVES-HYPNOTICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sedatives-hypnotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Also known as anti anxiety drugs</li>
<li>Sedative hypnotics refers to drugs that depress the CNS activity, relieve anxiety and induce sleep.</li>
<li>effective Sedatives ( anxiolytic ) drug should reduce anxiety and exert a calm effect.</li>
<li>Hypnotics drug should produce drowsiness and encourage the onset and maintenance of a state of sleep.</li>
<li>All sedative hypnotics cross the placenta barrier and may contribute to the depression neonatal vital function.</li>
<li>Sedative-hypnotics are detectable in breast milk and may exert depressant effects in the nursing infant.</li>
</ul>
<p>Classification of sedative hypnotics</p>
<ul>
<li>Benzodiazepines; clonazepam, diazepam, midazolam, lorazepam, triazolam, flurazepam, alprazolam, chlordiazepoxide.</li>
<li>barbiturates; phenobarbital, metharbital, thiopental sodium</li>
<li>Newer generation; zopiclodine, zolpidem.</li>
<li>Miscellaneous; chloral hydrate</li>
<li>B-adrenoreceptor antagonist; Flumezanil</li>
<li>The most commonly used are benzodiazepines and barbiturates medications.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Pharmacological actions</p>
<ul>
<li>Useful predominantly as anticonvulsants, muscle relaxant and in status epilepticus.</li>
<li>Abrupt withdrawal causes precipitation of epileptiform seizures.</li>
<li>They potentiate analgesics .</li>
<li>Wide margin of safety</li>
<li>give rise to drug dependency (abuse liability)</li>
<li>Obliterate moments of sequential events</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacodynamics-of-benzodiazepines-barbiturates-new-hypnotics">Pharmacodynamics of benzodiazepines, barbiturates &amp;new hypnotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics-of-benzodiazepines-barbiturates-new-hypnotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Molecular pharmacology of GABA (gamma aminobutyric acid) receptor (GABA is an inhibitory neurotransmitter)</li>
<li>The benzodiazepine, barbiturates, zolpidem, zaleplon and other drugs bind to molecular component of GABA, a receptor in neuronal membrane in the CNS. improving the symptoms of sleep disturbance, tremors and muscle tension.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="organ-level-effects">Organ level effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#organ-level-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sedation; exert calming effects with reduction of anxiety at relatively low doses.</li>
<li>Hypnosis; all sedative hypnotics induce sleep if high enough doses are given.</li>
<li>Muscle relaxation</li>
<li>Effects on respiratory and cardiovascular functions especially on patients with pulmonary disease</li>
<li>Anticonvulsant effects e.g. phenobarbitone</li>
<li>anesthesia, e.g. barbiturates thiopental</li>
<li>Tolerance ; psychological &amp; physiological Dependence</li>
</ul>
<p>Clinical uses</p>
<ul>
<li>Insomnia</li>
<li>Sedation and amnesia before and during medical surgical procedures.</li>
<li>Treatment of epilepsy and seizure state.</li>
<li>as a component of balanced anesthesia.</li>
<li>For control of ethanol and other sedative hypnotic withdrawal states.</li>
<li>For muscle relaxation in specific neural muscular disorders</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Direct toxic action</p>
<ul>
<li>relatively low doses may lead to Drowsiness , impaired judgement, diminished motor skills. sometimes with impact on driving, working and personal relationship.</li>
<li>Criminals use BZDs in cases of â€œdate rapeâ€ is based on their dose dependent amnestic effects.</li>
<li>At higher dose toxicity may present as lethargy or state of exhaustion or as gross symptoms equivalent to those of ethanol intoxication.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Benzodiazepines commonly</p>
<p>â€¢ Most commonly used sedatives hypnotics.</p>
<p>MOA exert their action as the other CNS depressants.</p>
<p>Classification</p>
<p>Short acting e.g. midazolam, triazolam, half life five hours.</p>
<p>Intermediate e.g. lorazepam, oxazepam, clonazepam. Half life five to 24 hours.</p>
<p>Long acting e.g. diazepam, chlordiazepoxide, prazepam. Half life 24 hours.</p>
<p>Unwanted effects</p>
<ul>
<li>Daytime drowsiness, ataxia, rebound insomnia on withdrawal</li>
<li>The elderly develop blurred vision, tremors , constipation, and anterograde amnesia.</li>
<li>Respiratory depression which may worsen in COPD</li>
<li>Decrease BP and heart rate.</li>
<li>Paradoxical effects in the first 2 weeks of therapy such as hostility, aggression, excitement, antisocial behavior</li>
<li>cross tolerance with other sedative/hypnotics agents e.g. alcohol/barbiturates.</li>
<li>withdrawal symptoms may develop any time after stopping E.G. anxiety, insomnia, GIT disturbance, tinnitus, perceptual disturbance, lack of appetite and perspiration. treat with flumazenil</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindication</p>
<ul>
<li>In pregnancy, shock, acute alcohol intoxication and neonatal withdrawal symptoms, in the elderly and during lactation</li>
</ul>
<p>Drug interaction</p>
<ul>
<li>Alcohol plus benzodiazepines cause severe CNS depression.</li>
<li>Cimetidine, disulfiram and oral contraceptives cause increase benzodiazepines effects.</li>
<li>Ranitidine and theophylline decrease benzodiazepine effects.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="barbiturates">barbiturates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#barbiturates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Include;</li>
<li>mephobarbital (mebaral)</li>
<li>pentobarbital (Nembutal)</li>
<li>Phenobarbital (luminal, solfoton)</li>
<li>Amobarbital</li>
<li>Thiopental sodium.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacological-effects">Pharmacological effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacological-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>CNS
I. Depression of CNS
II. Sedative hypnotic
III. Anticonvulsant
IV. General anesthetic (sodium thiopental)
V. Enhance analgesic effect of morphine</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-application">Therapeutic application<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-application" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sedatives</li>
<li>Hypnotic</li>
<li>Anticonvulsant</li>
<li>pre anesthetic medicament</li>
<li>Potentiate analgesic activity</li>
<li>anti epileptic; phenobarbitone, metharbital</li>
<li>general anesthesia ;thiopental sodium</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-reaction">Adverse reaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Acute drug dependence</li>
<li>Drug tolerance</li>
<li>Withdrawal symptoms</li>
</ul>
<p>Contraindication
Renal damage
Hepatic ailments
Pulmonary insufficient</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anticonvulsant-ant-seizure-anti-epileptic-medication">anticonvulsant/ant seizure /anti epileptic medication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anticonvulsant-ant-seizure-anti-epileptic-medication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Barbiturates: Phenobarbital (Luminal), Primidone (Mysoline) amobarbital, metharbital.</li>
<li>Hydantoins: phenytoin (Dilantin)</li>
<li>Benzodiazepines: Diazepam (Valium), Lorazepam (Ativan)</li>
<li>Carboxamide: Carbamazepine (Tegretol, carbatrol), oxcarbazepine (Trileptal)</li>
<li>Phenyltriazine: Lamotrigine (lamictal)</li>
<li>pyrrolidines: levetiracetam (Keppra)</li>
<li>Succinimides: ethosuximide (zorontin)</li>
<li>Miscellaneous: acetazolamide (Diamox), primidone(mysoline), valproic acid(depakene, Depakote), zonisamide (zonegran)</li>
</ul>
<p>Mechanism of action</p>
<ul>
<li>Unfortunately the mechanism of seizure activity is not well understood.</li>
<li>AEDs control seizure disorders by various mechanisms, which include:</li>
<li>Slowing the entrance of sodium and calcium back into the neuron and, thus extending the time it takes for the nerve to return to its active state.</li>
<li>Suppressing neuronal firing, which decreases seizure activity and prevents propagation of seizure activity into other areas of the brain.</li>
<li>Decreasing seizure activity by enhancing the inhibitory effects of gamma butyric acid (GABA.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phenobarbital">Phenobarbital<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phenobarbital" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Phenobarbital is used for partial seizures and generalized tonic clonic seizures.</li>
<li>This medication is not effective against absence seizures.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phenytoin">Phenytoin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phenytoin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>phenytoin effective against all major forms of epilepsy except absence seizures.</li>
<li>Use IV route for status epilepticus.</li>
</ul>
<p>Phenytoin is an ant dysrhythmic.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="carbamazepine">Carbamazepine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#carbamazepine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Carbamazepine is used for the treatment of partial (simple and complex) seizures, tonic-clonic seizures, bipolar disorder, and trigeminal and glossopharyngeal neuralgias.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-use-cont">Therapeutic use cont.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-use-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Ethosuximide is only indicated for absence seizures.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="valproic-acid">Valproic acid :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#valproic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Valproic acid is used for partial, generalized, and absence seizures; bipolar disorder; and migraine headaches.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gabapentin">Gabapentin:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gabapentin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Gabapentin is used as a single agent for control of partial seizures.</li>
<li>This medication is also used for neuropathic pain and the prevention of migraine headaches.
Diazepam : Diazepam is used in status epilepticus.</li>
</ul>
<p>Adverse drug reaction of anti epileptics/ anticonvulsant medication</p>
<p>â€¢ Almost all cause undesired effects</p>
<p>â€¢ All cross the placenta barrier;</p>
<p>âž¢Cleft lip, cardiac malformation; phenobarbitone, phenytoin.</p>
<p>âž¢Spina bifida; folate deficiency induced by sodium valproate, phenytoin, phenobarbital</p>
<p>phenytoin</p>
<p>â€¢ This is the oldest non sedative anti seizure drug introduced in 1938.</p>
<p>Mechanism of action</p>
<p>It blocks sodium channels and inhibit the generation of rapidly repetitive action potentials.</p>
<p>pharmacokinetics; oral ,IM, IV.</p>
<p>Metabolism; is in the liver.</p>
<p>Side /adverse effects and nursing education</p>
<p>CNS effects (nystagmus, sedation, ataxia, double vision, cognitive impairment)</p>
<p>â€¢ Monitor for symptoms and notify the provider if symptoms occur.</p>
<p>Gingival hyperplasia (softening and overgrowth of gum tissue, tenderness, and bleeding gums)</p>
<p>â€¢ Advise clients to maintain good oral hygiene (dental flossing, massaging gums).</p>
<p>â€¢ Skin rash â€¢ Stop medication if rash develops.</p>
<p>â€¢ Teratogenic (cleft palate, heart defects)</p>
<p>â€¢ Avoid use in pregnancy..</p>
<p>Side /adverse effects and nursing education</p>
<p>Cardiovascular effects (dysrhythmias, hypotension)</p>
<p>â€¢ Administer at slow IV rate and in dilute solution to prevent adverse CV effects.</p>
<p>Endocrine and other effects (coarsening of facial features, hirsutism, and interference with vitamin D metabolism)</p>
<p>â€¢ Instruct clients to report changes.</p>
<p>â€¢ Encourage clients to consume adequate amounts of calcium and vitamin D.</p>
<p>PSYCHOTHRAPEUTIC AGENTS</p>
<ul>
<li>These are antipsychotics, antidepressants and mood stabilizers</li>
</ul>
<p>ANTIDEPRESSANTS</p>
<ul>
<li>Depression is a mood (affective) disorder and is a widespread problem, ranking high among causes of disability.</li>
<li>Clients starting antidepressant medication therapy for depression need to be advised that symptom relief can take 1 to 3 weeks and possibly 2 to 3 months for full benefits to be achieved. Encourage continued adherence.</li>
<li>Clients with major depression may require hospitalization with close observation and suicide precautions until the antidepressant medications reach their peak effect.</li>
</ul>
<p>Antidepressants cont.â€™</p>
<p>Antidepressant mediations are classified into four main groups:</p>
<p>âž¢ Tricyclic antidepressants</p>
<p>âž¢ Selective serotonin reuptake inhibitors (SSRIs)</p>
<p>âž¢ Monoamine oxidase inhibitors (MAOIs)</p>
<p>âž¢ Atypical antidepressant</p>
<p>a)Tricyclic antidepressant;</p>
<p>Amitriptyline (Elavil), Imipramine (Tofranil), Doxepin (Sinequan) , Nortriptyline (Aventyl), Amoxapine (Asendin),</p>
<p>Trimipramine (Surmontil)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Tricyclic antidepressant medications block reuptake of norepinephrine and serotonin in the synaptic space, thereby intensifying the effects of these neurotransmitters.
Therapeutic Uses</li>
<li>Depression</li>
<li>Chronic pain</li>
<li>childhood Enuresis</li>
<li>Obsessive compulsive disorders (clomipramine)</li>
</ul>
<p>Side effects</p>
<ul>
<li>Sedation</li>
<li>Anticholinergic effects
âœ“ Dry mouth
âœ“Blurred vision
âœ“ Photophobia
âœ“ Urinary hesitancy or retention
âœ“ Constipation
âœ“Seizures and impotence</li>
<li>older patients; dizziness, postural hypotension, constipation, delayed micturition, edema, muscle tremors.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Tricyclic overdose</p>
<p>â€¢ Lethal 70 to 80 percent die before reaching the hospital</p>
<p>â€¢ CNS and cardiovascular systems are affected.</p>
<p>â€¢ death results from seizures and dysrhythmias</p>
<p>no specific antidote</p>
<p>âœ“ Decrease drug absorption with activated charcoal</p>
<p>âœ“ Speed elimination by alkalinizing urine</p>
<p>âœ“ Manage seizures and dysrhythmias</p>
<p>âœ“ Basic life support</p>
<p>Drug interactions</p>
<ul>
<li>Antipsychotics and steroids may inhibit TCAs</li>
<li>Aspirin may displace TCAs from binding site</li>
<li>TCAs and alcohol potentiate the effects of each other hence death due to severe respiratory distress.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-monoamine-oxidase-inhibitors-maoi-s">b)Monoamine Oxidase Inhibitors (MAOI s)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-monoamine-oxidase-inhibitors-maoi-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>phenelzine (Nardil)</li>
<li>Isocarboxazid (Marplan)</li>
<li>Tranylcypromine (Parnate)</li>
<li>Selegiline (Emsam) - transdermal MAOI</li>
</ul>
<p>Mechanism of action;
MAOIs inhibit the MAO enzyme system in the CNS.
Amines ( Norepinephrine, Dopamine And Serotonin) resulting in higher levels in the brain to transmit impulses.</p>
<p>Therapeutic use</p>
<ul>
<li>Highly effective considered second line treatment for depression not responsive to cyclics.</li>
<li>Atypical depression</li>
<li>Bulimia nervosa</li>
<li>Obsessive compulsive disorders (OCD)</li>
</ul>
<p>Side effects</p>
<p>Few side effects most common; orthostatic hypotension.</p>
<p>Tachycardia, dizziness, insomnia, anorexia, blurred vision, palpitation, drowsiness, headache, nausea, impotence</p>
<p>MAOIs overdose</p>
<p>â€¢ Symptoms appear 12 hours after ingestion.</p>
<p>these are; tachycardia, circulatory collapse, seizure, coma.</p>
<p>Treatment;</p>
<p>âž¢gastric lavage</p>
<p>âž¢Urine acidification</p>
<p>âž¢hemodialysis</p>
<p>MAOIs hypertensive crisis and tyramine</p>
<p>â€¢ Ingestion of food/drinks with amino acid tyramine leads to hypertensive crisis, which may lead to cerebral hemorrhage, stroke, coma, or death</p>
<p>â€¢ Avoid foods that contain tyramine;</p>
<p>âž¢aged mature cheese</p>
<p>âž¢Smoked/pickled or aged meat, fish, poultry(herring ,sausages, corned beef, salami, pepperoni).</p>
<p>âž¢Red wine(chianti, sherry, vermouth)</p>
<p>âž¢Italian broad beans (fava).</p>
<p>Contraindications/Precautions</p>
<ul>
<li>MAOIs are Pregnancy Risk Category C.</li>
<li>These medications are contraindicated in clients taking SSRIs and in those with pheochromocytoma, heart failure, cardiovascular and cerebral vascular disease, and severe renal insufficiency.</li>
<li>Use cautiously in clients with diabetes and seizure disorders or those taking TCAs.</li>
<li>Transdermal selegiline is contraindicated for clients taking carbamazepine (Tegretol) or oxcarbazepine (Trileptal), which may increase blood levels of the MAOI.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>c)Selective Serotonin Reuptake Inhibitors (SSRIs)</p>
<p>â€¢ Fluoxetine (Prozac)</p>
<p>â€¢ Citalopram (Celexa)</p>
<p>â€¢ Escitalopram oxalate (Lexapro)</p>
<p>â€¢ Paroxetine (Paxil)</p>
<p>â€¢ Sertraline (Zoloft)</p>
<p>Pharmacodynamics</p>
<p>â€¢ SSRI inhibit the reuptake of only serotonin at the part of the amine pump that is specifically for reuptake of serotonin.</p>
<p>â€¢ This explains why these drugs have lesser unwanted effects compared to TCAs.</p>
<p>â€¢ the drug of choice for Depression.</p>
<p>Therapeutic Uses</p>
<ul>
<li>Major depression</li>
<li>Obsessive compulsive disorders (OCD)</li>
<li>Bulimia nervosa</li>
<li>Premenstrual dysphoric disorders</li>
<li>Panic disorders</li>
<li>Posttraumatic disorder (PTSD)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>pharmacokinetics</p>
<ul>
<li>SSRIs are well absorbed orally</li>
<li>Wide distribution and half life of fifteen to 24 hour but fluoxetine has a half life of 24 to ninety six hours.</li>
<li>They achieve effects within 2 to 4 weeks.</li>
<li>Paroxetine and fluoxetine are not used with TCAs since they inhibit TCA hepatic metabolism</li>
</ul>
<p>Unwanted effects</p>
<p>This include nausea and vomiting, diarrhea, agitation, anorgasmia priapism.</p>
<p>Drug interaction</p>
<ul>
<li>MAOIs, TCAs, and St. Johnâ€™s wort increase the risk of serotonin syndrome.</li>
<li>Fluoxetine can displace warfarin (Coumadin) from bound protein and result in increased warfarin levels.</li>
<li>Fluoxetine can increase the levels of tricyclic antidepressants and lithium.</li>
<li>Fluoxetine suppresses platelet aggregation and thus increases the risk of bleeding when used concurrently with NSAIDs and anticoagulants.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="d-second-generation-antidepressants">d) Second generation antidepressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-second-generation-antidepressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Newer</p>
<ul>
<li>Fewer side effects than tricyclic but not superior in overall efficacy or onset of action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples-are">Examples are<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Trazodone,
Bupropion
Duloxetine</p>
<p>Mechanism of action</p>
<p>â€¢ selective inhibition of serotonin uptake</p>
<p>â€¢ Advantage over tricyclic and MAOIs little or no effect on cardiovascular system.</p>
<p>Therapeutic uses</p>
<p>Depression, bipolar affective disorders, obesity, eating disorders, obsessive compulsive disorders, panic attacks, myoclonus, treatment for various substance abuse problems (bupropion is used for smoking cessation treatment)</p>
<p>Side effects</p>
<ul>
<li>CNS; headache, dizziness, nervousness, insomnia, fatigue and tremors.</li>
<li>GI; nausea, diarrheal, constipation, dry mouth, sweating, sexual dysfunction .</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>ANTIPSYCHOTIC AGENTS/TRANQUILIZERS/NEUROLEPTICS</p>
<p>â€¢ Classification of neuroleptic is based on chemical structure or severity of resulting unwanted effects.</p>
<p>â€¢ Based on unwanted effect;</p>
<p>Conventional (typical, first generation)</p>
<p>Examples;</p>
<p>chlorpromazine, haloperidol, and fluphenazine</p>
<p>Newer (atypical, second generation)</p>
<p>Example; clozapine, loxapine, asenapine, olanzapine, quetiapine, paliperidone, risperidone, sertindole.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-cont">Classification cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The distinction between typical and atypical neuroleptic is not clear but rest on ; receptor profile , incidence of extrapyramidal effects which are less in the atypical group, efficacy in treatment and efficacy in negative symptoms.
Classification according to chemical structures;
Phenothiazines; chlorpromazine 100 to 1500 mg , trifluoperazine, fluphenazine 1 to 10 mg
Butyrophenones; haloperidol 2 to 20 mg
Dibenzodiazepine; clozapine 25 to 900 mg
Thienobenzodiazepines; olanzapine
Thioxanthene's; flupentixol 6 to 18 mg
Benzisoxazole; risperidone 1to 12mg</li>
</ul>
<p>Pharmacodynamics</p>
<ul>
<li>They act by blocking the dopamine receptor.</li>
</ul>
<p>Indication</p>
<ul>
<li>Treatment of acute and chronic psychosis</li>
<li>Schizophrenia</li>
<li>Bipolar disorders (primarily the manic phase)</li>
<li>Touretteâ€™s syndrome</li>
<li>Delusional and schizoaffective disorders</li>
<li>Dementia</li>
<li>Prevention of nausea/vomiting through blocking of dopamine in the chemoreceptor trigger zone of the medulla</li>
<li>hiccups</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side effects typical antipsychotic</p>
<ul>
<li>Extrapyramidal effects (dystonia, parkinsonism, tardative dyskinesia)</li>
<li>Anticholinergic effects; (dry mouth, blurred vision, urinary retention, constipation and impotence)</li>
<li>Cardiovascular effects; tachycardia, arrhythmias, postural hypotention</li>
<li>Galactorrhea,</li>
<li>gynecomastia</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="side-effect-atypical-antipsychotics">Side effect atypical antipsychotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effect-atypical-antipsychotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Clozopine; weight gain, agranulocytosis</li>
<li>Risperidone; insomnia anxiety, agitation</li>
<li>Olanzapine; weight gain, dizziness, sedation, anticholinergic effect</li>
</ul>
<p>Mood stabilizers</p>
<p>lithium carbonate</p>
<p>Expected Pharmacological Action</p>
<p>Lithium produces neurochemical changes in the brain, including serotonin receptor blockade.</p>
<p>There is evidence that the use of lithium can show a decrease in neuronal atrophy and/or an increase in neuronal growth.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Lithium is used in the treatment of bipolar disorders. Lithium controls episodes of acute mania, helps prevent the return of mania or depression, and decreases the incidence of suicide.</li>
<li>Other uses:</li>
<li>Alcoholism</li>
<li>Bulimia</li>
<li>Schizophrenia</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Absorption :rate and extent vary with dose form. absorption is complete within hours of oral use.</li>
<li>Distribution :wide distribution in the body, concentration in thyroid gland, bone and brain tissue exceed serum levels.</li>
<li>Metabolism :not metabolized</li>
<li>Excretion : excreted unchanged in urine. Half lif18 hours (adolescence)to 3 hour (elderly).</li>
</ul>
<p>Dosage adults :300mg to six hundred mg up to q.i.d increasing to achieve optimal dosage.</p>
<p>Adverse reaction</p>
<ul>
<li>Gastrointestinal distress (nausea, diarrhea, abdominal pain).</li>
<li>Fine hand tremors that can interfere with purposeful motor skills and can be exacerbated by factors such as stress and caffeine.</li>
<li>Polyuria, mild thirst.</li>
<li>Weight gain</li>
<li>Renal toxicity</li>
</ul>
<p>Goiter and hypothyroidism with long-term treatment Brady dysrhythmia, hypotension, and electrolyte imbalances .</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precautions</p>
<ul>
<li>Lithium is Pregnancy Risk Category D. This medication is teratogenic, especially during the first trimester.</li>
<li>Discourage clients from breastfeeding if lithium therapy is necessary.</li>
<li>Use cautiously in clients with renal dysfunction, heart disease, sodium depletion, and dehydration</li>
</ul>
<p>Medication/Food Interactions</p>
<ul>
<li>Sodium is excreted with the use of diuretics. Reduced serum sodium decreases lithium excretion, which can lead to toxicity.</li>
<li>Concurrent use of NSAIDs (ibuprofen [Motrin] and celecoxib [Celebrex]) will increase renal reabsorption of lithium, leading to toxicity.</li>
</ul>
<p>Avoid use of NSAIDs.</p>
<p>Use aspirin as a mild analgesic.</p>
<ul>
<li>Anticholinergics (antihistamines, tricyclic antidepressants) can induce urinary retention and polyuria, leading to abdominal discomfort</li>
<li>Advise clients to avoid medications with anticholinergic effects. rt.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-administration">Nursing Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Monitor plasma lithium levels while undergoing treatment. At initiation of treatment, monitor levels every 2 to 3 days and then every 1 to 3 months. Lithium blood levels should be obtained in the morning, usually 12 hr . after the last dose.</li>
<li>During initial treatment of a manic episode, levels should be between 0.8 to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.4</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.4 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.4</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span>.</li>
<li>Maintenance level range is between 0.4 to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.0</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.0 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.0</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span>.</li>
<li>Plasma levels &gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.5</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.5 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.5</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span> can result in toxicity.</li>
<li>Care for clients who have a toxic plasma lithium level in an inpatient setting and provide supportive measures. Hemodialysis may be indicated.</li>
<li>Advise clients that effects begin within 7 to 14 days.</li>
</ul>
<p>Nursing administration cont.â€™</p>
<ul>
<li>Advise clients to take lithium as prescribed. Lithium must be administered in 2 to 3 doses daily due to a short half life. Taking lithium with food will help decrease GI distress.</li>
<li>Encourage clients to adhere to laboratory appointments needed to monitor lithium effectiveness and adverse effects. Emphasize the high risk of toxicity due to the narrow therapeutic range.</li>
<li>Provide nutritional counseling. Stress the importance of adequate fluid and sodium intake.</li>
<li>Instruct clients to monitor for signs of toxicity and when to contact the provider. Clients should stop taking medication and seek medical attention if experiencing diarrhea, vomiting, or excessive sweating.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-mood-stabilizing-drugs">Other mood stabilizing drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-mood-stabilizing-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Carbamazepine (Tegretol)</li>
<li>Valproic acid (Depakote)</li>
<li>Lamotrigine (Lamictal) Purpose</li>
</ul>
<p>Expected Pharmacological Action: AEDs help treat and manage bipolar disorders by various mechanisms, which include:</p>
<ul>
<li>Slowing the entrance of sodium and calcium back into the neuron and, thus extending the time it takes for the nerve to return to its active state.</li>
<li>Potentiating the inhibitory effects of gamma butyric acid (GABA)</li>
<li>Inhibiting glutamic acid (glutamate) which in turn suppresses CNS excitation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Treatment of manic and depressive episodes, prevention of relapse of mania and depressive episodes.</li>
<li>Especially useful for clients with mixed mania and rapid cycling bipolar disorders.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cns-stimulants">CNS STIMULANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cns-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>MEDICATION</th><th>SHORT ACTING</th><th>INTERMEDIATE ACTING</th><th>LONG ACTING</th></tr></thead><tbody><tr><td>Methylphenidate</td><td>Ritalin, Methylin</td><td>Ritalin SR, Methylin ER</td><td>ethylin ER Ritalin LA,</td></tr><tr><td>Concerta, Daytrana</td><td></td><td></td><td></td></tr><tr><td>(transdermal)</td><td></td><td></td><td></td></tr><tr><td>Dexmethylphenidate</td><td>Focalin</td><td></td><td></td></tr><tr><td>Dextroamphetamine</td><td>Dexedrine</td><td></td><td>Dexedrine Spansule</td></tr><tr><td>Amphetamine mixture</td><td>Adderall</td><td></td><td>Adderall-XR</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cns-stimulants-cont">CNS stimulants cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cns-stimulants-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These medications raise the levels of norepinephrine, serotonin, and dopamine into the CNS.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>ADHD ( Attention Deficit Hyperactivity Disorder)</li>
<li>Conduct disorder</li>
</ul>
<p>Side effects</p>
<ul>
<li>CNS stimulation (insomnia, restlessness)</li>
<li>Weight loss</li>
<li>Cardiovascular effects (dysrhythmias, chest pain, high blood pressure)</li>
<li>These medications may increase the risk of sudden death in clients with heart abnormalities.</li>
<li>Development of psychotic symptoms such as hallucinations, paranoia Withdrawal reaction.</li>
<li>Hypersensitivity skin reaction to transdermal methylphenidate (hives, papules)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precautions</p>
<ul>
<li>These medications are contraindicated in clients who have a history of drug abuse, cardiovascular disorders, severe anxiety, and psychosis.</li>
</ul>
<p>Medication/Food Interactions:</p>
<p>Concurrent use of MAOI s may cause hypertensive crisis.</p>
<p>Concurrent use of caffeine may increase CNS stimulant effects.</p>
<p>Methylphenidate inhibits metabolism of phenytoin (Dilantin), warfarin (Coumadin), and phenobarbital, leading to increased serum levels.</p>
<p>OTC cold and decongestant medications with sympathomimetic action can increase CNS stimulant effects.</p>
<p>Nursing Administration</p>
<ul>
<li>
<p>Advise clients to swallow sustained-release tablets whole and to not chew or crush the tablets.</p>
</li>
<li>
<p>Teach clients the importance of administering the medication on a regular schedule.</p>
</li>
<li>
<p>Teach clients who use transdermal medication (Daytrana) to place the patch on one hip daily in the morning and leave it in place no longer than 9 hr. Alternate hips daily.</p>
</li>
<li>
<p>Instruct parents and clients that ADHD is not cured by medication and should be managed with an overall treatment plan that may include family therapy and cognitive therapy.</p>
</li>
<li>
<p>Instruct parents that these medications have special handling procedures controlled by federal law. Handwritten prescriptions are required for medication refills.</p>
</li>
<li>
<p>Instruct parents in safety and storage of medications.</p>
</li>
<li></li>
</ul>
<p>MUSCLE RELAXANT/NEUROMUSCULAR BLOCKING AGENTS</p>
<p>â€¢ Neuromuscular blocking agents have various uses including assisting with:</p>
<p>âœ“ sedation during general anesthesia,</p>
<p>âœ“ control of seizures during electroconvulsive therapy,</p>
<p>âœ“ suppression of gag reflex during endotracheal intubation.</p>
<p>â€¢ Medications include succinylcholine (Anectine) and vecuronium (Norcuron)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-parkinson-s-drugs">Anti -Parkinson's drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-parkinson-s-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Neuromuscular agents cont.'</p>
<p>Muscle relaxants and antispasmodic agents can affect both the central and peripheral nervous systems.</p>
<ul>
<li>
<p>These agents are used with spasticity related to muscle injury, cerebral palsy, spinal cord injury, and multiple sclerosis.</p>
</li>
<li>
<p>Agents include diazepam (Valium), baclofen (Lioresal), and dantrolene (Dantrium).</p>
</li>
<li>
<p>Bethanechol (Urecholine), a muscarinic agonist, is used for urinary retention.</p>
</li>
<li>
<p>Oxybutynin (Ditropan), a muscarinic antagonist, is used for neurogenic bladder</p>
</li>
<li></li>
</ul>
<p>Muscle relaxant/ Neuromuscular Blocking Agents cont.â€™</p>
<p>Depolarizing neuromuscular blocker: succinylcholine (Anectine)</p>
<p>Nondepolarizing neuromuscular blockers: pancuronium (Pavulon)</p>
<p>Other Medications:</p>
<p>Nondepolarizing neuromuscular blockers: atracurium (Tracrium), Vecuronium (Norcuron)</p>
<p>Expected Pharmacological Action</p>
<p>Neuromuscular blocking agents block acetylcholine (ACh) at the neuromuscular junction, resulting in muscle relaxation and hypotension. They do not cross the blood-brain barrier, so complete paralysis can be achieved without loss of consciousness or decreased pain sensation.</p>
<p>Neuromuscular agents cont.'</p>
<p>Therapeutic Uses</p>
<p>â€¢ Neuromuscular blocking agents are used as adjuncts to general anesthesia to promote muscle relaxation.</p>
<p>â€¢ These agents are used to control spontaneous respiratory movements in clients receiving mechanical ventilation.</p>
<p>â€¢ These agents are used as seizure control during electroconvulsive therapy.</p>
<p>â€¢ Neuromuscular blocking agents are used during endotracheal intubation and endoscopy</p>
<p>Side effect</p>
<ul>
<li>Respiratory arrest from paralyzed respiratory muscles</li>
<li>Hypotension</li>
<li>Low pseudo cholinesterase activity can lead to prolonged apnea</li>
<li>Signs of malignant hyperthermia include muscle rigidity accompanied by increased temperature, reaching levels as high as 43Â° C (109.4Â° F).</li>
<li>After 12 to 24 hr. postoperative, clients may experience muscle pain in the upper body and back.</li>
<li>Hyperkalemia</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Drug interaction</p>
<p>General anesthetics are often used concurrently in surgery.</p>
<p>â€¢ Dosage of tubocurarine should be reduced to prevent extreme neuromuscular blockade.</p>
<p>Aminoglycosides and tetracyclines can increase the effects of neuromuscular blockade.</p>
<p>â€¢ Take complete medication history of clients who are to receive neuromuscular blockade.</p>
<p>Neostigmine and other cholinesterase inhibitors increase the effects of depolarizing neuromuscular blockers, such as succinylcholine.</p>
<p>â€¢ Monitor clients during neuromuscular blockade reversal after surgery</p>
<p>Nursing Administration</p>
<ul>
<li>Clients must receive continuous cardiac and respiratory monitoring during therapy.</li>
<li>Monitor clients for respiratory depression and have life support equipment available.</li>
<li>Carefully monitor clients for return of respiratory function.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="local-anaesthetics">LOCAL ANAESTHETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-anaesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>local anesthetic bind reversibly to a specific receptor site within the pore of the sodium channels in nerves and block ion movement when applied locally to nerve tissues in appropriate concentration.</li>
<li>Local anesthetic can act on any part of the nervous system, on every type of nerve fibers, reversibly blocking the action potentials responsible for nerve conduction.</li>
<li>Thus a local anesthetic in contact with a nerve trunk can cause both sensory and motor paralysis in the area innervated.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Local anesthetic block conduction by decreasing or preventing the large transient increase in the permeability of excitable membranes.</li>
<li>This action is due to direct interaction with voltage gated sodium channels.</li>
<li>As the anesthetic action progressively develops in the nerve ,the threshold for electrical excitability increase. The rate of rise of the action potential also declines, impulse conduction slows, and nerve conduction eventually fails</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="local-anesthetics">Local anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Drug</th><th>Duration of action</th></tr></thead><tbody><tr><td>lidocaine</td><td>medium</td></tr><tr><td>Bupivacaine (Marcaine),levobupivacaine (chirocaine)</td><td>long</td></tr><tr><td>Ropivacaine (naropin)</td><td>long</td></tr><tr><td>Mepivacaine (carbocaine, isocaine)</td><td>medium</td></tr><tr><td>articaine</td><td>medium</td></tr><tr><td>benzocaine</td><td>Surface use only</td></tr><tr><td>Tetracaine (pontocaine)</td><td>long</td></tr><tr><td>Cocaine</td><td>medium</td></tr><tr><td>Procaine</td><td>short</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="neuromuscular-agents">Neuromuscular agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neuromuscular-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The action of non depolarizing muscle relaxant is antagonized, once muscle paralysis is no longer desired with an acetylcholinesterase inhibitor such as neostigmine or edrophonium</p>
<p>Skeletal muscle relaxants</p>
<p>Succinylcholine</p>
<p>â€¢ Succinylcholine mimics ACh by binding with cholinergic receptors at the neuromuscular junction. This agent fills the cholinergic receptors, preventing ACh from binding with them, and causes sustained depolarization of the muscle, resulting in muscle paralysis.</p>
<p>Reversal agent: Pseudo cholinesterase enzyme</p>
<p>â€¢ Pancuronium, atracurium, vecuronium</p>
<p>â€¢ These agents block ACh from binding with cholinergic receptors at the motor end plate. Muscle paralysis occurs because of inhibited nerve depolarization and skeletal muscle contraction.</p>
<p>â€¢ Reversal agent: Neostigmine (Prostigmin)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-anesthetics">General anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>General anesthetics depress the CNS sufficiently to permit surgery and other noxious or unpleasant procedures.</li>
<li>Gas have a low therapeutic indices and are require great care in administration.</li>
<li>The consideration of patients age, associated medical condition and medication use is important.</li>
<li>The physiological state induced by general anesthesia include; analgesia, amnesia, loss of consciousness, inhibition of sensory and autonomic reflexes, and skeletal muscle relaxation.</li>
</ul>
<p>a)Parenteral anesthetics</p>
<p>Pharmacokinetic principle</p>
<p>â€¢ After a single intravenous bolus these drugs preferentially partition into the highly perfused and lipophilic tissues of the brain and the spinal cord where they produce anesthesia within a single circulation.</p>
<p>â€¢ Blood levels falls rapidly, resulting in drug redistribution out of the cns back into the blood.</p>
<p>â€¢ The anesthetics then perfuse into less perfused tissues such as muscle and viscera , and at a slower rate into the poorly perfused but very hydrophobic adipose tissue.</p>
<p>Parenteral anesthetics</p>
<ul>
<li>Thiopental and Propofol are the two most commonly used parenteral agents.</li>
<li>thiopental has a long established track record of safety.</li>
<li>Propofol is advantageous for procedures where rapid return to a preoperative mental status is desirable.</li>
<li>Etomidate usually is reserved for patients at risk for hypotension and /myocardial ischemia</li>
<li>Ketamine is best suited for patients with asthma, children undergoing short ,painful procedures</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacological-characteristics-of-parenteral-anesthetics-iv">Pharmacological characteristics of parenteral anesthetics (IV)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacological-characteristics-of-parenteral-anesthetics-iv" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>DRUG</th><th>INDUCTION AND RECOVERY</th><th>COMMENTS</th></tr></thead><tbody><tr><td>etomidate</td><td>Rapid onset and moderate fast recovery</td><td>Provides cardiovascular stability, causes decreased steroidal genesis and involuntary muscle movement</td></tr><tr><td>ketamine</td><td>Moderate onset and recovery</td><td>Causes cardiovascular stimulation, increase cerebral blood flow and emergence reaction that impair recovery</td></tr><tr><td>midazolam</td><td>Slow onset and recovery; flumazenil reversal available</td><td>Provides cardiovascular stability and marked amnesia, used in balanced anesthesia and conscious sedation.</td></tr><tr><td>Propofol</td><td>Rapid onset and recovery</td><td>Used in induction and maintenance can cause hypotension, has useful antiemetic action.</td></tr><tr><td>thiopental</td><td>Rapid onset and recovery (bolus dose) slow recovery following infusion.</td><td>Standard induction agent, causes cardiovascular depression, avoid in porphyria's</td></tr><tr><td>fentanyl</td><td>Slow onset and recovery.</td><td></td></tr><tr><td>Naloxone reversal available</td><td>opioid used in balanced anesthesia and conscious sedation produces marked analgesia</td><td></td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inhalation-anesthetics">Inhalation anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inhalation-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>They have a low safety margin.</li>
<li>The selection of inhalation anesthetic is often marching a patient pathophysiology with drug side effects.</li>
<li>The inhalation anesthetics also vary widely in their physical properties, which govern the pharmacokinetics of the inhalation agents</li>
<li>They produce a rapid induction of anesthesia and a rapid recovery following discontinuation.</li>
<li>Examples are: nitrous oxide, halothane, desflurane, sevoflurane, enflurane, and methoxyflurane.</li>
</ul>
<p>Side effect of anesthetics</p>
<ul>
<li>Hemodynamic effect e.g. decrease in systemic arteria BP.</li>
<li>respiratory effects; elimination of both ventilatory drive and reflex that maintain airway patency, gag reflex is lost, no cough stimulus, lower esophageal sphincter tone is reduced.</li>
<li>Hypothermia, nausea and vomiting.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Other emergence Postoperative effects</p>
<ul>
<li>Hypotension and tachycardia,</li>
<li>myocardial ischemia,</li>
<li>post anesthesia shivering, (give small dose of meperidine 12 mg lowers the shivering triggers temperature.</li>
<li>Airway obstruction</li>
<li>Respiratory suppression</li>
<li>Hypoxemia may occur</li>
<li>Negative pressure pulmonary edema may occur due to strong inspiratory efforts against a closed glottis</li>
<li>pain control can be complicated</li>
<li>These emergence phenomena can be greatly reduced when opioids are employed as part of the intraoperative regimen</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>CVS: DIURETICS</p>
<ul>
<li>Diuretics are drugs that increase the rate of urine flow; clinically useful diuretics also increase the rate of excretion of sodium and accompanying anion chloride.</li>
<li>Most clinical application of diuretics aim to reduce extracellular fluid volume by decreasing total sodium chloride volume.</li>
<li>diuretics alter excretion of sodium and also may modify handling of other cations(potassium, hydrogen and magnesium) anions (chloride, bicarbonate, hydrogen phosphate ), and uric acid</li>
</ul>
<p>Clinical pharmacology of diuretics</p>
<p>â€¢ Edematous state :in heart failure, kidney disease and in renal failure.</p>
<p>â€¢ Non edematous state : in hypertension, nephrolithiasis hypercalcemia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification-of-diuretics">classification of diuretics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>âž¢Loop diuretics : furosemide</p>
<p>âž¢Thiazide diuretics: hydrochlorothiazide</p>
<p>âž¢Potassium sparing diuretics: spironolactone</p>
<p>âž¢Osmotic diuretic: mannitol</p>
<p>âž¢Carbonic anhydrase inhibitors: acetazolamide (DIAMOX)</p>
<p>Hormones Acting on the Nephron / Diuretics and Their Site of Action</p>
<p><img src="assets/images/image-20251214-e058334e.jpeg" alt="img-56.jpeg"></p>
<p>a)High Ceiling Loop Diuretics</p>
<p>furosemide (Lasix)</p>
<p>Other Medications:</p>
<p>â€¢ Ethacrynic acid (Edecrin)</p>
<p>â€¢ Bumetanide (Bumex)</p>
<p>â€¢ Torsemide (Demadex)</p>
<p>Expected Pharmacological Action</p>
<p>â€¢ High ceiling loop diuretics work in the ascending limb of loop of Henle to:</p>
<p>â€¢ Block reabsorption of sodium and chloride and to prevent reabsorption of water, Cause extensive diuresis even with severe renal impairment.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>High ceiling loop diuretics are used when there is an emergent need for rapid mobilization of fluid such as:</li>
<li>Pulmonary edema caused by heart failure</li>
<li>Conditions not responsive to other diuretics such as edema caused by liver, cardiac, or kidney disease; hypertension</li>
<li>These medications may also be used to treat hypercalcemia related to kidney stone formation.</li>
<li>Route of administration: Oral, IV, IM.</li>
</ul>
<p>Side effects</p>
<ul>
<li>
<p>Dehydration, hyponatremia, hypochloremia.</p>
</li>
<li>
<p>Hypotension</p>
</li>
<li>
<p>Ototoxicity (transient with furosemide and irreversible with ethacrynic acid)</p>
</li>
<li>
<p>Hypokalemia (K+ less than 3.5 mEq/L</p>
</li>
<li>
<p>Other adverse effects (hyperglycemia, hyperuricemia, and decrease in calcium and magnesium levels)</p>
</li>
<li>
<p>Contraindications/Precautions ;Pregnancy Risk Category C , Avoid using these medications during pregnancy unless absolutely required. Use cautiously in clients who have diabetes and/or gout</p>
</li>
<li></li>
</ul>
<p>Drug interaction</p>
<ul>
<li>Digoxin (Lanoxin) toxicity can occur in the presence of hypokalemia.</li>
<li>Concurrent use of antihypertensive can have additive hypotensive effect.</li>
<li>Hyponatremia can lead to decrease in lithium carbonate excretion, which may lead to toxicity.</li>
<li>NSAIDs reduce diuretic effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing administration</p>
<ul>
<li>Obtain the clientâ€™s baseline data to include orthostatic blood pressure, weight, electrolytes, and location and extent of edema.</li>
<li>Weigh clients at the same time each day; usually upon awakening.</li>
<li>Monitor the clientâ€™s blood pressure and I&amp;O.</li>
<li>Avoid administering the medication late in the day to prevent nocturia. Usual dosing time is 0800 and 1400.</li>
<li>Administer furosemide orally, IV bolus dose, or continuous IV infusion. Infuse IV doses at 20 mg/min or slower to avoid abrupt hypotension and hypovolemia.</li>
<li>If potassium level drops below 3.5 mEq/L, clients should be placed on a potassium supplement.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing administration cont.'</p>
<ul>
<li>
<p>If the medication is used for hypertension, teach clients to self-monitor blood pressure and weight by keeping a log.</p>
</li>
<li>
<p>Advise clients to get up slowly to minimize postural hypotension. If faintness or dizziness occurs, instruct clients to sit or lie down.</p>
</li>
<li>
<p>Teach clients to report significant weight loss, lightheadedness, dizziness, GI distress, and/ or general weakness to the provider.</p>
</li>
<li>
<p>Encourage clients to consume foods high in potassium, such as avocados and strawberries.</p>
</li>
<li>
<p>Instruct clients with diabetes to monitor for elevated blood glucose levels.</p>
</li>
<li>
<p>Instruct clients to observe for signs of low magnesium levels such as muscle twitching and tremors.</p>
</li>
<li></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-thiazide-diuretics">b)Thiazide Diuretics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-thiazide-diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>hydrochlorothiazide (Hydrodiuril)</li>
</ul>
<p>Other Medications:</p>
<ul>
<li>Chlorothiazide (Diuril)</li>
<li>Methyclothiazide (Enduron)</li>
</ul>
<p>Thiazide-type diuretics:</p>
<ul>
<li>indapamide (Lozide, Lozol)</li>
<li>chlorthalidone (Hygroton)</li>
<li>metolazone (Zaroxolyn)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Thiazide diuretics work in the early distal convoluted tubule to:</li>
<li>Block the reabsorption of sodium and chloride, and prevent the reabsorption of water at this site</li>
<li>Promote diuresis when renal function is not impaired</li>
</ul>
<p>Therapeutic Uses</p>
<ul>
<li>Thiazide diuretics are often the medication of first choice for essential hypertension.</li>
<li>These medications may be used for edema of mild-to-moderate heart failure and liver and kidney disease.</li>
</ul>
<p>Side/Adverse Effects</p>
<ul>
<li>dehydration</li>
<li>Hypokalemia (K+ less than 3.5 mEq/L)</li>
<li>Hyperglycemia</li>
</ul>
<p>Medication/Food Interactions</p>
<ul>
<li>Digoxin (Lanoxin) toxicity can occur in the presence of hypokalemia</li>
<li>Antihypertensive have additive hypotensive effects. Monitor the clientâ€™s blood pressure.</li>
<li>Hyponatremia can lead to decrease in lithium (Eskalith) excretion, which may lead to toxicity.</li>
<li>NSAIDs reduce diuretic effect</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing administration</p>
<ul>
<li>Chlorothiazide may be administered orally and IV, all others can only be given orally.</li>
<li>Obtain the clientâ€™s baseline data to include orthostatic blood pressure, weight, electrolytes, and location and extent of edema.</li>
<li>Monitor the clientâ€™s potassium levels</li>
<li>Instruct clients to take the medication first thing in the morning; if twice-a-day dosing is prescribed, be sure the second dose is taken by 1400 to prevent nocturia.</li>
<li>Encourage clients to consume foods high in potassium and maintain adequate fluid intake (1,500 mL per day, unless contraindicated).</li>
<li>If GI upset occurs, clients should take the medication with or after meals. â—</li>
<li>Alternate-day dosing can decrease electrolyte imbalance</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>c)Potassium-Sparing Diuretics</p>
<p>spironolactone (Aldactone)</p>
<p>Other Medications: triamterene (Dyrenium), amiloride (Midamor)</p>
<p>Expected Pharmacological Action</p>
<p>Potassium-sparing diuretics block the action of aldosterone (sodium and water retention), which results in potassium retention and the secretion of sodium and water.</p>
<p>Therapeutic Uses</p>
<ul>
<li>Potassium-sparing diuretics are combined with other diuretics for potassium-sparing effects.</li>
<li>Potassium-sparing diuretics are used for heart failure.</li>
<li>In primary hyperaldosteronism, potassium-sparing diuretics block actions of aldosterone.</li>
<li>Route of administration: Oral</li>
</ul>
<p>Side/Adverse Effects;</p>
<ul>
<li>Hyperkalemia (K+ greater than 5.0 mEq/L)</li>
<li>Endocrine effects (impotence in male clients; irregularities of menstrual cycle in female clients)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precaution</p>
<ul>
<li>Do not administer to clients who have hyperkalemia.</li>
<li>Potassium-sparing diuretics are contraindicated in clients who have severe renal failure and anuria.</li>
</ul>
<p>Medication/Food Interaction</p>
<ul>
<li>Concurrent use of ACE inhibitors increases the risk of hyperkalemia</li>
<li>Concurrent use of potassium supplements increases the risk of hyperkalemia</li>
</ul>
<p>Nursing Administration</p>
<ul>
<li>Obtain the clientâ€™s baseline data.</li>
<li>Monitor the clientâ€™s potassium levels regularly.</li>
<li>Can only be given orally.</li>
<li>Teach clients to avoid salt substitutes that contain potassium.</li>
<li>Teach clients to self-monitor blood pressure.</li>
<li>Instruct clients to keep a log of blood pressure and weight.</li>
<li>Warn clients that triamterene may turn urine a bluish color.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="d-osmotic-diuretics">d)Osmotic Diuretics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-osmotic-diuretics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>mannitol (Osmitrol)</li>
<li>Expected Pharmacological Action</li>
<li>Osmotic diuretics reduce intracranial pressure and intraocular pressure by raising serum osmolality and drawing fluid back into the vascular and extravascular space.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Osmotic diuretics prevent renal failure in specific situations, such as hypovolemic shock and severe hypotension.</li>
<li>These medications decrease intracranial pressure (ICP) caused by cerebral edema.</li>
<li>These medications decrease intraocular pressure (IOP).</li>
<li>Osmotic diuretics promote sodium retention and water excretion in clients with hyponatremia and fluid volume excess</li>
</ul>
<p>Side/Adverse Effects</p>
<ul>
<li>Renal failure</li>
<li>Heart failure, pulmonary edema</li>
<li>Fluid and electrolyte imbalances</li>
</ul>
<p>Contraindications/Precautions</p>
<ul>
<li>Use extreme caution in clients with heart failure.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Interactions</p>
<ul>
<li>Furosemide contributes to therapeutic effect by promoting renal excretion of fluid drawn into vasculature by osmotic diuretics.</li>
</ul>
<p>Nursing Administration</p>
<p>Administer mannitol by continuous IV infusion.</p>
<p>To prevent administering microscopic crystals, use a filter needle when drawing from the vial and a filter in the IV tubing.</p>
<p>Monitor daily weight, I &amp; 0, and serum electrolytes.</p>
<p>Monitor for signs of dehydration, acute renal failure, and edema.</p>
<p>Use of furosemide may help prevent rebound fluid retention; this contributes to therapeutic effect.</p>
<p>Carbonic anhydrase inhibitors</p>
<ul>
<li>Blockade of carbonic anhydrase activity induces a sodium bicarbonate diuresis, which reduces body bicarbonate levels.</li>
<li>These drugs include;</li>
<li>Acetazolamide (DIAMOX)</li>
<li>Dichlorphenamide (DARANIDE)</li>
<li>Methazolamide (GLAUCTABS)</li>
</ul>
<p>Acetazolamide administration causes a reduction in aqueous humour and CSF fluid production</p>
<p>acetazolamide cont.â€™</p>
<ul>
<li>the proximal tubule is the major site of action of carbonic anhydrase inhibitors.</li>
<li>the collecting duct is the secondary site of action .</li>
</ul>
<p>Clinical application</p>
<p>Glaucoma; because acetazolamide decreases the rate of aqueous humor production, a decline in IOP occurs.</p>
<p>The major indication of carbonate anhydrase inhibitor is open angle glaucoma.</p>
<p>It may also be given in secondary glaucoma</p>
<p>Preoperatively in acute angle glaucoma.</p>
<p>Treatment of epilepsy.</p>
<p>Altitude sickness familial periodic paralysis</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="toxicity">toxicity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#toxicity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hyper chloremic acidosis.</li>
<li>Renal potassium loss.</li>
</ul>
<p>Contraindication
Hepatic cirrhosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antihypertensive">antihypertensive<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antihypertensive" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="cardiovascular-pharmacology">Cardiovascular pharmacology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cardiovascular-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Antihypertensive drugs potential drug targets;</li>
<li>CNS: decrease sympathetic tone</li>
<li>Heart: decrease cardiac out put</li>
<li>Veins: dilate; decrease preload</li>
<li>arterioles: dilate; decrease preload</li>
<li>Kidneys: increase diuresis; inhibit renin angiotensin aldosterone</li>
</ul>
<p>Classification of anti hypertensives</p>
<ul>
<li>diuretics:</li>
</ul>
<p>âœ“Thiazide and related agents (hydrochlorothiazide, chlorthalidone)</p>
<p>âœ“Loop diuretics (furosemide, bumetanide,, torsemide, ethacrynic)</p>
<p>âœ“Potassium sparing diuretics (amiloride, triamterene, spironolactone)</p>
<ul>
<li>
<p>Angiotensin-converting enzyme (ACE) inhibitors ( captopril, enalapril, lisinopril, quinapril, Ramipril, benazepril)</p>
</li>
<li>
<p>Angiotensin II receptor blockers (ARBS)</p>
</li>
</ul>
<p>(losartan, candesartan, Irbesartan, valsartan, telmisartan, eprosartan)</p>
<ul>
<li>Calcium channel blockers (CCB)</li>
</ul>
<p>(verapamil, diltiazem, nifedipine, felodipine, nicardipine, isradipine, amlodipine)</p>
<p>Classification of antihypertensive</p>
<p>Vasodilators
âœ“ Arterial ( hydralazine, minoxidil, diazoxide fenoldopam)
âœ“ Arterial and venous (nitroprusside)
Sympatholytic drugs
Alpha adrenergic blockers; (prazosin, terazosin, doxazosin, phentolamine, phenoxybenzamine)
Beta adrenergic blockers; (metoprolol, atenolol, etc )
Mixed adrenergic; ( labetalol, carvedilol)
Centrally acting alpha2 agonists (methyldopa, clonidine, guanabenz)
Adrenergic neuron blocking agents;( guanethidine, reserpine)</p>
<p>: Angiotensin-Converting Enzyme (ACE) Inhibitors</p>
<p>captopril (Capoten)</p>
<p>â€¢ Other Medications: Enalapril (Vasotec), Enalaprilat (Vasotec IV), Fosinopril (Monopril), Lisinopril (Prinivil), Ramipril (Altace)</p>
<p>Mechanism of action</p>
<p>ACEIs prevents conversion of angiotensin I to angiotensin II which is a potent vasoconstrictor. this causes vasodilation, reduces peripheral resistance, and decreases secretion of aldosterone (thereby resulting in decrease sodium and water retention and extracellular volume)</p>
<p>Merits of ACEIs</p>
<ul>
<li>Safe for asthmatics, diabetics</li>
<li>Absence of rebound hypertension upon abrupt withdrawal.</li>
<li>Total absence of postural hypotension.</li>
<li>maintains renal blood flow.</li>
<li>devoid of electrolyte imbalance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<ul>
<li></li>
</ul>
<ul>
<li>Therapeutic Uses</li>
<li>Hypertension</li>
<li>Heart failure</li>
<li>Myocardial infarction (To decrease mortality and to decrease risk of heart failure and left ventricular dysfunction)</li>
<li>Diabetic and nondiabetic nephropathy</li>
<li>For clients at high risk for a cardiovascular event, Ramipril can be used to prevent MI, stroke, or death.</li>
</ul>
<p>Side/Adverse Effects</p>
<ul>
<li>Cough related to inhibition of kinase II (alternative name for ACE) which results in increase in bradykinin</li>
<li>First-dose orthostatic hypotension.</li>
<li>Hyperkalemia</li>
</ul>
<p>Rash and dysgeusia (altered taste), primarily with captopril</p>
<ul>
<li>Angioedema.</li>
<li>Neutropenia (rare but serious complication of captopril)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precautions</p>
<ul>
<li>These medications are Pregnancy Risk Category D during the second and third trimester, related to fetal injury.</li>
<li>renal stenosis when present bilaterally or in a single remaining kidney.</li>
<li>history of angioedema following use of ACE inhibitor.</li>
<li>Use cautiously in clients with renal impairment and</li>
<li>collagen vascular disease because they are at greater risk for developing neutropenia. Closely monitor these clients for signs of infection.</li>
<li>hypotension</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-food-interactions">Medication/Food Interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-food-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Diuretics can contribute to first-dose hypotension</li>
<li>Antihypertensive medications may have an additive hypotensive effect.</li>
<li>Potassium supplements and potassium-sparing diuretics increase the risk of hyperkalemia.</li>
<li>ACE inhibitors can increase levels of lithium carbonate (Eskalith)</li>
<li>Use of NSAIDs may decrease the antihypertensive effect of ACE inhibitors.</li>
</ul>
<p>Nursing Administration</p>
<ul>
<li>Administer ACE inhibitors orally except enalapril, which is the only ACE inhibitor for IV use.</li>
<li>Advise clients that the medication may be prescribed as a single formulation or in combination with hydrochlorothiazide.</li>
<li>Advise clients that blood pressure has to be monitored after the first dose for at least 2 hr. to detect hypotension.</li>
<li>Instruct clients that captopril should be taken at least 1 hr. before meals. All other ACE inhibitors can be taken with or without food.</li>
<li>Advise clients to notify the provider if cough, rash, dysgeusia (lack of taste), and/or signs of infection occur</li>
</ul>
<p>Angiotensin II Receptor Blockers (ARBs)</p>
<p>â€¢ losartan (Cozaar)</p>
<p>â€¢ Other Medications: Valsartan (Diovan) , Irbesartan (Avapro) , Candesartan (Atacand) , Olmesartan (Benicar)</p>
<p>Expected Pharmacological Action</p>
<p>These medications block the action of angiotensin II in the body.</p>
<p>This results in:</p>
<p>â€¢ Vasodilation (mostly arteriole)</p>
<p>â€¢ Excretion of sodium and water, and retention of potassium (through effects on the kidney)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hypertension,</li>
<li>Heart failure and prevention of mortality following MI,</li>
<li>Stroke prevention ,</li>
<li>Delay progression of diabetic nephropathy</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The major difference between ARBs and ACE inhibitors is that cough and hyperkalemia are not side effects of ARBs</p>
<p>Side/Adverse Effects</p>
<p>â€¢ Angioedema</p>
<p>contraindication</p>
<p>â€¢ Hypersensitivity</p>
<p>â€¢ Pregnancy</p>
<p>â€¢ renal stenosis when present bilaterally or in a single remaining kidney</p>
<p>considerations</p>
<p>monitor BP, HR, Weight, Edema, Blood Urea Nitrogen, Serum Creatinine.</p>
<p>can be used in patients intolerant to aceis (due to cough)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="calcium-channel-blockers">CALCIUM CHANNEL BLOCKERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#calcium-channel-blockers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Nifedipine (Adalat, Procardia)</li>
<li>Verapamil (Calan)</li>
<li>Amlodipine (Norvasc)</li>
</ul>
<p>Other Medications:</p>
<ul>
<li>Amlodipine (Norvasc)</li>
<li>Felodipine (Plendil)</li>
<li>Nicardipine (Cardene, Cleviprex)</li>
<li>Diltiazem (Cardizem)</li>
</ul>
<p>Mechanism of action of CCB</p>
<p>Mechanism of action of</p>
<p>â€¢ inhibits calcium influx in the smooth muscles and the myocardium.</p>
<p>â€¢ Blocking of calcium channels in blood vessels leads to vasodilation of peripheral arterioles and arteries/arterioles of the heart, slows down heart conduction and reduction of blood pressure.</p>
<p>NIFEDIPINE (ADALAT)</p>
<p>â€¢ give rise to coronary vasodilation.</p>
<p>â€¢ Enhances coronary blood flow.</p>
<p>â€¢ Reduces total periphery resistance, reduces systolic and diastolic pressure</p>
<p>Therapeutic use</p>
<ul>
<li>Chronic angina</li>
<li>Congestive heart failure</li>
<li>Acute myocardial infarction</li>
<li>Peripheral vascular disorders</li>
</ul>
<p>Adverse drug reaction</p>
<p>Palpitation, nausea, vomiting, flushing, headache, edema.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="amlodipine">amlodipine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#amlodipine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Serves as a long acting calcium channel blocker.</li>
</ul>
<p>Therapeutic use</p>
<ul>
<li>Treatment of essential hypertension.</li>
<li>Angina pectoris</li>
</ul>
<p>Adverse drug reaction
Palpitation,epixtasis,cough,nocturia,musclecramps,breathless,importen ce, conjunctivitis</p>
<p>verapamil</p>
<ul>
<li>Enhances coronary blood flow rate,vasodilation.</li>
<li>Exerts anti arrhythmic action.</li>
<li>Reduces peripheral resistance.</li>
</ul>
<p>Therapeutic uses</p>
<ul>
<li>Supraventricular tachycardia.</li>
<li>Acute coronary spasms</li>
<li>Angina pectoris</li>
<li>Hypertension with myocardial infarction</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Adverse reaction</p>
<ul>
<li>Dizziness, vertigo, constipation, hypotension, nausea, pedal edema</li>
</ul>
<p>Advantages of calcium channel blockers</p>
<ul>
<li>Exhibits rapid onset and longer duration of action hence administered once a day.</li>
<li>Do not exhibit cardiac depression.</li>
<li>Do not cause adverse effects on the fetus.</li>
<li>Cause no sedation.</li>
<li>Recommended for patients having angina and asthma.</li>
<li>Do not cause male impotence.</li>
<li>Mostly indicated for the elderly, pregnant and asthmatic.</li>
<li>safe with history of renal impairment.</li>
<li>Do not exhibit action on electrolyte balance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>considerations</p>
<ul>
<li>Monitor BP, HR, rhythm,</li>
<li>Control calcium supplement.</li>
<li>Inform patient not to stop drug abruptly.</li>
<li>Patient to report signs of adverse effects such as irregular heart beat, shortness of breath, oedema in the hands and feet, dizziness, constipation, nausea and hypotension.</li>
<li>Discontinue in breast feeding because they are excreted in breast milk and have potential for adverse effects in neonates.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="direct-acting-vasodilators">DIRECT ACTING VASODILATORS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#direct-acting-vasodilators" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="hydralazine">HYDRALAZINE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hydralazine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Hydralazine (APRESOLINE) causes direct relaxation of the arterio smooth muscle secondary to a fall in the intracellular calcium. this is associated with powerful stimulation of the sympathetic nervous system, due to baroreceptor mediated reflexes</p>
<p>Toxicity and precaution</p>
<ul>
<li>These includes; headache, nausea, flushing, hypotension, palpitation, tachycardia, dizziness and angina pectoris.</li>
<li>Myocardial ischemia (increased oxygen demand)</li>
<li>Immunological reactions, drug induced lupus syndrome. this occurs after six months of treatment with hydralazine.</li>
<li>symptoms include, arthralgia, arthritis and fever.</li>
<li>The treatment can result in an illness that resembles serum sickness, hemolytic anaemia, vasculitis, and glomerulonephritis.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Therapeutic uses</p>
<ul>
<li>Due to adverse effect profile, hydralazine is no longer a first line drug in the treatment of hypertension.</li>
<li>Used in patients with CCF(in combination with nitrates for patients who cannot tolerate ACE inhibitors.</li>
<li>Treatment of hypertension emergencies in pregnancy.</li>
</ul>
<p>(especially preeclampsia).</p>
<p>The usual dose is twenty five to 100mgs twice a day</p>
<p>He maximum recommended dose of hydralazine is 200mg/day.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindication">Contraindication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Parenteral administration in coronary artery disease.</li>
<li>Elderly patients</li>
</ul>
<p>ALPHA ADRENERGIC BLOCKERS (SYMPATHOLYTICS)</p>
<ul>
<li>Medication: prazosin (Minipress)</li>
<li>doxazosin mesylate (Cardura)</li>
</ul>
<p>Expected Pharmacological Action</p>
<ul>
<li>It inhibits Alpha adrenergic receptor causing Venous and arterial dilation leading to reduction in total peripheral vascular resistance.</li>
<li>Smooth muscle relaxation of the prostatic capsule and bladder neck</li>
</ul>
<p>Therapeutic uses</p>
<ul>
<li>Primary hypertension.</li>
<li>Doxazosin mesylate (Cardura) may be used to decrease symptoms of benign prostatic hypertrophy (BPH), which include urgency, frequency, and dysuria.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/Adverse Effects</p>
<ul>
<li>
<p>First-dose orthostatic hypotension</p>
</li>
<li>
<p>Start treatment with low dosage of medication.</p>
</li>
<li>
<p>First dose may be given at night.</p>
</li>
<li>
<p>Monitor blood pressure for 2 hr. after the initiation of treatment.</p>
</li>
<li>
<p>Instruct clients to avoid activities requiring mental alertness for the first 12 to 24 hr.</p>
</li>
<li>
<p>Instruct clients to change positions slowly and to lie down if feeling dizzy, lightheaded, or faint</p>
</li>
<li></li>
</ul>
<p>Contraindications/Precautions</p>
<p>â€¢ Pregnancy</p>
<p>â€¢ clients with hypersensitivity to medication</p>
<p>â€¢ Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>â€¢ Antihypertensive medications may have an additive hypotensive effect</p>
<p>Instruct clients to observe for signs of hypotension (dizziness, lightheadedness, faintness).</p>
<p>Instruct clients to lie down if these symptoms occur, and to change positions slowly.</p>
<p>â€¢ NSAIDs and clonidine may decrease the antihypertensive effects of prazosin.</p>
<p>Advise clients to avoid OTC NSAIDs.</p>
<p>Nursing Administration</p>
<ul>
<li>Obtain baseline blood pressure and heart rate.</li>
<li>Instruct clients that the medication can be taken with food.</li>
<li>Recommend that clients take the initial dose at bedtime to decrease â€œfirst-doseâ€ hypotensive effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>CENTRALLY ACTING ALPHA2 AGONISTS</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clonidine-catapres">clonidine (Catapres)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clonidine-catapres" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>guanfacine HCl (Tenex),</li>
<li>methyldopa (Aldomet)</li>
</ul>
<p>Expected Pharmacological Action</p>
<ul>
<li>
<p>These medications act within the CNS to decrease sympathetic outflow resulting in decreased stimulation of the adrenergic receptors (both alpha and beta receptors) of the heart and peripheral vascular system.</p>
</li>
<li>
<p>Decrease in sympathetic outflow to the myocardium results in bradycardia and decreased cardiac output (CO).</p>
</li>
<li>
<p>Decrease in sympathetic outflow to the peripheral vasculature results in vasodilation, which leads to decreased blood pressure.</p>
</li>
<li></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Primary hypertension (administered alone, with a diuretic, or with another antihypertensive agent)</li>
<li>Severe cancer pain (administered parenterally by epidural infusion)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="investigational-use">Investigational use<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#investigational-use" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Migraine headache</li>
<li>Flushing from menopause</li>
<li>Management of ADHD and Tourette's syndrome</li>
<li>Management of withdrawal symptoms from alcohol, tobacco, and opioids</li>
</ul>
<p>Side/Adverse Effects</p>
<ul>
<li>Drowsiness and sedation</li>
<li>Dry mouth</li>
<li>Rebound hypertension</li>
</ul>
<p>contraindication</p>
<ul>
<li>Clonidine is Pregnancy Risk Category C.</li>
<li>Avoid use during lactation.</li>
<li>This medication is contraindicated for clients taking anticoagulant medications</li>
<li>Avoid use of transdermal patch on affected skin in scleroderma and systemic lupus erythematosus (SLE).</li>
<li>Use cautiously in clients with cerebrovascular disease, recent MI, diabetes mellitus, major depressive disorder, or chronic renal failure</li>
</ul>
<ul>
<li>
<p>Antihypertensive medications may have an additive hypotensive effect.</p>
<ul>
<li>
<p>Concurrent use of prazosin (Minipress), MAOI s, and tricyclic antidepressants can counteract the antihypertensive effect of clonidine.</p>
</li>
<li>
<p>Additive CNS depression can occur with concurrent use of other CNS depressants, such as alcohol.</p>
</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-administration">Nursing Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administer medication by oral, epidural, and transdermal routes.</li>
<li>Medication is usually administered twice a day in divided doses. Take larger dose at bedtime to decrease the occurrence of daytime sleepiness.</li>
<li>Transdermal patches are applied every seven days. Advise clients to apply patch on hairless, intact skin on torso or upper arm.</li>
</ul>
<p>Methyldopa (ALDOMET)</p>
<ul>
<li>Acts through its metabolites (amethylnorepinephrine)which stimulates central alpha adrenergic receptors, thus increasing total peripheral resistance.</li>
<li>It does not affect glomerular filtration, cardiac output or heart rate.</li>
</ul>
<p>Therapeutic effects</p>
<p>moderate to severe hypertension</p>
<p>Adverse effects:</p>
<p>GIT upsets, sedation, depression, nasal stuffiness, myocarditis edema, orthostatic hypotension, diarrhea, dry mouth, erectile dysfunction, eosinophilia, hemolytic anemia, fever.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>contraindication</p>
<ul>
<li>Hypersensitivity, activity liver disease, those who developed liver cirrhosis with previous treatment of methyldopa.</li>
</ul>
<p>Caution;</p>
<ul>
<li>Patients taking diuretics and antihypertensive.</li>
<li>Those taking levodopa because of potential for additive antihypertensive effects.</li>
</ul>
<p>Consideration</p>
<ul>
<li>patient to avoid hazardous task.</li>
<li>Lower dose in impaired renal disease.</li>
<li>Monitor liver functions.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Caution cont.'</p>
<ul>
<li>Monitor HB, RBCs for signs of anemia.</li>
<li>Monitor weight, fluid input and out put.</li>
<li>Signs of drug induced depression,</li>
<li>Take BP in different patients position during dose adjustments, warn of signs and symptoms of adverse effects and toxicity</li>
<li>Tolerance may develop 2to 3 weeks after start of treatment.</li>
<li>Urine may darken on exposure to air(as drug is broken down to its metabolites)</li>
<li>Dose increase should be made with the evening dose to minimize the effects of drowsiness.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>BETA ADRENERGIC BLOCKERS (SYMPATHOLYTICS)</p>
<p>Cardioselective: Beta1</p>
<p>â€¢ Metoprolol (Lopressor)</p>
<p>â€¢ Atenolol (Tenormin)</p>
<p>â€¢ Metoprolol succinate (Toprol XL)</p>
<p>â€¢ Esmolol HCL (Brevibloc)</p>
<p>Nonselective: (Beta1 and Beta2)</p>
<p>â€¢ Propranolol (Inderal)</p>
<p>â€¢ Nadolol (Corgard)</p>
<p>â€¢ Labetalol (Normodyne)</p>
<p>Expected Pharmacological Action</p>
<p>They block beta- adrenergic receptors in the myocardium and in the electrical conduction system of the heart.</p>
<p>â€¢ Decreased heart rate</p>
<p>â€¢ Decreased myocardial contractility</p>
<p>â€¢ Decreased rate of conduction through the AV node</p>
<p>Therapeutic Uses</p>
<p>hypertension , Angina, arrhythmias, heart failure and myocardial infarction.</p>
<p>Other uses may include: Treatment of hyperthyroidism, migraine headache, pheochromocytoma, and glaucoma</p>
<p>adverse effects</p>
<ul>
<li>Bradycardia, fatigue, dizziness, nightmares, depression, memory loss, hallucination, impotence, cold extremities, elevated serum cholesterol.</li>
</ul>
<p>Contraindication</p>
<p>severe hypotension, bradycardia, congestive heart failure, asthma, diabetics, critically abnormal lipid profile</p>
<p>Consideration</p>
<ul>
<li>Explain the rationale of therapy and importance of taking drugs as prescribed.</li>
<li>Patient should not discontinue drugs abruptly because it can cause MI or angina</li>
</ul>
<p>Consideration cont.'</p>
<ul>
<li>Advise clients to avoid sudden changes in position to prevent occurrence of orthostatic hypotension</li>
<li>Administer medications orally, usually once or twice a day.</li>
<li>Administer the following medications by IV route: atenolol, metoprolol, labetalol, propranolol.</li>
<li>Teach clients to self monitor heart rate and blood pressure at home on a daily basis.</li>
<li>Monitor weight &amp; signs of hypovolemic shock especially in diabetic patients.</li>
<li>Glucagon is prescribed to reverse signs of overdose.</li>
<li>Dose are lowered in geriatrics due to delayed metabolism and enhanced side effects.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Medications for Hypertensive Crisis</p>
<p>nitroprusside sodium (Nitropress)</p>
<p>Other Medications:</p>
<p>Nitroglycerin (Nitrostat IV)</p>
<p>Nicardipine (Cardene)</p>
<p>Clevidipine (Cleviprex)</p>
<p>Enalaprilat (Vasotec IV)</p>
<p>Esmolol HCL (Brevibloc)</p>
<p>mechanism of Action Direct vasodilation of arteries and veins resulting in rapid reduction of blood pressure (decreased preload and afterload) â— Therapeutic Uses Hypertensive emergencies</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="side-effects">Side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Excessive hypotension</p>
<ul>
<li>Administer medication slowly because rapid administration will cause blood pressure to go down rapidly. - Monitor the client's blood pressure and ECG.</li>
</ul>
<p>interactions</p>
<p>Nitroprusside should not be administered in the same infusion as any other medication.</p>
<p>Nursing Administration</p>
<p>â€¢ Prepare medication by adding to diluent for IV infusion.</p>
<p>â€¢ Note color of solution. Solution may be light brown in color. Discard solution of any other color.</p>
<p>â€¢ Protect IV container and tubing from light.</p>
<p>â€¢ Discard medication after 24 hr.</p>
<p>â€¢ Monitor vital signs and ECG continuously</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cardiac-glycoside">CARDIAC GLYCOSIDE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cardiac-glycoside" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>two main types</p>
<ul>
<li>cardenolides (digitalis, convallaria, oleandra)</li>
<li>Bufadienolides (Helleborus, Poison Arrow Frog)</li>
</ul>
<p>Mechanism of action
Cardiac glycoside slows down the heart rate and increase the force of contraction</p>
<p>Pharmacological action</p>
<ul>
<li>Enhances myocardial contractility and is used in congestive cardiac failure.</li>
<li>Enhances cardiac output, minimizes dilated cardiac size, blood volume and venous pressure.</li>
<li>They modulate autonomic nervous system activity, and this contributes to their efficacy in management of heart failure.</li>
<li>Diuretic effect, reduce oedema.</li>
<li>It is usually given only when diuretics and ACEIs have failed.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indication">indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Congestive heart failure, heart failure with atrial fibrillation, or pts who remain symptomatic despite therapy with ACE inhibitors and b Adrenergic receptor antagonists</li>
<li>Left ventricular failure.</li>
<li>Atrial fibrillation.</li>
</ul>
<p>digoxin</p>
<ul>
<li>It is the most commonly used digitalis</li>
</ul>
<p>forms</p>
<p>Tablets (Lanoxin)</p>
<p>Capsules (lanoxicaps)</p>
<p>Parenteral digoxin is available for intravenous administration and maintenance doses can be given intravenously when oral dosin is impractical.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="digoxin-cont">Digoxin cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#digoxin-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="positive-inotropic-effect">Positive inotropic effect<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#positive-inotropic-effect" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> increased force of myocardial contraction Increased force and efficiency of myocardial contraction improves the heart's effectiveness as a pump,
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> improving stroke volume and cardiac output.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> Increase perfusion of the kidneys which facilitates excretion of fluid by the kidneys</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="negative-chronotropic-effect">Negative chronotropic effect<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#negative-chronotropic-effect" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> decreased heart rate ,
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> At therapeutic levels, digoxin slows the rate of SA node depolarization and the rate of impulses through the conduction system of the heart.
<span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi mathvariant="normal">âœ“</mi></mrow><annotation encoding="application/x-tex">\checkmark</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6922em;"></span><span class="mord amsrm">âœ“</span></span></span></span></span> A decreased heart rate gives the ventricles more time to fill with blood coming from the atria, which leads to increased SV and increased CO.</p>
<p>Digoxin cont.â€™</p>
<p>Therapeutic Uses</p>
<p>â€¢ Treatment of heart failure</p>
<p>â€¢ Dysrhythmias (atrial fibrillation)</p>
<p>side/adverse effects</p>
<p>â€¢ Dysrhythmias (caused by interfering with the electrical conduction in the myocardium)</p>
<p>â€¢ Cardiotoxicity leading to bradycardia.</p>
<p>â€¢ GI effects include anorexia (usually the first sign), nausea, vomiting, and abdominal pain.</p>
<p>â€¢ Teach clients to monitor for these effects and report to the provider if they occur.</p>
<p>â€¢ CNS effects include fatigue, weakness, vision changes (diplopia, blurred vision, yellow-green or white halos around objects).</p>
<p>Digoxin cont.â€™</p>
<p>Contraindications/Precautions</p>
<p>â€¢ In Pregnancy</p>
<p>â€¢ clients with disturbances in ventricular rhythm, including ventricular fibrillation, ventricular tachycardia, and second- and third-degree heart block.</p>
<p>â€¢ Use cautiously in clients who have hypokalemia, partial AV block, advanced heart failure, and renal insufficiency.</p>
<p>Medication interaction</p>
<ul>
<li>Thiazide diuretics, such as hydrochlorothiazide (HCTZ), and loop diuretics, such as furosemide (Lasix), may lead to hypokalemia, which increases the risk of developing dysrhythmias</li>
<li>ACE inhibitors and ARBs increase the risk of hyperkalemia, which can lead to decreased therapeutic effects of digoxin.</li>
<li>Sympathomimetic medications such as dopamine (Intropin) complement the inotropic action of digoxin and increase the rate and force of heart muscle contraction.</li>
<li>Quinidine increases the risk of digoxin toxicity when used concurrently.</li>
<li>Verapamil (Calan) increases plasma levels</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>MEDICATIONS AFFECTING THE RESPIRATORY SYSTEM (bronchodilators)</p>
<p>Over view: Asthma is a chronic inflammatory disorder of the airways. It is an intermittent and reversible airflow obstruction that affects the bronchioles. The obstruction occurs either by inflammation or airway hyper-responsiveness leading to bronchoconstriction.</p>
<p>â€¢ Medication management usually addresses both inflammation and bronchoconstriction</p>
<p>â€¢ These same medications may be used in symptomatic treatment of chronic obstructive pulmonary disease (COPD</p>
<ul>
<li></li>
</ul>
<ul>
<li>Advise clients to take the medication as prescribed. If a dose is missed, the next dose should NOT be doubled.</li>
<li>Check pulse rate and rhythm before administration of digoxin and record. Notify the provider if heart rate is less than 60/min in an adult, less than 70/min in children, and less than 90/min in infants. Administer digoxin at the same time daily.</li>
<li>Monitor digoxin levels periodically during treatment and maintain therapeutic levels between 0.5 to 2.0 ng/mL to prevent digoxin toxicity.</li>
<li>Avoid taking OTC medications to prevent adverse and side effects and medication interactions.</li>
<li>Instruct clients to observe symptoms of hypokalemia, such as muscle weakness, and to notify the provider if symptoms occur.</li>
<li>Instruct clients to observe symptoms of digoxin toxicity (anorexia, fatigue, weakness), and to notify the provider if symptoms occur.</li>
</ul>
<p>Management of digoxin toxicity</p>
<ul>
<li>Digoxin and potassium-sparing medication should be stopped immediately.</li>
<li>Monitor K+ levels. For levels less than 3.5 mEq/L, administer potassium intravenously or by mouth. Do not give any further K+ if the level is greater than 5.0 mEq/L.</li>
<li>Treat dysrhythmias with phenytoin (Dilantin) or lidocaine.</li>
<li>Treat bradycardia with atropine.</li>
<li>For excessive overdose, activated charcoal, cholestyramine, or Digibind can be used to bind digoxin and prevent absorption.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Bronchodilators cont.'</p>
<p>Medications include:</p>
<p>Classification of Bronchodilator ;</p>
<ul>
<li>beta2-adrenergic agonists short acting; salbutamol,</li>
<li>beta2-adrenergic agonists long acting; salmeterol and formoterol</li>
<li>Methyl xanthine's e.g. theophylline</li>
<li>inhaled anticholinergics e.g. tiotropium</li>
<li>anti-inflammatory agents such as glucocorticoids, mast cell stabilizers, and leukotriene modifiers.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="beta2-adrenergic-agonists">Beta2-Adrenergic Agonists<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#beta2-adrenergic-agonists" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>albuterol (Proventil, Ventolin)</li>
<li>Formoterol (Foradil Aerolizer)</li>
<li>Salmeterol (Serevent)</li>
<li>Terbutaline (Brethine)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="albuterol-proventil-ventolin">albuterol ( Proventil, Ventolin)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#albuterol-proventil-ventolin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Mechanism of Action</li>
<li>Beta2-adrenergic agonists act by selectively activating the beta2-receptors in the bronchial smooth muscle, resulting in bronchodilation. As a result of this: Bronchospasm is relieved, Histamine release is inhibited, Ciliary motility is increased.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Medication</th><th>Route</th><th>Therapeutic uses</th></tr></thead><tbody><tr><td>Albuterol (Proventil, Ventolin)</td><td>- Inhaled, short-acting</td><td></td></tr><tr><td>Oral, long-acting</td><td>- Prevention of asthma attack (exercise-induced) - Treatment for ongoing asthma attack - Long-term control of asthma</td><td></td></tr><tr><td>Formoterol (Foradil Aerolizer) Salmeterol (Serevent)</td><td>- Inhaled, long-acting</td><td>- Long-term control of asthma</td></tr><tr><td>Terbutaline (Brethine)</td><td>Oral, long-acting</td><td>- Long-term control of asthma</td></tr></tbody></table>
<p>Side effects</p>
<p>â€¢ Inhaled agents (short and long acting) have minimal adverse effects.</p>
<p>â€¢ Oral agents can cause tachycardia and angina because of activation of alpha1 receptors in the heart.</p>
<p>â€¢ Tremors caused by activation of beta2 receptors in skeletal muscle.</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Beta2-adrenergic agonists are Pregnancy Risk Category C.</p>
<p>â€¢ These agents are contraindicated in clients with tachydysrhythmia.</p>
<p>â€¢ Use cautiously in clients who have diabetes, hyperthyroidism, heart disease, hypertension, and angina</p>
<p>Medication and food interaction</p>
<p>â€¢ Use of beta-adrenergic blockers (propranolol) can negate effects of both medications.</p>
<p>â€¢ MAOIs and tricyclic antidepressants can increase the risk of tachycardia and angina.</p>
<p>Nursing Administration</p>
<p>Instruct clients to follow manufacturerâ€™s instructions for use of device: metered-dose inhaler (MDI), dry-powder inhaler(DPI), and nebulizer.</p>
<p>When a client is prescribed an inhaled beta2-agonist and an inhaled glucocorticoid, advise the client to inhale the beta2-agonist before inhaling the glucocorticoid.</p>
<p>The beta2-agonist promotes bronchodilation and enhances absorption of the glucocorticoid.</p>
<p>Advise clients not to exceed prescribed dosages.</p>
<p>Ensure that clients know the appropriate dosage schedule (if the medication is to be taken on a fixed or a when-necessary schedule).</p>
<p>Formoterol and salmeterol are both long-acting beta2-agonist inhalers. These inhalers are used every 12 hr. for long-term control and are not to be used to abort an asthma attack. A short-acting beta2-agonist should be used if clients need to treat an acute attack.</p>
<ul>
<li>Advise clients to observe for signs of an impending asthma attack and to keep a log of the frequency and intensity of attacks.</li>
<li>Instruct clients to notify the provider if there is an increase in the frequency and intensity of asthma attacks.</li>
</ul>
<p>METHYLXANTHINES</p>
<p>theophylline (Theolair, Theo-24)</p>
<p>Expected Pharmacological Action</p>
<p>Theophylline causes relaxation of bronchial smooth muscle, resulting in bronchodilation.</p>
<p>Therapeutic Uses</p>
<p>Oral theophylline is used for long-term control of chronic asthma.</p>
<p>Route of administration: oral or IV (emergency use only)</p>
<p>Side/adverse effects</p>
<p>Mild toxicity reaction may include GI distress and restlessness.</p>
<p>â€¢ More severe reactions can occur with higher therapeutic levels and can include dysrhythmias and seizures.</p>
<p>Contraindications/Precautions</p>
<p>â€¢ in Pregnancy</p>
<p>â€¢ Use cautiously in clients who have heart disease, hypertension, liver and renal dysfunction, and diabetes.</p>
<p>â€¢ Use cautiously in children and older adults.</p>
<p>Nursing Administration</p>
<p>â€¢ Advise clients to take the medication as prescribed. If a dose is missed, the following dose should not be doubled.</p>
<p>â€¢ Instruct clients not to chew or crush sustained-release preparations. These medications should be swallowed whole.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inhaled-anticholinergics">INHALED ANTICHOLINERGICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inhaled-anticholinergics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>ipratropium (Atrovent)</li>
<li>tiotropium (Spiriva)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>These medications block muscarinic receptors of the bronchi, resulting in bronchodilation.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>These medications are used to relieve bronchospasm associated with chronic obstructive pulmonary disease (COPD)</li>
<li>These medications are used for allergen-induced and exercise-induced asthma.
Route of administration: inhalation</li>
</ul>
<p>SIDE/ADVERSE EFFECTS</p>
<p>Local anticholinergic effects (dry mouth, hoarseness)</p>
<p>Advise clients to sip fluids and suck on hard candies to control dry mouth.</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Inhaled anticholinergics are Pregnancy Risk Category B.</p>
<p>â€¢ These agents are contraindicated in clients who have an allergy to peanuts because the medication preparations may contain soy lecithin.</p>
<p>â€¢ Use cautiously in clients who have narrow-angle glaucoma and benign prostatic hypertrophy (due to anticholinergic effects).</p>
<ul>
<li>
<p>Nursing Administration</p>
<ul>
<li>
<p>Advise clients to rinse the mouth after inhalation to decrease unpleasant taste.</p>
</li>
<li>
<p>Usual adult dosage is two puffs. Instruct clients to wait the length of time directed between puffs.</p>
</li>
<li>
<p>If clients are prescribed two inhaled medications, instruct clients to wait at least 5 min between medications</p>
</li>
</ul>
</li>
<li></li>
</ul>
<ul>
<li>Medication/Food Interactions</li>
<li>Caffeine increases CNS and cardiac adverse effects of theophylline.</li>
<li>Caffeine can also increase theophylline levels.</li>
</ul>
<p>Advise clients to avoid consuming caffeinated beverages (coffee, caffeinated colas).</p>
<ul>
<li>Phenobarbital and phenytoin decrease theophylline levels.</li>
<li>Cimetidine (Tagamet), ciprofloxacin (Cipro), and other fluoroquinolone antibiotics increase theophylline level.</li>
</ul>
<p>GLUCOCORTICOIDS</p>
<p>Inhalation: beclomethasone dipropionate (QVAR)</p>
<p>Oral: prednisone (Deltasone)</p>
<p>Inhalation:</p>
<p>â€¢ Budesonide (Pulmicort Flexhaler)</p>
<p>â€¢ Fluticasone propionate and salmeterol (Advair)</p>
<p>â€¢ Fluticasone propionate (Flovent)</p>
<p>â€¢ Triamcinolone acetonide (Azmacort)</p>
<p>systemic :</p>
<p>â€¢ Oral Prednisolone E 30 to 40mg for initial to 7 days,</p>
<p>â€¢ IV/IM dexamethasone</p>
<p>â€¢ IV Hydrocortisone sodium succinate (Solu-Cortef) (</p>
<p>â€¢ IV Methylprednisolone sodium succinate (Solu-Medrol)</p>
<ul>
<li>
<p>Expected Pharmacological Action</p>
<ul>
<li>
<p>These medications prevent inflammation, suppress airway mucus production, and promote responsiveness of beta2 receptors in the bronchial tree.</p>
</li>
<li>
<p>The use of glucocorticoids does not provide immediate effects, but rather promotes decreased frequency and severity of exacerbations and acute attacks.</p>
</li>
<li>
<p>Therapeutic Uses</p>
</li>
<li>
<p>Short-term IV agents are used for status asthmaticus.</p>
</li>
<li>
<p>Inhaled agents are used for long-term prophylaxis of asthma.</p>
</li>
<li>
<p>Short-term oral therapy is used to treat symptoms following an acute asthma attack.</p>
</li>
<li>
<p>Long-term oral therapy is used to treat chronic asthma.</p>
</li>
<li>
<p>Replacement therapy is used for primary adrenocortical insufficiency.</p>
</li>
<li>
<p>Promote lung maturity and decrease respiratory distress in fetuses at risk for preterm birth</p>
</li>
</ul>
</li>
</ul>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Beclomethasone dipropionate</p>
<p>Difficulty speaking, hoarseness, and candidiasis</p>
<p>â€¢ Advise clients to use a spacer with MDI.</p>
<p>â€¢ Advise clients to rinse mouth or gargle with water or salt water after use.</p>
<p>â€¢ Advise clients to monitor for redness, sores, or white patches and to report to provider if they occur.</p>
<p>â€¢ Candidiasis may be treated with nystatin oral suspension.</p>
<p>prednisolone when used for more than 10 days</p>
<ul>
<li>Suppression of adrenal gland function, such as a decrease in the ability of the adrenal cortex to produce glucocorticoids: Can occur with inhaled agents and oral agents</li>
</ul>
<p>Taper the clientâ€™s dose.</p>
<ul>
<li>Bone loss (can occur with inhaled agents and oral agents)</li>
<li>Myopathy as evidenced by muscle weakness</li>
<li>Hyperglycemia and glycosuria</li>
<li>Myopathy as evidenced by muscle weakness a</li>
<li>Peptic ulcer disease</li>
<li>Infection</li>
<li>Disturbances of fluid and electrolytes (fluid retention as evidenced by weight gain, and edema and hypokalemia as evidenced by muscle weakness)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precautions</p>
<p>â€¢ Pregnancy risk category C</p>
<p>â€¢ Contraindicated in clients who have received a live virus vaccine</p>
<p>â€¢ Contraindicated in clients with systemic fungal infections</p>
<p>â€¢ Use cautiously in children, and in clients who have diabetes, hypertension, peptic ulcer disease, and/or renal dysfunction.</p>
<p>â€¢ Use cautiously in clients taking NSAIDs.</p>
<p>Medication/Food Interactions</p>
<p>â€¢ Concurrent use of potassium-depleting diuretics increases the risk of hypokalemia.</p>
<p>â€¢ Concurrent use of NSAIDs increases the risk of GI ulceration. Concurrent use of glucocorticoids and hypoglycemic agents (oral and insulin) will counteract the effects</p>
<p>Nursing Administration</p>
<p>â€¢ Instruct clients to use glucocorticoid inhalers on a regular, fixed schedule for long-term therapy of asthma.</p>
<p>â€¢ Glucocorticoids are not to be used to treat an acute attack.</p>
<p>â€¢ Administer using an MDI device, DPI, or nebulizer.</p>
<p>â€¢ When a client is prescribed an inhaled beta2-agonist and an inhaled glucocorticoid, advise the client to inhale the beta2-agonist before inhaling the glucocorticoid. The beta2-agonist promotes bronchodilation and enhances absorption of the glucocorticoid.</p>
<p>â€¢ Oral glucocorticoids are used short-term, 3 to 10 days following an acute asthma attack.</p>
<p>â€¢ If client is on long-term oral therapy, additional dosages of oral glucocorticoids are required in times of stress (infection, trauma).</p>
<p>â€¢ Clients who discontinue oral glucocorticoid medications or switch from oral to inhaled agents require additional doses of glucocorticoids during periods of stress.</p>
<p>MASTCELL STABILIZERS ANTI INFLATORY DRUGS (cromolyn sodium (Intal)</p>
<p>others are: nedocromil sodium (Tilade)</p>
<p>Expected Pharmacological Action</p>
<ul>
<li>Anti-inflammatory action</li>
<li>These medications stabilize mast cells, which inhibits the release of histamine and other inflammatory mediators.</li>
<li>These medications suppress inflammatory cells (eosinophils, macrophages).</li>
</ul>
<p>Complications Safest of all asthma medications, Safe to use for children</p>
<p>therapeutic uses</p>
<ul>
<li>Management of chronic asthma</li>
<li>Prophylaxis of exercise-induced asthma</li>
<li>Prevention of allergen-induced attack</li>
<li>Allergic rhinitis by intranasal route</li>
<li>Route of administration: inhalation</li>
</ul>
<p>Contraindications/Precautions</p>
<ul>
<li>These agents are Pregnancy Risk Category B.</li>
<li>Fluorocarbons in aerosols make this medication contraindicated for clients who have coronary artery disease, dysrhythmias, and status asthmaticus.</li>
<li>Use cautiously in clients with liver and kidney impairment.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing Administration</p>
<p>â€¢ Advise clients to take medication 15 min before exercise or exposure to allergen.</p>
<p>â€¢ Advise clients that long-term prophylaxis may take several weeks for full therapeutic effects to be established.</p>
<p>â€¢ Advise clients that this is not a bronchodilator and is not intended for aborting an asthmatic attack.</p>
<p>â€¢ Instruct clients in the proper use of administration devices (nebulizer, MDI).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="leukotriene-modifiers">LEUKOTRIENE MODIFIERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#leukotriene-modifiers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>leukotriene receptor antagonist ;</p>
<ul>
<li>Montelukast (Singulair)</li>
<li>Zileuton (Zyflo),</li>
<li>Zafirlukast (Accolate)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Leukotriene modifiers prevent the effects of leukotrienes, thereby suppressing inflammation, bronchoconstriction, airway edema, and mucus production.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Leukotriene modifiers are used for long-term therapy of asthma in adults and children 15 years and older and to prevent exercise-induced bronchospasm.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="route-of-administration-oral">Route of administration: oral<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#route-of-administration-oral" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Contraindications/Precautions</p>
<p>â€¢ Use cautiously in clients with liver dysfunction</p>
<p>Medication/Food Interactions</p>
<p>â€¢ Zileuton and zafirlukast inhibit metabolism of warfarin (Coumadin), leading to increased warfarin levels.</p>
<p>â€¢ Zileuton and Zafirlukast inhibit metabolism of theophylline, leading to increased theophylline levels.</p>
<p>Nursing Administration</p>
<p>â€¢ Advise clients to take zileuton as prescribed. Zileuton can be given with or without food.</p>
<p>â€¢ Advise clients that zafirlukast should not be given with food, and to administer it 1 hr. before or 2 hr. after meals.</p>
<p>â€¢ Advise clients to take Montelukast once daily at bedtime.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="git-drugs-peptic-ulcer-disease">GIT DRUGS ( PEPTIC ULCER DISEASE)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#git-drugs-peptic-ulcer-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="acid-peptic-disease-includes">acid peptic disease includes:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acid-peptic-disease-includes" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>peptic ulcers (gastric ulcer, duodenal ulcer, NSAIDS induced ulcers)</li>
<li>gasro oesophageal reflux disease,</li>
<li>hypersecretory states like Zollinger Ellison Syndrome (ulcerogenic tumour of the islets of Langerhans.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="principles-of-therapy">Principles of therapy<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-therapy" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The aim of therapy is to;</p>
<ul>
<li>relieve symptoms,</li>
<li>induced ulcer healing and cure in the long run</li>
<li>Decreased risk of complications</li>
<li>Stopping reoccurrence .</li>
</ul>
<p>Classification of agents used in treatment of peptic ulcer:</p>
<p>â€¢ Inhibition of acid secretion</p>
<p>âž¢H2 receptor agonist e.g. cimetidine, ranitidine, famotidine roxatidine.</p>
<p>âž¢Proton pump inhibitors e.g. omeprazole, pantoprazole, esomeprazole, lansoprazole.</p>
<p>âž¢Anticholinergics e.g. pirenzepine.</p>
<p>âž¢Prostaglandin analogue e.g. misoprostol.</p>
<p>â€¢ neutralization of gastric acids</p>
<p>âž¢Sodium bicarbonate systemic</p>
<p>âž¢Non systemic: magnesium hydroxide, aluminium hydroxide, magnesium trisilicate.</p>
<p>â€¢ Mucosal protective agents e.g. sucralfate, colloidal bismuth.</p>
<p>â€¢ Anti helicobacter pylori drugs (ANTIBIOTICS) e.g. Clarithromycin, Ampicillin, Metronidazole, Tetracycline, Tinidazole</p>
<p>anti H. pylori drugs</p>
<p>â€¢ Amoxicillin (Amoxil)</p>
<p>â€¢ Bismuth (Pepto-Bismol)</p>
<p>â€¢ Clarithromycin (Biaxin)</p>
<p>â€¢ Metronidazole (Flagyl)</p>
<p>â€¢ Tetracycline</p>
<p>Expected Pharmacological Action</p>
<p>â€¢ Eradication of H. pylori bacteria</p>
<p>â€¢ Therapy should include: Combination of 2 or 3 antibiotics for 14 days</p>
<p>The disease process is only altered by the use of antibiotics. All other medications make an environment that is conducive to healing</p>
<p>Two weeks regimen</p>
<ul>
<li>Tetracycline 500mg QID and metronidazole 200mg BID and Bismuth sub salylicylate.</li>
<li>Amoxicillin 100mg BID and clarithromycin 500mg BID+ Lansoprazole 30mgs BID.</li>
<li>Clarithromycin 500mg TDS +Omeprazole.</li>
</ul>
<p>ONE WEEK REGIMEN</p>
<p>Clarithromycin 250mg BID + Metronidazole 400mgs + Omeprazole 20mgs BID.</p>
<p>Amoxicillin 500mg Bid + Clarithromycin 250mg Bid+ Omeprazole 20mg</p>
<p>Histamine2 -Receptor Antagonists</p>
<ul>
<li>ranitidine hydrochloride (Zantac)</li>
<li>Cimetidine (Tagamet)</li>
<li>Nizatidine (Axid)</li>
<li>Famotidine (Pepcid)</li>
</ul>
<p>Expected Pharmacological Action: Histamine2-receptor antagonists suppress the secretion of gastric acid by selectively blocking H2 receptors in parietal cells lining the stomach</p>
<ul>
<li></li>
</ul>
<ul>
<li>Therapeutic Uses</li>
<li>gastric and peptic ulcers,</li>
<li>gastroesophageal reflux disease (GERD),</li>
<li>hypersecretory conditions, such as Zollinger-Ellison syndrome.</li>
<li>Histamine2-receptor antagonists are used in conjunction with antibiotics to treat ulcers caused by H. pylori.</li>
</ul>
<p>Side/Adverse Effects</p>
<ul>
<li>Cimetidine may block androgen receptors, resulting in decreased libido and impotence.</li>
<li>Cimetidine may cause CNS effects (lethargy, depression, confusion)</li>
<li>Ranitidine, nizatidine, and famotidine have few adverse effects and interactions.</li>
</ul>
<p>Contraindications/Precautions</p>
<p>â€¢ These medications are Pregnancy Risk Category B</p>
<p>â€¢ Use in older adults can cause antiadrenergic effects (e.g., impotence) and CNS effects (e.g., confusion).</p>
<p>â€¢ H2-receptor antagonists decrease gastric acidity, which promotes bacterial colonization of the stomach and the respiratory tract. Use cautiously in clients who are at a high risk for pneumonia, such as clients with chronic obstructive pulmonary disease (COPD).</p>
<p>Medication/Food Interactions</p>
<p>â€¢ Cimetidine can inhibit medication metabolizing enzymes and thus increase the levels of warfarin, phenytoin (Dilantin), theophylline, and lidocaine.</p>
<p>â€¢ Concurrent use of antacids can decrease absorption of histamine2 -receptor antagonists.</p>
<p>Nursing Administration</p>
<p>Cimetidine, ranitidine, and famotidine can be administered IV for acute situations.</p>
<p>Advise clients to practice good nutrition. Suggest eating six small meals rather than three large meals a day.</p>
<p>Inform clients that adequate rest and reduction of stress may promote healing.</p>
<p>Clients should avoid smoking, because smoking can delay healing.</p>
<p>Encourage clients to avoid aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) unless taking low-dose aspirin therapy for prevention of cardiovascular disease.</p>
<p>If alcohol exacerbates symptoms, advise clients to stop drinking.</p>
<ul>
<li>
<p>Availability of these medications OTC may discourage clients from seeking appropriate health care.</p>
<ul>
<li>
<p>Encourage clients to see the provider if symptoms persist.</p>
</li>
<li>
<p>The medication regimen can be complex, often requiring clients to take two to three different medications for an extended period of time. Encourage clients to adhere to the medication regimen and provide support.</p>
</li>
<li>
<p>Ranitidine can be taken with or without food</p>
</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="proton-pump-inhibitor">Proton Pump Inhibitor<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#proton-pump-inhibitor" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>omeprazole (Prilosec)</li>
<li>Pantoprazole (Protonix)</li>
<li>Lansoprazole (Prevacid)</li>
<li>Rabeprazole sodium (AcipHex)</li>
<li>Esomeprazole (Nexium)</li>
</ul>
<p>Expected Pharmacological Action</p>
<ul>
<li>Proton pump inhibitors reduce gastric acid secretion by irreversibly inhibiting the enzyme that produces gastric acid.</li>
<li>Proton pump inhibitors reduce basal and stimulated acid production.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>gastric and peptic ulcers,</li>
<li>GERD,</li>
<li>hypersecretory conditions such as Zollinger-Ellison syndrome.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="complications">Complications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#complications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Insignificant side effects and adverse effects with short-term treatment</li>
<li>Low incidence of headache, diarrhea, and nausea/vomiting</li>
</ul>
<ul>
<li>Contraindications/Precautions These medications are Pregnancy Risk Category C. Use cautiously with children and women who are breastfeeding. Contraindicated for clients hypersensitive to medication These medications increase the risk for pneumonia. Omeprazole decreases gastric acid pH, which promotes bacterial colonization of the stomach and the respiratory tract. Use cautiously in clients at high risk for pneumonia, such as clients with COPD. Long-term use of proton pump inhibitors increases the risk of gastric cancer and osteoporosis.</li>
</ul>
<p>Medication/Food Interactions</p>
<ul>
<li>Digoxin (Lanoxin) levels may be increased when used concurrently with omeprazole.</li>
<li>Monitor digoxin levels carefully if prescribed concurrently.</li>
<li>Absorption of ketoconazole (formerly Nizoral), itraconazole (Sporanox), and atazanavir (Reyataz) is extremely decreased when taken concurrently with proton pump inhibitors.</li>
</ul>
<p>Nursing Administration</p>
<ul>
<li>
<p>Do not crush, chew, or break sustained-release capsules.</p>
</li>
<li>
<p>Clients may sprinkle the contents of the capsule over food to facilitate swallowing.</p>
</li>
<li>
<p>Clients should take omeprazole once a day prior to eating in the morning.</p>
</li>
<li>
<p>Encourage clients to avoid alcohol and irritating medications such as NSAIDs.</p>
</li>
<li></li>
</ul>
<ul>
<li>
<p>Active ulcers should be treated for 4 to 6 weeks.</p>
<ul>
<li>
<p>Pantoprazole (Protonix) can be administered to clients intravenously. In addition to low incidence of headache and diarrhea, there may be irritation at the injection site leading to thrombophlebitis. Monitor the clientâ€™s IV site for signs of inflammation (redness, swelling, local pain) and change the IV site if indicated.</p>
</li>
<li>
<p>Teach clients to notify the provider for any sign of obvious or occult GI bleeding such as coffee-ground emesis.</p>
</li>
</ul>
</li>
</ul>
<p>ANTICHOLINERGICS</p>
<p>Piperazine :</p>
<ul>
<li>
<p>it is a selective M1 receptor blocker</p>
</li>
<li>
<p>Produces less effects.</p>
</li>
<li>
<p>Reduces acid secretion by 40 to fifty percent</p>
</li>
<li>
<p>Has a small therapeutic window</p>
</li>
</ul>
<p>Prostaglandins analogue</p>
<ul>
<li>They have o cytoprotective role by inhibiting acid secretion by increasing mucus and bicarbonate secretion.</li>
<li>Inhibit gastrin secretion and increase mucosal blood flow.</li>
</ul>
<p>misoprostol</p>
<ul>
<li>a synthetic pge1 analogue and inhibits acid output.</li>
<li>ulcer heal in 4 to six weeks but relieving pain</li>
</ul>
<p>Therapeutic Use</p>
<p>prevent ulceration and bleeding induced by NSAIDS</p>
<p>MUCOSAL PROTECTANT</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sucralfate-carafate">sucralfate (Carafate)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sucralfate-carafate" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The acidic environment of the stomach and duodenum changes sucralfate into a thick substance that adheres to an ulcer. This protects the ulcer from further injury that may be caused by acid and pepsin.</p>
<p>This viscous substance can stick to the ulcer for up to 6 hr.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ul>
<li>
<p>promotes healing of duodenal and gastric ulcers</p>
</li>
<li>
<p>Poorly absorbed systemically, not used frequently due to a large doses.</p>
</li>
<li>
<p>Should not be used with antacids, H2 Antagonist, PPIs as it is dependent on gastric PH.</p>
</li>
</ul>
<p>colloidal bismuth compounds</p>
<ul>
<li>promote healing of duodenal and gastric ulcers.</li>
<li>Act by binding to an ulcer, denaturing the protein and creating a physical barrier.</li>
<li>Inhibition of pepsin, activation of mucous production, increase of prostaglandins.</li>
<li>It is effective in healing of duodenal and gastric ulcers.</li>
<li>Effective in non ulcer gastritis, caused by H.pylori</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>considerations</p>
<ul>
<li>take before meals and at bed time for 4 to 8 weeks.</li>
<li>Poor acceptance due to blackening of tongue, dentures and stool</li>
<li>inconvenience of dosing used as a regimen of multiple therapy for H.Pylori not used alone.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>LAXATIVES</p>
<p>This are drugs tha promote deafacation</p>
<p>*laxatives; mild action</p>
<p>*Purgative; strong action</p>
<p>*Classification</p>
<p>Bulk forming purgatives</p>
<p>âž¢Magnesium sulphate, magnesium hydroxide, sodium phosphate, lactulose, sodium tartrate, osmotic cathartic.</p>
<p>âž¢Vegetable fibres, bran</p>
<p>âž¢Hydrophillic colloids, methyl cellulose</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="irritants-and-stimulants">- Irritants and stimulants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#irritants-and-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Diphenylmethanes; phenolphthalein, Bisacodyl
Anthraquinone derivatives; senna, cascara
Fixed oil; castor oil</p>
<ul>
<li>Stool softeners; docusate, mineral oil, glycerin suppositories</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action-of-laxatives">Mechanism of action of laxatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-laxatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Laxatives cause retention of fluid in colonic contents increasing bulk and softness of stool and its transit.</li>
<li>They may decrease absorption of water and electrolyte by acting on intestinal mucosa.</li>
<li>They may enhance intestinal motility reducing absorption of water.</li>
</ul>
<p>Bulk forming purgatives</p>
<p>Osmotic or saline cathartics</p>
<p>â€¢ They are poorly absorbed hold water through osmosis.</p>
<p>â€¢ In addition the ions stimulate secretion and motility.</p>
<p>â€¢ Main used salts are; magnesium sulphate, sodium sulphate, magnesium hydroxide, sodium potassium tartrate.</p>
<p>â€¢ Sodium salts contraindicated in congestive heart failure.</p>
<p>Considerations</p>
<p>â€¢ Cause after constipation therefore not used routinely</p>
<p>â€¢ Preferred for pre-operative care before colonoscopy and in poisoning.</p>
<p>Lactulose</p>
<p>â€¢ A synthetic disaccharide containing fructose and galactose absorbed in the GIT.</p>
<p>â€¢ Produces soft stools within 1-3 days</p>
<p>â€¢ Side effects; abnominal cramps, flatulence,</p>
<p>â€¢ Contraindicated in patients requiring galactose free diet.</p>
<p>Vegetable fibres</p>
<p>â€¢ Dietary fibres derived from whole grains, vegetables and fruits. They contains the indigestible portion of cell wall.</p>
<p>â€¢ Dietary fibre act by binding water and ions in the intestine softens stool and promotes peristables. Also increases faecel mass.</p>
<p>Indications</p>
<p>â€¢ Prevention and treatment of functional constipation.</p>
<p>â€¢ Used for symptomatic relief of mild diarrhea</p>
<p>Adverse effects</p>
<p>Flatulance</p>
<p>Intestinal obstruction, oesophageal obstruction may occur.</p>
<p>Contraidication</p>
<p>Stenosis</p>
<p>Ulceration</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="irritant-and-stimulant-purgatives">Irritant and stimulant purgatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#irritant-and-stimulant-purgatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>They promote accumulation of water and electrolytes in the lumen.</li>
<li>Enhance intestinal motility</li>
<li>Increased water secretion is through activation of cAMP and synthesis of prostaglandins</li>
<li>Phenolpthalein and bisacodly are widely used.</li>
<li>Castor oil is hydrolysed to glycerol and ricinoleic acid which stimulates peristalsis. Effect in the small intestines causes rapid complete evacuation.</li>
<li>Side effects include; Cramping, dehydration.</li>
<li>Regular use bordestroys mucosa</li>
<li>Should be avoided in pregnant women, can intiate labour.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="stool-softeners">Stool softeners<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#stool-softeners" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="docusates">Docusates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#docusates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Used as an emulsifying, wetting and dispersing agent.</li>
<li>soften stool with 1-3days</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="liquid-paraffin">Liquid paraffin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#liquid-paraffin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It's a mineral oil.</li>
<li>Pharmacologically inert and acts as lubricants and softens stool.</li>
</ul>
<p>Adverse effects of liquid paraffin</p>
<ul>
<li>Leakage of oil past anal sphincter</li>
<li>Affect absorption of fat soluble vitamins.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="glcerin">Glcerin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glcerin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Used as a suppository, produces effects within 30mins.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indication-of-laxatives">Indication of laxatives<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication-of-laxatives" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Constipation not responding to non- pharmacological measures: fibre rich diet, regular exercise, regular bowel movements, ( bulk laxatives are the <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> choice).</li>
<li>Before and after surgery to produce soft stool in patients with haemorrhoids and fissures.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="contraindications">Contraindications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Undiagnosed abnominal pain
Appendicitis
Intestinal obstruction
Should be avoided during later stages of preganancy.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-diarrhoeal-agents">Anti- diarrhoeal agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-diarrhoeal-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Diarrhoea is marked by frequent passage of unformed or liquid stools.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="treatment-of-diarrhoea">Treatment of diarrhoea<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#treatment-of-diarrhoea" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>fluid and electrolyte replacement</li>
<li>Nutritional management</li>
<li>Drug therapy</li>
</ul>
<p>Drug Therapy</p>
<p>Anti-diarrhea drugs include;</p>
<p>a) Antimotility drugs</p>
<p>b) Antisecretory drugs</p>
<p>c) Adsorbents</p>
<p>d) Antibacterial agents</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="atimotility-drugs">Atimotility drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#atimotility-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>E.g loperamide, diphenoxylate</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="loperamide">Loperamide<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#loperamide" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Acts mainly on GIT receptor.</li>
<li>Acts quickly and has a longer duration of action</li>
<li>Decreases GIT motility and is excreted unchanged indicated for non infective diarrhea, mild travellors diarrhea.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="adverse-effects">Adverse effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Skin rash , abdominal cramps with excessive use paralytic ileus</li>
<li>Contraindication; below 4years, infective diarrhea, ulcerative colitis</li>
</ul>
<p>Antisecretory drugs</p>
<p>Racecadotril</p>
<p>â€¢ Enkephalinase inhibitor that increases endogenous enkephalin level and reduce intestinal hyper tension of water and electrolytes.</p>
<p>â€¢ Used for systematic treatment of diarrhea.</p>
<p>â€¢ Has no side effects like bloating and after constipation.</p>
<p>â€¢ Should not be used in pregnancy, lactation and children.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adsorbents">Adsorbents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adsorbents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Include kaolin, pectin, methylcellulose , magnesium aluminium silicate.</li>
<li>They act by absorbing microorganisms and/ toxins by altering normal flora or by protecting the mucosa of the intestines.</li>
<li>Their efficacy is doubtful</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antimicrobial-agents">Antimicrobial agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antimicrobial-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Cholera; tetracyclines, norfloxacin/ciprofloxacin</li>
<li>Infections with camphylobacter; erythromycin and flouroquinolones</li>
<li>Amoebiasis or giardiasis; metronidazole, diloxanide furoate, ornidazole</li>
<li>Shigella spcs, ciprofloxacin, norfloxacin or cotrimoxazole.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="miscellaneous">Miscellaneous<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#miscellaneous" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Contain viable lactic acid bacilli.</li>
<li>Improve intestinal microflora</li>
<li>Known as probiotics</li>
<li>Useful in rotavirus diarrhoea and anti biotic induced diarrhoea</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="d-anti-emetics">D.ANTI EMETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-anti-emetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Vomitting is reflex action that results in forceful evacuation of gatric contents.</li>
<li>Conditions pregnancy, ulcers, motion sickness, chemotherapy.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="anti-emetics">Anti emetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-emetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Applied to suppress or prevent vomiting.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification">Classification<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Anti muscarinic: scopolamine (hyoscine), dicyclomine
H1 antagonist: promethazine, doxylamine,
Prokinetic drugs; metoclopramide, domperidone, cisapride, mosapride.
Neuroleptics; phenothiazines, chlorpromazine
Adjuvant antiemetics; dexamethasone, benzodiazepines</p>
<ol>
<li>Prokinetic drugs</li>
</ol>
<p>a. Metroclopramide</p>
<ul>
<li>Effective for all types of vomiting, post- operatively, radiation, chemotherapy.</li>
<li>Less effective in motion sickness.</li>
<li>Blocks dopamine receptors, enters CNS</li>
</ul>
<p>Side effects: extrapyramidal effects, dystonia, dyskinesia.</p>
<p>Indications;</p>
<ul>
<li>Anti emetic</li>
<li>Dyspesia</li>
<li>facilitate lactation</li>
</ul>
<p>b. Domperidone</p>
<ul>
<li>Peripheral D2 receptor agonist .</li>
<li>Causes less extra pyramidal effects, doesnot cross the blood brain barrier.</li>
<li>Lower efficacy than metoclopramide</li>
</ul>
<p>Uses; levodopa or bromocriptine induced vomiting.</p>
<p>Side effects; increased prolactin, galactorrhoea, dry mouth, rashes. Headache.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="2-anti-muscarinic">2. Anti muscarinic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-anti-muscarinic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="scopolamine-hyoscine">Scopolamine (hyoscine)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#scopolamine-hyoscine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Alkaloid related to atropine</li>
<li>Most effective in prophylaxis of motion sickness</li>
<li>Antimuscarinic action blocks afferent pathways for vomiting reflex.</li>
<li>Has short duration of action</li>
<li>Produces anticholinergic effects; blurred vision, dry mouth, sedation.</li>
<li>Not effective with vomiting of other aetiologies.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-neuroleptics">3. Neuroleptics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-neuroleptics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Phenothiazines: chlorpromazine</li>
<li>potent anti emetics in vomiting due to drug toxicity, chemotherapy.</li>
<li>They act by blocking the D2 receptors in the medulla oblongata chemoreceptor trigger zone.</li>
<li>Not effective in motion sickness</li>
<li>Dosage is lower than antipsychotics</li>
</ul>
<p>Side effects; sedation, extrapyramidal effects; dyskinesia, dystonia</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="4-h1-antagonist">4. H1 antagonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-h1-antagonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Doxylamie useful in motion sickness</li>
<li>Modest effect on chemotherapy</li>
<li>Reduce extra pyramidal effects of D2 receptor antagonist.</li>
<li>Are antagonist therefore avoided in pregnancy.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adjuvant-antiemetics">Adjuvant antiemetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adjuvant-antiemetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Corticosteroids; dexamethasone, methylprednisolone, used to control chemotherapy vomiting.</p>
<ul>
<li>Act by blocking prostaglandins.</li>
<li>Cause insomnia and hyperglycemia</li>
</ul>
<p>Cannabinoids; tetrahydrocannabinol</p>
<ul>
<li>active principle of marijuana</li>
<li>Reduce chemotherapy emesis.</li>
<li>For patients intolerant or refractory to others antiemetics</li>
</ul>
<p>Side effects; hallucinations. Disorientation, vertigo, sedation</p>
<p>HEMATOLOGIC DRUGS â€“ ANTI COAGULANTS</p>
<ul>
<li>Anti coagulant refers to any substance which inhibits normal blood clotting, lowers coagulability of blood.</li>
<li>The anti coagulant interfere with normal coagulation process by interfering with the clotting cascade and thrombin formation.</li>
<li>These agents are used to inhibit clot formation but they do not dissolve existing clots.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Classification of anticoagulants</p>
<p>â€¢ Parenteral anticoagulants:</p>
<p>Heparin</p>
<p>âž¢Low molecular weight heparin; enoxaparin, dalteparine, nadroparin, arteparin.</p>
<p>âž¢Semisynthetic heparinoid; heparin sulphate, dextran sulphate, ancrod, danaparoid.</p>
<p>âž¢Others; lepirudin, bivalirudin, argatroban</p>
<p>â€¢ Oral anticoagulant; warfarin, acenocoumarin, dicoumarol</p>
<p>â€¢ Fibrinolytic; streptokinase urokinase, alteplase</p>
<p>HEPARIN</p>
<p>mechanism of action: heparin acts prophylactically to prevent the formation of clots in the vasculate.it activates anti thrombin III which inhibits thrombin and clotting factor IX, X, XI, XII, consequently conversion of fibrinogen to fibrin does not occur and the formation of a fibrin clot is prevented</p>
<p>Therapeutic Uses</p>
<p>Heparin sodium, LMWH, fondaparinux sodium</p>
<p>â€¢ In conditions necessitating prompt anticoagulant activity (evolving stroke, pulmonary embolism, massive deep venous thrombosis)</p>
<p>â€¢ As an adjunct for clients having open heart surgery or renal dialysis</p>
<p>â€¢ As low-dose therapy for prophylaxis against postoperative venous thrombosis (for example, hip/knee replacement surgery, abdominal surgery)</p>
<p>â€¢ In conjunction with thrombolytic therapy when treating an acute myocardial infarction</p>
<p>â€¢ Treatment of disseminated intravascular coagulation</p>
<p>Administration</p>
<p>â€¢ These medications cannot be absorbed by the intestinal tract and must be given by subcutaneous injection or IV infusion.</p>
<p>â€¢ Heparin sodium: Subcutaneously every 12 hr., continuous or intermittent IV infusion</p>
<p>â€¢ Enoxaparin, dalteparin sodium, tinzaparin: Subcutaneously every 12 hr. for 2 to 8 days</p>
<p>â€¢ Fondaparinux sodium: Subcutaneously every 12 hr. for 5 to 9 day.</p>
<p>Side/Adverse Effects</p>
<p>â€¢ Hemorrhage secondary to heparin overdose</p>
<p>â€¢ thrombocytopenia,</p>
<p>â€¢ Hypersensitivity reactions (chills, fever, urticaria)</p>
<p>â€¢ Administer a small test dose prior to the administration of heparin. Toxicity/overdose</p>
<p>â€¢ Administer protamine sulfate, which binds with heparin and forms a heparin-protamine complex that has no anticoagulant properties.</p>
<p>â€¢ Protamine sulfate should be administered slowly intravenously, no faster than 20 mg/min or 50 mg in 10 min.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="enoxaparin">Enoxaparin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#enoxaparin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hemorrhage Monitor vital signs <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>â‹…</mo></mrow><annotation encoding="application/x-tex">\cdot</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4445em;"></span><span class="mord">â‹…</span></span></span></span></span> Advise clients to observe for signs and symptoms of bleeding, such as increased heart rate, decreased blood pressure, bruising, petechiae, hematomas, black tarry stools. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>â‹…</mo></mrow><annotation encoding="application/x-tex">\cdot</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.4445em;"></span><span class="mord">â‹…</span></span></span></span></span> Monitor platelet count. Instruct client to avoid aspirin.</li>
<li>Neurologic damage from hematoma formed during spinal or epidural anesthesia</li>
<li>Thrombocytopenia, as evidenced by low platelet count, Monitor platelets. Discontinue medication for platelet count less than 100,000/mm3 .</li>
<li>Toxicity/overdose; Administer protamine sulfate</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Parenteral anticoagulants are contraindicated in clients with low platelet counts (thrombocytopenia) or uncontrollable bleeding.</li>
<li>These medications should not be used during or following surgeries of the eye(s), brain, or spinal cord; lumbar puncture; or regional anesthesia.</li>
<li>Clients who have hemophilia, increased capillary permeability, dissecting aneurysm, peptic ulcer disease, severe hypertension, hepatic or renal disease, or threatened abortion</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-food-interactions">Medication/Food Interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-food-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Anti-platelet agents such as aspirin, NSAIDs, and other anticoagulants may increase risk for bleeding.</li>
</ul>
<p>Nursing Administration; Heparin sodium:</p>
<p>â€¢ Obtain the clientâ€™s baseline vital signs.</p>
<p>â€¢ Obtain baseline and monitor complete blood count (CBC), platelet count, and hematocrit levels.</p>
<p>â€¢ Read label carefully. Heparin is dispensed in units and in different concentrations.</p>
<p>â€¢ Check dosages with another nurse before administration.</p>
<p>â€¢ Use an infusion pump for continuous IV administration. Monitor rate of infusion every 30 to 60 min.</p>
<p>â€¢ Monitor PTT every 4 to 6 hr. until appropriate dose is determined, then monitor daily.</p>
<p>â€¢ For subcutaneous injections, use a 20 to 22 gauge needle to withdraw medication from the vial. Then, change the needle to a smaller needle (gauge 25 or 26, 1/2 to 5/8 in length).</p>
<p>â€¢ Administer deep subcutaneous injections in the abdomen ensuring a distance of 2 inches from the umbilicus. Do not aspirate.</p>
<p>â€¢ Apply pressure for 1 to 2 min after the injection. Rotate and record injection sites.</p>
<p>â€¢ Instruct clients to monitor for signs of bleeding (bruising, gums bleeding, abdominal pain, nose bleeds, coffee-ground emesis and tarry stools).</p>
<p>â€¢ Instruct clients not to take over-the-counter NSAIDs, aspirin, or medications containing salicylates.</p>
<p>â€¢ Advise clients to use an electric razor for shaving and a soft toothbrush.</p>
<p>ORAL ANTI COAGULANTS</p>
<p>â€¢ These are the most commonly used oral anti coagulants;</p>
<p>â€¢ Warfarin,</p>
<p>â€¢ Dicoumarol,</p>
<p>â€¢ Acenocoumarol</p>
<p>Mechanism of action</p>
<p>Vitamin K antagonist; these agents inhibit the liver synthesis of vitamin K clotting factor II,VII, IX, X.</p>
<p>Advantages over heparin</p>
<p>â€¢ Bioavailability is almost 100 percent.</p>
<p>â€¢ Low volume distribution,</p>
<p>â€¢ Long half life.</p>
<p>Pharmacokinetics</p>
<p>â€¢ Produces delayed action,</p>
<p>â€¢ possibility of genetic resistance</p>
<p>Clinical indication</p>
<p>â€¢ Treatment deep venous thrombosis.</p>
<p>â€¢ Pulmonary embolism</p>
<p>â€¢ Prevent blood clotting in patients with thrombophlebitis, pulmonary embolism and embolism from arterial fibrillation.</p>
<p>Contraindication /precaution</p>
<p>â€¢ Not given to pregnant women because it crosses the placenta barrier, it is teratogenic, and can cause an a abortion.</p>
<p>â€¢ Not given to patients with bleeding disorders e.g. hemophilia, peptic ulcer, sever renal/ liver disease and eclampsia.</p>
<p>Monitoring</p>
<p>â€¢ Monitor prothrombin time usually done before administering the dose.</p>
<p>â€¢ The PT SHOULD BE 1.5-2.5 times the reference value to be therapeutic</p>
<p>â€¢ If it is below the recommended range warfarin should be increased.</p>
<p>â€¢ If it above the recommended range warfarin should be decreased.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-effects-of-warfarin">Adverse effects of warfarin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-effects-of-warfarin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Hematologic effects: increased bleeding, thrombocytopenia</li>
<li>Anorexia, nausea, vomiting, diarrhoea and dermatitis.</li>
<li>Hemorrhage</li>
<li>Interference with bone formation in early pregnancy</li>
</ul>
<p>Drug interaction</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="potentiation-activity">Potentiation activity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#potentiation-activity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Inhibition of metabolism: chloramphenicol, ciprofloxacin, cotrimoxazole, cimetidine.</li>
<li>Displacement from plasma protein; ethacrynic acid.</li>
<li>Platelet function inhibition; NSAIDs (Aspirin)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="retarded-activity">retarded activity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#retarded-activity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>inhibition of absorption; Sucralfate</li>
<li>Enzyme induction; barbiturates, carbamazepine, rifampicin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acenocoumarol">acenocoumarol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acenocoumarol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>take 2-3 DAYS.</li>
</ul>
<p>Indication</p>
<ul>
<li>Arterial fibrillation,</li>
<li>pulmonary embolism,</li>
<li>prophylaxis following insertion of heart valve.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="adverse-drug-reaction">adverse drug reaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-drug-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Alopecia, diarrhoea, hepatic dysfunction, pancreatitis vomiting</p>
<p>Nursing Administration of warfarin</p>
<p>â€¢ Administration is usually oral, once daily.</p>
<p>â€¢ Obtain the clientâ€™s baseline vital signs.</p>
<p>â€¢ Monitor PT levels (therapeutic level 18 to 24 sec) and INR levels (therapeutic levels 2 to 3). INR levels are the most accurate. Hold dose and notify the provider if these levels exceed therapeutic ranges.</p>
<p>â€¢ Obtain baseline and monitor CBC, platelet count, and Hct levels.</p>
<p>â€¢ Instruct clients that anticoagulant effects may take 8 to 12 hr and full therapeutic effect is not achieved for 3 to 5 days. For clients in the hospital setting, explain the need for continued heparin infusion when starting oral warfarin.</p>
<p>â€¢ Advise clients that anticoagulation effects can persist for up to 5 days following discontinuation of medication because of long half-life.</p>
<p>â€¢ Advise clients to avoid alcohol and over-the-counter and non-prescription medications to prevent adverse effects and medication interactions, such as risk of bleeding.</p>
<p>â€¢ Advise clients to employ nonmedication measures to avoid development of thrombi, including avoiding sitting for prolonged periods of time, not wearing constricting clothing, and elevating and moving legs when sitting.</p>
<p>â€¢ Advise clients to wear a medical alert bracelet indicating warfarin use.</p>
<p>Nursing administration of warfarin</p>
<p>â€¢ Be prepared to administer vitamin K for warfarin overdose.</p>
<p>â€¢ Teach clients to self-monitor PT and INR at home as appropriate.</p>
<p>â€¢ Advise clients to record dosage, route, and time of warfarin administration on a daily basis.</p>
<p>â€¢ Plan for frequent PT monitoring for clients who are prescribed medications that interact with warfarin. The client is at greatest risk for harm when the interacting medication is being deleted or added. Frequent PT monitoring will allow for dosage adjustments as necessary.</p>
<p>â€¢ Advise clients to notify the provider regarding warfarin use.</p>
<p>â€¢ Advise clients to use a soft-bristle toothbrush to prevent gum bleeding</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="thrombolytic-fibrinolytic-medications">Thrombolytic /Fibrinolytic Medications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thrombolytic-fibrinolytic-medications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Two phenomena which causes hemostasis include,</p>
<ul>
<li>Coagulation of blood .</li>
<li>Formation of a thrombus
formation of a thrombus is restricted through:</li>
</ul>
<ol>
<li>Fibrin inhibition: anti thrombin III, Ant plasmin, Antitrypsin, Macroglobulin</li>
<li>Fibrinolysis: tissue plasminogen activator and CF XII activate fibrin bound plasminogen to active plasmin, restrict formation of a thrombus.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action-of-fibrinolytic">Mechanism of action of fibrinolytic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-fibrinolytic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Thrombolytic/fibrinolytic medications dissolve clots that have already formed. Clots are dissolved by conversion of plasminogen to plasmin, which destroys fibrinogen and other clotting factors. The result is clot disintegration.
The commonly used fibrinolytic include:</p>
<ul>
<li>Streptokinase (Streptase)</li>
<li>Urokinase</li>
<li>Alteplase (Activase, tPA),</li>
<li>Anistreplase</li>
<li>Reteplase (Retavase)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="streptokinase">streptokinase<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#streptokinase" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action">Mechanism of action:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>streptokinase is a semi synthetic that acts systematically to dissolve the blood clot by activating plasminogen to plasmin.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clinical-indication">Clinical indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clinical-indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Acute myocardial infarction</li>
<li>Deep vein thrombosis (DVT)</li>
<li>Massive pulmonary emboli</li>
<li>thrombo embolic stroke (alteplase)</li>
<li>Peripheral arterial thrombosis</li>
<li>To open clotted iv catheters</li>
</ul>
<p>Adverse reaction</p>
<p>â€¢ Allergic reaction (urticaria, itching, flushing, bronchospasms); possible severe anaphylactic reaction.</p>
<p>â€¢ Serious risk of bleeding from different sites (within brain, needle puncture sites, wounds)</p>
<p>â€¢ Hypotension</p>
<p>â€¢ Arrhythmias</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Any prior intracranial hemorrhage (hemorrhagic stroke)</p>
<p>â€¢ Active internal bleeding</p>
<p>â€¢ History of significant closed head or facial trauma in the past 3 months</p>
<p>â€¢ Acute pericarditis</p>
<p>â€¢ Brain tumors</p>
<p>â€¢ Use cautiously in clients who have severe hypertension, a recent episode of ischemic stroke (6 months prior to start of treatment), or a recent major surgery (2 to 4 weeks prior to start of treatment).</p>
<p>urokinase</p>
<ul>
<li>Isolated from human renal cells from tissue cultures.</li>
<li>Helps in direct conversion of plasminogen to plasmin.</li>
</ul>
<p>Therapeutic uses</p>
<ul>
<li>Myocardial infarction.</li>
<li>Venous thrombosis.</li>
<li>Pulmonary embolism.</li>
</ul>
<p>Adverse reaction</p>
<ul>
<li>Fever.</li>
<li>Hemorrhage.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>alteplase</p>
<p>Mechanism of action</p>
<p>â€¢ Recombinant tissue plasminogen activator (t-PA)</p>
<p>â€¢ helps in Critical activation of plasminogen bound in fibrin clot. Reduces the risk of systemic bleeding to an appreciable extent.</p>
<p>â€¢ Half life 4-8 minutes</p>
<p>â€¢ More efficacious than others</p>
<p>Therapeutic use</p>
<p>Lysis of occlusive coronary artery thrombi associated with myocardial infarction.</p>
<p>Deep venous thrombosis.</p>
<p>Ischemic cerebrovascular disease</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-reaction">Adverse reaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Nausea</li>
<li>Fever</li>
<li>Rash, pruritic</li>
<li>Mild hypertension</li>
<li>Localized bleeding</li>
</ul>
<p>Nursing Administration of thrombolytic agents</p>
<p>â€¢ Use of thrombolytic agents must take place within 4 to 6 hr. of onset of symptoms</p>
<p>â€¢ monitor in a setting that provides for close supervision and continuous monitoring during and after administration of the medication.</p>
<p>â€¢ Obtain baseline platelet counts, hemoglobin (Hgb), hematocrit (Hct), a PTT, PT, INR, and fibrinogen levels, and monitor periodically.</p>
<p>â€¢ Obtain baseline vital signs (heart rate, blood pressure) and monitor frequently per protocol.</p>
<p>â€¢ Nursing care includes continuous monitoring of hemodynamic status to assess for therapeutic and adverse effects of thrombolytic (relief of chest pain, signs of bleeding). Follow facility protocol.</p>
<p>â€¢ Provide for client safety per facility protocol.</p>
<p>â€¢ Ensure adequate IV access for administration of emergency medications and availability of emergency equipment.</p>
<p>â€¢ Do not mix any medications in IV with thrombolytic agents.</p>
<p>Nursing administration cont.â€™</p>
<ul>
<li>
<p>Minimize bruising or bleeding by limiting venipunctures and subcutaneous/intramuscular injections.</p>
</li>
<li>
<p>Discontinue thrombolytic therapy if life-threatening bleeding occurs. Treat blood loss with whole blood, packed red blood cells, and/or fresh frozen plasma. IV aminocaproic acid (Amicar) should be available for administration in the event of excessive fibrinolysis.</p>
</li>
<li>
<p>Following thrombolytic therapy, administer heparin or aspirin as prescribed to decrease the risk of rethrombosis.</p>
</li>
<li>
<p>Following thrombolytic therapy, administer beta blockers as prescribed to decrease myocardial oxygen consumption and to reduce the incidence and severity of reperfusion arrhythmias.</p>
</li>
<li>
<p>Administer H2 antagonists, such as ranitidine (Zantac), or proton pump inhibitors, such as omeprazole (Prilosec), as prescribed to prevent GI bleeding.</p>
</li>
<li></li>
</ul>
<p>Anti platelets drugs</p>
<ul>
<li>These are agents that decrease the formation of platelet plug by decreasing their responsiveness to various stimuli that would cause them to risk and combine together on a vessel wall.</li>
</ul>
<p>This include;</p>
<ul>
<li>Acetyl salicylic acid (aspirin)</li>
<li>Thienopyridine analogues</li>
</ul>
<p>Ticlopidine,</p>
<p>Clopidogrel</p>
<ul>
<li>Glycoprotein receptor antagonist:</li>
</ul>
<p>Abciximab</p>
<p>Eptifibatide</p>
<p>Tirofiban</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action-of-platelet-inhibitors">mechanism of action of platelet inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-platelet-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>these agents inhibit the aggregation of platelets in the clotting process by blocking receptor sites on the platelets membrane, preventing platelet to platelet interaction, there by prolonging the bleeding time.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="acetyl-salicylic-acid-aspirin">Acetyl salicylic acid (aspirin)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acetyl-salicylic-acid-aspirin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Universally accepted anti platelet drug.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Irreversibly causes inhibition of cyclooxygenase (COX) that leads to formation of thromboxane A2 and prostacyclin.</li>
<li>TXA2 is the key platelet activator inhibition of platelets action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Primary prevention of acute myocardial infarction</li>
<li>Prevention of reinfarction in clients following an acute myocardial infarction</li>
<li>Prevention of stroke</li>
<li>Acute coronary syndromes (abciximab, tirofiban, eptifibatide)</li>
<li>Intermittent claudication (cilostazol, pentoxifylline, dipyridamole)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="route-of-administration">Route of administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#route-of-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Aspirin: Oral</li>
<li>Abciximab: IV</li>
<li>Clopidogrel: Oral</li>
<li>Pentoxifylline: Oral</li>
</ul>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<ul>
<li>Aspirin GI effects (nausea, vomiting, dyspepsia) Advise clients to use enteric-coated tablets and to take aspirin with food. Concurrent use of a proton pump inhibitor, such as omeprazole (Prilosec), may be appropriate.</li>
<li>Hemorrhagic stroke</li>
<li>Prolonged bleeding time, gastric bleed, thrombocytopenia</li>
<li>Tinnitus, hearing loss</li>
</ul>
<p>Nursing Administration</p>
<ul>
<li>
<p>Advise clients that prevention of strokes, myocardial infarctions, and reinfarction can be accomplished with low-dose aspirin (81 mg).</p>
</li>
<li>
<p>Aspirin 325 mg should be taken during initial acute episode of myocardial infarction</p>
</li>
<li>
<p>Advise clients to notify the provider regarding aspirin use.</p>
</li>
<li></li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="thienopyridine-analogues">Thienopyridine analogues<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#thienopyridine-analogues" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="clopidogre-and-ticlopidine">Clopidogre and ticlopidine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#clopidogre-and-ticlopidine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Clopidogre and ticlopidine reduces platelets aggregation by inhibiting the ADP pathway of platelets.</li>
<li>These drugs achieved their antiplatelet effects by irreversibly blocking the ADP receptor on platelets.</li>
<li>unlike aspirin, these drugs have no effects on prostaglandin metabolism.</li>
<li>Important for aspirin intolerant</li>
<li>Use of clopidogre or ticlopidine to prevent thrombosis is now considered standard practice in patients undergoing placement of coronary stent.</li>
<li>Clopidogrel plus aspirin is used for long term treatment of severe cases of coronary syndromes.</li>
<li>Rashes caused by ticlopidine.</li>
</ul>
<p>Hemostatic agents/ coagulants</p>
<ul>
<li>Haemostatic agents help to stop bleeding at the local site.thus enhancing and promoting coagulation and formation of network fibrin around the wound.</li>
</ul>
<p>These drugs are :</p>
<p>Aminocaproic acid and tranexamic</p>
<ul>
<li>These are fibrin stabilizers that maintain or stabilize the clot in the bleeding vessels.</li>
</ul>
<p>Protamine sulfate</p>
<ul>
<li>This agent antagonizes the anticoagulant effects of heparin.</li>
<li>It is derived from fish testis and is high in arginine content.</li>
<li>The positive charge interacts with the negative charge of heparin to form a stable inactive complex.</li>
</ul>
<p>Drugs for various bleeding conditions</p>
<p>â€¢ epistasis â€“ adrenaline</p>
<p>â€¢ Overdose of fibrinolytic, bleeding post surgery â€“ aminocaproic acid</p>
<p>â€¢ Menorrhagia, metrorrhagia â€“ adrenochrome, ethamesylate.</p>
<p>â€¢ PPH â€“ carboprost</p>
<p>Vitamin K</p>
<p>Is a fat soluble vitamin occurs in two forms :</p>
<p>vitamin K1 (phytonadione):leafy vegetables</p>
<p>Vitamin k2 (menadione): GIT through microbes.</p>
<p>Bile salts are required for absorption of vitamin K from the intestines.</p>
<p>VIT .K cont.</p>
<p>Deficiency occurs due to two conditions</p>
<p>â€¢ Prolonged gut sterilization. VIT. K2</p>
<p>â€¢ Obstructive jaundice. VIT. K1, K2.</p>
<p>Phytonadione</p>
<p>may be given orally, IM, IV</p>
<p>if given orally give with bile salts.</p>
<p>Menadione sodium bisulphate</p>
<p>Oral, IM ,IV, or SC</p>
<p>does not require bile salts</p>
<p>Takes longer duration</p>
<p>Vitamin K is given to antagonize oral anticoagulants.</p>
<p>The response to vitamin K is slow, requiring about 24 hours thus, if immediate hemostasis or bleeding control is required, fresh frozen plasma should be ordered.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Vitamin K deficiency.</li>
<li>Treatment of hemorrhagic disease of the newborn.</li>
<li>newborn and premature to cover the reduced intestinal synthesis.</li>
<li>Prolonged anti microbial therapeutic activity.</li>
<li>Obstructive jaundice.</li>
<li>malabsorption</li>
</ul>
<p>hematinic</p>
<p>a hematinic is a nutrient required in the formation of blood cells the main hematinic are iron , B12 and Folate. deficiency can lead to anemia</p>
<p>Iron and iron salts</p>
<p>â€¢ Iron deficiency is the most common nutritional anaemia in humans</p>
<p>â€¢ It result from inadequate iron intake, malabsorption, blood loss, or an increased requirement as with pregnancy.</p>
<p>â€¢ When severe it results in microcytic hypochromic anemia.</p>
<p>Ferrous sulphate</p>
<p>pharmacokinetics</p>
<p>Iron is given orally as a ferrous salt 50 -100MG is administered daily for the treatment of anemia .</p>
<p>Iron is absorbed readily in presence of gastric acid.</p>
<p>Ferrous sulphate cont.'</p>
<ul>
<li>It is given before meals though many patients cannot tolerate it due to its irritating effects.</li>
<li>After sometime the patient shows improved appetite, increased erythrocyte cell count and decreased microcytic hypochromic anaemia .</li>
<li>At lest six months of therapy is necessary to restore iron levels to storage site.</li>
<li>It can be given parenterally as iron dextran or iron sucrose that is by slow im or iv.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Unwanted effects</p>
<ul>
<li>Oral can cause GIT discomfort</li>
<li>Liquid form for infants can stain teeth.</li>
<li>Allergic reactions are possible with chills, urticaria, sweating , fever and even anaphylaxis after parenteral administration.</li>
<li>Patients pass black or dark stool this in harmless results of unabsorbed iron.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="folic-acid">folic acid<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#folic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Folic acid is essential in the production of DNA and erythropoiesis (RBC, WBC, and platelets).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Treatment of megaloblastic (macrocytic) anemia secondary to folic acid deficiency</li>
<li>Prevention of neural tube defects during pregnancy; therefore it is needed in all women of child-bearing age who may become pregnant.</li>
<li>Treatment of malabsorption syndrome such as sprue</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="contraindications-precautions">Contraindications/Precautions .<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Indiscriminate use of folic acid is inappropriate because of the risk of masking signs of vitamin B12 deficiency.</p>
<p>Medication/Food Interactions</p>
<p>â€¢ Decreased folate levels with concurrent use of sulfonamides, sulfasalazine, or methotrexate.</p>
<p>Nursing Administration</p>
<p>â€¢ Assess clients for signs and symptoms of megaloblastic anemia (pallor, easy fatigability, palpitations, paresthesia of hands or feet).</p>
<p>â€¢ Obtain the clientâ€™s baseline folic acid levels, RBC and reticulocyte counts, Hgb, and Hct levels. Monitor periodically.</p>
<p>â€¢ Advise clients with folic acid deficiency to concurrently increase intake of food sources of folic acid, such as green leafy vegetables and liver. Monitor clients for risk factors indicating that folic acid therapy may be needed, such as heavy alcohol use and child-bearing age.</p>
<p>NB :vitamin B12 will be covered in nutrition.</p>
<p>Insulin, oral hypoglycemic agents</p>
<ul>
<li>
<p>Overview</p>
</li>
<li>
<p>Diabetes mellitus is a chronic illness that results from an absolute or relative deficiency of insulin.</p>
</li>
<li>
<p>Various insulins are available to manage diabetes. These medications differ in their onset, peak, and duration.</p>
</li>
<li>
<p>Oral hypoglycemic agents work in various ways to increase available insulin or modify carbohydrate metabolism.</p>
</li>
<li>
<p>Newer injectable medication are used to supplement insulin or oral agents to manage glucose control.</p>
</li>
<li></li>
</ul>
<p>Review regulation of insulin secretion and its function in control of blood glucose level from A/P.</p>
<p>diabetes mellitus and effects of insulin</p>
<ul>
<li>
<p>DM consists of agroup of disorders characterized hyperglycemia, altered metabolism of lipids, carbohydrates and proteins and increased complications from vascular diseases.</p>
</li>
<li>
<p>Most patients can be classified clinically as having either type1 or type 2 DM.</p>
</li>
<li>
<p>The criteria for the diagnosis of DM include symptoms (e.g.polyuria, polydipsia, and unexplained weight loss)and a random plasma glucose concentration of greater than 200ml/dl )11.1mmol.</p>
</li>
<li>
<p>A fasting plasma glucose of greater than (126ml/dl) 7mmol</p>
</li>
<li>
<p>there two types of DM . DM TYPE 1 and DM TYPE 2</p>
</li>
<li></li>
</ul>
<p>Insulin Therapy</p>
<ul>
<li>Insulin polypeptide hormone is the mainstay for treatment</li>
<li>Of all types of diabetes.</li>
<li>Insulin may be administered IM , IV, SC.</li>
<li>long term treatment relies on subcutaneous injections of the hormone.</li>
</ul>
<p>Expected Pharmacological Action
âœ“ Promotes cellular uptake of glucose (decreases glucose levels)
âœ“ Converts glucose into glycogen
âœ“ Moves potassium into cells (along with glucose)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Therapeutic Uses</p>
<p>â€¢ Insulin is used for glycemic control of diabetes mellitus (type 1, type 2, gestational) to prevent complications.</p>
<p>â€¢ Clients with type 2 diabetes mellitus may require insulin when:</p>
<p>â€¢ Oral hypoglycemic, diet, and exercise are unable to control blood glucose levels.</p>
<p>âœ“ Severe renal or liver disease is present.</p>
<p>âœ“ Painful neuropathy is present.</p>
<p>âœ“ Undergoing surgery or diagnostic tests.</p>
<p>âœ“Experiencing severe stress such as infection and trauma.</p>
<p>âœ“Undergoing emergency treatment of diabetes ketoacidosis (DKA) and hyperosmolar hyperglycemic nonketotic syndrome (HHNS).</p>
<p>âœ“ Requiring treatment of hyperkalemia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-insulin-classified-according-to-duration-of-action">Classification of insulin; classified according to duration of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-insulin-classified-according-to-duration-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>|  classification | Generic
(trade name) | Onset | Peak | duration  |
| --- | --- | --- | --- | --- |
|  Rapid acting | Lispro insulin
(Humalog), Insulin
aspart (NovoLog),
Insulin glulisine
(Apidra) | Less than 15 min | Less than 15 min 0.5
to 1 hr. | 3 to 4 hr.  |
|  Short acting | - Regular insulin
(Novolin R) | 0.5 to 1 hr. | 2 to 3 hr. | 5 to 7 hr.  |
|  Intermediate acting | neutral protamine
Hagedorn(NPH)
insulin (Humulin N),
lente insulin | 1 to 2 hr. | 4 to 12 hr. | 18 to 24 hr.  |
|  Long acting | Ultra lente, Insulin
glargine (Luntus) | 1 hr. | None | 10.4 to 24 hr.  |</p>
<p>Premixed insulins</p>
<ul>
<li>70% NPH and 30% Regular (Humulin 70/30) â€“ mixture of intermediate acting and short-acting insulin</li>
<li>75% insulin lispro protamine and 25% insulin lispro (Humalog 75/25) â€“ mixture of intermediate acting and rapid-acting insulin Complications</li>
</ul>
<p>SIDE/ADVERSE EFFECTS NURSING INTERVENTIONS/CLIENT EDUCATION</p>
<p>Risk for hypoglycemia (too much insulin)</p>
<ul>
<li>
<p>Monitor clients for signs of hypoglycemia. If abrupt onset, client will experience sympathetic nervous system (SNS) symptoms (tachycardia, palpitations, diaphoresis, shakiness). If gradual onset, client will experience parasympathetic (PNS) symptoms (headache, tremors, weakness).</p>
</li>
<li>
<p>Administer glucose. For conscious clients, administer a snack of 15 g of carbohydrate (4 oz. orange juice, 2 oz. grape juice, 8 oz. milk, glucose tablets per manufacturerâ€™s suggestion to equal 15 g).</p>
</li>
<li></li>
</ul>
<p>If the client is not fully conscious, do not risk aspiration. Administer glucose parenterally such as IV glucose, or SC/IM glucagon.</p>
<ul>
<li>Encourage clients to wear a medical alert bracelet.</li>
</ul>
<p>Lipohypertrophy</p>
<ul>
<li>atrophy of the sub cutaneous fat at the site of insulin injection is probably an immune response to insulin.</li>
<li>It may occur with human insulin if patients inject themselves repeatedly in the same site</li>
<li>Instruct clients to systematically rotate injection sites and to allow 1 inch between injection sites.</li>
</ul>
<p>Insulin allergy resistant</p>
<ul>
<li>
<p>identify the underlying cause.</p>
</li>
<li>
<p>If allergic reaction to porcine insulin human insulin should be used.</p>
</li>
<li>
<p>Antihistamines may provide relieve in patients with cutaneous reaction.</p>
</li>
<li>
<p>Glucocorticoids are used in patients with resistant to insulin or more severe systemic reactions</p>
</li>
<li></li>
</ul>
<p>Drug interaction</p>
<ul>
<li>
<p>Drug interaction is often caused by ethanol, adrenergic receptor antagonist, and salicylates.</p>
</li>
<li>
<p>Adrenergic receptor antagonist pose a risk of hypoglycemia due to inhibition of catecholamine effects on gluconeogenesis and glycogenolysis.</p>
</li>
<li>
<p>These agents may also mask he autonomic symptoms associated with hypoglycemia.</p>
</li>
<li>
<p>Salicylates enhance cell sensitivity to glucose and potentiate insulin secretion and also have a weak insulin â€“ like action in the periphery.</p>
</li>
<li>
<p>Epinephrine, glucocorticoid, atypical antipsychotic drugs such as clozapine and olanzapine, and ARVS (protease inhibitors) have direct effects on peripheral tissues that counter the effect of insulin.</p>
</li>
<li>
<p>Phenytoin, clonidine, ca2+channel blockers cause hyperglycemia by inhibiting insulin secretion directly or in directly via depletion of K+ (diuretics).</p>
</li>
<li></li>
</ul>
<p>Nursing education</p>
<p>â€¢ Ensure proper storage of insulin.</p>
<p>âœ“ Unopened vials of a single type of insulin may be stored in the refrigerator until their expiration date.</p>
<p>âœ“ Vials of premixed insulins may be stored for up to 3 months.</p>
<p>âœ“ Insulins premixed in syringes may be kept for 1 to 2 weeks under refrigeration. Keep the syringes in a vertical position, with the needles pointing up. Prior to administration, the insulin should be resuspended by gently moving the syringe.</p>
<p>âœ“ Store the vial that is in use at room temperature, avoiding proximity to sunlight and intense heat. Discard after 1 month.</p>
<ul>
<li></li>
</ul>
<ul>
<li>Administer NPH by subcutaneous route.</li>
<li>Instruct clients to administer SC insulin in one general area to have consistent rates of absorption. Absorption rates from subcutaneous tissue increase from thigh to upper arm to abdomen.</li>
<li>Use only insulin-specific syringes that correspond to the concentration of insulin being administered. Administer U-100 insulin with a U-100 syringe; administer U-500 insulin with a U-500 syringe.</li>
<li>Select an appropriate needle length to ensure insulin is injected into subcutaneous tissue versus intradermal (too short) or intramuscular (too long).</li>
<li>Encourage clients to enhance their diabetes medication therapy with a proper diet and consistent activity</li>
</ul>
<ul>
<li>
<p>For insulin suspensions, the nurse should gently rotate the vial between his or her palms to disperse the particles throughout the vial prior to withdrawing insulin.</p>
<ul>
<li>
<p>Do not administer short-acting insulins if they appear cloudy or discolored.</p>
</li>
<li>
<p>Insulin glargine and insulin detemir are both clear in color, not administered IV, and should not be mixed in a syringe with any other insulin.</p>
</li>
<li>
<p>Administer lispro, aspart, glulisine, and regular insulin by subcutaneous injection, continuous subcutaneous infusion, and IV route.</p>
</li>
<li>
<p>Adjust the clientâ€™s insulin dosage to meet insulin needs.</p>
</li>
<li>
<p>The clientâ€™s dosage may need to be increased in response to the clientâ€™s increase in caloric intake, infection, stress, growth spurts, and in the second and third trimesters of pregnancy.</p>
</li>
<li>
<p>The clientâ€™s dosage may need to be reduced in response to level of exercise or first trimester of pregnancy.</p>
</li>
</ul>
</li>
</ul>
<table><thead><tr><th>Oral hypoglycemic</th><th>Classification</th></tr></thead><tbody><tr><td>Medications</td><td>Expected pharmacological action</td></tr><tr><td>Sulfonylureas</td><td></td></tr></tbody></table>
<ul>
<li>1st generation - tolbutamide (Orinase), chlorpropamide (Diabinese)</li>
<li>2nd generation - glipizide (Glucotrol, Glucotrol XL) ,glyburide (DiaBeta, Micronase , glibenclamide) glimepiride (Amaryl) | Results in insulin release from the pancreas  |
|  Meglitinides repaglinide (Prandin) nateglinide (Starlix) | Results in insulin release from the pancreas  |
|  Biguanides
metformin HCl (Glucophage) | - Reduces the production of glucose within the liver through suppression of gluconeogenesis</li>
<li>Increases muscles' glucose uptake and use  |
|  Thiazolidinedione's (Glitazones) , rosiglitazone (Avandia), pioglitazone (Actos) | - Increases cellular response to insulin by decreasing insulin resistance</li>
<li>Results in increased glucose uptake and decreased glucose production  |
|  Alpha glucosidase inhibitors acarbose (Precose), miglitol (Glyset) | - Slows carbohydrate absorption and digestion  |
|  Gliptins - Sitagliptin (Januvia | - Augments naturally occurring incretin hormones, which  |</li>
</ul>
<p>Therapeutic Uses</p>
<p>â€¢ All classifications of oral hypoglycemic agents control blood glucose levels in clients with type 2 diabetes mellitus and are used in conjunction with diet and exercise lifestyle changes.</p>
<p>Metformin HCl is used to treat polycystic ovary syndrome (PCOS).</p>
<p>SIDE/ADVERSE EFFECTS</p>
<p>Glipizide and repaglinide</p>
<p>â€¢ Hypoglycemia</p>
<p>metformin</p>
<p>â€¢ Gastrointestinal effects (anorexia, nausea, vomiting, which frequently results in weight loss of 3 to 4 kg [6 to 8 lb])</p>
<p>â€¢ Vitamin B12 and folic acid deficiency caused by altered absorption</p>
<p>â€¢ Lactic acidosis (hyperventilation, myalgia, sluggishness, somnolence) â€“ 50% mortality rate</p>
<p>Rosiglitazone</p>
<p>â€¢ Fluid Rosiglitazone retention</p>
<p>â€¢ Elevations in low density lipoproteins (LDL) cholesterol</p>
<p>â€¢ Hepatotoxicity .</p>
<p>Side/ adverse effects</p>
<p>acarbose</p>
<p>â€¢ Intestinal effects (abdominal distention and cramping, hyperactive bowel sounds, diarrhea, excessive gas).</p>
<p>â€¢ Risk for anemia due to the decrease of iron absorption</p>
<p>â€¢ Hepatoxicity with long-term use</p>
<p>Sitagliptin</p>
<p>â€¢ generally well tolerated</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pregnancy Risk Category C: Glipizide, repaglinide, rosiglitazone</li>
<li>Pregnancy Risk Category B: Metformin HCl (Glucophage), acarbose (Precose), sitagliptin (Januvia)</li>
<li>These oral agents are generally avoided in pregnancy and lactation, but the provider may decide to prescribe them.</li>
<li>Use cautiously in clients with renal failure, hepatic dysfunction, or heart failure because of the risk of medication accumulation and resulting hypoglycemia. Severity of disease may indicate contraindication.</li>
<li>Contraindicated in the treatment of diabetic ketoacidosis (DKA) Metformin HCl is contraindicated for clients with severe infection, shock, and any hypoxic condition.</li>
<li>Acarbose is contraindicated for clients with gastrointestinal disorders, such as inflammatory disease, ulceration, or obstruction.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-interaction">Medication interaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-interaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacology">PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>NJIRU R.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="objective">Objective<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#objective" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>By the end of this unit the learner should be able to administer drugs safely in the management of patients and to promote health and prevent illness.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="introduction-to-pharmacology">INTRODUCTION TO PHARMACOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#introduction-to-pharmacology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Definition of terms:
*Pharmacology is the study of effects of chemical substances on the function of living systems.</li>
</ul>
<ul>
<li>pharmacology is the science of drugs which includes their preparation, use and effects.
*It is also the science that deals with the origin, chemistry, effects and uses of drugs.
*Pharmacy: Branch of health science that deals with preparation and dispensing of drugs.
*pharmacotherapy: The study of therapeutic uses and effects of drugs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="terminology">Terminology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terminology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pharmacognosy: the study of drugs that come from natural sources e.g. plants, animals and minerals as well as search for new drugs from natural sources.
*Pharmacokinetics :this is the study of the body acts on the drugs; it is characterized by absorption, distribution, metabolism(biotransformation)and excretion/elimination. It can further be described as how the body handles a drug from site of administration to the site of action and elimination.</li>
<li>Pharmacodynamics/mechanism of action: the study of how drugs act on the body.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>*Pharmacogenetics: the study of the effects that genetics have on an individuals response to drugs.
Contra-indication: A health condition/ state that will prelude the administration of a drug e.g. aspirin is contraindicated in peptic ulcer disease.
Half life or half time (t1/2): Time taken for plasma concentration to fall by half following its elimination in the body.
Drug interactions :effects produced when some drugs are given together
Desired therapeutic effect: This should indicate the mechanism of action of a drug e.g.an analgesic is for pain relief, accompanied by central nervous system depression inhibition of inflammation, neutralization of acid in the stomach, vasodilation in angina or muscle relaxation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Toxicology: This branch of pharmacology which deals with the an desirable effects of chemicals on living systems from individual cells to complex body systems.</li>
<li>Drug: Any substance used in diagnosis, cure, treatment and prevention of disease/condition or any substance that brings a change in biological functions through its chemical actions. The term drug, medication, and medicine are used synonymously.</li>
<li>Placebo: Any component of therapy that is without specific biological activity e.g. inactive substance such as normal saline or distilled water usually used in clinical trials research and for psychological treatment.</li>
</ul>
<p>drug reactions and interactions</p>
<p>Any physiologically active drug has the potential to cause an undesirable reaction that may induce illness in the recipient. These include toxic reaction, side effects, allergic reactions, cumulative reaction, tolerance and dependence and detrimental drug reaction.</p>
<ul>
<li>Side effects: these are physiological effects exerted by the chemical that are not related to the desired therapeutic effects. you must therefore be familiar with serious side effect and commonly occurring effects.</li>
<li>Adverse drug reaction: this an injury occurring by taking medication .It may occur following a single dose or prolonged administration of a drug or result from a combination of two or more drugs. The study of ADR is known as pharmacovigilance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Drug interaction: this is when an interactant chemical modifies the therapeutic results that are anticipated with a drug the interact may be another drug, some combination of a drug, natural or artificial components in the diet, pollutants chemical from the environment, endogenous body chemicals and Chemicals used for diagnostic laboratory test. Drug interaction may be detriment or beneficial drug and may vary from one person to another. This may affect the absorption, distribution ,metabolism or excretion of the drugs.</li>
<li>Allergic reactions: This the body's immunological response to a drug following previous exposure to the same drug.</li>
</ul>
<p>Cont.</p>
<ul>
<li>Idiosyncratic reactions: this is genetically determined, un expected response to a drug. The response may take the form of extreme sensitivity to low doses or extreme insensitivity to high doses to the drug.</li>
<li>Chain reaction: Medication are often added to a regime to control side effects of other drugs. This can initiate a chain reaction e.g. cortisone is prescribed to treat a serious inflammatory condition it can cause hypertension, ulcers, diabetes and a reactivation of arrested tuberculosis.</li>
<li>Cumulative reaction: Drugs accumulate in the body whenever the dosage exceeds the amount the body can eliminate through metabolism or excretion</li>
<li>Tolerance and dependence: Tolerance occurs when a person no longer responds to the drug in the way that person initially responded as a result of continued use of the drug causing a need to increase dose of a drug to achieve the same effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>cont.</p>
<ul>
<li>There three basic types of tolerance.</li>
</ul>
<p>metabolic /pharmacokinetics tolerance this occurs due to increased metabolism of a drug leading to reduction in drug concentration at the receptor site.</p>
<p>cellular/pharmacodynamic tolerance this caused by adaptive changes that take place at the receptor site or drug action site.</p>
<p>cross tolerance when tolerance to one drug confers tolerance to another drug. Drugs that have the same chemical structure tend to portray cross tolerance e.g. people tolerance to one barbiturates are usually tolerant to all barbiturates e.g., phenobarbital, thiopental. However drugs of similar class can also portray cross-tolerance.</p>
<ul>
<li>Intolerance: low threshold to normal pharmacological response. A drug causes an exaggeration of a normal pharmacological response e.g. morphine may cause coma instead of respiratory distress which occurs with administration of a normal dose.</li>
</ul>
<p>Cont.</p>
<ul>
<li>Dependence: A state arising from repeated periodic or continuous administration of a drug that results in harm to the individual or sometimes society. People feel desire or compulsion to continue using the drug and feel ill if abruptly withdrawn or an antidote is used. Substance that cause dependence are taken to induce a good feelings or avoid discomfort of their absence.</li>
</ul>
<p>Types dependence:</p>
<p>a. psychological dependence: usually first to appear, where the individual have a craving for the effect the drug produces motional distress like fear, anxiety and irritability occur when the drug is withdrawn.</p>
<p>b. Physical dependence: this dependence is usually defined in terms of withdrawal/abstinence syndrome that are physical in nature e.g. tremors, ataxia, shivering.</p>
<p>Cont.</p>
<ul>
<li>Iatrogenic responses: these are responses produced an intentionally during the cause of treatment e.g. penicillin may cause hepatic toxicity, steroid may cause Cushing's syndrome.</li>
<li>Anaphylaxis: A sudden serious life threating allergic reaction and should be treated as a medical emergency, it causes more than one of the following ; an itchy rash throat and tongue swelling, shortness of breath ,vomiting, lightheadedness and low blood sugar.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-development">drug development<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-development" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>After a chemical that has shown therapeutic value has been identified, it must under go a series of scientific test to evaluate its actual therapeutic and toxic effects. The process is controlled by legally established bodies e.g. pharmacy and poisons board and food &amp; drug administration (FDA)development IN Kenya and USA respectively. Before receiving legal approval to be marketed to the public ,drugs must pass through several sequential stages of development.
Pre-clinical trials: this phase involves testing the drug on laboratory animals to test their pharmacodynamics, pharmacokinetics and toxicology. The toxicity studies include mutagenic, carcinogenic and reproductive studies.</li>
</ul>
<p>Conti.</p>
<p>Phase I: clinical pharmacology</p>
<p>This is first phase human volunteers, usually 20-50 (healthy volunteers or volunteer patients depending on the class of drug and its safety)are used to test the drug. Pharmacodynamics and pharmacokinetics era tested. Toxicity and therapeutic effects are further tested.</p>
<p>Phase II: therapeutic exploration</p>
<p>Tests are done on patients who have the disease usually 100-200 patients are involved in the study. Pharmacodynamics and pharmacokinetics era determined as well as dosing requirements and efficacy of the drug at the given dose</p>
<p>Phase III: Therapeutic confirmation</p>
<p>The drug is used on Avast clinical market 300-3000 patients are involved. Prescriber observes patients closely for drug adverse effects and therapeutic effects.</p>
<p>Conti.</p>
<p>Phase IV: continuous evaluation</p>
<p>the prescribers are expected to report to the regulatory bodies any unexpected effects which then evaluates this information. A drug may be withdrawn from the market if it produces toxic effects e.g. thalidomide.</p>
<p>â€¢ Orphan drug : drugs that have been discovered but are not financially viable and therefore have not been adopted by any drug company. may be useful in treating a rare disease or may have potentially dangerous adverse effects. They are often abandoned after preclinical trials or phase I studies.</p>
<p>sources of drugs</p>
<p>a)Plants sources: plants have been used as a source of drugs since pre-historic times. Plants are an important source of chemicals that are developed into drugs. Any part of a plant; including leaves, roots and back can be used. Drug can be processed using the synthetic version of the active chemical found in plants e.g. dronabinol which contains the active ingredients delta-9-tetrahydrocannabinol found in marijuana.it prevents nausea and vomiting in cancer patients but does not cause adverse effects as when one smokes marijuana.</p>
<p>Examples of active ingredients in plants.</p>
<p>i)alkaloids: Taste bitter and are poorly absorbed in water but become soluble if dissolved in acids examples of drugs derived from alkaloids includes; atropine, caffeine, cocaine, quinine, codeine and morphine.</p>
<p>Conti.</p>
<p>ii)Glycosides: these are digitalis products e.g. digoxin, digitoxin which are gotten from digitalis purpureal or foxglove plants.</p>
<p>iii)Gums: these are polysaccharides exudates that can be used for bulk laxatives and dental adhesives.</p>
<p>iii)Resins: the most common resins is benzoin which is used as an antiseptic.</p>
<p>iv)Oils: These can be volatile oils like peppermint, spearmint, menthol, cinnamon, lemon camphor. They have pleasant fragrance and evaporate easily. The other types of oils is fixed oils which include castor oil used as a laxative, olive oil for cooking, emollients used in cosmetics and solvents for injections.</p>
<p>Conti.</p>
<p>b) Animal sources: these are used to replace human chemicals that are not produced adequately due to disease or genetic problems e.g. insulin from pancreases of pigs and cows. Thyroid drugs and growth hormone preparations from animals hypothalamus. Despite these animal sources most of these products are being currently produced synthetically which provides purer and safer products than animal sources.</p>
<p>c)Inorganic sources: salts of various elements have therapeutic effect in the human body e.g., aluminum ( used as antacids),fluoride( used to prevent dental cavities and osteoporosis), gold( used for rheumatoid arthritis), iron( used for anemia) and potassium (used in potassium K+ supplements.)</p>
<p>Conti.</p>
<p>d)Synthetic sources: Many drugs are developed synthetically after chemicals in plants ,animals or other environment have been screened for signs of therapeutic activity. This eliminates side effects and increases drug potency. Drugs have genetic engineering are used to produce chemicals that have therapeutic effects.</p>
<p>e)Microbiological sources: example penicillins,tetracycline</p>
<p>f)recombinant DNA technology</p>
<p>uses of drugs</p>
<ol>
<li>curative: this is the primary therapy e.g. in treating infections or auxiliary therapy e.g. application of anaesthetic medication.</li>
<li>suppress signs and symptoms, hence improve quality of life without attaining cure e.g. anti diabetics.</li>
<li>prevent/prophylaxis- this could be primary e.g. use of vaccines to prevent one from getting a disease or secondary to stop progression of an existing disease.</li>
<li>diagnosis- for instance the use of tuberculin test to diagnose PTB</li>
</ol>
<p>drug nomenclature</p>
<p>Nomenclature is the systematic naming of drugs especially pharmaceutical drug Drugs in majority of circumstances have three types of names.</p>
<ol>
<li>i)Chemical/molecular/ scientific name: this is the chemical/molecular structure of a drug. It states the structure in terms of atoms and molecules accompanied by a diagram of the chemical structure. Most useful to a few technically trained personnel e.g. chemist or research pharmacist the names are unsuitable for general use since they are long. e.g. acetyl-p-amino-phenol is for paracetamol or acetaminophen</li>
<li>ii)generic/non-proprietary/approved name; this is the abbreviated and approved name. it is the official medical name assigned by the producer in collaboration with the food and drugs board and nomenclature committee. The generic name can be used by any interested party and it removes confusion of giving several names to the same drug regardless of who manufactures them once they have the same chemical structure. A generic name is not capitalized e.g. acetylsalicylic acid commonly known as aspirin,</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="conti">Conti.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conti" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>iii)Trade name/proprietary/brand name: name given to the drug by the manufacturing and marketing company. One drug may have so many trade name e.g. acetaminophen has about 30 names some are paramol, Tylenol, Panadol etc. they are usually capitalized.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="example-of-drugs-chemical-name-generic-name-and-trade-name">example of drugs chemical name, generic name and trade name.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#example-of-drugs-chemical-name-generic-name-and-trade-name" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Chemical name</th><th>Generic name</th><th>Trade names</th></tr></thead><tbody><tr><td>2-(4-isobutylphenyl)propanoic acid</td><td>ibrufen</td><td>Brufen, advil, nurofen</td></tr><tr><td>N-acetyl-para-aminophenol</td><td>Paracetamol, acetaminophen</td><td>Calpol, Panadol, tylenol</td></tr><tr><td>2-(2-methl-5-nitro-1h-imidazol1-</td><td></td><td></td></tr><tr><td>y)ethyl benzoate.</td><td>metronidazole</td><td>Flagyl ,metrogyl</td></tr></tbody></table>
<p>two major methods of dispensing drugs</p>
<ul>
<li>Over the counter drugs (OTC):they do not need a prescription and can be purchased at the chemical shops; examples pain relief, blood tonics, vitamin preparation, ORS, antacids, antimalarial.</li>
<li>Prescription drugs: They need a prescription and must be controlled from abuse and dependence; e.g. antibiotics, anti-hypertensives, sedatives, diabetics drugs etc.</li>
</ul>
<p>Patients education -about OTC drugs</p>
<ul>
<li>You need to give your attention to all the drugs the patient is taking whether prescription or OTC.</li>
<li>Caution patient not to treat themselves with OTC drugs.</li>
<li>Inform them that most of the OTC medication contain more than one active ingredient.</li>
<li>Tell he patient that interactions can occur when takes more than one OTC medication at a time or takes one with a prescription drugs.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="patients-education-about-drugs-prescription-drugs">patients education about drugs - prescription drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#patients-education-about-drugs-prescription-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Inform patient about special consideration and drug safety precaution.</li>
<li>Encourage: complete medication list complete adverse reaction list.</li>
<li>Patients compliance.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Pharmacokinetics is the process by which the body, sick or well, handles and affects the drug.</li>
<li>It is characterized by four processes</li>
</ul>
<p>i) absorption ;This is the process by which a drug is transferred from the site of administration into the circulating fluids of the body e.g. Blood and lymph.</p>
<ul>
<li>The rate of absorption is vital because it determines when the drug is available to exert its action.</li>
<li>Bioavailability: This is the fraction extent to which a dose of drug reaches its site of action .for example;1. hepatic metabolism and biliary excretion may occur before a drug taken orally reaches systemic circulation.(first pass effect)</li>
</ul>
<ol start="2">
<li>Drug given intravenously its bioavailability is 100%thus bioavailability must be considered when calculating none intravenous routes of administration.</li>
</ol>
<p>factors affecting absorption</p>
<ul>
<li>Route of drug administration.</li>
<li>Dose.</li>
<li>Dosage formulation.</li>
<li>Food and fluids administered with the drugs.</li>
<li>Status of the absorptive surface.</li>
<li>Rate of blood flow to the small intestines.</li>
<li>acidity of the stomach</li>
<li>Status of GI motility.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Factors influencing drug administration</p>
<p>â€¢ The nature of the absorbing surface.</p>
<p>â€¢ Blood flow to the site of administration; increase in blood flow facilitates abortion ; and e.g. sublingual route and pulmonary epithelium.</p>
<p>â€¢ The health status of the person taking the drug. This affects the rate of absorption and transportation.</p>
<p>â€¢ The lipid solubility of drugs the higher the solubility the more a drug is absorbed especially in the GIT.</p>
<p>â€¢ The PH of the drug.</p>
<p>â€¢ Drug concentration and critical concentration.</p>
<p>routes of drug administration</p>
<p>A drugs route of administration affects the rate and extend of absorption.</p>
<p>â€¢ Enteral route : drugs given along any portion of the GIT.it is most common, safe, convenient. and economical. but it is the slowest, it can be orally, sublingually, and rectally.</p>
<p>â€¢ Parenteral route: intradermally, subcutaneous, intramuscular, intrathecal intravenous.</p>
<p>â€¢ Pulmonary route: administered by in halation.</p>
<p>â€¢ topical: applied on the skin, mucus membrane of eyes, ears, nasal mucosa, bladder, vagina and the penis.</p>
<p>Factors to consider when choosing the route of drug administration</p>
<ol>
<li>
<p>The time at which the effect of the drug is required.</p>
</li>
<li>
<p>The method most suitable for the drug required.</p>
</li>
<li>
<p>The site of drug action.</p>
</li>
<li>
<p>Patients status whether conscious or unconscious.</p>
</li>
<li>
<p>Desire off the patient.</p>
</li>
</ol>
<p>Conti.</p>
<ul>
<li>When prescribing drugs the dose may vary with certain factors ; age, route, assimilation.</li>
</ul>
<p>ii)distribution: this is the transport of a drug in body fluids to various tissues of the body and ultimately site of action.</p>
<p>The rate of distribution depends on;</p>
<ul>
<li>The permeability of the capillary to the drug.</li>
<li>Lipid solubility and ionization of the drug. lipid soluble drugs are more rapidly absorbed and distributed than their lipid insoluble drugs</li>
<li>Cardiac function e.g. cardiac out put and regional blood, drug are fast distributed to areas with rich blood flow(Heart, kidneys, brain) later to areas of low blood flow (muscle, fat tissue).</li>
</ul>
<p>Conti.</p>
<ul>
<li>Drugs are widely distributed in body water (free fraction of drug)and partly as bound to plasma proteins and or tissues.</li>
<li>Plasma protein and tissue binding of drug reservoirs that sustain pharmacological action of a drug. The bound fraction and the free fraction are usually in a state of equilibrium</li>
<li>other proteins involved in drug binding include; lipoproteins, glycoprotein and globulins.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Biological membranes which limit the distribution of drugs</p>
<ul>
<li>Blood brain barrier: allows distribution of only lipid soluble drugs e.g. general anesthetics, barbiturates into the brain and spinal cord.</li>
<li>Placenta barrier: lipid soluble and some lipid insoluble can diffuse through hence some drug meant for the mother may pass through and harm the baby e.g. steroids ,narcotis and anaesthetics.</li>
<li>Blood-testes barrier: this may limit some chemotherapeutic agents used for treating testicular neoplasms.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>metabolism</p>
<p>iii)metabolism/biotransformation:</p>
<p>the biological transformation of a drug into an inactive metabolite, a more soluble compound ,or a more potent metabolite.</p>
<p>The Liver is the main organ of metabolism.</p>
<p>The Kidneys, gut mucosa, lungs and the skin are also involved in drug metabolism.</p>
<p>NB: Delayed drug metabolism results in accumulation of drug in the body and prolonged effect of the drug</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="factors-influencing-metabolism">Factors influencing metabolism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-influencing-metabolism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Physiological factors like starvation, liver diseases, cardiovascular problems, these depress microsomal enzyme systems.</li>
<li>Age people with extreme ages have decreased metabolism</li>
<li>Genetic predisposition genetic differences in the rate of metabolism of some drugs exist.</li>
<li>Prior administration of the particular drugs or other drugs e.g. repeated administration of a particular drug may cause induction or inhibition</li>
</ul>
<p>Enzyme induction or inhibition</p>
<ul>
<li>enzyme induction this is a situation whereby the re is an increase in amount and activity of the liver microsomal enzymes usually due to exposure to certain substances such as drugs and endogenous substances.</li>
<li>A drug may induce its own metabolism</li>
</ul>
<p>pharmacological Importance of enzyme induction</p>
<ol>
<li>Drug interaction may occur.</li>
<li>Disease may result .</li>
<li>Tolerance (metabolic) to the drug.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>conti.</p>
<ul>
<li>Enzyme inhibition this refers to decrease synthesis and activity of liver microsomal enzymes.it results in reduced metabolism of other drugs/inhibiting drug and endogenous substance.</li>
<li>General enzyme inhibition(beyond liver enzymes )has a greater pharmacological importance utility than enzyme induction.</li>
<li>Examples of drugs that inhibit enzymes include chloramphenicol and cimetidine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>excretion</p>
<p>iv) Excretion: this the process by which drugs and pharmacologically active or inactive metabolites are eliminated from he body primarily through the Kidneys.</p>
<p>Net renal excretion of a drug is as a result of 3 processes</p>
<ol>
<li>
<p>filtration (passive glomerular filtration)</p>
</li>
<li>
<p>re-absorption,</p>
</li>
<li>
<p>active tubular secretion.</p>
</li>
</ol>
<p>other routes through which drugs are eliminated include</p>
<p>intestines or biliary excretion e.g. neomycin</p>
<p>Pulmonary elimination e.g. volatile liquids (general anaesthetics)</p>
<p>Sweat and saliva elimination e.g. thiazides.</p>
<p>Breast milk elimination e.g. narcotics.</p>
<p>Pharmacodynamics/mechanism of action</p>
<p>The study of how drugs act on the body. It is the chemical changes or effects that a drug has on body cell and tissues.</p>
<p>â€¢ Drug action: the cellular process involved in the drug and cell interaction.</p>
<p>â€¢ Drug effects: the physiology reaction of the body to the drug.</p>
<p>The common drug molecules (targets) on which drugs bind to produce therapeutic effects include enzymes, carrier molecules, ion channels, and receptors.</p>
<p>â€¢ The receptor : these are proteins that are found within or on the surface of cells</p>
<p>Two terms related to receptors are affinity and efficacy.</p>
<p>â€¢ Efficacy the tendency of a drug to activate the receptor once bound.</p>
<p>â€¢ Affinity the tendency of a drug to bind to the receptor.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-interactions">Drug interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="harmful-interactions">Harmful interactions-<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#harmful-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>-Oral contraceptives and anti TB drugs - contraceptive failure.
-Tetracycline and antacids - cimetidine renders tetracycline ineffective.
-Anticoagulants warfarin and aspirin - may result to bleeding.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="beneficial-drug-interactions">Beneficial drug interactions-<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#beneficial-drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>-Amino glycoside &amp; penicillin's achieve synergic antimicrobial effects
-probenecid plus penicillin prolong action of penicillin..
-Morphine poisoning-naloxone is used as an antidote.</p>
<p>Conti.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="synergism">Synergism<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#synergism" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This can either be</p>
<p>summation- this occurs when the effect of two drugs having the same action are additive e.g. beta blockers plus thiazide diuretics have an additive anti hypertensive effects.</p>
<p>Potentiating- this means to make more powerful, occurs when the action of one drug increases the action of another. e.g trimethoprim plus sulfamethoxazole.</p>
<p>antagonism</p>
<ul>
<li>Agonist- drug binds to a receptor there is a response.</li>
<li>Antagonist-drug binds to a receptor-no response, prevents binding of agonist(alpha and beta blockers)</li>
<li>Partial agonist-a drug that is able to both stimulate and block at receptor.</li>
<li>Antagonism- occurs when two or more drugs oppose the action of one another producing opposite pharmacodynamic effects e.g.</li>
</ul>
<p>Antacids and tetracycline form a complex which is excreted in feaces chemical antagonism.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="administration-of-medication">Administration of medication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#administration-of-medication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administration of medication involves all the activities related to safe drug use which are the nursing responsibilities.</li>
</ul>
<ol>
<li>Assessing the risk to a client of a new drug order.</li>
<li>Delivering the drug dose to the proper body tissues.</li>
<li>Assessing the client's response to drug therapy.</li>
<li>Treatment of adverse reactions to drugs.</li>
<li>Consulting with the doctor about adjusting the prescribed regime.</li>
<li>Educating the client about proper use of drugs substances.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="principles-of-drug-administration">Principles of drug administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-drug-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>For a Nurse administration of medication is an important responsibility.to avoid errors a nurse must adhere to the principles of drug administration.</li>
<li>To provide safe administration of drugs a nurse should practice the rights of drug administration. they are</li>
</ul>
<ol>
<li>Right patient.</li>
<li>Right drug.</li>
<li>Right dose.</li>
<li>Right time.</li>
<li>Right route.</li>
</ol>
<p>conti.</p>
<p>Five additional right are essential in professional nursing practice. they are</p>
<ol>
<li>
<p>The right assessment e.g. patients ability to swallow, allergies, contraindication, new signs and symptoms that may indicate adverse effects of administration, heart, liver or kidney disorders.</p>
</li>
<li>
<p>The right documentation.</p>
</li>
<li>
<p>The clients right to information of name, purpose, action and potential side effects.</p>
</li>
<li>
<p>The right evaluation.</p>
</li>
<li>
<p>The clients right to refuse medication regardless of the consequences.</p>
</li>
</ol>
<p>Conti.</p>
<ul>
<li>Right client/patient:</li>
</ul>
<p>-You should make sure that the right client receives the right drug.</p>
<p>-You should only give drugs to the person for whom they are prescribed or recommended for.</p>
<p>-If the patient is wearing an identification bracelet, check the clients name on the identification bracelet with the name, hospital number on the medication card in your hand.</p>
<p>-Alternatively if the patient is conscious and sane simply call out the patients name.</p>
<p>Conti.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="right-drug">Right drug<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#right-drug" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>â€¢ You must check and double check the package label , the cardex and the medication card or sheet.</p>
<p>â€¢ The right drug label should be read at list three times;</p>
<p>-before removing the drug from the cupboard.</p>
<p>-Before preparing or measuring the actual prescribed does.</p>
<p>-Before replacing the drug on the shelf just before administering the drug to the client.</p>
<p>â€¢ You must prepare the medication you give yourself and DO NOT giver drugs prepared by someone else.</p>
<p>â€¢ You should recheck the order, label and the medication card if a client questions the medication.</p>
<p>A Mentally alert person will notice a change in medication or mention problems that have arisen from the medication.</p>
<p>ensure that you take the following precaution when administering medicine.</p>
<ol>
<li>
<p>All doses are best prepared from the original container.</p>
</li>
<li>
<p>Medicines should not be prepared in the dark</p>
</li>
<li>
<p>You should caution clients about the use of non-labelled pillboxes</p>
</li>
<li>
<p>Do not mix supplies of several tablets or capsules in a single container</p>
</li>
<li>
<p>make sure you check medication label before removing from the shelf before pouring or measuring and when returning to the shelf.</p>
</li>
</ol>
<p>right dose:</p>
<p>-to obtain the right dose you must carefully measure the medicine.</p>
<p>-when pouring solid drugs such as capsules and tablets use proper technique to avoid contaminating the drugs. you should pour the medication in the container cap, and transfer the number of units required from the cap to the medication cup</p>
<p>-if a half a tablet is required a scored tablet may be cut into two pieces with a knife-edge or folded in a clean paper and broken with the fingers. this procedure is easiest with large tablets.</p>
<p>-for small tablets which provide little leverage for fingers ,should be cut with a knife.</p>
<p>-DO NOT ATTEMPT to split NON-SCORED tablets or to divide a dose of a single capsule.</p>
<p>-when you split tablets, give the two halves in successive doses so that any deviation from the prescribed dose due to uneven breakage is levelled out as quickly as possible.</p>
<p>-DO NOT break all the tablets available and mix the halves.</p>
<p>Liquids should be measured with a scale that provides a mark for the required dose e.g. plastic glasses or spoons.</p>
<p>Dosage calculation use the (WIG) calculation; what you want multiply by what's in and divide by what you got equal to amount to give.</p>
<p>Right route:</p>
<p>â€¢ The right route must be used for drug delivery.</p>
<p>â€¢ Most drugs are given orally or by topical application .</p>
<p>â€¢ Ensure the patient understands how the drug is to be taken.</p>
<p>â€¢ sub lingual or chewable tablets should NOT BE swallowed whole.</p>
<p>â€¢ Crush oral drugs if swallowing is difficult or if they are to be taken in liquid form.</p>
<p>â€¢ Demonstrate to the patient the procedures for application of topical drugs.</p>
<p>â€¢ Always check the doctors orders ,the cardex and the treatment sheet to verify the medication route.</p>
<p>Alert the doctor if the route is not in accord with which is recommended for the drug preparation.</p>
<p>Right time:</p>
<ul>
<li>Under normal circumstances the right time for drug administration Is not indicated by the doctor. The doctor only indicates the number of times a drug is to be given.</li>
<li>For example;</li>
</ul>
<p>The hourly interval between doses</p>
<p>The relationship of dose to the clients activity ,such as before or after meals, on rising or retiring, every 4hours, hour, 12 hours.</p>
<p>Patients with poor time orientation, short term memory defects or distracting activity schedule need some systems for guiding them in self medication.</p>
<ul>
<li>Most hospitals have set up routines for intervals and times for medication</li>
<li>Nonetheless you must be familiar with times for medications and the appropriate times for administering them.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>medication in children</p>
<p>Take great care when administering drugs in children;</p>
<p>â€¢ There is high risk of errors due to changes in weight and age.</p>
<p>â€¢ Most drugs have not been tested in children.</p>
<p>â€¢ Many drugs are marked in dosage forms and concentration suitable for adults. Therefore this requires dilution, calculation preparation and administration of very small doses.</p>
<p>â€¢ Children have limited sites for IV (intravenous)administration ,several drugs may be given through the same site.</p>
<p>â€¢ This increases the need for small volumes of fluid and flushing between sites.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-errors">medication errors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-errors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Wrong client</li>
<li>Wrong route</li>
<li>Wrong medication or IV fluids</li>
<li>Wrong dose or IV rate</li>
<li>Omission of dose</li>
<li>Incorrect discontinuation of treatment.</li>
</ul>
<p>drug records</p>
<p>â€¢ Every health institution has its own records for drug accountability,</p>
<p>these are;</p>
<ol>
<li>
<p>patients drug order card/treatment sheet</p>
</li>
<li>
<p>Antibiotic register oral and injectables this has, stock at hand, drugs received from pharmacy, drug issued to patients, date and time issued, signature of the dispensing nurse. this book is balanced at he end of each page.</p>
</li>
<li>
<p>Handing over register for the purpose of handing over drug during each shift.</p>
</li>
<li>
<p>Requisition register for ordering drugs from pharmacy should always be accompanied by the drug register.</p>
</li>
</ol>
<p>drug storage</p>
<ul>
<li>Many factors can change your medication including heat, .air , light, and moisture. This will infective or even harmful.</li>
<li>Drugs require careful storage and handling to maintain their safety and potency.</li>
<li>Every medication has its owner recommended storage condition from room temperature, refrigeration and freezing thus check the specific storage condition.</li>
<li>They must be kept in special spaces secured from access by unauthorized persons.</li>
<li>Storage areas should be kept clean, cool, and dry with no direct sun light.</li>
<li>Drugs should not be placed on the floor.</li>
<li>Sterile substances should be protected from contamination.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Drugs are best kept in their original containers. original containers protect their content.</p>
<ul>
<li>Do not transfer sterile substances from container to container as it increases the probability of contamination. Protect the label from soiling to ensure it remains legible.</li>
<li>Drugs should only be labeled in pharmacy.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Stock control;</p>
<p>This is done by use of a medication stock sheet for each drug .</p>
<p>Content of the sheet is the</p>
<p>-name of the drug</p>
<p>-date and time</p>
<p>-quantity stock</p>
<p>-quantity received</p>
<p>-quantity used</p>
<p>-quantity discarded</p>
<p>-Expiary date.</p>
<p>Use FEFO (first expiry first out) when arranging and issuing drugs , for drugs with the same expiry date use FIFO (first in first out)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-drugs">Classification of drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Classification systems enable us to readily identify the similarities and differences among a large number of medications within or outside a classification.
Drugs can be classified according to;</p>
<ol>
<li>
<p>Body systems as follows;
-Respiratory medications
-Cardiovascular system medications
-Nervous system medications
-GIT medications</p>
</li>
<li>
<p>Their functions or use e.g.
-antidepressant
-diuretics
-analgesics
-antibiotics
3.Their chemical make up
-estrogens
-opioids</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antibiotics-anti-infective-agents">antibiotics/anti- infective agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antibiotics-anti-infective-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antibiotics are among the most commonly used and misused of all drugs.</li>
<li>The inevitable consequence of their widespread use has been the emergence of antibiotic-resistance pathogens.</li>
<li>There different groups of antibacterial agents based on molecular structure and members of each group have a comparable pharmacokinetic and pharmacodynamics.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-antibiotics">Classification of antibiotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-antibiotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Beta- lactam antibiotics</li>
<li>tetracycline</li>
<li>Aminoglycoside</li>
<li>Macrolides</li>
<li>Quinolones</li>
<li>Azoles</li>
<li>Antimycobacterial</li>
<li>Sulphonemides</li>
<li>lincosamides</li>
<li>Unclassified antibiotics like chloramphenicol, spectinomycin and vancomycin</li>
</ul>
<p>Beta â€“lactam antibiotics</p>
<p>All beta â€“lactam compounds ,so named because of their unique four membered lactam ring as a basic chemical structure.</p>
<p>They are sub divided in to</p>
<p>â€¢ Penicillin</p>
<p>â€¢ Cephalosporins</p>
<p>â€¢ Others e.g. carbapenems and monobactams</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="penicillins">penicillins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#penicillins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification-of-penicillins">Classification of penicillins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-penicillins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Narrow spectrum e.g. benzyl penicillin, phenoxy methyl penicillin, penethicillin.</li>
<li>Antistaphylococcal penicillin also called beta-lactamase resistant penicillin, or penicillinase resistant penicillin's e.g. nafcillin, cloxacillin, flucloxacillin, methicillin.</li>
<li>Broad spectrum penicillin e.g. ampicillin, amoxicillin, bacampicillin</li>
<li>Antipseudomonal (extended spectrum penicillin) e.g. carbecillin, carfecillin, ticarcillin, temocillin.</li>
</ul>
<p>Mechanism of action</p>
<ul>
<li>All beta lactam anti biotics inhibit bacteria cell wall synthesis.</li>
<li>By inactivating enzymes located in the bacteria cell membrane .</li>
<li>They are bactericidal agents acting against multiplying bacteria (diving cells) as resting bacteria do not make new cell walls.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Mechanism of bacterial resistance</p>
<p>general mechanism of bacteria resistance to antibiotics including beta â€“lactams are;</p>
<ol>
<li>
<p>Decreased penetration to the target cells</p>
</li>
<li>
<p>Alteration of the target site</p>
</li>
<li>
<p>Inactivation of the antibiotics by a bacterial enzyme e.g. beta â€“lactamase.</p>
</li>
</ol>
<p>pharmacokinetics</p>
<ul>
<li>Benzylpenicillin is destroyed by gastric acid hence it is parenterally administered.</li>
<li>Phenoxymethylpenicillin can be orally given.</li>
<li>Metabolism is in the liver.</li>
<li>Half life less than 2hours.</li>
<li>poor lipid solubility hence they donâ€™t cross the BBB.</li>
<li>distribution in body fluids and tissues with a few exception. they are polar hence extracellular concentrations exceed he intracellular.</li>
<li>Elimination in the kidneys by glomerular filtration and tubular secretion.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="benzyl-penicillin-g">Benzyl penicillin G<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#benzyl-penicillin-g" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Penicillin G is gastric acid unstable is used where high plasma concentration era required.</li>
<li>Maximum plasma concentration is reached after 15 minute of administration</li>
<li>Half life 0.5 hours hence reasonably spaced doses have to be large to maintain a therapeutic concentration high doses can be maintained by use of probenecid.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indication-for-penicillin-g">Indication for penicillin G<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication-for-penicillin-g" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>It is generally active against gram positive and gram negative cocci, hence indicated for treatment of conditions such as;</p>
<ul>
<li>Otitis media</li>
<li>Gonococcus infection</li>
<li>Throat infections</li>
<li>Streptococcal endocarditis</li>
<li>Meningococcal meningitis</li>
<li>Pneumonia meningitis</li>
<li>actinomycosis</li>
</ul>
<p>cloxacillin</p>
<ul>
<li>half live is 30 minutes</li>
</ul>
<p>indication for infections due to penicillinase (enzyme against penicillin) producing staphylococci especially skin infections and soft tissue infections e.g. cellulitis, otitis externa, impetigo</p>
<p>Dosage; Adults by oral 500mg every 6 hours at least 30 minutes before meals because food decreases absorption.</p>
<p>IM 250mg every 4-6 hours.</p>
<p>IV injection or infusion 500mg every 4-6 hours .</p>
<p>The dose may be increased in severe infections.</p>
<ul>
<li>A child less than 2 years should get <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi mathvariant="normal">/</mi><mn>4</mn></mrow><annotation encoding="application/x-tex">1 / 4</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/4</span></span></span></span></span> of adult dose.</li>
<li>Children 2-10 years should receive <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1</mn><mi mathvariant="normal">/</mi><mn>2</mn></mrow><annotation encoding="application/x-tex">1 / 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/2</span></span></span></span></span> of adult dose.</li>
</ul>
<p>Ampicillin</p>
<ul>
<li>Is gastric stable, it is moderately 50 % absorbed orally as food interferes with absorption..</li>
<li>The drug is concentrated in the bile and it under goes enteral hepatic recycling.</li>
<li>Excretion is through the kidneys 1/3 of the administered drug appears unchanged in urine.</li>
<li>Almost all staphylococcus aureus ,50% of E.coli, and 50% of haemophilus influenza are now resistant .</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications">Indications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Urinary tract infections.</li>
<li>Sinusitis .</li>
<li>Chronic bronchitis.</li>
<li>Invasive salmonellosis gonorrhea</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="side-effects">Side effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Diarrhea is quiet common, nausea
Macular rashes resembling measles/rubella - discontinue treatment</p>
<p>Dosage</p>
<p>â€¢ Adults oral 0.25 to 1g 6 hourly at least 30 minutes before food.</p>
<p>â€¢ Different dose are used in treating different condition.</p>
<p>â€¢ Gonorrhea 2-3g is administered as a single dose with probenecid.</p>
<p>â€¢ UTI :500mg every 8 hours IM/IV/infusion.</p>
<p>â€¢ Children under age 10 years give half the adult dose.</p>
<p>amoxicillin</p>
<ul>
<li>This is a broad spectrum penicillin.</li>
<li>A derivative of ampicillin and differs by only one hydroxyl (OH) group.</li>
<li>Have similar anti bacteria spectrum as ampicillin.</li>
<li>when given orally absorption is better than ampicillin.</li>
<li>Absorption is not affected by food in the stomach.</li>
<li>Half life is 1 hourâ€™</li>
</ul>
<p>Indication</p>
<ul>
<li>UTI, otitis media, sinusitis, chronic bronchitis, inversive salmonellosis and gonorrhea.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>dosage</p>
<ul>
<li>Adult dose orally 250mgs 8 hourly which can be doubled in severe infections.</li>
<li>Children up to 10 years of age get 125mg 8 hourly this is doubled in severe infections.</li>
<li>IM/IV adults 500 mg 8 hourly.</li>
<li>IM/IV children get 50-100mg /kg daily in divided doses.</li>
</ul>
<p>Side effects</p>
<p>Diarrhea is less frequent with the use of amoxicillin than ampicillin</p>
<p>co- amoxiclav</p>
<ul>
<li>Amoxicillin ( 250mg or 500mg )can be combined with clavulanic acid (125mg) to make co- amoxiclav.</li>
<li>clavulanic acid itself has no significant anti bacteria activity but binds to beta-lactamase and there by competitively inhibits its activity hence protecting the penicillin. This potentiate the action of penicillin.</li>
</ul>
<p>Indication</p>
<p>Active against beta-lactamase producing bacteria that are resistant to amoxicillin which include; staphylococcus aureus, 50% of E-coli, 15% of H. influenzae strains and klebsiella spp,</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-effect-of-penicillin-s">adverse effect of penicillin's<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-effect-of-penicillin-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>1gE -mediated allergic reactions.</li>
<li>serum sickness.</li>
<li>Dermatological reactions e.g. eryema multiforme ,steven johsons syndrome and exfoliative dermatitis.</li>
<li>Neurologic reactions.</li>
<li>Gastrointestinal reactions.</li>
<li>Hepatobiliary reaction.</li>
<li>Renal reactions.</li>
</ul>
<ul>
<li>
<p>Nursing Administration</p>
<ul>
<li>
<p>Instruct clients that penicillin V, amoxicillin, and amoxicillin-clavulanate may be taken with meals. All others should be taken with a full glass of water 1 hours before meals or 2 hours after.</p>
</li>
<li>
<p>Instruct clients to report any signs of an allergic response such as skin rash, itching, and/or hives.</p>
</li>
<li>
<p>IM injection should be done cautiously to avoid injection into a nerve or an artery.</p>
</li>
<li>
<p>Advise clients to complete the entire course of therapy regardless of presence of absence of symptoms.</p>
</li>
</ul>
</li>
</ul>
<p>cephalosporins are the most frequently prescribed class of antibiotics.</p>
<ul>
<li>They are structurally and pharmacologically related to the penicillins. they have a wider spectrum of activity than penicillins hence they are more expensive.</li>
</ul>
<p>mechanisms of action</p>
<ul>
<li>They are bactericidal, interfere with the bacterial cell wall synthesis.</li>
</ul>
<p>Classification of cephalosporins</p>
<ul>
<li>They are grouped in â€œgenerationsâ€ based on their spectrum of antimicrobial activity.</li>
<li>The first cephalosporins were designated first generation while later, more extended generation cephalosporins.</li>
<li>Each newer generation of cephalosporins has a significantly greater gram negative antimicrobial properties than the preceding generation, in most cases with decreased activity against gram positive organism.</li>
<li>The newer agents have a much longer half life resulting in the decreased of dosing frequency.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>first generation cephalosporins</p>
<ul>
<li>These are generally active against gram positive bacteria. They have moderate activity against gram negative bacterial.</li>
<li>They include;</li>
<li>cephalexin.</li>
<li>Cephaloridine</li>
<li>Cephalothin</li>
<li>Cephapirin</li>
<li>Cefazolin</li>
<li>Cephradine</li>
<li>Cefadroxil.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>second generation cephalosporin</p>
<ul>
<li>They have a greater gram-negative spectrum eg H.influenza n. gonorrhea, E.coli, shigella.</li>
<li>Also some gram-positive organism e.g. clostridium, staphylococcus, streptococcus and pneumococcus.</li>
<li>they are more resistant to beta lactamase.</li>
</ul>
<p>Indication</p>
<ul>
<li>Upper and lower respiratory tract infection</li>
<li>Sinusitis</li>
<li>Otitis media</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Third generation cephalosporins</p>
<ul>
<li>They are especially better than SECOND AND FIRST generation cephalosporin against gram negative bacteria.</li>
<li>These are;</li>
<li>Cefriaxone</li>
<li>Cefperazone</li>
<li>Cefotaxime</li>
<li>Ceftazidine</li>
<li>Cefodizime</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Fourth generation cephalosporin</p>
<ul>
<li>These drugs are very good against both gram positive and gram negative bacteria</li>
<li>Examples ;</li>
<li>Cefepime</li>
<li>Cefditoren and loracarbef.</li>
</ul>
<p>Pharmacokinetic of cephalosporins</p>
<p>Usually given parenterally, though few may be given orally e.g.</p>
<p>cephalexin</p>
<p>cephradine</p>
<p>cefadroxil</p>
<p>Distribution- Wide distribution because of lipid solubility.</p>
<p>Metabolism- in the liver with half life of 1-4 hours.</p>
<p>Excretion- excreted unchanged in urine especially tubular secretion.</p>
<p>â€¢ Dosage should be reduced for patients with renal impairment.</p>
<p>â€¢ Active excretion in the kidneys can be blocked by probenecid.</p>
<p>Indication; Septicemia, Pneumonia, Meningitis, Biliary tract infection, Peritonitis, Urinary tract infection, sinusitis</p>
<p>Unwanted effects of cephalosporins</p>
<ul>
<li>Hypersensitivity is the most common</li>
</ul>
<p>10% of the patients sensitive to penicillin are sensitive to cephalosporin.</p>
<ul>
<li>
<p>Hemorrhage due to interference with blood clotting factors.</p>
</li>
<li>
<p>Use of cephalosporin for more than two weeks causes thrombocytopenia, neutropenia, interstitial nephritis and abnormal liver function tests.</p>
</li>
</ul>
<p>Drug interactions</p>
<ul>
<li>Cephalosporin with alcohol- disulfiram like effects.</li>
</ul>
<p>Patient should avoid alcohol when taking the drug.</p>
<ul>
<li>
<p>Cephalosporin with high frusemide and torsemide are likely to cause nephrotoxicity.</p>
</li>
<li>
<p>Cephalosporin with aminoglycoside â€“ nephrotoxicity.</p>
</li>
<li>
<p>Cephalosporin with oral anticoagulant like warfarin may cause bleed because both interfere with clotting factors.</p>
</li>
</ul>
<p>Ceftriaxone (Rocephin)</p>
<ul>
<li>Half life 4hours hence requires to be administered once a daily.</li>
</ul>
<p>Indication; Septicemia, Pneumonia, UTI, RTI, soft tissue infections.</p>
<p>Contraindication;</p>
<ul>
<li>penicillin sensitivity</li>
<li>Administer with caution in renal impairment.</li>
<li>Do not administer to infants below 6 weeks.</li>
<li>Cephalosporin hypersensitivity.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<ul>
<li>
<p>Nursing administration</p>
<ul>
<li>
<p>Instruct clients to complete the prescribed course of therapy, even though symptoms may resolve before the full course of antimicrobial treatment is completed.</p>
</li>
<li>
<p>Advise clients to take oral cephalosporins with food.</p>
</li>
<li>
<p>Instruct clients to store oral cephalosporin suspensions in a refrigerator.</p>
</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="tetracyclines">tetracyclines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tetracyclines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>First isolated in 1948, isolated from Streptomyces fungi.</li>
<li>Naturally occurring;
-tetracycline
-chlortetracycline
-oxytetracycline
-demeclocycline
Semi-synthetic
Doxycycline, lymecycline, meclocycline, methacyline, minocycline, rolitetracycline.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Tetracyclines are partially absorbed in the alimentary tract EXCEPT minocycline and doxycycline which have a good absorption.</li>
<li>Absorption is increased in absence of food</li>
<li>antacids and milk decrease absorption as they contain metals like magnesium, calcium, aluminum ,iron which chelate with them.</li>
<li>Distribution is narrow but they cross the placenta barrier.</li>
<li>Metabolism is in the liver</li>
<li>Excretion in urine via glomerular filtration unchanged.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacodynamics">pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Tetracyclines are broad spectrum bacteriostatic.</li>
<li>They inhibit protein synthesis by binding to the 30s sub unit of the bacterial ribosomes.</li>
<li>Indication; psittacosis, pneumonia, brucellosis, shigellosis, rickettsia diseases e.g. Q fever, typhus, cholera, borrelia ( lame disease, relapsing fever)acne ,amoebic dysentery, spirochetes, protozoa, bacillary dysentery and chlamydia infections</li>
</ul>
<p>aminoglycosides</p>
<p>Examples;</p>
<p>Gentamycin, kanamycin, amikacin, tobramycin, streptomycin, neomycin,</p>
<p>They are always used in combination of beta lactam antibiotic because of their synergism effect.</p>
<p>pharmacokinetics; they are water soluble hence hey not absorbed through the gut .</p>
<p>They are given IM/IV route</p>
<p>distribution; narrowly distributed hence do not cross the blood brain barrier.</p>
<p>Pharmacodynamics/mechanism of action</p>
<ul>
<li>they are bactericidal act by binding to the 30s ribosomal sub unit and they inhibit bacterial protein synthesis.</li>
<li>Drug interaction;</li>
<li>-muscle weakness or paralysis when given with neural muscular blocking agent.</li>
<li>Ototoxicity when given with ototoxic agent.</li>
<li>Synergic effect when give with beta lactam antibiotic .</li>
<li>Bone marrow depression when give with bone marrow depressing agents.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Unwanted effects</p>
<ul>
<li>Have serious un wanted effects and that are dose dependent</li>
</ul>
<p>these are; nausea, vomiting, diarrhea , lethargy, hypersensitivity and headache.</p>
<p>Others are ,nephrotoxicity, ,ototoxicity, bone marrow depression, neuromuscular blockade, palpitation, numbness, tingling sensation, depression and disorientation.</p>
<p>Contraindication</p>
<ul>
<li>Patients with hearing deficit because thy damage the 8^{th} cranial nerve(vestibular cochlear/auditory nerve)</li>
<li>Myasthenia gravis since they cause neural muscular blockade.</li>
<li>Patients with severe renal disease as they are nephrotoxic</li>
<li>Hypersensitivity</li>
<li>Neonates, geriantrics, infant, botulism and patients with packinsonism</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Gentamycin</p>
<ul>
<li>This is the most active aminoglycoside.</li>
<li>Half life 2-3 hours and reaches peak plasma concentration within 30 minute.</li>
<li>route of administration IM/IV.</li>
<li>indication gram negative and gram positive; septicemia, meningitis, endocarditis, UTI, neonatal sepsis and acute pyelonephritis among other infections.</li>
</ul>
<p>Contraindications; is like for the other aminoglycoside.</p>
<p>dosage adults GIVE 2-5 MG/kg body weight daily 8hrly for 7 days. Reduce the dose in renal impairment and the elderly.</p>
<p>Children below 2wks 3mgs/kg body weight every 12 hours.</p>
<p>Those aged 2wks-12years 2mg/kg every 8 hourly.</p>
<p>Aminoglycoside can replace penicillin in penicillin sensitive patients</p>
<ul>
<li>
<p>Gentamycin combine with penicillin have a synergic antibiotic effect expands the spectrum of antibiotics activity and prevent emergence of resistance..</p>
</li>
<li>
<p>Neomycin and kanamycin can be used for hepatic coma to reduce normal flora and therefore ammonia gas formation.</p>
</li>
<li>
<p>Amikacin has broadest antibacterial spectrum because it is stable to 8 of the 9 classified aminoglycoside inactivating enzymes whereas gentamycin is inactivated by five of them.</p>
</li>
<li>
<p>Amikacin is indicated for serious gram negative infections resistant to gentamycin.</p>
</li>
<li>
<p>Neomycin and framycetin are too toxic for systemic use hence used topically for treatment of aer, nose and skin infections,</p>
</li>
<li></li>
</ul>
<p>quinolones</p>
<ul>
<li>these are broad spectrum antibiotic though some like nalidixic acid and cinoxacin have a narrow antibacterial spectrum.</li>
</ul>
<p>other newer quinolones include</p>
<p>norfloxacin</p>
<p>Ciprofloxacin</p>
<p>Ofloxacin</p>
<p>Levofloxacin</p>
<p>Acrofloxacin</p>
<p>pefloxacin</p>
<p>Pharmacodynamics</p>
<ul>
<li>They are act by inhibiting bacterial DNA gyrase the enzyme that maintains the Helical twist/structure of the DNA.</li>
<li>They are bactericidal but some are bacteriostatic</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Pharmacokinetics</p>
<ul>
<li>
<p>Quinolones are absorbed in the gut though aluminum and magnesium antacid interfere with the absorption.</p>
</li>
<li>
<p>Distribution wide distribution such that they cross the placenta and are distributed in breast milk.</p>
</li>
<li>
<p>They are concentrated in the lungs, kidneys, prostate, and phagocytes.</p>
</li>
<li>
<p>They donâ€™t cross the BBB except ofloxacin and pefloxacin.</p>
</li>
<li>
<p>Metabolism they under go hepatic metabolism with a variable half life</p>
</li>
<li>
<p>Norfloxacin and ciprofloxacin half life of 2-3 hours, 5 hour ofloxacin, perfloxacin10 hour.</p>
</li>
<li>
<p>Excretion/elimination via renal and biliary.</p>
</li>
<li></li>
</ul>
<p>Adverse effects</p>
<p>â€¢ GIT effects like nausea, vomiting, and diarrhea</p>
<p>â€¢ CNS effects like dizziness, headache, confusion and convulsions.</p>
<p>â€¢ Allergic reactions in form of skin rashes,</p>
<p>They are reported to cause arthropathy in immature animals hence not recommended for children and adolescence unless the benefit out ways the risk.</p>
<p>â€¢ Photosensitivity</p>
<p>â€¢ Bone marrow suppression.</p>
<p>contraindication</p>
<ul>
<li>History of epilepsy or seizures.</li>
<li>Glucose-7-phosphatedehydrogenase deficiency.</li>
<li>Myasthenia gravis.</li>
<li>Pregnancy and breast feeding.</li>
</ul>
<p>Indication; quinolones are basically indicated for UTI ciprofloxacin has a broader spectrum of antibacterial activity.</p>
<p>These are often caused by gram negative organisms like E.coli, proteus spp. Therefore infections like complicated UTI, inversive otitis externa, salmonella typhi infection, gonorrhea, bacteria prostatitis and cervicitis.</p>
<p>They are also indicated for anthrax which has been used as a biological warfare.</p>
<p>So the soldiers can take quinolones just before they go to war just in case they are at risk of exposure to anthrax.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="drug-interactions">drug interactions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#drug-interactions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>These antibiotics are enzyme (cytochrome p-450) inhibitor hence interact with other drugs at metabolism e.g. theophylline, warfarin, and caffeine.</li>
<li>NSAIDS and quinolones causes an increase in the risk of convulsion.</li>
<li>NSAIDS tends to potentiate the effect.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ciprofloxacin">ciprofloxacin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ciprofloxacin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>half life is 3hours</li>
<li>It is mostly effective against gram negative bacteria e.g. salmonella, shigella, Campylobacter, pseudomonas, enterobacteria.</li>
<li>It is indicated for chlamydia and some mycobacteria</li>
</ul>
<p>Indication UTI and genital urinary tract infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="dosage">Dosage<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Oral 250-750mg bd.</li>
<li>IV infusion (30-60) 200-400mg twice daily.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>Cationic compounds (aluminum-magnesium antacids, iron salts, sucralfate, milk and dairy products) decrease absorption of ciprofloxacin;</li>
</ul>
<p>Administer cationic compounds 6 hrs. before or 2 hrs after ciprofloxacin</p>
<ul>
<li>Plasma levels of theophylline can be the increased with concurrent use of ciprofloxacin;</li>
</ul>
<p>Monitor levels and adjust dosage accordingly.</p>
<ul>
<li>Plasma levels of warfarin can be increased with concurrent use of ciprofloxacin;</li>
</ul>
<p>Monitor prothrombin time and INR, and adjust the dosage of warfarin accordingly.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="administration">Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Ciprofloxacin is available in oral and intravenous forms.</li>
<li>Decrease doses of ciprofloxacin in clients with renal dysfunction.</li>
<li>Intravenous ciprofloxacin should be administered slowly over 60 min.</li>
<li>For inhalation anthrax infection, ciprofloxacin is administered every 12 hrs for 60 days.</li>
<li>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</li>
</ul>
<p>MACROLIDES</p>
<ul>
<li>These broad spectrum antimicrobials including;</li>
<li>Erythromycin</li>
<li>Azithromycin</li>
<li>Spiramycin</li>
<li>Clarithromycin</li>
</ul>
<p>Pharmacodynamics; they inhibit protein synthesis by irreversibly binding to ribosomal 50s sub unit of the sensitive micro-organism hence they are bacteriostatic.</p>
<p>But sometimes can be bactericidal if the dose is high.</p>
<p>Example azithromycin is bactericidal against streptococcus pyogenes, streptococcus pneumonia and hemophilus influenza</p>
<p>pharmacokinetics</p>
<ul>
<li>They can be administered orally though erythromycin is unstable in acidic environment.</li>
<li>Distribution is good except that the drugs do not cross the BBB</li>
<li>Metabolism is in the liver and have variable half life.</li>
</ul>
<p>E.g. clarithromycin has4.5 hours , azithromycin less than 3.5 hours and erythromycin has1.4 to 2 hours.</p>
<ul>
<li>
<ul>
<li><strong>Therapeutic Uses/indication</strong></li>
</ul>
</li>
</ul>
<ul>
<li>Used to treat infections in <strong>clients with a penicillin allergy</strong>, such as for <strong>prophylaxis against rheumatic fever</strong> and <strong>bacterial endocarditis</strong>.</li>
<li>Used for clients <strong>with Legionnairesâ€™ disease, whooping cough</strong> (pertussis), <strong>and acute diphtheria</strong> (eliminates the carrier state of diphtheria) .</li>
<li>Used for chlamydia infections (<strong>urethritis and cervicitis; pneumonia</strong> caused by Mycoplasma pneumoniae**; respiratory tract infections** caused by <strong>Streptococcus pneumoniae and Neisseria gonorrhea.</strong></li>
</ul>
<p>Complications /Side/Adverse Effects; Nursing Interventions/Client Education</p>
<p>Gastrointestinal discomfort</p>
<p>â€¢ (nausea, vomiting, epigastric pain) Administer erythromycin with meals.</p>
<p>â€¢ Observe for GI symptoms and notify the provider.</p>
<p>Hepatotoxicity (abdominal pain, lethargy, jaundice) . Instruct clients to notify the provider because the medication should be discontinued. Prolonged QT interval causing dysrhythmias and possible sudden cardiac death</p>
<p>â€¢ Use in clients with prolonged QT intervals is not recommended.</p>
<p>â€¢ Avoid concurrent use with medications that affect hepatic drug metabolizing enzymes.</p>
<p>Contraindications/Precautions.</p>
<p>â€¢ pre-existing liver disease</p>
<p>erythromycin</p>
<p>â€¢ Erythromycin is the commonest macrolide in use.</p>
<p>Pharmacokinetic;</p>
<p>Erythromycin is inactivated by gastric enzymes hence it is administered as protected enteric coated tablets.</p>
<p>It is hydrolyzed in the 1^{st} phase metabolism to release the active erythromycin.</p>
<p>It is dissolved and absorbed in the small intestines where it undergoes enetro hepatic recirculation.</p>
<p>â€¢ Distribution is very good as it is well distributed in the spleen, liver, placenta, breast milk and inflamed meninges.</p>
<p>â€¢ Excretion 90% in feaces and small amounts in urine.</p>
<p>Dosage and route of administration</p>
<ul>
<li>Orally adults and children above 8years 250-500mg 6 hourly.</li>
<li>Maximum dose is 4g in severe infections.</li>
<li>Children up to 2years 125mg 6hourly.</li>
<li>IV infusion 25-50/kg body wt. daily as continuous infusion.</li>
</ul>
<p>Drug interaction</p>
<p>Macrolides are enzyme inhibitor and they interfere with the metabolism of drugs like warfarin, carbamazepine, theophylline , corticosteroids, oral contraceptives, digoxin, and cyloserine and sodium valproate</p>
<ul>
<li>food tends to decrease the absorption of macrolide, hence should be given one hour before food or 2-3 hours after meals.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Azithromycin</p>
<ul>
<li>azithromycin is derived from erythromycin by adding a methylated nitrogen into the lactogen ring,</li>
<li>Its specrum of activity and clinical uses are virtually identical to those of clarithromycin.</li>
<li>Azithromycin is active against mycobacteria avium complex and toxoplasma gondii</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sulphonamide">sulphonamide<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sulphonamide" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>These are among the first antibacterial drugs to be discovered in 1935.</li>
<li>Examples</li>
<li>Sulphfamethoxazole,</li>
<li>sulphadiazine,</li>
<li>sulfisoxazole,</li>
<li>sulphadimidine,</li>
<li>sulfasazine,</li>
<li>sulfametopyrazine,</li>
<li>sulphaloxate</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>they have good absorption except a few of them sulpadiazine and which are poorly absorbed in the gut.</li>
<li>Distribution widely distributed in body tissues and fluid including crossing the BBB.</li>
<li>They are metabolized in the liver withhalf life of 10 hours.</li>
<li>Majority are excreted in urine hence dose should be reduced in renal impairment.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side and adverse effects</p>
<p>â€¢ Hypersensitivity including Stevens-Johnson syndrome</p>
<ul>
<li>
<p>Do not administer TMP-SMZ to clients with allergies to: Sulfonamides (sulfa), Thiazide diuretics [hydrochlorothiazide (HCTZ)] , Sulfonylurea-type oral hypoglycemics [tolbutamide (Orinase)], Loop diuretics [furosemide (Lasix)]</p>
</li>
<li>
<p>Stop TMP-SMZ at the first indication of hypersensitivity, such as rash.</p>
</li>
</ul>
<p>â€¢ Blood dyscrasias (hemolytic anemia, agranulocytosis, aplastic anemia) â€¢</p>
<p>-Draw the clientâ€™s baseline and periodic CBC levels to detect any hematologic disorders.</p>
<ul>
<li>Observe for any bleeding episodes, sore throat, or pallor. â€¢ If the above symptoms occur, instruct clients to notify the provider.</li>
</ul>
<p>â€¢ Crystalluria</p>
<ul>
<li>
<p>Maintain adequate oral fluid intake.</p>
</li>
<li>
<p>Instruct client to drink 2 to 3 L/day.</p>
</li>
</ul>
<p>â€¢ Kernicterus (jaundice, increased bilirubin levels)</p>
<ul>
<li>
<p>Avoid administering TMP-SMZ to women who are pregnant near term, breastfeeding mothers, and infants younger than 2 months.</p>
</li>
<li>
<p>Monitor the clientâ€™s liver function. Photosensitivity</p>
</li>
<li>
<p>Avoid prolonged exposure to sunlight, use sunscreen, and wear appropriate</p>
</li>
</ul>
<p>cotrimoxazole(sulphonamides 400mg/trimethoprim 80mg) serpin.</p>
<ul>
<li>. This has replaced use of sulphonamide due to resistance.</li>
</ul>
<p>Dosage for children</p>
<ul>
<li>6weeks to 5months 120mg every 12 hours</li>
<li>6months to 5years 240mg 10 hourly</li>
<li>6years to 12 years 480mg 12hourly</li>
</ul>
<p>Indications</p>
<ul>
<li>Pneumocystic carinii pneumonia</li>
<li>Toxoplasmosis</li>
<li>UTI</li>
<li>sometimes chronic bronchitis</li>
<li>Others sulphonamides are used for topical application for prophylaxis of burns, leg ulcers, pressure sores because of their wide anti bacteria spectrum</li>
</ul>
<p>drug Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>
<p>Sulfonamides can increase the effects of warfarin (Coumadin), phenytoin (Dilantin), sulfonylurea oral hypoglycemic, and tolbutamide (Orinase) by inhibiting hepatic metabolism.</p>
</li>
<li>
<p>dosages of these medications may be required during therapy.</p>
</li>
</ul>
<p>Nursing Administration Instruct clients to take the drugs on an empty stomach with a full glass of water. (Plenty of oral fluids)</p>
<ul>
<li>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</li>
</ul>
<p>Nursing Evaluation of Medication Effectiveness</p>
<ul>
<li>Depending on therapeutic intent, effectiveness may be evidenced by: Improvement of infection symptoms, such as improvement of urinary tract symptoms (decreased frequency, burning, and pain during urination) and negative urine cultures</li>
</ul>
<p>AZOLES</p>
<ul>
<li>This includes several classes of drugs e.g. metronidazole and tinidazole which have both anti bacteria and anti protozoal activity.</li>
<li>others are fluconazole, itraconazole econazole, ketoconazole, and miconazole which are anti fungal drugs .( to be covered under anti fungal drugs)</li>
<li>others are mebendazole, thiabendazole, which are anti helminths (to be covered under ant-helminths)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>metronidazole</p>
<ul>
<li>It is very effective against anaerobic bacterial and protozoa.</li>
</ul>
<p>Pharmacodynamics/MOA</p>
<ul>
<li>metronidazole is converted into an active form and bind to the bacterial DNA and prevents nucleic acid formation which consequently interferes with bacterial replication hence its bacteriostatic.</li>
</ul>
<p>Pharmacokinetics;</p>
<p>well absorbed after oral and rectal administration</p>
<p>Distribution is wide.</p>
<p>Metabolism is in the liver.</p>
<p>It is excreted in urine partly unchanged and partly as metabolite.</p>
<p>Half life is 8 hours.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="indications">indications<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indications" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>used for treatment of sepsis caused by orgasms like Bacteroides
and anaerobic cocci.</li>
<li>Intra-abdominal infections</li>
<li>Septicemia, wounds, pelvic infection</li>
<li>Osteomyelitis.</li>
<li>pelvic infections</li>
<li>Infections of the brain and lungs.</li>
<li>Used in prevention of post operative infection especially after bowel, antibiotic related colitis, eg pseudomembranous colitis, amoebiasis EH</li>
<li>other indications include giardiasis, acute ulcers, gingivitis, and dental infections. and anaerobic vaginosis</li>
<li>Treatment of protozoal infections (intestinal amoebiasis, giardiasis, trichomoniasis) and obligate anaerobic bacteria (Bacteroides fragilis, antibiotic-induced Clostridium difficile, Gardnerella vaginalis)</li>
<li>Treatment of H. pylori in clients who have peptic ulcer disease in combination with tetracycline and bismuth salicylate.</li>
</ul>
<p>Dosage and route of administration</p>
<p>Established anaerobe are usually treated for 7 days.</p>
<p>â€¢ The dose per oral is then 8oomgs initially for 3 days then 400mg or 500mg 8 hourly, or just 400mg 8 hourly for 7 days.</p>
<p>â€¢ By rectum 1gm every 8 hours for 3 days then1gm 12 hourly.</p>
<p>â€¢ By infusion 500mg 8 hourly.</p>
<p>â€¢ In children 7.5/kg every 8 hours by any route.</p>
<p>for surgical prophylaxis</p>
<p>â€¢ Per oral 400mg 8 hourly started 24 hours before surgery then continued postoperatively by IV infusion until oral administration can be resumed for 2days</p>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Gastrointestinal discomfort (nausea, vomiting, dry mouth, and metallic taste) Advise clients to observe for symptoms and to notify the provider.</p>
<p>Darkening of urine Advise clients that this is a harmless effect of metronidazole.</p>
<p>CNS symptoms (numbness of extremities, ataxia, and seizures)</p>
<p>Advise clients to notify the provider if symptoms occur.</p>
<p>Stop metronidazole.</p>
<p>Contraindications/Precautions</p>
<ul>
<li>Use cautiously in clients with renal dysfunction to prevent accumulation of toxic levels with prolonged use.</li>
<li>Avoid use during the first trimester of pregnancy and use with caution during the rest of pregnancy because metronidazole can pass through the placenta.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Interactions</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>â€¢ Alcohol causes a disulfiram-like reaction/ Advise clients to avoid alcohol consumption.</p>
<p>Metronidazole inhibits inactivation of warfarin.</p>
<p>â€¢ Monitor prothrombin time and INR, and adjust warfarin dosage accordingly</p>
<p>Nursing Administration</p>
<p>â€¢ Administer by oral or IV route.</p>
<p>â€¢ Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<p>Nursing Evaluation of Medication Effectiveness</p>
<p>â€¢ Depending on therapeutic intent, effectiveness may be evidenced by: Improvement of symptoms (resolution of bloody mucoid diarrhea, formed stools, negative stool results for ameba and Giardia, , decrease or absence of watery vaginal/ urethral discharge, negative blood cultures for anaerobic organisms in the CNS, blood, bones and joints, and soft tissues)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="chloramphenicol">Chloramphenicol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chloramphenicol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>It is soluble in water and poorly soluble in alcohol</li>
<li>Chloramphenicol succinate which is used for parenteral administration is highly water soluble</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>The usual dosage of chloramphenicol is 50-100mg/kg/d.</li>
<li>After oral administration crystalline chloramphenicol is rapidly and completely absorbed.</li>
<li>A 1g oral dose produces blood levels between 10and 15mcg/ml</li>
<li>Chloramphenicol palmitate is a pro drug that is hydrolyzed in the intestine to yield free chloramphenicol.</li>
</ul>
<p>Pharmacodynamic chloramphenicol potent inhibitor of microbial protein synthesis.</p>
<p>It binds to the 50s sub unit of the bacteria ribosome</p>
<p>It is bacteriostatic, broad spectrum against both aerobic and anaerobic gram positive and gram negative bacterial.</p>
<p>clinical uses</p>
<ul>
<li>it is rarely used due to it potential toxicity and bacterial resistance.</li>
<li>Used to treat; serious rickettsia infections such as typhus and rocky mountain spotted fever.</li>
<li>Alternative for beta lactam antibiotics for treatment of meningococcal meningitis and pneumococcal meningitis</li>
<li>Topical eye infections</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Adverse reactions</p>
<p>GIT disturbance nausea, vomiting and diarrhea.</p>
<p>-This rare in children.</p>
<p>-Oral and vaginal candidiasis may occur due to alteration of the normal flora.</p>
<p>Born marrow disturbance</p>
<p>-suppression of the born marrow</p>
<p>-Aplastic anemia it is irreversible and fatal</p>
<p>Toxicity for new born infants:</p>
<ul>
<li>new born infants lack glucuronic acid for the conjugation and detoxification of chloramphenicol.</li>
</ul>
<p>-Therefore drugs may accumulate resulting in gray baby syndrome with vomiting flaccidity, hypothermia, gray colour, shock and collapse</p>
<p>ANTI-FUNGAL DRUGS</p>
<ul>
<li>Fungi are saprophytic organism as they lack chlorophyll which is present in plants.</li>
<li>Many fungi are commensals in the bodies of healthy people but pose a problem when immune system is compromised.</li>
<li>Since 1970s incidence of fungal infections has increased due to the following reasons</li>
</ul>
<ol>
<li>Increase use of broad spectrum antibiotics which decrease non pathogenic bacterial that compete with the fungi.</li>
<li>Increases number of people with immunosuppression, use of cancer chemotherapy, and immunosuppressants, diabetes mellitus or have burns.</li>
<li>Inversive procedures may introduce fungi into systemic circulation.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and non opportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis)</li>
<li>Resistant is usually due to a</li>
</ul>
<p>1.decrease in membrane ergosterol content
2.Or a change in membrane structure</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-of-anti-fungal-drugs">Classification of anti fungal drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-anti-fungal-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Topical anti-fungal</li>
</ol>
<ul>
<li>Polyenes anti-fungal agents e.g. nystatin</li>
<li>Benzoic acid</li>
</ul>
<ol start="2">
<li>Systemic anti fungal</li>
</ol>
<ul>
<li>Polyenes anti-fungal agents e.g. amphotericin B</li>
<li>Fluorinated pyramids e.g. only flu cytosine</li>
<li>Azoles ;imidazole and triazoles
-Imidazole's include clotrimazole and econazole, sulconazole, fenticonazole, ketoconazole, and miconazole
-triazole include fluconazole, itraconazole and voriconazoles among others</li>
</ul>
<ol start="3">
<li>Miscellaneous; terbinafine and Griseofulvin</li>
</ol>
<ul>
<li>
<p>Polyenes anti-fungal agents; nystatin and amphotericin B are the only ones in clinical use.</p>
<ul>
<li>MOA; they act by binding to the ergostel in fungal cell walls forming pores or channels which increase permeability and allow leakage of fungal cellular molecules e.g. potassium and magnesium</li>
</ul>
</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and nonopportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis).</li>
<li>Some antifungals treat superficial fungal infections:</li>
<li>dermatophytic infections (tinea Pedis [ringworm of the foot], tinea cruris [ringworm of the groin]); candida infections of the skin and mucous membranes; and fungal infections of the nails (Onychomycosis).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="amphotericin-b">Amphotericin B<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#amphotericin-b" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Amphotericin B has been available for use since 1950s</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="moa-pharmacodynamics">MOA/PHARMACODYNAMICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#moa-pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Amphotericin B deoxycholate is an antifungal agent that acts on fungal cell membranes to cause cell death.</li>
<li>Depending on concentration, these agents can be fungi static (slows growth on the fungus) or fungicidal (destroys the fungus).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetics">PHARMACOKINETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>administered intravenously</li>
<li>wide distribution though poor penetration to the CNS</li>
<li><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>90</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">90 \%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">90%</span></span></span></span></span> bound to plasma, half life of 24 and 15 days</li>
<li>excretion predominantly via the biliary route(slow excretion over a period of days)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Antifungals are the treatment of choice for systemic fungal infection (Candidiasis, Aspergillosis, Cryptococcosis, Mucormycosis) and nonopportunistic mycoses, (Blastomycosis, Histoplasmosis, Coccidioidomycosis).</li>
</ul>
<p>side/ adverse reactions</p>
<p>Infusion reactions (fever, chills, rigors, and headache) 1 to 3 hr. after initiation</p>
<p>â€¢ Pretreat with diphenhydramine (Benadryl) and acetaminophen.</p>
<p>â€¢ Meperidine (Demerol), Dantrolene, or hydrocortisone may be given for rigors.</p>
<p>Thrombophlebitis Observe infusion sites for signs of erythema, swelling, and pain.</p>
<p>â€¢ Rotate injection sites.</p>
<p>â€¢ Administer in a large vein and administer heparin before infusing amphotericin B</p>
<p>Nephrotoxicity</p>
<p>â€¢ Obtain baseline kidney function (BUN and creatinine) and do weekly kidney function test, Monitor I&amp;O.</p>
<p>â€¢ Infuse 1 L of saline on the day of amphotericin B infusion.</p>
<p>Hypokalemia</p>
<p>â€¢ Monitor electrolyte levels, especially potassium.</p>
<p>â€¢ Administer potassium supplements accordingly.</p>
<p>Bone marrow suppression â€¢ Obtain baseline CBC and hematocrit, and monitor weekly.</p>
<p>ketoconazole</p>
<p>Hepatotoxicity (anorexia, nausea, vomiting, jaundice, dark urine, and clay-colored stools)</p>
<p>â€¢ Obtain baseline liver function studies and monitor liver function monthly.</p>
<p>â€¢ If symptoms occur, notify provider and discontinue medication.</p>
<p>Effects on sex hormones:</p>
<p>â€¢ In males, gynecomastia (enlargement of breast), decreased libido, erectile dysfunction</p>
<p>â€¢ In females, irregular menstrual flow</p>
<p>Advise clients to observe for these symptoms and to notify the provider.</p>
<p>Contraindications/Precautions</p>
<ul>
<li>Antifungals are contraindicated in clients with renal dysfunction because of the risk for nephrotoxicity.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<ul>
<li>Aminoglycosides (gentamicin, streptomycin, cyclosporine) have additive nephrotoxic risk when used concurrently with antifungal medications.</li>
</ul>
<p>Avoid use of these antimicrobials when clients are taking amphotericin B due to additive nephrotoxicity risk.</p>
<ul>
<li>Antifungal effects of Flucytosine (Ancobon) are potentiated with concurrent use of amphotericin B.</li>
</ul>
<p>Potentiating the effects of flucytosine allows for a reduction in amphotericin B dosages.</p>
<p>Nursing Administration</p>
<ul>
<li>Amphotericin B is highly toxic and should be reserved for severe life-threatening fungal infections</li>
</ul>
<p>Systemic infection for mucocutaneous infections</p>
<p>Griseofulvin</p>
<p>â€¢ Griseofulvin is a very insoluble fungistatic drug derived from a species of penicillium.</p>
<p>â€¢ It is only used in the systemic treatment of dermatophytosis.</p>
<p>â€¢ It is administered in a microcrystalline at a dose of 1g per day.</p>
<p>â€¢ Absorption is improved when it is given with fatty foods.</p>
<p>â€¢ Nail infections may require therapy for months to allow regrowth of the new protected nail and is often followed by relapse.</p>
<p>Topical anti fungal</p>
<p>Nystatin</p>
<p>â€¢ Nystatin is a polyene macrolide much like amphotericin B.</p>
<p>â€¢ it is too toxic for parenteral administration and is only used topically</p>
<p>â€¢ nystatin is currently available in creams, ointments, suppositories and other forms for application to skin and mucous membrane.</p>
<p>â€¢ nystatin is active against most candida species and is most commonly used for suppression of local candida infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-mycobacterial-agents-anti-tuberculosis">Anti mycobacterial agents (anti-tuberculosis)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-mycobacterial-agents-anti-tuberculosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The main mycobacterial infection are the tuberculosis and leprosy. The treatment of tuberculosis assumes the principle of combination therapy for two main reasons,
I. To prevent emergency of resistance (tubercle bacilli develops resistant very fast when monotherapy is used).
II. To reduce the rate of spread by reducing bacterial population rapidly.
For this reason the available tablets contain multiple drugs in a fixed dose combination (FDC).</li>
</ul>
<p>anti-TB contiâ€™</p>
<ul>
<li>Anti TB are divided into two first line and second line</li>
</ul>
<p>I. First line; this is not a universal principle but depend on local scientific evidence.</p>
<p>The drugs include isoniazid, ethambutol, pyrazinamide and streptomycin.</p>
<p>ii Second line drugs include capreomycin, cycloserine, clarithromycin and ciprofloxacin</p>
<p>Anti TB cont.â€™</p>
<ul>
<li>First initial phase: takes two months and three drugs are used concomitantly.</li>
<li>These includes Isoniazid (H), Rifampicin (R) Pyrazinamide (Z) plus (Ethambutol or streptomycin) if resistant organism are suspected. This combination reduces bacterial population rapidly.</li>
<li>Continuation phase takes four months and two drugs are used these are isoniazid and rifampicin</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="isoniazid">ISONIAZID<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#isoniazid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Expected Pharmacological Action</li>
<li>This medication is highly specific for mycobacteria. Isoniazid inhibits growth of mycobacteria by preventing synthesis of mycolic acid in the cell wall.</li>
<li>Therapeutic Uses; Indicated for active and latent tuberculosis</li>
<li>Latent: INH only - 6 to 9 months</li>
<li>Active: Multiple medication therapy including INH, for a minimum of 6 months</li>
<li>The initial phase (induction phase) focuses on eradicating the active tubercle bacilli, which will result in non infectious sputum.</li>
<li>The second phase (continuation phase) works toward eliminating any other pathogens in the body.</li>
</ul>
<p>isoniazid cont.â€™</p>
<ul>
<li>Length of treatment varies and may be as short as 6 months for medication-sensitive tuberculosis (2 months for the initial phase and 4 months for the continuation phase) or as long as 24 months for medication-resistant infections.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<ul>
<li>Allergic skin eruptions are the commonest side effects</li>
<li>Others are fever , GIT disturbance</li>
<li>Peripheral neuropathy (tingling, numbness, burning, and pain resulting from deficiency of pyridoxine, vitamin B6 ).</li>
</ul>
<p>Instruct clients to observe for symptoms and to notify the provider if symptoms occur.</p>
<p>Administer 50 to 200 mg of vitamin B6 daily.</p>
<ul>
<li>Hepatotoxicity (anorexia, malaise, fatigue, nausea, and yellowish discoloration of skin and eyes).</li>
</ul>
<p>Instruct clients to observe for symptoms and notify the provider if symptoms occur.</p>
<p>Monitor liver function tests.</p>
<p>Instruct clients to avoid consumption of alcohol.</p>
<p>Medication may need to be discontinued if liver function test results are elevated.</p>
<p>Contraindications/Precautions</p>
<p>INH is contraindicated for clients with liver disease.</p>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>INH inhibits metabolism of phenytoin, leading to buildup of medication and toxicity.</p>
<p>Ataxia and incoordination may indicate toxicity.</p>
<p>Monitor the clientâ€™s levels of phenytoin.</p>
<p>Dosage of phenytoin may need to be adjusted based on phenytoin levels.</p>
<p>Concurrent use of alcohol, rifampin, and pyrazinamide increases the risk for hepatotoxicity.</p>
<p>Instruct clients to avoid alcohol consumption.</p>
<p>Monitor liver function.</p>
<p>Interactions cont.'</p>
<ul>
<li>Induce liver enzymes ,hence affect the metabolism of warfarin, glucocorticoids, narcotics, oral anti diabetes, dapsone and estrogens and oral contraceptives.</li>
<li>Advice clients on oral contraceptives to change method of family planning or use a back up method.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Nursing Administration</p>
<p>â€¢ Administer by oral route</p>
<p>â€¢ For active tuberculosis, direct observation therapy (DOT) is done to ensure adherence.</p>
<p>â€¢ Advise clients to take INH 1 hours before meals or 2 hours after.</p>
<p>â€¢ If gastric discomfort occurs, the client may take INH with meals.</p>
<p>â€¢ Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<p>rifampicin</p>
<ul>
<li>This is one of the most active anti TB .it is also active against gram positive and gram negative bacteria.</li>
<li>Mechanism of action: Rifampin is bactericidal as a result of inhibition of protein synthesis.</li>
<li>Indications:</li>
</ul>
<p>Rifampin is a broad-spectrum antibiotic effective for gram-positive and gram-negative bacteria,</p>
<p>M. tuberculosis, and M. Leprae.</p>
<p>pharmacokinetics</p>
<ul>
<li>Given orally</li>
<li>Has a wide distribution</li>
<li>It causes orange tinge coloration to saliva ,sputum, tears, sweat and urine.</li>
<li>It is excreted in urine and under goes enterohepatic recycling.</li>
<li>Metabolism is in the liver and the metabolites has anti bacterial activity but poorly absorbed from the gut.</li>
<li>Half life is one to five hours but reduces during treatment since it induces microsomal enzymes, hence its own metabolism.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/adverse effects</p>
<p>i) Discoloration of body fluids.</p>
<p>â€¢ Inform clients of expected orange color of urine, saliva, sweat, and tears.</p>
<p>ii)Hepatotoxicity (jaundice, anorexia, and fatigue)</p>
<p>â€¢ Monitor the clientâ€™s liver function.</p>
<p>â€¢ Inform clients regarding symptoms of anorexia, fatigue, and malaise, and instruct them to notify the provider if symptoms occur.</p>
<p>â€¢ Avoid alcohol.</p>
<p>iii) Mild gastrointestinal discomfort associated (anorexia, nausea, and abdominal discomfort.</p>
<p>â€¢ Abdominal discomfort is mild and usually does not require intervention</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Use cautiously in clients with liver dysfunction.</li>
</ul>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Rifampin accelerates metabolism of warfarin (Coumadin), oral contraceptives, protease inhibitors, and NNRTIs (medications for HIV), resulting in diminished effectiveness.</p>
<p>â€¢ Increased dosages of HIV medications may be necessary.</p>
<p>â€¢ Monitor PT (prothrombin time) and INR (international normalized ratio)</p>
<p>â€¢ Clients may need to use alternative form of birth control.</p>
<p>Concurrent use with INH and pyrazinamide increases risk of hepatotoxicity.</p>
<p>â€¢ Instruct clients to avoid alcohol consumption. Monitor liver function.</p>
<p>Nursing Evaluation of Medication Effectiveness</p>
<p>Depending on therapeutic intent, effectiveness may be evidenced by:</p>
<p>â€¢ Improvement of tuberculosis symptoms such as clear breath sounds, no night sweats, increased appetite, no afternoon rises of temperature</p>
<p>â€¢ 3 negative sputum cultures for tuberculosis, usually taking 3 to 6 months to achieve.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ethambutol">ethambutol<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ethambutol" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Pharmacodynamics;</li>
<li>Mechanism of action through inhibiting inhibition of bacterial growth through suppression of RNA synthesis. Resistance emergence occurs rapidly if used on its own.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetic">Pharmacokinetic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>good absorption from GIT.</li>
<li>Metabolism is in the liver.</li>
<li>Excretion in urine.</li>
<li>It can reach therapeutic concentrated with CSF for tuberculosis.</li>
</ul>
<p>Unwanted effects</p>
<p>These are common.</p>
<p>â€¢ Optic neuritis dose related especially if renal function decreases.</p>
<p>this leads to visual disturbances, red/ green color blindness followed by decreased visual acuity.</p>
<p>Monitor color vision in long treatments</p>
<p>Contraindication</p>
<p>â€¢ Patients with known optic neuritis</p>
<p>Patients who are unable to appreciate and report visual side effects or changes in vision e.g.</p>
<p>â€¢ young children and unconscious patients</p>
<p>pyrazinamide</p>
<ul>
<li>It is often inactive in neutral PH.</li>
</ul>
<p>Pharmacodynamics.</p>
<ul>
<li>
<p>its mechanism of action is unknown but it is tuberculostatic at acidic PH.</p>
</li>
<li>
<p>it is very effective against intracellular organism in macrophages since after phagocytosis, in which PH is low.</p>
</li>
</ul>
<p>Pharmacokinetic</p>
<ul>
<li>
<p>it has good gut absorption .</p>
</li>
<li>
<p>it is widely distributed in that it crosses the BBB</p>
</li>
<li>
<p>excreted in the kidneys</p>
</li>
</ul>
<p>DAPSONE</p>
<ul>
<li>pharmacodynamics</li>
<li>DAPSONE is chemically related to sulphonemides and it acts by inhibiting the enzyme dihydrofolate reluctance hence inhibits folate synthesis.</li>
<li>Its action is antagonized by PABA. resistance to this drug</li>
<li>Has increased, hence it â€˜s combined with other drugs during treatment.</li>
<li>Pharmacokinetic</li>
<li>Good oral absorption.</li>
<li>It under goes enteral hepatic recycling.</li>
<li>It has a half life of 24 to 48 hours</li>
<li>it is excreted in feces</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Unwanted effects</p>
<ul>
<li>Hemolysis of white blood cells .</li>
<li>Anorexia , nausea and vomiting.</li>
<li>Fever and allergic dermatitis,</li>
<li>neuropathy</li>
<li>Leprareation where there is exacerbation of lepromatous lesions can occur and a syndrome resembling infectious mononucleosis which can be fatal.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Antiviral agents</p>
<ul>
<li>Viruses present a more difficulty problem of chemotherapy than do higher organisms, e.g. bacteria, for they are intracellular parasites that use the metabolism of the host cells.</li>
<li>Antiviral agents are most active when virus are replicating.</li>
<li>The earlier the treatment is given the better.</li>
<li>Apart from primary infections ,viral illness is often the consequences of reactivation of latent virus in the body.</li>
<li>Patients whose immune system is compromised may suffer particular severe illness.</li>
<li>Viruses are capable of developing resistance.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antiviral-and-antiretroviral-cont">Antiviral and antiretroviral cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiviral-and-antiretroviral-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Drug</th><th>viruses</th><th>Chemical type</th><th>target</th></tr></thead><tbody><tr><td>Non nucleotide reverse</td><td></td><td></td><td></td></tr><tr><td>transcriptase inhibitor.</td><td></td><td></td><td></td></tr><tr><td>(NNRTIs);Nevirapine,</td><td></td><td></td><td></td></tr><tr><td>Delavirdine.</td><td>HIV Virus</td><td>Non nucleotide analogue</td><td>Reverse transcriptase</td></tr><tr><td>protease inhibitors;</td><td></td><td></td><td></td></tr><tr><td>Saquinavir, Ritonavir,</td><td></td><td></td><td></td></tr><tr><td>Indinavir, Nelfinavir.</td><td>HIV virus</td><td>Peptide analogue</td><td>HIV protease</td></tr><tr><td>Ribavirin</td><td>Broad spectrum: HCV, HSV,</td><td></td><td></td></tr><tr><td>Measles, Lasa fever, SARS</td><td>Triazole carboxamide</td><td>RNA mutagen</td><td></td></tr><tr><td>Amantadine/Rimantadine</td><td>Influenza A strains</td><td>Tricyclic amine</td><td>Matrix</td></tr><tr><td>protein/hemagglutinin</td><td></td><td></td><td></td></tr><tr><td>Zanamivir, oseltamivir</td><td></td><td></td><td></td></tr><tr><td>phosphate</td><td>Influenza strains A and B</td><td>Neuraminic acid mimetic</td><td>Neuraminidase inhibitor</td></tr><tr><td>Pleconaril</td><td>picornaviruses</td><td>Small cyclic</td><td>Blocks attachment and</td></tr><tr><td>coating</td><td></td><td></td><td></td></tr><tr><td>Interferons</td><td>Hepatitis B and C virus</td><td>protein</td><td>Cell defense</td></tr></tbody></table>
<table><thead><tr><th>Drug(</th><th>Viruses</th><th>chemical</th><th>Target</th></tr></thead><tbody><tr><td>vidarabine</td><td>herpesvirus</td><td>Nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>acyclovir</td><td>Herpes simplex (HSV)</td><td>Nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>Ganciclovir and valganciclovir</td><td>Cytomegalovirus (CMV)</td><td>nucleoside analogue</td><td>Virus polymerase</td></tr><tr><td>Nucleoside reverse transcriptase inhibitor (NRTI) zidovudine( AZT) didanosine (ddI), zalcitabine (ddC), stavudine (D4T), lamivudine (3TC)</td><td>Retroviruses (HIV)</td><td>Nucleoside analogue</td><td>Reverse transcriptase</td></tr><tr><td>Non nucleotide reverse transcriptase inhibitor (NNRTI) nevirapine and delavirdine</td><td>HIV virus</td><td>Non nucleotide analogue</td><td>Reverse transcriptase</td></tr><tr><td>Protease inhibitors saquinavir, Ritonavir, indinavir, nelfinavir</td><td>HIV virus</td><td>Peptide analogue</td><td>HIV protease</td></tr></tbody></table>
<p>ACYCLOVIR</p>
<ul>
<li>Expected Pharmacological Action</li>
<li>Acyclovir prevents the reproduction of viral DNA and thus interrupts cell replication.</li>
</ul>
<p>Therapeutic Uses</p>
<ul>
<li>Acyclovir is used to treat herpes simplex and varicella-zoster viruses</li>
</ul>
<p>Ganciclovir is used for treatment and prevention of cytomegalovirus (CMV).</p>
<ul>
<li>Prevention therapy using ganciclovir is given for clients who have HIV/AIDS, organ transplants, and other immunocompromised states.</li>
<li>Interferon alfa-2b and lamivudine are used to treat hepatitis.</li>
<li>Oseltamivir is used to treat influenza A and B.</li>
<li>Ribavirin is used to treat respiratory syncytial virus (RSV) and influenza.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Complications Side/Adverse Effects Nursing Interventions/Client education</p>
<p>Acyclovir Phlebitis and inflammation at the site of infusion</p>
<p>â€¢ Rotate IV injection sites.</p>
<p>â€¢ Monitor IV sites for swelling and redness.</p>
<p>Nephrotoxicity</p>
<p>â€¢ Administer acyclovir infusion slowly over 1 hr.</p>
<p>â€¢ Ensure adequate hydration during infusion and 2 hr. after to minimize nephrotoxicity by administering IV fluids and increasing oral fluid intake as prescribed.</p>
<p>Mild discomfort associated with oral therapy (nausea, headache, diarrhea)</p>
<p>â€¢ Observe for symptoms and notify the provider.</p>
<p>Complications Side/Adverse Effects Nursing Interventions/Client education cont.'</p>
<p>Ganciclovir</p>
<p>Granulocytopenia and thrombocytopenia</p>
<p>â€¢ Obtain baseline CBC and platelet count.</p>
<p>â€¢ Administer granulocyte colony-stimulating factors.</p>
<p>â€¢ Monitor WBC, absolute neutrophil, and platelet counts.</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Acyclovir should be used cautiously in clients with renal impairment or dehydration, and clients taking nephrotoxic medications.</p>
<p>â€¢ Ganciclovir is Pregnancy Risk Category C;</p>
<p>â€¢ contraindicated in clients with a neutrophil count below 500/mm3 or platelet counts less than 25,000/mm3, and should be used cautiously in clients with pre-existing low white and platelet counts.</p>
<p>Interactions Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Acyclovir</p>
<p>â€¢ Probenecid may decrease elimination of acyclovir.</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>â€¢ Concurrent use of zidovudine may cause drowsiness.</p>
<p>â€¢ Use with caution</p>
<p>Ganciclovir</p>
<p>â€¢ Cytotoxic medications may cause increased toxicity.</p>
<p>â€¢ Use together with caution.</p>
<p>Nursing Administration</p>
<p>Acyclovir:</p>
<p>For topical administration, advise clients to put on rubber gloves to avoid transfer of virus to other areas of the body.</p>
<p>Administer IV infusion slowly over 1 hr or longer.</p>
<p>Inform clients to expect symptom relief but not cure.</p>
<p>Instruct clients to wash affected area with soap and water 3 to 4 times/day and to keep the lesions dry after washing.</p>
<p>Advise clients to refrain from sexual contact while lesions are present.</p>
<p>Clients with healed herpetic lesions should continue to use condoms to prevent transmission of the virus.</p>
<p>Nursing administration</p>
<p>Ganciclovir</p>
<p>Administer IV infusion slowly, with an infusion pump, over at least 1 hr.</p>
<p>Administer oral medication with food.</p>
<p>Administer intraocular for CMV retinitis.</p>
<p>Instruct clients to complete the prescribed course of antimicrobial therapy, even though symptoms may resolve before the full course is completed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antiretroviral-drugs">Antiretroviral drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiretroviral-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>antiretroviral therapy goal is to delay disease progression and to prolong survival by suppressing the replication of the virus.</li>
<li>Two types of antiretroviral combination are recommended for initial HIV therapy;</li>
</ul>
<ol>
<li>first line ; 1 NNRTI plus 2NRTI.</li>
<li>second line; 1PI plus 2 NRTI.</li>
<li>protease inhibitors are preserved for second line</li>
</ol>
<p>five goals of ART</p>
<ol>
<li>to reduce amount of HIV virus in the body.</li>
<li>Support and restore the immune system.</li>
<li>Improve the quality of life.</li>
<li>Reduce HIV related illness and deaths.</li>
<li>reduce general risk of transmission.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action-of-arvs">Mechanism of action of ARVs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-of-arvs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Block reverse transcriptase to disrupt copying of HIV genetic cord(NRTIs, NNRTIs).</li>
<li>Block protease enzyme, preventing maturation of new virions.(PIs).</li>
<li>Prevent fusion of HIV with cell membranes (fusion inhibitors).</li>
<li>Block CCR5 co receptor (CCR5 antagonist)</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="hiv-life-cycle-targets-for-antivirals">HIV life cycle: Targets for antivirals<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#hiv-life-cycle-targets-for-antivirals" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p><img src="assets/images/image-20251214-a5ff7bde.jpeg" alt="img-57.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="zidovudine-retrovir">ZIDOVUDINE (REtrovir)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#zidovudine-retrovir" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Other Medications:</li>
<li>Didanosine (Videx)</li>
<li>Stavudine (Zerit)</li>
<li>Lamivudine (Epivir)</li>
<li>Abacavir (Ziagen)</li>
</ul>
<p>Combination Medications:
Abacavir, lamivudine zidovudine (Trizivir)
Abacavir, lamivudine (Epzicom)
Lamivudine, zidovudine (Combivir)</p>
<p>Expected Pharmacological Action</p>
<ul>
<li>Reduces HIV symptoms by inhibiting DNA synthesis and thus viral replication.</li>
</ul>
<p>Therapeutic Uses</p>
<ul>
<li>Used to treat HIV infection</li>
<li>Route of Administration: Oral, IV</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Suppressed bone marrow resulting in anemia, agranulocytosis (neutropenia) and thrombocytopenia</p>
<p>â€¢ Monitor CBC and platelets.</p>
<p>â€¢ Advise clients that transfusions may be needed.</p>
<p>Lactic acidosis</p>
<p>â€¢ Monitor for symptoms of lactic acidosis, such as hyperventilation, nausea, and abdominal pain.</p>
<p>â€¢ Pregnancy increases the risk of lactic acidosis.</p>
<p>Nausea, vomiting, diarrhea</p>
<p>â€¢ Clients may take the medication with food to reduce gastric irritation. Monitor fluids and electrolytes.</p>
<p>Hepatomegaly/fatty liver</p>
<p>â€¢ Monitor liver enzymes</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Probenecid, valproic acid, and methadone may increase zidovudine.</p>
<p>â€¢ Reduce dosage</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>Ganciclovir or medications that decrease bone marrow production may further suppress bone marrow.</p>
<p>â€¢ Use together with caution.</p>
<p>Rifampin and ritonavir may reduce zidovudine levels.</p>
<p>â€¢ Adjust dosage if needed.</p>
<p>Phenytoin may alter both medication levels.</p>
<p>â€¢ Monitor medication levels.</p>
<p>Nursing Administration</p>
<ul>
<li>Monitor for bone marrow suppression.</li>
<li>Obtain baseline CBC and platelets at the start of therapy and every 4 weeks.</li>
<li>Anemia may be treated with epoetin alfa or transfusions.</li>
<li>Neutropenia may be treated with colony-stimulating factors.</li>
<li>Advise clients to monitor for fever, sore throat, increased bleeding, bruising or fatigue.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="non-nucleoside-reverse-transcriptase-inhibitors-nnrti-s">Non-nucleoside reverse transcriptase inhibitors (NNRTI s)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#non-nucleoside-reverse-transcriptase-inhibitors-nnrti-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Select medication: delavirdine (Rescriptor), efavirenz (Sustiva)</li>
<li>Other Medications: nevirapine (Viramune), etravirine (Intelence)</li>
<li>Expected Pharmacological Action</li>
<li>NNRTIs act directly on reverse transcriptase to stop HIV reprication</li>
<li>Therapeutic Uses</li>
<li>Primary HIV-1 infection</li>
<li>Often used in combination with other antiretroviral agents to prevent medication resistance</li>
<li>Route of administration:</li>
<li>Oral</li>
<li>Monitor for rash.</li>
</ul>
<p>Complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Rash, which may become serious and lead to Stevenâ€™s-Johnson syndrome</p>
<p>â€¢ Monitor for rash.</p>
<p>â€¢ Treat with diphenhydramine (Benadryl), if prescribed.</p>
<p>â€¢ Notify the provider for fever or blistering.</p>
<p>Flu-like symptoms, headache, fatigue</p>
<p>â€¢ Monitor for adverse reactions.</p>
<p>â€¢ Encourage rest and adequate oral fluid intake</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="contraindications-precautions">Contraindications/Precautions<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contraindications-precautions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>NNRTIs are Pregnancy Risk Category C.</li>
<li>These medications are contraindicated in clients with medication hypersensitivity.</li>
<li>Use with caution in clients who have liver disease.</li>
</ul>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Antacids may decrease absorption of delavirdine.</p>
<p>â€¢ Allow 1 hr. between medications.</p>
<p>NNRTIs may increase effects of amphetamines, antihistamines, calcium channel blockers, ergot alkaloids, quinidine, warfarin, and others.</p>
<p>â€¢ Monitor for medication toxicity.</p>
<p>Rifampin and phenytoin may cause decrease in levels of delavirdine.</p>
<p>â€¢ Do not use together.</p>
<p>Didanosine may reduce both medicationsâ€™ absorption.</p>
<p>Allow 1 hour between medications.</p>
<p>NNRTIs hypotension and changes in vision.</p>
<p>â€¢ may cause increase in sildenafil level.</p>
<p>â€¢ Monitor for Use together with caution.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="protease-inhibitors">Protease inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#protease-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Members of this group are;
ritonavir (Norvir)
Saquinavir (Invirase)
Indinavir (Crixivan)
Amprenavir (Agenerase)
Nelfinavir (Viracept)
Mechanism Of Action
Protease inhibitors act against HIV-1 and HIV-2 to alter and inactivate the virus by inhibiting enzymes needed for HIV replication.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication">Indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Used to treat HIV infections
Should be used with another antiretroviral medication to reduce medication resistance
Route of administration: Oral</p>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>â€¢ Diabetes mellitus/hyperglycemia ; Monitor serum glucose,</p>
<p>Adjust diet and administer anti-diabetic medications as prescribed. Advise clients to monitor for increased thirst and urine output.</p>
<p>â€¢ hypersensitivity reaction;</p>
<p>Monitor for rash.</p>
<p>Notify the provider if rash develops.</p>
<p>â€¢ Nausea and vomiting; Take medication with food to reduce GI effects and increase absorption.</p>
<p>â€¢ Elevated serum lipids</p>
<p>Monitor for hyperlipidemia.</p>
<p>Adjust diet.</p>
<p>â€¢ Thrombocytopenia, leukopenia</p>
<p>Monitor CBC. Monitor for signs of infection (fever, sore throat). Monitor for bleeding, blood in stool and bruising</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medication-food-interactions-nursing-interventions-client-education">Medication/Food Interactions Nursing Interventions/Client Education<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medication-food-interactions-nursing-interventions-client-education" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Ritonavir may cause these medications to accumulate to toxic levels: Bupropion, carbamazepine, diazepam, lidocaine, prednisone clozapine, lovastatin, simvastatin, alprazolam, and ergotamine.
Avoid concurrent use.</li>
<li>Ritonavir may increase medication levels of sildenafil, tadalafil, and vardenafil.
Use with caution. Dosages of these medications may need to be reduced.</li>
<li>Ritonavir decreases levels of ethynyl estradiol in oral contraceptives. Instruct clients to use an alternative form of birth control.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="entry-fusion-inhibitors">Entry/fusion inhibitors<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#entry-fusion-inhibitors" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Enfuvirtide this is the first antiretroviral to target the host cell attachment.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action-pharmacodynamics">Mechanism of action/pharmacodynamics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action-pharmacodynamics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It inhibits fusion of the cellular and viral membranes.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacokinetic">Pharmacokinetic<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacokinetic" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It is give by S.C. injection half life is 4 hours.
adverse effects</li>
<li>Limited to mild injection site reactions</li>
<li>Hypersensitivity and peripheral neuropathy may occur.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="standard-1st-line-regime-for-adults-in-kenya">Standard 1st line regime for adults in Kenya<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#standard-1st-line-regime-for-adults-in-kenya" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Stavudine (D4T)/Zidovudine (AZT)+ Lamivudine (3TC)+ Nevirapine (NVP)</li>
</ul>
<p>OR</p>
<ul>
<li>Stavudine (D4T)/Zidovudine (AZT) + Lamivudine (3TC) + Efavirenz</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="assignment">Assignment<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#assignment" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Find out the standard 1st line and the 2nd line ART regime in children.</p>
<p>ANALGESICS, NON STEROIDAL ANTI INFLAMMATORY DRUGS(NSAIDS)</p>
<ul>
<li>Analgesics may be defined as any member or group of drugs used to achieve analgesia, relief from pain. They relieve pain without causing any loss of consciousness.</li>
<li>Analgesics drug works in various ways on the periphery and the CNS.</li>
<li>NSAIDs are referred to as non narcotic analgesics or non-opioid analgesics.</li>
<li>They differ from opioids in the aspects;
-they are less potent
-fail to produce drowsiness or CNS depression
-non additive in nature
-posses anti inflammatory/antipyretic activities</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nsaids-cont">NSAIDs cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nsaids-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>1st generation NSAIDs (COX-1 and COX-2 inhibitors):</li>
<li>Aspirin</li>
<li>Ibuprofen (Motrin, Advil)</li>
<li>Naproxen (Naprosyn)</li>
<li>Indomethacin (Indocin)</li>
<li>Diclofenac (Voltaren)</li>
<li>Ketorolac (Toradol)</li>
<li>Meloxicam (Mobic)</li>
<li>2nd generation NSAIDs (selective COX-2 Inhibitor):</li>
<li>Celecoxib (Celebrex)</li>
</ul>
<p>Mechanism of action</p>
<p>â€¢ Inhibition of prostaglandin synthase, also known as cox â€” Inhibition of COX-1 can result in decreased platelet aggregation and kidney damage.</p>
<p>â€¢ Inhibition of COX-2 results in decreased inflammation, fever, and pain.</p>
<p>Therapeutic Uses /indication ( analgesic , antipyretic, and anti inflammatory)</p>
<p>â€¢ Inflammation suppression.</p>
<p>â€¢ Analgesia for mild to moderate pain, such as with osteoarthritis and rheumatoid arthritis.</p>
<p>â€¢ Fever reduction.</p>
<p>â€¢ Dysmenorrhea.</p>
<p>â€¢ Inhibition of platelet aggregation, which protects against stroke and myocardial infarction. (aspirin)</p>
<p>â€¢ The exception of acetaminophen which is an analgesic and antipyretic.</p>
<p>Side/Adverse Effects Nursing Interventions/Client Education</p>
<ul>
<li>Gastrointestinal discomfort (dyspepsia, abdominal pain, heartburn, nausea)</li>
<li>Damage to gastric mucosa may lead to GI bleeding and perforation, especially with long-term use. â€¢</li>
<li>Advise clients to take medication with food or with a full glass of water or milk.</li>
<li>Advise clients to avoid alcohol.</li>
<li>Observe for signs of bleeding (passage of black or dark-colored stools, severe abdominal pain, nausea, vomiting).</li>
<li>Administer a proton pump inhibitor, such as omeprazole (Prilosec), or an H2 receptor antagonist, such as ranitidine (Zantac) to decrease the risk of ulcer formation. Use prophylaxis agents such as misoprostol (Cytotec).</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>side/adverse effects cont.â€™</p>
<p>Renal dysfunction (decreased urine output, weight gain from fluid retention, increased BUN and creatinine levels)</p>
<p>â€¢ Use cautiously with older adults and clients who have heart failure.</p>
<p>â€¢ Monitor I&amp;O and kidney function (BUN, creatinine).</p>
<p>Increased risk of heart attack and stroke (non aspirin NSAIDs)</p>
<p>â€¢ Use the smallest effective dose for clients with known cardiovascular disease.</p>
<p>â€¢ Salicylism may occur with aspirin. Signs and symptoms include tinnitus, sweating, headache and dizziness, and respiratory alkalosis.</p>
<p>â€¢ Advise clients to notify the provider and to stop taking aspirin if symptoms occur.</p>
<p>â€¢ Reyer syndrome is rare, but serious in childhood.</p>
<p>â€¢ This occurs when aspirin is used for fever reduction in children who have a viral illness, such as chickenpox or influenza</p>
<p>â€¢ Advise clients to avoid giving aspirin when a child has a viral illness, such as chickenpox or influenza.</p>
<p>Complication and adverse effects cont.'</p>
<p>Aspirin toxicity</p>
<p>â€¢ Aspirin toxicity should be managed as a medical emergency in the hospital.</p>
<p>Therapy includes:</p>
<p>â€¢ Cooling with tepid water.</p>
<p>â€¢ Correction of dehydration and electrolyte imbalance with IV fluids.</p>
<p>â€¢ Reversal of acidosis and promotion of salicylate excretion with bicarbonate.</p>
<p>â€¢ Gastric lavage Activated charcoal may also be given to decrease absorption.</p>
<p>â€¢ Hemodialysis may be indicated.</p>
<p>Contraindications for aspirin and other 1st generation NSAIDs include</p>
<ul>
<li>Pregnancy (Pregnancy Risk Category D)</li>
<li>Peptic ulcer disease</li>
<li>Bleeding disorders such as hemophilia, vitamin K deficiency</li>
<li>Hypersensitivity to aspirin and other NSAIDs</li>
<li>Children with chickenpox or influenza (aspirin)</li>
<li>Use NSAIDs cautiously in older adults, clients who smoke cigarettes, and in clients with H. pylori infection, hypovolemia, asthma, chronic urticaria, and/or a history of alcoholism.</li>
<li>Celecoxib is contraindicated in clients with allergy to sulfonamides.</li>
<li>Ketorolac is contraindicated in clients with advanced renal dysfunction</li>
<li>Use should be no longer than five days because of the risk for kidney damage.</li>
<li>2nd generation NSAIDs should be used cautiously in clients who have known cardiovascular disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="acetaminophen">acetaminophen<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acetaminophen" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="mechanism-of-action">Mechanism Of Action;<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Acetaminophen slows the production of prostaglandins in the central nervous system.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Analgesic (relief of pain) effect</li>
<li>Antipyretic (reduction of fever) effects</li>
</ul>
<p>complications Side/Adverse Effects Nursing Interventions/Client Education</p>
<p>Acute toxicity that results in liver damage with early symptoms of nausea, vomiting, diarrhea, sweating, and abdominal discomfort progressing to, hepatic failure, coma and death</p>
<p>â€¢ Advise clients to take acetaminophen as prescribed and not to exceed 4 g/day.</p>
<p>â€¢ Administer the antidote, acetylcysteine (Mucomyst).</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Use cautiously in clients who consume three or more alcoholic drinks/day and those taking warfarin (interferes with metabolism).</p>
<p>Medication/Food Interactions Nursing Interventions/Client Education</p>
<p>Alcohol increases the risk of liver damage.</p>
<p>â€¢ Advise clients about the potential risk of liver damage with consumption of alcohol.</p>
<p>Acetaminophen slows metabolism of warfarin (Coumadin) leading to increased levels of warfarin.</p>
<p>â€¢ This places clients at risk for bleeding.</p>
<p>â€¢ Instruct clients to observe for signs of bleeding (bruising, petechiae, hematuria).</p>
<p>â€¢ Monitor prothrombin time and INR levels and adjust dosages of warfarin accordingly</p>
<p>Opioid analgesics/narcotic analgesics</p>
<p>â€¢ Opioids are classified as agonists, agonist-antagonists, and antagonist.</p>
<p>Opioid Agonists</p>
<p>â€¢ morphine sulfate</p>
<p>â€¢ Fentanyl (Sublimaze, Duragesic)</p>
<p>â€¢ Meperidine (Demerol)</p>
<p>â€¢ Methadone (Dolophine)</p>
<p>â€¢ Codeine, oxycodone (OxyContin)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Opioid agonist produce analgesia by binding to specific proteinscoupled receptors that are located in the brain and the spinal cord regions involved in the transmission and modulation of pain</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication-therapeutic-uses">Indication/Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication-therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Relief of moderate to severe pain (postoperative, myocardial infarction, cancer)</li>
<li>Sedation</li>
<li>Reduction of bowel motility</li>
<li>Codeine: cough suppression</li>
</ul>
<p>route of administration</p>
<ul>
<li>Morphine sulfate â€“ Oral, subcutaneous, IM, rectal, IV, epidural, and intrathecal</li>
<li>Fentanyl (Sublimaze, Duragesic) â€“ IV, IM, transmucosal and transdermal</li>
<li>Meperidine (Demerol) â€“ Oral, subcutaneous IM, and IV</li>
<li>Codeine â€“ Oral, subcutaneous IM, and IV</li>
<li>Methadone (Dolophine) â€“ Oral, subcutaneous, and IM</li>
<li>Oxycodone (OxyContin) â€“ Oral, rectal</li>
<li>Hydromorphone (Dilaudid) â€“ Oral, subcutaneous, IM, IV</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side/Adverse Effects Nursing Interventions/Client Education (morphine sulphate)</p>
<p>Respiratory depression.</p>
<p>â€¢ Monitor the clientâ€™s vital signs.</p>
<p>â€¢ Stop opioids if the clientâ€™s respiratory rate is less than 12/ min, and then notify the provider.</p>
<p>â€¢ Have naloxone (Narcan) and resuscitation equipment available.</p>
<p>â€¢ Avoid the use of opioids with CNS depressant medications (barbiturates, benzodiazepines, and consumption of alcohol).</p>
<p>Constipation</p>
<p>â€¢ Increased fluid intake and physical activity.</p>
<p>â€¢ Administer a stimulant laxative, such as Bisacodyl (Dulcolax), to counteract decreased bowel motility, or a stool softener, such as docusate sodium (Colace), to prevent constipation.</p>
<p>Side/ adverse effects cont.'</p>
<p>Orthostatic hypotension</p>
<ul>
<li>Advise clients to sit or lie down if symptoms of lightheadedness or dizziness occur.</li>
<li>Avoid sudden changes in position by slowly moving clients from a lying to a sitting or standing position.</li>
<li>Provide assistance with ambulation as needed.</li>
</ul>
<p>Urinary retention</p>
<ul>
<li>Advise clients to void every 4 hr.</li>
<li>Monitor I&amp;O.</li>
<li>Assess the clientâ€™s bladder for distention by palpating the lower abdomen area every 4 to 6 hr. side and adverse effects</li>
</ul>
<p>Adverse effects cont.'</p>
<p>Cough suppression</p>
<p>Advise clients to cough at regular intervals to prevent accumulation of secretions in the airway.</p>
<p>Auscultate the clientâ€™s lungs for crackles, and instruct clients to increase intake of fluid to liquefy secretions.</p>
<p>Sedation</p>
<p>Advise clients to avoid hazardous activities such as driving or operating heavy machinery.</p>
<p>Biliary colic</p>
<p>Avoid giving morphine to clients who have a history of biliary colic. Use meperidine as an alternative.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="emesis">Emesis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#emesis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Administer an antiemetic such as promethazine (Phenergan).</li>
</ul>
<p>Opioid overdose triad of coma, respiratory depression, and pinpoint pupils</p>
<ul>
<li>Monitor the client's vital signs.</li>
<li>Provide mechanical ventilation.</li>
<li>Administer opioid antagonists, such as naloxone (Narcan) or nalmefene (Revex)</li>
</ul>
<p>Contraindications/Precautions</p>
<ul>
<li>Morphine is contraindicated after biliary tract surgery.</li>
<li>Morphine is contraindicated for premature infants during and after delivery because of respiratory depressant effects.</li>
<li>Meperidine is contraindicated for clients with renal failure because of the accumulation of normeperidine, which can result in seizures and neurotoxicity.</li>
</ul>
<p>Use cautiously with: Clients who have asthma, emphysema, and/or head injuries; infants, and older adults.</p>
<p>Use cautiously with:</p>
<ul>
<li>
<p>Clients who have asthma, emphysema, and/or head injuries; infants, and older adult clients (risk of respiratory depression).</p>
</li>
<li>
<p>Clients who are pregnant (risk of physical dependence of the fetus).</p>
</li>
<li>
<p>Clients in labor (risk of respiratory depression in the newborn and inhibition of labor by decreasing uterine contractions)</p>
</li>
<li>
<p>Clients who are extremely obese (greater risk for prolonged side effects because of the accumulation of medication that is metabolized at a slower rate)</p>
</li>
<li>
<p>Clients with inflammatory bowel disease (risk of megacolon or paralytic ileus)</p>
</li>
<li>
<p>Clients with an enlarged prostate (risk of acute urinary retention)</p>
</li>
<li>
<p>Clients with hepatic or renal disease</p>
</li>
<li></li>
</ul>
<p>Opioid agonist-antagonist</p>
<ul>
<li>butorphanol (Stadol)</li>
<li>Nalbuphine hydrochloride (Nubain)</li>
<li>Buprenorphine hydrochloride (Buprenex)</li>
</ul>
<p>Expected Pharmacological Action</p>
<ul>
<li>These medications act as antagonists on mu receptors and agonists on kappa receptors.</li>
</ul>
<p>Compared to pure opioid agonists, agonist-antagonists have:</p>
<ul>
<li>A low potential for abuse causing little euphoria.</li>
<li>In fact, high doses can cause adverse effects (anxiety, restlessness, mental confusion).</li>
<li>Less respiratory depression.</li>
<li>Less analgesic effect.</li>
</ul>
<p>opioid agonist- antagonist</p>
<p>cont.â€™ |</p>
<p>Indication</p>
<p>â€¢ Relief of moderate to severe pain</p>
<p>â€¢ Treatment of opioid dependence (buprenorphine)</p>
<p>â€¢ Adjunct to balanced anesthesia</p>
<p>â€¢ Relief of labor pain (butorphanol)</p>
<p>Route of administration:</p>
<p>â€¢ Butorphanol â€“ IV, IM, intranasal</p>
<p>â€¢ Nalbuphine â€“ IV, IM, subcutaneous</p>
<p>â€¢ Buprenorphine â€“ IV, sublingual, epidural</p>
<p>Side effects</p>
<p>Abstinence syndrome (cramping, hypertension, vomiting )</p>
<p>Sedation respiratory depression</p>
<p>Dizziness</p>
<p>Increased intracranial pressure, headache</p>
<p>Contraindications/Precautions</p>
<p>Use cautiously in clients who have a history of myocardial infarction, renal or liver disease, respiratory depression, or head injury, and clients who are physically dependent on opioids.</p>
<p>Interactions medication/Food Interactions Nursing Interventions/Client Education</p>
<p>â€¢ CNS depressants and alcohol may cause additive effects.</p>
<p>â€¢ Use together cautiously.</p>
<p>â€¢ Monitor respirations.</p>
<p>â€¢ Opioid agonists may antagonize and reduce analgesic effects of the opioid. Do not use concurrently.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="opioid-antagonist">Opioid antagonist<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#opioid-antagonist" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Naloxone (Narcan)</li>
<li>Naltrexone (Re Via, Depade ),</li>
<li>nalmefene (Revex )</li>
</ul>
<p>Mechanism of Action Opioid antagonists interfere with the action of opioids by competing for opioid receptors. Opioid antagonists have no effect in the absence of opioids.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Treatment of opioid overdose Reversal of effects of opioids, such as respiratory depression
Reversal of respiratory depression in an infant</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="route-of-administration">Route of administration:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#route-of-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Naloxone- IM, IV, subcutaneous
nalmefene - IV, IM, subcutaneous
Naltrexone - Oral</p>
<p>Opioid antagonist cont.â€™</p>
<p>Therapeutic Uses</p>
<p>Treatment of opioid overdose Reversal of effects of opioids, such as respiratory depression</p>
<p>Reversal of respiratory depression in an infant</p>
<p>Route of administration:</p>
<p>Naloxone,</p>
<p>nalmefene â€“ IV, IM, subcutaneous</p>
<p>Naltrexone â€“ Oral</p>
<p>Opioid anti-agonist cont.â€™</p>
<p>Side Effects</p>
<p>â€¢ Tachycardia and tachypnea</p>
<p>â€¢ Abstinence syndrome (cramping, hypertension, vomiting)</p>
<p>â€¢ Pulmonary edema</p>
<p>Contraindications/Precautions</p>
<p>â€¢ Opioid antagonists are Pregnancy Risk Category B.</p>
<p>â€¢ These medications are contraindicated in clients with opioid dependency.</p>
<p>Adjuvants medication for pain</p>
<p>â€¢ Tricyclic antidepressants: amitriptyline (Elavil) â€“ oral/IM</p>
<p>â€¢ Anticonvulsants: carbamazepine (Tegretol) â€“ gabapentin (Neurontin) oral</p>
<p>â€¢ CNS stimulants: methylphenidate (Ritalin) â€“ oral</p>
<p>â€¢ Antihistamines: hydroxyzine (Vistaril) â€“ oral/IM</p>
<p>â€¢ Glucocorticoids: dexamethasone (Decadron) â€“ oral, IV, IM</p>
<p>â€¢ Bisphosphonates: etidronate (Didronel) â€“ oral</p>
<p>â€¢ NSAIDs: ibuprofen (Motrin) â€“ oral</p>
<p>â€¢ Other Medication: Tricyclic antidepressants: imipramine (Tofranil) â€“ oral</p>
<p>â€¢ Anticonvulsants: phenytoin (Dilantin) â€“ oral, IV, IM</p>
<p>â€¢ CNS stimulants: dextroamphetamine (Dexedrine) â€“ oral</p>
<p>â€¢ Glucocorticoids: prednisone (Deltasone) â€“ oral</p>
<p>â€¢ Bisphosphonates: pamidronate (Aredia) â€“ IV</p>
<p>â€¢ NSAIDs: ketorolac (Toradol)</p>
<p>Expected Pharmacological Action</p>
<p>â€¢ Adjuvant medications for pain enhance the effects of opioids</p>
<p>Therapeutic Uses</p>
<p>â€¢ These medications are used in combination with opioids and cannot be used as a substitute for opioids.</p>
<p>â€¢ NSAIDs are used to treat inflammation.</p>
<p>â€¢ Tricyclic antidepressants are used to treat depression and neuropathic pain such as cramping, aching, burning, darting, and lancinating pain.</p>
<p>â€¢ Anticonvulsants are used to relieve neuropathic pain.</p>
<p>â€¢ CNS stimulants augment analgesia and decrease sedation.</p>
<p>â€¢ Antihistamines decrease anxiety, prevent insomnia and relieve nausea.</p>
<p>â€¢ Glucocorticoids decrease pain from intracranial pressure and spinal cord compression.</p>
<p>â€¢ Bisphosphonates manage hypercalcemia and bone pain</p>
<p>ANTI HELMINTHIC</p>
<p>â€¢ Benzimidazole (BZAs)</p>
<p>These are broad spectrum anthelmintic agents.</p>
<p>Thiabendazole., Mebendazole and Albendazole have been used extensively for human helminth infections.</p>
<p>â€¢ Other drugs are ;pyrantel pamoate, ivermectin, praziquental, piperazine citrate , benzdiazepines and diethylcarbamazine.</p>
<p>Indication/uses;</p>
<p>Thiabendazole is active against a wide range of nematodes that infect the GI tract but it clinical use has declined due to its toxicity.</p>
<p>Mebendazole is used for the treatment of intestinal roundworm infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthic-cont">Anthelminthic cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthic-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Albendazole is used primarily against a variety of intestinal and tissue nematodes but also against Larva forms of certain cestodes (cysticercosis, hydatidosis)</li>
<li>Used with ivermectin or diethylcarbamazine for control of helminthes</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthics-action">Anthelminthics action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthics-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The BZAs inhibit microtubule polymerization by binding to b-tubulin.</li>
<li>Mebendazole and Albendazole are highly effective in treating the major infections (ascariasis, enterobiasis, trichuriasis, and hookworm)'
-These drugs are active against both larva and adult stages of the nematodes, and they are ovicidal for ascaris and trichuris .
-Immobilization and death of susceptible GI parasites occur slowly and their clearance from the GI tract may not be complete until several days after treatment.
Albendazole is more effective than mebendazole for strongyloidiasis, cystic hydatid disease caused By Echinococcus Granulosus And Neurocysticercosis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anthelminthic-cont">Anthelminthic cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anthelminthic-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The choice of drug depends on specific helminths involved</li>
<li>Example cestodes infestations e.g. echinococcus granulosus the drugs used are thiabendazole, Albendazole, piperazine citrate, pyrantel pamoate, ivermectin and diethylcarbamazine (hetrazan).</li>
</ul>
<p>Absorption, fate, and excretion</p>
<ul>
<li>thiabendazole is absorbed rapidly after oal ingestion and reaches peak plasma concentration after 1 hour. Most of the drug is excreted in urine.</li>
<li>Mebendazole is rapidly metabolized resulting to low systemic bioavailability.</li>
<li>Albendazole is variably absorbed after oral administration, a fatty meal enhances absorption. It is well distributed into various tissues including hydatid cysts. It excreted in urine.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>ANTI PROTOZOA AND ANTIMALARIA</p>
<ul>
<li>The common protozoa infection include;</li>
<li>Amoebiasis ,</li>
<li>trypanosomiasis,</li>
<li>giardiasis,</li>
<li>malaria,</li>
<li>cutaneous and visceral leishmaniasis</li>
<li>Chagas disease,</li>
<li>toxoplasmosis and</li>
<li>trichomoniasis</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="antimalarial">antimalarial<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antimalarial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Examples include; quinine, chloroquine, mefloquine, proguanil, pyrimethamine/sulfadoxine, tetracycline, doxycycline &amp; minocycline, primaquine, and also artemether-Lumefantrine (coartem)</p>
<ul>
<li>The first line treatment of uncomplicated malaria in Kenya is Artemether-Lumefantrine.</li>
<li>The second line treatment for uncomplicated malaria in Kenya is dihydroartemisinic-piperaquine (DHA-PPQ)</li>
<li>This is available in a fixed dose combination with adult tablets containing <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>30</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mn>320</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">30 \mathrm{mg} / 320 \mathrm{mg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">30</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/320</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span></span></span></span></span> of DHA-PPQ</li>
<li>Pediatric tablets containing <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>20</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mn>160</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">20 \mathrm{mg} / 160 \mathrm{mg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">20</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/160</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span></span></span></span></span> of DHA-PPQ</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="dosage-artemether-lumefantrine">Dosage; Artemether Lumefantrine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#dosage-artemether-lumefantrine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>WEGHT IN KG</th><th>AGE IN YEARS</th><th>NUMBER OF TABLETS PER DOSE</th><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr><td></td><td></td><td>day 1</td><td></td><td>day 2</td><td></td><td>day 3</td><td></td></tr><tr><td></td><td></td><td><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>1</mn><mtext>st&nbsp;</mtext></msup></mrow><annotation encoding="application/x-tex">1^{\text {st }}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7936em;"></span><span class="mord"><span class="mord">1</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.7936em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">st&nbsp;</span></span></span></span></span></span></span></span></span></span></span></span></span></span> dose</td><td>8 hours</td><td>24 hours</td><td>36 hours</td><td>48 hours</td><td>60 hours</td></tr><tr><td>5-14</td><td>5/12- 3 years</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>15-24</td><td>3-7 years</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td><td>2</td></tr><tr><td>25-34</td><td>8-11 years</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td><td>3</td></tr><tr><td>Above 34</td><td>Above 12 years</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-malaria-cont">anti-malaria cont.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-malaria-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Other anti-malarial drugs for uncomplicated malaria are;</li>
<li>Amodiaquine plus artesunate</li>
<li>Mefloquine plus artesunate</li>
<li>Halofantrine (halfan) .this drug can cause arrhythmias, and is contraindicated in patients with heart disease.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="quinine">Quinine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#quinine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Quinine is an alkaloid derived from cinchona tree.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indication">Indication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Reserved for severe and complicated malaria.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pharmacodynamics-mechanism-of-action">Pharmacodynamics/mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics-mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>It binds to plasmodium DNA to prevent protein synthesis but its exact mode of action remains uncertain.</li>
<li>It is used to treat plasmodium falciparum in areas of multiple drug resistant.</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Quinine is well absorbed in the gut but absorption is delayed by antacids. It can be given via slow IV Infusion.</li>
<li>Metabolism occurs in the liver, the excretion is in the kidneys.</li>
<li>It is used for the treat of chloroquine resistant P . falciparum often With Combination Of Pyrimethamine/ Sulfadoxine</li>
</ul>
<p>unwanted effects</p>
<ul>
<li>has a low therapeutic widow and it produces effects in the skeletal muscles and can cause; GI irritation, renal damage, hemolytic anemia (rarely)associated with â€œblack water feverâ€ in previously sensitized patients.</li>
<li>black water fever has a fatality rate of 25% due to intravascular coagulation and renal failure.</li>
</ul>
<p>unwanted effects cont.â€™</p>
<p>â€¢ Hypotension</p>
<p>â€¢ Hypoglycemia</p>
<p>â€¢ Cinchonism</p>
<p>Dosage;</p>
<p>Loading dose IV Quinine 20mg/kg body wt. in 500mls of 5% or 10% dextrose (MAX 1200MG) for 4 hours then 10mg/kg body wt. as intravenous infusion in 500mls of 5% or 10% dextrose to run for 4hrs every 8 hourly ( maximum 600mgs)</p>
<p>After 3 IV doses of quinine, one should try to change into oral treatment and treatment should continue for 7 days.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="quinine-cont">quinine cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#quinine-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>for children loading dose is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>20</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">20 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">20</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wt. in <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>15</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">l</mi><mi mathvariant="normal">s</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">15 \mathrm{mls} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">15</span><span class="mord"><span class="mord mathrm">mls</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> of isotonic fluid to run over 4 hours and maintenance dose <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>10</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">10 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">10</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wtin 10mls /kg of isotonic fluids to run over 4 hours every 12 hourly un til the patient can take orally.</li>
<li>Oral quinine is given <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>10</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">g</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">k</mi><mi mathvariant="normal">g</mi></mrow></mrow><annotation encoding="application/x-tex">10 \mathrm{mg} / \mathrm{kg}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">10</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">mg</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm" style="margin-right: 0.01389em;">kg</span></span></span></span></span></span> body wt 8 hourly to complete a total of (parenteral + oral ) 7 days.</li>
</ul>
<p>Prevention of malaria</p>
<ul>
<li>Chemoprophylaxis; mefloquine or atovaquone-proguanil or doxycycline.</li>
<li>Intermittent presumptive treatment (IPT) in recommended for pregnant women in areas of high malaria transmission.</li>
<li>Current recommended IPT medication is sulphadoxine 500mg ,pyrimethamine 25mg given as a dose of 3 tablets.</li>
</ul>
<p>Amoebicidal drugs</p>
<p>metronidazole was covered under azoles antibiotics.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="sedatives-hypnotics">SEDATIVES-HYPNOTICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sedatives-hypnotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Also known as anti anxiety drugs</li>
<li>Sedative hypnotics refers to drugs that depress the CNS activity, relieve anxiety and induce sleep.</li>
<li>effective Sedatives ( anxiolytic ) drug should reduce anxiety and exert a calm effect.</li>
<li>Hypnotics drug should produce drowsiness and encourage the onset and maintenance of a state of sleep.</li>
<li>All sedative hypnotics cross the placenta barrier and may contribute to the depression neonatal vital function.</li>
<li>Sedative-hypnotics are detectable in breast milk and may exert depressant effects in the nursing infant.</li>
</ul>
<p>Classification of sedative hypnotics</p>
<ul>
<li>Benzodiazepines; clonazepam, diazepam, midazolam, lorazepam, triazolam, flurazepam, alprazolam, chlordiazepoxide.</li>
<li>barbiturates; phenobarbital, metharbital, thiopental sodium</li>
<li>Newer generation; zopiclodine, zolpidem.</li>
<li>Miscellaneous; chloral hydrate</li>
<li>B-adrenoreceptor antagonist; Flumezanil</li>
<li>The most commonly used are benzodiazepines and barbiturates medications.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Pharmacological actions</p>
<ul>
<li>Useful predominantly as anticonvulsants, muscle relaxant and in status epilepticus.</li>
<li>Abrupt withdrawal causes precipitation of epileptiform seizures.</li>
<li>They potentiate analgesics .</li>
<li>Wide margin of safety</li>
<li>give rise to drug dependency (abuse liability)</li>
<li>Obliterate moments of sequential events</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacodynamics-of-benzodiazepines-barbiturates-new-hypnotics">Pharmacodynamics of benzodiazepines, barbiturates &amp;new hypnotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacodynamics-of-benzodiazepines-barbiturates-new-hypnotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Molecular pharmacology of GABA (gamma aminobutyric acid) receptor (GABA is an inhibitory neurotransmitter)</li>
<li>The benzodiazepine, barbiturates, zolpidem, zaleplon and other drugs bind to molecular component of GABA, a receptor in neuronal membrane in the CNS. improving the symptoms of sleep disturbance, tremors and muscle tension.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="organ-level-effects">Organ level effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#organ-level-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sedation; exert calming effects with reduction of anxiety at relatively low doses.</li>
<li>Hypnosis; all sedative hypnotics induce sleep if high enough doses are given.</li>
<li>Muscle relaxation</li>
<li>Effects on respiratory and cardiovascular functions especially on patients with pulmonary disease</li>
<li>Anticonvulsant effects e.g. phenobarbitone</li>
<li>anesthesia, e.g. barbiturates thiopental</li>
<li>Tolerance ; psychological &amp; physiological Dependence</li>
</ul>
<p>Clinical uses</p>
<ul>
<li>Insomnia</li>
<li>Sedation and amnesia before and during medical surgical procedures.</li>
<li>Treatment of epilepsy and seizure state.</li>
<li>as a component of balanced anesthesia.</li>
<li>For control of ethanol and other sedative hypnotic withdrawal states.</li>
<li>For muscle relaxation in specific neural muscular disorders</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Direct toxic action</p>
<ul>
<li>relatively low doses may lead to Drowsiness , impaired judgement, diminished motor skills. sometimes with impact on driving, working and personal relationship.</li>
<li>Criminals use BZDs in cases of â€œdate rapeâ€ is based on their dose dependent amnestic effects.</li>
<li>At higher dose toxicity may present as lethargy or state of exhaustion or as gross symptoms equivalent to those of ethanol intoxication.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Benzodiazepines commonly</p>
<p>â€¢ Most commonly used sedatives hypnotics.</p>
<p>MOA exert their action as the other CNS depressants.</p>
<p>Classification</p>
<p>Short acting e.g. midazolam, triazolam, half life five hours.</p>
<p>Intermediate e.g. lorazepam, oxazepam, clonazepam. Half life five to 24 hours.</p>
<p>Long acting e.g. diazepam, chlordiazepoxide, prazepam. Half life 24 hours.</p>
<p>Unwanted effects</p>
<ul>
<li>Daytime drowsiness, ataxia, rebound insomnia on withdrawal</li>
<li>The elderly develop blurred vision, tremors , constipation, and anterograde amnesia.</li>
<li>Respiratory depression which may worsen in COPD</li>
<li>Decrease BP and heart rate.</li>
<li>Paradoxical effects in the first 2 weeks of therapy such as hostility, aggression, excitement, antisocial behavior</li>
<li>cross tolerance with other sedative/hypnotics agents e.g. alcohol/barbiturates.</li>
<li>withdrawal symptoms may develop any time after stopping E.G. anxiety, insomnia, GIT disturbance, tinnitus, perceptual disturbance, lack of appetite and perspiration. treat with flumazenil</li>
</ul>
<p>Contraindication</p>
<ul>
<li>In pregnancy, shock, acute alcohol intoxication and neonatal withdrawal symptoms, in the elderly and during lactation</li>
</ul>
<p>Drug interaction</p>
<ul>
<li>Alcohol plus benzodiazepines cause severe CNS depression.</li>
<li>Cimetidine, disulfiram and oral contraceptives cause increase benzodiazepines effects.</li>
<li>Ranitidine and theophylline decrease benzodiazepine effects.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="barbiturates">barbiturates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#barbiturates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Include;</li>
<li>mephobarbital (mebaral)</li>
<li>pentobarbital (Nembutal)</li>
<li>Phenobarbital (luminal, solfoton)</li>
<li>Amobarbital</li>
<li>Thiopental sodium.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="pharmacological-effects">Pharmacological effects<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pharmacological-effects" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>CNS
I. Depression of CNS
II. Sedative hypnotic
III. Anticonvulsant
IV. General anesthetic (sodium thiopental)
V. Enhance analgesic effect of morphine</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-application">Therapeutic application<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-application" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Sedatives</li>
<li>Hypnotic</li>
<li>Anticonvulsant</li>
<li>pre anesthetic medicament</li>
<li>Potentiate analgesic activity</li>
<li>anti epileptic; phenobarbitone, metharbital</li>
<li>general anesthesia ;thiopental sodium</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="adverse-reaction">Adverse reaction<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#adverse-reaction" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Acute drug dependence</li>
<li>Drug tolerance</li>
<li>Withdrawal symptoms</li>
</ul>
<p>Contraindication
Renal damage
Hepatic ailments
Pulmonary insufficient</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anticonvulsant-ant-seizure-anti-epileptic-medication">anticonvulsant/ant seizure /anti epileptic medication<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anticonvulsant-ant-seizure-anti-epileptic-medication" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Barbiturates: Phenobarbital (Luminal), Primidone (Mysoline) amobarbital, metharbital.</li>
<li>Hydantoins: phenytoin (Dilantin)</li>
<li>Benzodiazepines: Diazepam (Valium), Lorazepam (Ativan)</li>
<li>Carboxamide: Carbamazepine (Tegretol, carbatrol), oxcarbazepine (Trileptal)</li>
<li>Phenyltriazine: Lamotrigine (lamictal)</li>
<li>pyrrolidines: levetiracetam (Keppra)</li>
<li>Succinimides: ethosuximide (zorontin)</li>
<li>Miscellaneous: acetazolamide (Diamox), primidone(mysoline), valproic acid(depakene, Depakote), zonisamide (zonegran)</li>
</ul>
<p>Mechanism of action</p>
<ul>
<li>Unfortunately the mechanism of seizure activity is not well understood.</li>
<li>AEDs control seizure disorders by various mechanisms, which include:</li>
</ul>
<p>âœ“ Slowing the entrance of sodium and calcium back into the neuron and, thus extending the time it takes for the nerve to return to its active state.</p>
<p>âœ“ Suppressing neuronal firing, which decreases seizure activity and prevents propagation of seizure activity into other areas of the brain.</p>
<p>âœ“ Decreasing seizure activity by enhancing the inhibitory effects of gamma butyric acid (GABA.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phenobarbital">Phenobarbital<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phenobarbital" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Phenobarbital is used for partial seizures and generalized tonic clonic seizures.</li>
<li>This medication is not effective against absence seizures.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phenytoin">Phenytoin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phenytoin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>phenytoin effective against all major forms of epilepsy except absence seizures.</li>
<li>Use IV route for status epilepticus.</li>
</ul>
<p>Phenytoin is an ant dysrhythmic.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="carbamazepine">Carbamazepine<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#carbamazepine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Carbamazepine is used for the treatment of partial (simple and complex) seizures, tonic-clonic seizures, bipolar disorder, and trigeminal and glossopharyngeal neuralgias.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-use-cont">Therapeutic use cont.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-use-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Ethosuximide is only indicated for absence seizures.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="valproic-acid">Valproic acid :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#valproic-acid" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Valproic acid is used for partial, generalized, and absence seizures; bipolar disorder; and migraine headaches.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="gabapentin">Gabapentin:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#gabapentin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Gabapentin is used as a single agent for control of partial seizures.</li>
<li>This medication is also used for neuropathic pain and the prevention of migraine headaches.
Diazepam : Diazepam is used in status epilepticus.</li>
</ul>
<p>Adverse drug reaction of anti epileptics/ anticonvulsant medication</p>
<p>â€¢ Almost all cause undesired effects</p>
<p>â€¢ All cross the placenta barrier;</p>
<p>âž¢Cleft lip, cardiac malformation; phenobarbitone, phenytoin.</p>
<p>âž¢Spina bifida; folate deficiency induced by sodium valproate, phenytoin, phenobarbital</p>
<p>phenytoin</p>
<p>â€¢ This is the oldest non sedative anti seizure drug introduced in 1938.</p>
<p>Mechanism of action</p>
<p>It blocks sodium channels and inhibit the generation of rapidly repetitive action potentials.</p>
<p>pharmacokinetics; oral ,IM, IV.</p>
<p>Metabolism; is in the liver.</p>
<p>Side /adverse effects and nursing education</p>
<p>CNS effects (nystagmus, sedation, ataxia, double vision, cognitive impairment)</p>
<p>â€¢ Monitor for symptoms and notify the provider if symptoms occur.</p>
<p>Gingival hyperplasia (softening and overgrowth of gum tissue, tenderness, and bleeding gums)</p>
<p>â€¢ Advise clients to maintain good oral hygiene (dental flossing, massaging gums).</p>
<p>â€¢ Skin rash â€¢ Stop medication if rash develops.</p>
<p>â€¢ Teratogenic (cleft palate, heart defects)</p>
<p>â€¢ Avoid use in pregnancy..</p>
<p>Side /adverse effects and nursing education</p>
<p>Cardiovascular effects (dysrhythmias, hypotension)</p>
<p>â€¢ Administer at slow IV rate and in dilute solution to prevent adverse CV effects.</p>
<p>Endocrine and other effects (coarsening of facial features, hirsutism, and interference with vitamin D metabolism)</p>
<p>â€¢ Instruct clients to report changes.</p>
<p>â€¢ Encourage clients to consume adequate amounts of calcium and vitamin D.</p>
<p>PSYCHOTHRAPEUTIC AGENTS</p>
<ul>
<li>These are antipsychotics, antidepressants and mood stabilizers</li>
</ul>
<p>ANTIDEPRESSANTS</p>
<ul>
<li>Depression is a mood (affective) disorder and is a widespread problem, ranking high among causes of disability.</li>
<li>Clients starting antidepressant medication therapy for depression need to be advised that symptom relief can take 1 to 3 weeks and possibly 2 to 3 months for full benefits to be achieved. Encourage continued adherence.</li>
<li>Clients with major depression may require hospitalization with close observation and suicide precautions until the antidepressant medications reach their peak effect.</li>
</ul>
<p>Antidepressants cont.â€™</p>
<p>Antidepressant mediations are classified into four main groups:</p>
<p>âž¢ Tricyclic antidepressants</p>
<p>âž¢ Selective serotonin reuptake inhibitors (SSRIs)</p>
<p>âž¢ Monoamine oxidase inhibitors (MAOIs)</p>
<p>âž¢ Atypical antidepressant</p>
<p>a)Tricyclic antidepressant;</p>
<p>Amitriptyline (Elavil), Imipramine (Tofranil), Doxepin (Sinequan) , Nortriptyline (Aventyl), Amoxapine (Asendin),</p>
<p>Trimipramine (Surmontil)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Tricyclic antidepressant medications block reuptake of norepinephrine and serotonin in the synaptic space, thereby intensifying the effects of these neurotransmitters.
Therapeutic Uses</li>
<li>Depression</li>
<li>Chronic pain</li>
<li>childhood Enuresis</li>
<li>Obsessive compulsive disorders (clomipramine)</li>
</ul>
<p>Side effects</p>
<ul>
<li>Sedation</li>
<li>Anticholinergic effects
âœ“ Dry mouth
âœ“Blurred vision
âœ“ Photophobia
âœ“ Urinary hesitancy or retention
âœ“ Constipation
âœ“Seizures and impotence</li>
<li>older patients; dizziness, postural hypotension, constipation, delayed micturition, edema, muscle tremors.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Tricyclic overdose</p>
<p>â€¢ Lethal 70 to 80 percent die before reaching the hospital</p>
<p>â€¢ CNS and cardiovascular systems are affected.</p>
<p>â€¢ death results from seizures and dysrhythmias</p>
<p>no specific antidote</p>
<p>âœ“ Decrease drug absorption with activated charcoal</p>
<p>âœ“ Speed elimination by alkalinizing urine</p>
<p>âœ“ Manage seizures and dysrhythmias</p>
<p>âœ“ Basic life support</p>
<p>Drug interactions</p>
<ul>
<li>Antipsychotics and steroids may inhibit TCAs</li>
<li>Aspirin may displace TCAs from binding site</li>
<li>TCAs and alcohol potentiate the effects of each other hence death due to severe respiratory distress.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="b-monoamine-oxidase-inhibitors-maoi-s">b)Monoamine Oxidase Inhibitors (MAOI s)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-monoamine-oxidase-inhibitors-maoi-s" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>phenelzine (Nardil)</li>
<li>Isocarboxazid (Marplan)</li>
<li>Tranylcypromine (Parnate)</li>
<li>Selegiline (Emsam) - transdermal MAOI</li>
</ul>
<p>Mechanism of action;
MAOIs inhibit the MAO enzyme system in the CNS.
Amines ( Norepinephrine, Dopamine And Serotonin) resulting in higher levels in the brain to transmit impulses.</p>
<p>Therapeutic use</p>
<ul>
<li>Highly effective considered second line treatment for depression not responsive to cyclics.</li>
<li>Atypical depression</li>
<li>Bulimia nervosa</li>
<li>Obsessive compulsive disorders (OCD)</li>
</ul>
<p>Side effects</p>
<p>Few side effects most common; orthostatic hypotension.</p>
<p>Tachycardia, dizziness, insomnia, anorexia, blurred vision, palpitation, drowsiness, headache, nausea, impotence</p>
<p>MAOIs overdose</p>
<p>â€¢ Symptoms appear 12 hours after ingestion.</p>
<p>these are; tachycardia, circulatory collapse, seizure, coma.</p>
<p>Treatment;</p>
<p>âž¢gastric lavage</p>
<p>âž¢Urine acidification</p>
<p>âž¢hemodialysis</p>
<p>MAOIs hypertensive crisis and tyramine</p>
<p>â€¢ Ingestion of food/drinks with amino acid tyramine leads to hypertensive crisis, which may lead to cerebral hemorrhage, stroke, coma, or death</p>
<p>â€¢ Avoid foods that contain tyramine;</p>
<p>âž¢aged mature cheese</p>
<p>âž¢Smoked/pickled or aged meat, fish, poultry(herring ,sausages, corned beef, salami, pepperoni).</p>
<p>âž¢Red wine(chianti, sherry, vermouth)</p>
<p>âž¢Italian broad beans (fava).</p>
<p>Contraindications/Precautions</p>
<ul>
<li>MAOIs are Pregnancy Risk Category C.</li>
<li>These medications are contraindicated in clients taking SSRIs and in those with pheochromocytoma, heart failure, cardiovascular and cerebral vascular disease, and severe renal insufficiency.</li>
<li>Use cautiously in clients with diabetes and seizure disorders or those taking TCAs.</li>
<li>Transdermal selegiline is contraindicated for clients taking carbamazepine (Tegretol) or oxcarbazepine (Trileptal), which may increase blood levels of the MAOI.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>c)Selective Serotonin Reuptake Inhibitors (SSRIs)</p>
<p>â€¢ Fluoxetine (Prozac)</p>
<p>â€¢ Citalopram (Celexa)</p>
<p>â€¢ Escitalopram oxalate (Lexapro)</p>
<p>â€¢ Paroxetine (Paxil)</p>
<p>â€¢ Sertraline (Zoloft)</p>
<p>Pharmacodynamics</p>
<p>â€¢ SSRI inhibit the reuptake of only serotonin at the part of the amine pump that is specifically for reuptake of serotonin.</p>
<p>â€¢ This explains why these drugs have lesser unwanted effects compared to TCAs.</p>
<p>â€¢ the drug of choice for Depression.</p>
<p>Therapeutic Uses</p>
<ul>
<li>Major depression</li>
<li>Obsessive compulsive disorders (OCD)</li>
<li>Bulimia nervosa</li>
<li>Premenstrual dysphoric disorders</li>
<li>Panic disorders</li>
<li>Posttraumatic disorder (PTSD)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>pharmacokinetics</p>
<ul>
<li>SSRIs are well absorbed orally</li>
<li>Wide distribution and half life of fifteen to 24 hour but fluoxetine has a half life of 24 to ninety six hours.</li>
<li>They achieve effects within 2 to 4 weeks.</li>
<li>Paroxetine and fluoxetine are not used with TCAs since they inhibit TCA hepatic metabolism</li>
</ul>
<p>Unwanted effects</p>
<p>This include nausea and vomiting, diarrhea, agitation, anorgasmia priapism.</p>
<p>Drug interaction</p>
<ul>
<li>MAOIs, TCAs, and St. Johnâ€™s wort increase the risk of serotonin syndrome.</li>
<li>Fluoxetine can displace warfarin (Coumadin) from bound protein and result in increased warfarin levels.</li>
<li>Fluoxetine can increase the levels of tricyclic antidepressants and lithium.</li>
<li>Fluoxetine suppresses platelet aggregation and thus increases the risk of bleeding when used concurrently with NSAIDs and anticoagulants.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="d-second-generation-antidepressants">d) Second generation antidepressants<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#d-second-generation-antidepressants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Newer</p>
<ul>
<li>Fewer side effects than tricyclic but not superior in overall efficacy or onset of action.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="examples-are">Examples are<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examples-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Trazodone,
Bupropion
Duloxetine</p>
<p>Mechanism of action</p>
<p>â€¢ selective inhibition of serotonin uptake</p>
<p>â€¢ Advantage over tricyclic and MAOIs little or no effect on cardiovascular system.</p>
<p>Therapeutic uses</p>
<p>Depression, bipolar affective disorders, obesity, eating disorders, obsessive compulsive disorders, panic attacks, myoclonus, treatment for various substance abuse problems (bupropion is used for smoking cessation treatment)</p>
<p>Side effects</p>
<ul>
<li>CNS; headache, dizziness, nervousness, insomnia, fatigue and tremors.</li>
<li>GI; nausea, diarrheal, constipation, dry mouth, sweating, sexual dysfunction .</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>ANTIPSYCHOTIC AGENTS/TRANQUILIZERS/NEUROLEPTICS</p>
<p>â€¢ Classification of neuroleptic is based on chemical structure or severity of resulting unwanted effects.</p>
<p>â€¢ Based on unwanted effect;</p>
<p>Conventional (typical, first generation)</p>
<p>Examples;</p>
<p>chlorpromazine, haloperidol, and fluphenazine</p>
<p>Newer (atypical, second generation)</p>
<p>Example; clozapine, loxapine, asenapine, olanzapine, quetiapine, paliperidone, risperidone, sertindole.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="classification-cont">Classification cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>The distinction between typical and atypical neuroleptic is not clear but rest on ; receptor profile , incidence of extrapyramidal effects which are less in the atypical group, efficacy in treatment and efficacy in negative symptoms.
Classification according to chemical structures;
Phenothiazines; chlorpromazine 100 to 1500 mg , trifluoperazine, fluphenazine 1 to 10 mg
Butyrophenones; haloperidol 2 to 20 mg
Dibenzodiazepine; clozapine 25 to 900 mg
Thienobenzodiazepines; olanzapine
Thioxanthene's; flupentixol 6 to 18 mg
Benzisoxazole; risperidone 1to 12mg</li>
</ul>
<p>Pharmacodynamics</p>
<ul>
<li>They act by blocking the dopamine receptor.</li>
</ul>
<p>Indication</p>
<ul>
<li>Treatment of acute and chronic psychosis</li>
<li>Schizophrenia</li>
<li>Bipolar disorders (primarily the manic phase)</li>
<li>Touretteâ€™s syndrome</li>
<li>Delusional and schizoaffective disorders</li>
<li>Dementia</li>
<li>Prevention of nausea/vomiting through blocking of dopamine in the chemoreceptor trigger zone of the medulla</li>
<li>hiccups</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Side effects typical antipsychotic</p>
<ul>
<li>Extrapyramidal effects (dystonia, parkinsonism, tardative dyskinesia)</li>
<li>Anticholinergic effects; (dry mouth, blurred vision, urinary retention, constipation and impotence)</li>
<li>Cardiovascular effects; tachycardia, arrhythmias, postural hypotention</li>
<li>Galactorrhea,</li>
<li>gynecomastia</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="side-effect-atypical-antipsychotics">Side effect atypical antipsychotics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#side-effect-atypical-antipsychotics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Clozopine; weight gain, agranulocytosis</li>
<li>Risperidone; insomnia anxiety, agitation</li>
<li>Olanzapine; weight gain, dizziness, sedation, anticholinergic effect</li>
</ul>
<p>Mood stabilizers</p>
<p>lithium carbonate</p>
<p>Expected Pharmacological Action</p>
<p>Lithium produces neurochemical changes in the brain, including serotonin receptor blockade.</p>
<p>There is evidence that the use of lithium can show a decrease in neuronal atrophy and/or an increase in neuronal growth.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Lithium is used in the treatment of bipolar disorders. Lithium controls episodes of acute mania, helps prevent the return of mania or depression, and decreases the incidence of suicide.</li>
<li>Other uses:</li>
<li>Alcoholism</li>
<li>Bulimia</li>
<li>Schizophrenia</li>
</ul>
<p>pharmacokinetics</p>
<ul>
<li>Absorption :rate and extent vary with dose form. absorption is complete within hours of oral use.</li>
<li>Distribution :wide distribution in the body, concentration in thyroid gland, bone and brain tissue exceed serum levels.</li>
<li>Metabolism :not metabolized</li>
<li>Excretion : excreted unchanged in urine. Half lif18 hours (adolescence)to 3 hour (elderly).</li>
</ul>
<p>Dosage adults :300mg to six hundred mg up to q.i.d increasing to achieve optimal dosage.</p>
<p>Adverse reaction</p>
<ul>
<li>Gastrointestinal distress (nausea, diarrhea, abdominal pain).</li>
<li>Fine hand tremors that can interfere with purposeful motor skills and can be exacerbated by factors such as stress and caffeine.</li>
<li>Polyuria, mild thirst.</li>
<li>Weight gain</li>
<li>Renal toxicity</li>
</ul>
<p>Goiter and hypothyroidism with long-term treatment Brady dysrhythmia, hypotension, and electrolyte imbalances .</p>
<p>Contraindications/Precautions</p>
<ul>
<li>Lithium is Pregnancy Risk Category D. This medication is teratogenic, especially during the first trimester.</li>
<li>Discourage clients from breastfeeding if lithium therapy is necessary.</li>
<li>Use cautiously in clients with renal dysfunction, heart disease, sodium depletion, and dehydration</li>
</ul>
<p>Medication/Food Interactions</p>
<ul>
<li>Sodium is excreted with the use of diuretics. Reduced serum sodium decreases lithium excretion, which can lead to toxicity.</li>
<li>Concurrent use of NSAIDs (ibuprofen [Motrin] and celecoxib [Celebrex]) will increase renal reabsorption of lithium, leading to toxicity.</li>
</ul>
<p>Avoid use of NSAIDs.</p>
<p>Use aspirin as a mild analgesic.</p>
<ul>
<li>Anticholinergics (antihistamines, tricyclic antidepressants) can induce urinary retention and polyuria, leading to abdominal discomfort</li>
<li>Advise clients to avoid medications with anticholinergic effects. rt.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="nursing-administration">Nursing Administration<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#nursing-administration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Monitor plasma lithium levels while undergoing treatment. At initiation of treatment, monitor levels every 2 to 3 days and then every 1 to 3 months. Lithium blood levels should be obtained in the morning, usually 12 hr . after the last dose.</li>
<li>During initial treatment of a manic episode, levels should be between 0.8 to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.4</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.4 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.4</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span>.</li>
<li>Maintenance level range is between 0.4 to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.0</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.0 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.0</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span>.</li>
<li>Plasma levels &gt; <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>1.5</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">E</mi><mi mathvariant="normal">q</mi></mrow><mi mathvariant="normal">/</mi><mi mathvariant="normal">L</mi></mrow><annotation encoding="application/x-tex">1.5 \mathrm{mEq} / \mathrm{L}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1.5</span><span class="mord"><span class="mord mathrm">mEq</span></span><span class="mord">/</span><span class="mord mathrm">L</span></span></span></span></span> can result in toxicity.</li>
<li>Care for clients who have a toxic plasma lithium level in an inpatient setting and provide supportive measures. Hemodialysis may be indicated.</li>
<li>Advise clients that effects begin within 7 to 14 days.</li>
</ul>
<p>Nursing administration cont.â€™</p>
<ul>
<li>Advise clients to take lithium as prescribed. Lithium must be administered in 2 to 3 doses daily due to a short half life. Taking lithium with food will help decrease GI distress.</li>
<li>Encourage clients to adhere to laboratory appointments needed to monitor lithium effectiveness and adverse effects. Emphasize the high risk of toxicity due to the narrow therapeutic range.</li>
<li>Provide nutritional counseling. Stress the importance of adequate fluid and sodium intake.</li>
<li>Instruct clients to monitor for signs of toxicity and when to contact the provider. Clients should stop taking medication and seek medical attention if experiencing diarrhea, vomiting, or excessive sweating.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="other-mood-stabilizing-drugs">Other mood stabilizing drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#other-mood-stabilizing-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Carbamazepine (Tegretol)</li>
<li>Valproic acid (Depakote)</li>
<li>Lamotrigine (Lamictal) Purpose</li>
</ul>
<p>Expected Pharmacological Action: AEDs help treat and manage bipolar disorders by various mechanisms, which include:</p>
<ul>
<li>Slowing the entrance of sodium and calcium back into the neuron and, thus extending the time it takes for the nerve to return to its active state.</li>
<li>Potentiating the inhibitory effects of gamma butyric acid (GABA)</li>
<li>Inhibiting glutamic acid (glutamate) which in turn suppresses CNS excitation</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="therapeutic-uses">Therapeutic Uses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Treatment of manic and depressive episodes, prevention of relapse of mania and depressive episodes.</li>
<li>Especially useful for clients with mixed mania and rapid cycling bipolar disorders.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cns-stimulants">CNS STIMULANTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cns-stimulants" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>MEDICATION</th><th>SHORT ACTING</th><th>INTERMEDIATE ACTING</th><th>LONG ACTING</th></tr></thead><tbody><tr><td>Methylphenidate</td><td>Ritalin, Methylin</td><td>Ritalin SR, Methylin ER</td><td>ethylin ER Ritalin LA,</td></tr><tr><td>Concerta, Daytrana</td><td></td><td></td><td></td></tr><tr><td>(transdermal)</td><td></td><td></td><td></td></tr><tr><td>Dexmethylphenidate</td><td>Focalin</td><td></td><td></td></tr><tr><td>Dextroamphetamine</td><td>Dexedrine</td><td></td><td>Dexedrine Spansule</td></tr><tr><td>Amphetamine mixture</td><td>Adderall</td><td></td><td>Adderall-XR</td></tr></tbody></table>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="cns-stimulants-cont">CNS stimulants cont.'<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cns-stimulants-cont" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="expected-pharmacological-action">Expected Pharmacological Action :<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#expected-pharmacological-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These medications raise the levels of norepinephrine, serotonin, and dopamine into the CNS.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="therapeutic-uses">Therapeutic Uses:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#therapeutic-uses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>ADHD ( Attention Deficit Hyperactivity Disorder)</li>
<li>Conduct disorder</li>
</ul>
<p>Side effects</p>
<ul>
<li>CNS stimulation (insomnia, restlessness)</li>
<li>Weight loss</li>
<li>Cardiovascular effects (dysrhythmias, chest pain, high blood pressure)</li>
<li>These medications may increase the risk of sudden death in clients with heart abnormalities.</li>
<li>Development of psychotic symptoms such as hallucinations, paranoia Withdrawal reaction.</li>
<li>Hypersensitivity skin reaction to transdermal methylphenidate (hives, papules)</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Contraindications/Precautions</p>
<ul>
<li>These medications are contraindicated in clients who have a history of drug abuse, cardiovascular disorders, severe anxiety, and psychosis.</li>
</ul>
<p>Medication/Food Interactions:</p>
<p>Concurrent use of MAOI s may cause hypertensive crisis.</p>
<p>Concurrent use of caffeine may increase CNS stimulant effects.</p>
<p>Methylphenidate inhibits metabolism of phenytoin (Dilantin), warfarin (Coumadin), and phenobarbital, leading to increased serum levels.</p>
<p>OTC cold and decongestant medications with sympathomimetic action can increase CNS stimulant effects.</p>
<p>Nursing Administration</p>
<ul>
<li>
<p>Advise clients to swallow sustained-release tablets whole and to not chew or crush the tablets.</p>
</li>
<li>
<p>Teach clients the importance of administering the medication on a regular schedule.</p>
</li>
<li>
<p>Teach clients who use transdermal medication (Daytrana) to place the patch on one hip daily in the morning and leave it in place no longer than 9 hr. Alternate hips daily.</p>
</li>
<li>
<p>Instruct parents and clients that ADHD is not cured by medication and should be managed with an overall treatment plan that may include family therapy and cognitive therapy.</p>
</li>
<li>
<p>Instruct parents that these medications have special handling procedures controlled by federal law. Handwritten prescriptions are required for medication refills.</p>
</li>
<li>
<p>Instruct parents in safety and storage of medications.</p>
</li>
<li></li>
</ul>
<p>MUSCLE RELAXANT/NEUROMUSCULAR BLOCKING AGENTS</p>
<p>â€¢ Neuromuscular blocking agents have various uses including assisting with:</p>
<p>âœ“ sedation during general anesthesia,</p>
<p>âœ“ control of seizures during electroconvulsive therapy,</p>
<p>âœ“ suppression of gag reflex during endotracheal intubation.</p>
<p>â€¢ Medications include succinylcholine (Anectine) and vecuronium (Norcuron)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="anti-parkinson-s-drugs">Anti -Parkinson's drugs<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#anti-parkinson-s-drugs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Neuromuscular agents cont.'</p>
<p>Muscle relaxants and antispasmodic agents can affect both the central and peripheral nervous systems.</p>
<ul>
<li>
<p>These agents are used with spasticity related to muscle injury, cerebral palsy, spinal cord injury, and multiple sclerosis.</p>
</li>
<li>
<p>Agents include diazepam (Valium), baclofen (Lioresal), and dantrolene (Dantrium).</p>
</li>
<li>
<p>Bethanechol (Urecholine), a muscarinic agonist, is used for urinary retention.</p>
</li>
<li>
<p>Oxybutynin (Ditropan), a muscarinic antagonist, is used for neurogenic bladder</p>
</li>
<li></li>
</ul>
<p>Muscle relaxant/ Neuromuscular Blocking Agents cont.â€™</p>
<p>Depolarizing neuromuscular blocker: succinylcholine (Anectine)</p>
<p>Nondepolarizing neuromuscular blockers: pancuronium (Pavulon)</p>
<p>Other Medications:</p>
<p>Nondepolarizing neuromuscular blockers: atracurium (Tracrium), Vecuronium (Norcuron)</p>
<p>Expected Pharmacological Action</p>
<p>Neuromuscular blocking agents block acetylcholine (ACh) at the neuromuscular junction, resulting in muscle relaxation and hypotension. They do not cross the blood-brain barrier, so complete paralysis can be achieved without loss of consciousness or decreased pain sensation.</p>
<p>Neuromuscular agents cont.'</p>
<p>Therapeutic Uses</p>
<p>â€¢ Neuromuscular blocking agents are used as adjuncts to general anesthesia to promote muscle relaxation.</p>
<p>â€¢ These agents are used to control spontaneous respiratory movements in clients receiving mechanical ventilation.</p>
<p>â€¢ These agents are used as seizure control during electroconvulsive therapy.</p>
<p>â€¢ Neuromuscular blocking agents are used during endotracheal intubation and endoscopy</p>
<p>Side effect</p>
<ul>
<li>Respiratory arrest from paralyzed respiratory muscles</li>
<li>Hypotension</li>
<li>Low pseudo cholinesterase activity can lead to prolonged apnea</li>
<li>Signs of malignant hyperthermia include muscle rigidity accompanied by increased temperature, reaching levels as high as 43Â° C (109.4Â° F).</li>
<li>After 12 to 24 hr. postoperative, clients may experience muscle pain in the upper body and back.</li>
<li>Hyperkalemia</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<p>Drug interaction</p>
<p>General anesthetics are often used concurrently in surgery.</p>
<p>â€¢ Dosage of tubocurarine should be reduced to prevent extreme neuromuscular blockade.</p>
<p>Aminoglycosides and tetracyclines can increase the effects of neuromuscular blockade.</p>
<p>â€¢ Take complete medication history of clients who are to receive neuromuscular blockade.</p>
<p>Neostigmine and other cholinesterase inhibitors increase the effects of depolarizing neuromuscular blockers, such as succinylcholine.</p>
<p>â€¢ Monitor clients during neuromuscular blockade reversal after surgery</p>
<p>Nursing Administration</p>
<ul>
<li>Clients must receive continuous cardiac and respiratory monitoring during therapy.</li>
<li>Monitor clients for respiratory depression and have life support equipment available.</li>
<li>Carefully monitor clients for return of respiratory function.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id=""><span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="local-anaesthetics">LOCAL ANAESTHETICS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-anaesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>local anesthetic bind reversibly to a specific receptor site within the pore of the sodium channels in nerves and block ion movement when applied locally to nerve tissues in appropriate concentration.</li>
<li>Local anesthetic can act on any part of the nervous system, on every type of nerve fibers, reversibly blocking the action potentials responsible for nerve conduction.</li>
<li>Thus a local anesthetic in contact with a nerve trunk can cause both sensory and motor paralysis in the area innervated.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="mechanism-of-action">Mechanism of action<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#mechanism-of-action" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ul>
<li>Local anesthetic block conduction by decreasing or preventing the large transient increase in the permeability of excitable membranes.</li>
<li>This action is due to direct interaction with voltage gated sodium channels.</li>
<li>As the anesthetic action progressively develops in the nerve ,the threshold for electrical excitability increase. The rate of rise of the action potential also declines, impulse conduction slows, and nerve conduction eventually fails</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="local-anesthetics">Local anesthetics<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#local-anesthetics" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<table><thead><tr><th>Drug</th><th>Duration of action</th></tr></thead><tbody><tr><td>lidocaine</td><td>medium</td></tr><tr><td>Bupivacaine (Marcaine),levobupivacaine (chirocaine)</td><td>long</td></tr><tr><td>Ropivacaine (naropin)</td><td>long</td></tr><tr><td>Mepivacaine (carbocaine, isocaine)</td><td>medium</td></tr><tr><td>articaine</td><td>medium</td></tr><tr><td>benzocaine</td><td>Surface use only</td></tr><tr><td>Tetracaine (pontocaine)</td><td>long</td></tr><tr><td>Cocaine</td><td>medium</td></tr><tr><td>Procaine</td><td>short</td></tr></tbody></table></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>